WorldWideScience

Sample records for boosting high-intensity focused

  1. Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation

    Directory of Open Access Journals (Sweden)

    Zhong Pei

    2010-01-01

    Full Text Available Abstract Background The conventional treatment protocol in high-intensity focused ultrasound (HIFU therapy utilizes a dense-scan strategy to produce closely packed thermal lesions aiming at eradicating as much tumor mass as possible. However, this strategy is not most effective in terms of inducing a systemic anti-tumor immunity so that it cannot provide efficient micro-metastatic control and long-term tumor resistance. We have previously provided evidence that HIFU may enhance systemic anti-tumor immunity by in situ activation of dendritic cells (DCs inside HIFU-treated tumor tissue. The present study was conducted to test the feasibility of a sparse-scan strategy to boost HIFU-induced anti-tumor immune response by more effectively promoting DC maturation. Methods An experimental HIFU system was set up to perform tumor ablation experiments in subcutaneous implanted MC-38 and B16 tumor with dense- or sparse-scan strategy to produce closely-packed or separated thermal lesions. DCs infiltration into HIFU-treated tumor tissues was detected by immunohistochemistry and flow cytometry. DCs maturation was evaluated by IL-12/IL-10 production and CD80/CD86 expression after co-culture with tumor cells treated with different HIFU. HIFU-induced anti-tumor immune response was evaluated by detecting growth-retarding effects on distant re-challenged tumor and tumor-specific IFN-γ-secreting cells in HIFU-treated mice. Results HIFU exposure raised temperature up to 80 degrees centigrade at beam focus within 4 s in experimental tumors and led to formation of a well-defined thermal lesion. The infiltrated DCs were recruited to the periphery of lesion, where the peak temperature was only 55 degrees centigrade during HIFU exposure. Tumor cells heated to 55 degrees centigrade in 4-s HIFU exposure were more effective to stimulate co-cultured DCs to mature. Sparse-scan HIFU, which can reserve 55 degrees-heated tumor cells surrounding the separated lesions, elicited an

  2. Treatment with high intensity focused ultrasound: Secrets revealed

    International Nuclear Information System (INIS)

    For many decades open surgery remained the only way available for local control of body tumors. In order to decrease the patients’ morbidity and mortality several image guided minimally invasive procedures have been adopted. High intensity focused ultrasound (HIFU) is an extracorporeal non invasive method for tumor ablation. High intensity ultrasonic waves can be focused to a focal point resulting in lethal elevation of the temperature at the target site with consequent damage of the tumoral cells. The advances in HIFU technology during the past two decades expanded the HIFU applications to include ablation of both benign and malignant tumors with different treatment strategies being implemented for each type. The aim of this review is to introduce the reader to the details of the treatment process including pretreatment preparation, treatment planning, different ablation strategies, patients’ after care as well as the follow up regimens for the most common HIFU applications.

  3. High-Intensity Focused Ultrasound Therapy: an Overview for Radiologists

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Young Sun; Rhim, Hyun Chul; Lim, Hyo Keun; Choi, Dong Il [Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea, Republic of); Choi, Min Joo [College of Medicine, Cheju National University, Jeju (Korea, Republic of)

    2008-08-15

    High-intensity focused ultrasound therapy is a novel, emerging, therapeutic modality that uses ultrasound waves, propagated through tissue media, as carriers of energy. This completely non-invasive technology has great potential for tumor ablation as well as hemostasis, thrombolysis and targeted drug/gene delivery. However, the application of this technology still has many drawbacks. It is expected that current obstacles to implementation will be resolved in the near future. In this review, we provide an overview of high-intensity focused ultrasound therapy from the basic physics to recent clinical studies with an interventional radiologist's perspective for the purpose of improving the general understanding of this cutting-edge technology as well as speculating on future developments

  4. High intensity focused ultrasound in clinical tumor ablation

    OpenAIRE

    Zhou, Yu-Feng

    2011-01-01

    Recent advances in high intensity focused ultrasound (HIFU), which was developed in the 1940s as a viable thermal tissue ablation approach, have increased its popularity. In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well-defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft-tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio- and chemo-therapy, HIFU has the ad...

  5. Salvage radiotherapy after high intensity focused ultrasound for prostate cancer

    OpenAIRE

    Dickinson, Peter; Sundar, Santhanam

    2012-01-01

    High-intensity focused ultrasound (HIFU) is a technique that has been used to treat localised prostate cancer. There is no standard treatment for patients who relapse with prostate cancer following primary treatment with HIFU; here we report the case of a patient who was successfully treated with external beam radiotherapy for disease relapse following HIFU. To date, our patient remains disease free with no toxicity from his treatment.

  6. High-Intensity Focused Ultrasound Therapy: an Overview for Radiologists

    OpenAIRE

    Kim, Young-sun; Rhim, Hyunchul; Choi, Min Joo; Lim, Hyo Keun; Choi, Dongil

    2008-01-01

    High-intensity focused ultrasound therapy is a novel, emerging, therapeutic modality that uses ultrasound waves, propagated through tissue media, as carriers of energy. This completely non-invasive technology has great potential for tumor ablation as well as hemostasis, thrombolysis and targeted drug/gene delivery. However, the application of this technology still has many drawbacks. It is expected that current obstacles to implementation will be resolved in the near future. In this review, w...

  7. Use of High Intensity Focused Ultrasound for Treating Malignant Tumors

    Institute of Scientific and Technical Information of China (English)

    WenzhiChen; ZhibiaoWang; FengWu; JinBai; HuiZhu; JianzhongZou; KequanLi; FanglinXie; ZhilongWang

    2004-01-01

    OBJECTIVE To investigate the efficacy and side effects of high intensity focused ultrasound(HIFU) in the treatment of malignant solid tumors. METHODS Thirty patients who refused surgery and/or were refractory to chemotherapy were treated by HIFU alone, with the efficacy and side effects monitored as follows: observation of vital organ signs; functional assay of important organs; imaging examinations including: digital subtraction angiography (DSA), CT, MRI, single photon emission computed tomography (SPECT), large core needle biopsy, complications and metastasis. RESULTS After HIFU therapy, the vital signs remained stable and the functions of the heart, lung, kidney and liver were also normal. DSA images showed that small or larger arteries were not damaged. After a follow-up of 10-38 months(mean 23.1 months), 26 patients(87%) were alive. The volume of the tumor underwent complete regression in 10 patients. Shrinkage of the tumor volume ≥50% was observed in 13 patients. Eight of 13 patients were examined by large core needle biopsy, all showing necrosis and/or fibrosis though 3 patients(10%) had local recurrence. Two of these were retreated again by HIFU and the locally recurrent tumors were controlled. New metastases developed in 5 patients after H IFU. Two patients suffered from peripheral nerve injuriy and they have recovered during the follow-up. One patient developed skin injury. CONCLUSION High intensity focused ultrasound is effective and safe in the treatment of malignant solid tumors.

  8. High-Intensity Focused Ultrasound in Small Renal Masses

    Directory of Open Access Journals (Sweden)

    Eduardo Solsona Narbón

    2008-12-01

    Full Text Available High-intensity focused ultrasound (HIFU competes with radiofrequency and cryotherapy for the treatment of small renal masses as a third option among ablative approaches. As an emerging technique, its possible percutaneous or laparoscopic application, low discomfort to the patient and the absence of complications make this technology attractive for the management of small renal masses. This manuscript will focus on the principles, basic research and clinical applications of HIFU in small renal masses, reviewing the present literature. Therapeutic results are controversial and from an clinical view, HIFU must be considered a technique under investigation at present time. Further research is needed to settle its real indications in the management of small renal masses; maybe technical improvements will certainly facilitate its use in the management of small renal masses in the near future.

  9. Blood coagulation using High Intensity Focused Ultrasound (HIFU)

    Science.gov (United States)

    Nguyen, Phuc V.; Oh, Junghwan; Kang, Hyun Wook

    2014-03-01

    High Intensity Focused Ultrasound (HIFU) technology provides a feasible method of achieving thermal coagulation during surgical procedures. One of the potential clinical benefits of HIFU can induce immediate hemostasis without suturing. The objective of this study was to investigate the efficiency of a HIFU system for blood coagulation on severe vascular injury. ngHIFU treatment was implemented immediately after bleeding in artery. The ultrasound probe was made of piezoelectric material, generating a central frequency of 2.0 MHz as well as an ellipsoidal focal spot of 2 mm in lateral dimension and 10 mm in axial dimension. Acoustic coagulation was employed on a perfused chicken artery model in vitro. A surgical incision (1 to 2 mm long) was made with a scapel on the arterial wall, and heparinized autologous blood was made to leak out from the incision with a syringe pump. A total of 5 femoral artery incisions was treated with the HIFU beam. The intensity of 4500 W/cm2 at the focus was applied for all treatments. Complete hemostasis was achieved in all treatments, along with the treatment times of 25 to 50 seconds. The estimated intraoperative blood loss was from 2 to 5 mL. The proposed HIFU system may provide an effective method for immediate blood coagulation for arteries and veins in clinical applications.

  10. Treatment of Acne Scars With High Intensity Focused Radio Frequency.

    Science.gov (United States)

    Ibrahimi, Omar A; Weiss, Robert A; Weiss, Margaret A; Halvorson, Christian R; Mayoral, Flor; Ross, E Victor; Cohen, Joel L

    2015-09-01

    In this multi-site case series, the efficacy of high intensity focused radiofrequency (RF) delivered to the dermis was evaluated for treating acne scars. A novel delivery system that uses insulated microneedles to deliver a desired thermal effect to multiple depths of the dermis while sparing the epidermis from RF injury was used. Four (4) healthy subjects from four different practices were evaluated and used in this case report. The subjects were treated between 3 or 4 times depending on the severity of the acne scars presented. The depth of thermal delivery was adjusted before each pass and all subjects received at a minimum, three passes to the treated area. Before and after photographs along with adverse effects were recorded. The theory behind the use of insulated needles with the active RF delivery at the distal tip is to allow for significant thermal injury to several layers of the dermis while avoiding thermal injury to the epidermis. This case report demonstrates significant improvement on acne scars and that all skin types should be safely treatable with minimum downtime realized. PMID:26355629

  11. Development of a High Intensity Focused Ultrasound (HIFU) Hydrophone System

    International Nuclear Information System (INIS)

    The growing clinical use of High Intensity Focused Ultrasound (HIFU) has driven a need for reliable, reproducible measurements of HIFU acoustic fields. We have previously presented data on a reflective scatterer approach, incorporating several novel features for improved bandwidth, reliability, and reproducibility [Proc. 2005 IEEE Ultrasonics Symposium, 1739-1742]. We now report on several design improvements which have increase the signal to noise ratio of the system, and potentially reduced the cost of implementation. For the scattering element, we now use an artificial sapphire material to provide a more uniform radiating surface. The receiver is a segmented, truncated spherical structure with a 10 cm radius; the scattering element is positioned at the center of the sphere. The receiver is made from 25 micron thick, biaxially stretched PVDF, with a Pt-Au electrode on the front surface. In the new design, a specialized backing material provides the stiffness required to maintain structural stability, while at the same time providing both electrical shielding and ultrasonic absorption. Compared with the previous version, the new receiver design has improved the noise performance by 8-12 dB; the new scattering sphere has reduced the scattering loss by another 14 dB, producing an effective sensitivity of -298 dB re 1 microVolt/Pa. The design trade-off still involves receiver sensitivity with effective spot size, and signal distortion from the scatter structure. However, the reduced cost and improved repeatability of the new scatter approach makes the overall design more robust for routine waveform measurements of HIFU systems.

  12. Nakagami imaging for detecting thermal lesions induced by high-intensity focused ultrasound in tissue.

    Science.gov (United States)

    Rangraz, Parisa; Behnam, Hamid; Tavakkoli, Jahan

    2014-01-01

    High-intensity focused ultrasound induces focalized tissue coagulation by increasing the tissue temperature in a tight focal region. Several methods have been proposed to monitor high-intensity focused ultrasound-induced thermal lesions. Currently, ultrasound imaging techniques that are clinically used for monitoring high-intensity focused ultrasound treatment are standard pulse-echo B-mode ultrasound imaging, ultrasound temperature estimation, and elastography-based methods. On the contrary, the efficacy of two-dimensional Nakagami parametric imaging based on the distribution of the ultrasound backscattered signals to quantify properties of soft tissue has recently been evaluated. In this study, ultrasound radio frequency echo signals from ex vivo tissue samples were acquired before and after high-intensity focused ultrasound exposures and then their Nakagami parameter and scaling parameter of Nakagami distribution were estimated. These parameters were used to detect high-intensity focused ultrasound-induced thermal lesions. Also, the effects of changing the acoustic power of the high-intensity focused ultrasound transducer on the Nakagami parameters were studied. The results obtained suggest that the Nakagami distribution's scaling and Nakagami parameters can effectively be used to detect high-intensity focused ultrasound-induced thermal lesions in tissue ex vivo. These parameters can also be used to understand the degree of change in tissue caused by high-intensity focused ultrasound exposures, which could be interpreted as a measure of degree of variability in scatterer concentration in various parts of the high-intensity focused ultrasound lesion. PMID:24264647

  13. CT and Ultrasound Guided Stereotactic High Intensity Focused Ultrasound (HIFU)

    International Nuclear Information System (INIS)

    To demonstrate the feasibility of CT and B-mode Ultrasound (US) targeted HIFU, a prototype coaxial focused ultrasound transducer was registered and integrated to a CT scanner. CT and diagnostic ultrasound were used for HIFU targeting and monitoring, with the goals of both thermal ablation and non-thermal enhanced drug delivery. A 1 megahertz coaxial ultrasound transducer was custom fabricated and attached to a passive position-sensing arm and an active six degree-of-freedom robotic arm via a CT stereotactic frame. The outer therapeutic transducer with a 10 cm fixed focal zone was coaxially mounted to an inner diagnostic US transducer (2-4 megahertz, Philips Medical Systems). This coaxial US transducer was connected to a modified commercial focused ultrasound generator (Focus Surgery, Indianapolis, IN) with a maximum total acoustic power of 100 watts. This pre-clinical paradigm was tested for ability to heat tissue in phantoms with monitoring and navigation from CT and live US. The feasibility of navigation via image fusion of CT with other modalities such as PET and MRI was demonstrated. Heated water phantoms were tested for correlation between CT numbers and temperature (for ablation monitoring). The prototype transducer and integrated CT/US imaging system enabled simultaneous multimodality imaging and therapy. Pre-clinical phantom models validated the treatment paradigm and demonstrated integrated multimodality guidance and treatment monitoring. Temperature changes during phantom cooling corresponded to CT number changes. Contrast enhanced or non-enhanced CT numbers may potentially be used to monitor thermal ablation with HIFU. Integrated CT, diagnostic US, and therapeutic focused ultrasound bridges a gap between diagnosis and therapy. Preliminary results show that the multimodality system may represent a relatively inexpensive, accessible, and simple method of both targeting and monitoring HIFU effects. Small animal pre-clinical models may be translated to large

  14. Extracorporeal High-Intensity Focused Ultrasound Treatment for Breast Cancer

    Institute of Scientific and Technical Information of China (English)

    HuiZhu; FengWu; WenzhiChen; YoudeCao; JinBai; ZhibiaoWang

    2004-01-01

    OBJECTIVE To evaluate the clinical safety and efficacy of using highintensity focused ultrasound (HIFU) therapy, for breast cancer, and to select the appropriate methods in evaluating the therapeutic effects.METHODS A total of 24 patients with breast cancer underwent HIFU treatment 1-2 weeks before receiving modified radical mastectomy. During and after HIFU therapy, changes in blood pressure, breath, pulse and peripheral blood oxygen saturation were monitored. At the same time, the damage of the skin and tissue produced by HIFU at the target region was evaluated as well. Surgically excised samples were used for pathological examinations to evaluate the HIFU-induced destruction of the targeted tissue. Three patients received Tc-ECT and 1 MRI examinations before and after HIFU.RESULTS HIFU treatment had no apparent influence on either the tissue nearby the target or on vital signs of the patients. Pathological, tc-ECT and MRI examinations demonstrated that targeted tissue showed complete coagulative necrosis.CONCLUSION Under the guidance of real-time ultrasonic imaging, HIFU can effectively and safely destroy the breast cancer mass and 99MTc-ECT and MRI examination can be utilized to evaluate the therapeutic effects.HIFU may become one of the options for breast cancer therapy in the future.

  15. Effects of High Intensity Focused Ultrasound on the Brain

    Science.gov (United States)

    Vykhodtseva, Natalia; McDannold, Nathan; Hynynen, Kullervo

    2007-05-01

    Bio-effects in the brain resulting from short focused ultrasound (FUS) pulses (1-10 ms, PRF=0.5, 1.0, and 2.0 Hz, frequency=1.63 MHz) at high acoustic power (up to 700W) were examined. Fifty-seven locations were targeted through a craniotomy in the brains of 11 rabbits. Temperature rise was measured with MRI-based thermometry. The animals were sacrificed 4 h or 48 h after sonications for histological evaluations. A range of effects was observed: (1) Vascular changes (vasoconstriction/occlusion). (2) Homogenization of tissue. (3) Concentric circular lesions; (4) Hemorrhagic lesions similar to what was described earlier as inertial cavitation effects. Overall, the type of damage correlated with the acoustical power, with substantial overlapping among categories. Vascular changes were found at ˜140-180W, the thresholds for homogenized tissue and hemorrhagic lesions were approximately 200W and 350W, respectively. Some of these effects might be exploited for new therapies. Vascular occlusion might also be exploited for therapy; the lesions with homogenized tissue may suggest a new mechanism for non-thermal tissue ablation; small ones for ophthalmology and for functional neurosurgery (if produced in nerve tracts). The mechanism for this effect is unknown, but with the acoustic intensities used, non-linear absorption, strong radiation forces and microbubble activity were likely to have been present. MRI-based temperature changes suggest that thermal effects were probably not responsible for these lesions, as the average focal temperature (approximately 47°C) was slightly below the threshold for thermal damage. The overlap between types of tissue effects for a given acoustic intensity indicates that a method to guide such cavitation-based therapies is needed. MRI was promising in some ways — we can detect where the effects were happening and whether or not cavitation occurred. While the artifacts in temperature mappings will make temperature measurements problematic

  16. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate

    OpenAIRE

    van Leenders, G J L H; Beerlage, H; Ruijter, E.; de la Rosette, J J M C H; van de Kaa, C A

    2000-01-01

    Aims—Investigation of the histopathological changes in prostatectomy specimens of patients with prostate cancer after high intensity focused ultrasound (HIFU) and identification of immunohistochemical markers for tissue damage after HIFU treatment.

  17. High-Intensity Focused Ultrasound (HIFU) in Localized Prostate Cancer Treatment

    OpenAIRE

    Alkhorayef, Mohammed; Mahmoud, Mustafa Z.; Alzimami, Khalid S.; Sulieman, Abdelmoneim; Fagiri, Maram A.

    2015-01-01

    Summary Background High-intensity focused ultrasound (HIFU) applies high-intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue through ablation. This study intended to review HIFU to explain the fundamentals of HIFU, evaluate the evidence concerning the role of HIFU in the treatment of prostate cancer (PC), review the technologies used to perform HIFU and the published clinical literature regarding the procedure as a primary treatment for PC. Material/Meth...

  18. High intensity focused ultrasound (HIFU) as the alternative method of treatment of oncourological diseases

    OpenAIRE

    Blyumberg B.I.; Fomkin R.N.; Popkov V.M.

    2012-01-01

    Increasing interest devoted to technology of high intensity focused ultrasound (high-intensity focused ultrasound, HIFU), basically, is explained by a wide spectrum of potential fields of application at minimum invasiveness of the given method. In oncourology HIFU is applied in prostate and kidney cancer. In case of tumors of renal parenchyma the given technique is being clinically tested, while HIFU is currently used in the practice of European oncourologists in treatment of prostate cancer....

  19. Focusing of high intensity ultrasound through the rib cage using a therapeutic random phased array

    OpenAIRE

    Bobkova, Svetlana; Gavrilov, Leonid; Khokhlova, Vera; Shaw, Adam; Hand, Jeffrey; ,

    2010-01-01

    A method for focusing high intensity ultrasound through a rib cage that aims to minimize heating of the ribs whilst maintaining high intensities at the focus (or foci) is proposed and tested theoretically and experimentally. Two approaches, one based on geometric acoustics and the other accounting for diffraction effects associated with propagation through the rib cage, are investigated theoretically for idealized source conditions. It is shown that for an idealized radiator the diffraction a...

  20. Transcranial MR-guided High Intensity Focused Ultrasound for Non-Invasive Functional Neurosurgery

    Science.gov (United States)

    Werner, Beat; Morel, Anne; Zadicario, Eyal; Jeanmonod, Daniel; Martin, Ernst

    2010-03-01

    While the development of transcranial MR-guided High Intensity Focused Ultrasound has been driven mainly by applications for tumor ablation this new intervention method is also very attractive for functional neurosurgery due to its non-invasiveness, the absence of ionizing radiation and the closed-loop intervention control by MRI. Here we provide preliminary data to demonstrate the clinical feasibility, safety and precision of non-invasive functional neurosurgery by transcranial MR-guided High Intensity Focused Ultrasound.

  1. High-intensity focused ultrasound ablation for treatment of hepatocellular carcinoma and hypersplenism: preliminary study.

    Science.gov (United States)

    Zhu, Jing; Zhu, Hui; Mei, Zhechuan; Jin, Chengbing; Ran, Lifeng; Zhou, Kun; Yang, Wei; Zhang, Lian; She, Chaokun

    2013-10-01

    The purpose of this work was to preliminarily investigate the efficacy and safety of high-intensity focused ultrasound treatment of hepatocellular carcinoma and hypersplenism. Nine patients with hepatocellular carcinoma complicated by hypersplenism (5 male and 4 female; median age, 56 years; range, 51-66 years) were treated with ultrasound-guided high-intensity focused ultrasound. Complications were recorded. Laboratory examination and magnetic resonance imaging were used to evaluate the efficacy. After high-intensity focused ultrasound treatment, mean spleen ablation ± SD of 28.76% ± 6.1% was discovered; meanwhile, the white blood cell count, platelet count, and liver function of the patients were substantially improved during the follow-up period. In addition, symptoms such as epistaxis and gingival bleeding were ameliorated or even eliminated, and the quality of life was improved. Follow-up imaging showed a nonperfused volume in the spleen and an absence of a tumor blood supply at the treated lesions in the liver. For the first time to our knowledge, high-intensity focused ultrasound ablation was used to treat hepatocellular carcinoma complicated by hypersplenism. High-intensity focused ultrasound may be an effective and safe alternative for treatment of hepatocellular carcinoma complicated by hypersplenism, but further studies are necessary to clarify the mechanisms. PMID:24065267

  2. Bone metastasis treatment using magnetic resonance-guided high intensity focused ultrasound

    NARCIS (Netherlands)

    Yeo, Sin Yuin; Elevelt, Aaldert; Donato, Katia; van Rietbergen, Bert; ter Hoeve, Natalie D.; van Diest, Paul J.; Grüll, Holger

    2015-01-01

    Objectives: Bone pain resulting from cancer metastases reduces a patient's quality of life. Magnetic Resonance-guided High Intensity Focused Ultrasound (MR-HIFU) is a promising alternative palliative thermal treatment technique for bone metastases that has been tested in a few clinical studies. Here

  3. Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: Past, present, and future

    OpenAIRE

    Mearini, Luigi; Porena, Massimo

    2010-01-01

    Upon a review of recently published articles on high-intensity focused ultrasound (HIFU) in the treatment of prostate cancer, we evaluated the current status of HIFU as a primary treatment option for localized prostate cancer and its use as salvage therapy when radiation failed. We also briefly discuss current issues in indications, definition of response, and finally the future of HIFU development.

  4. Dynamics of cavitation clouds within a high-intensity focused ultrasonic beam

    NARCIS (Netherlands)

    Lu, Yuan; Katz, Joseph; Prosperetti, Andrea

    2013-01-01

    In this experimental study, we generate a 500 kHz high-intensity focused ultrasonic beam, with pressure amplitude in the focal zone of up to 1.9 MPa, in initially quiescent water. The resulting pressure field and behavior of the cavitation bubbles are measured using high-speed digital in-line hologr

  5. Systematic review of high-intensity focused ultrasound ablation in the treatment of breast cancer

    NARCIS (Netherlands)

    Peek, M.C.L.; Ahmed, M.; Napoli, A.; Haken, ten B.; McWilliams, S.; Usiskin, S.I.; Pinder, S.E.; Hemelrijck, Van M.; Douek, M.

    2015-01-01

    Background: A systematic review was undertaken to assess the clinical efficacy of non-invasive high-intensity focused ultrasound (HIFU) ablation in the treatment of breast cancer. Methods: MEDLINE/PubMed library databases were used to identify all studies published up to December 2013 that evaluate

  6. Triggered Drug Release from Superhydrophobic Meshes using High-Intensity Focused Ultrasound

    OpenAIRE

    Yohe, Stefan T.; Kopechek, Jonathan A.; Porter, Tyrone M.; Colson, Yolonda L.; Grinstaff, Mark W.

    2013-01-01

    Application of high-intensity focused ultrasound to drug-loaded superhydrophobic meshes affords triggered drug release by displacing an entrapped air layer. The air layer within the superhydrophobic meshes is characterized using direct visualization and B-mode imaging. Drug-loaded superhydrophobic meshes are cytotoxic in an in vitro assay after ultrasound treatment.

  7. Clinical Application of High-intensity Focused Ultrasound in Cancer Therapy

    OpenAIRE

    Hsiao, Yi-Hsuan; Kuo, Shou-Jen; Tsai, Horng-Der; Chou, Ming-Chih; Yeh, Guang-Perng

    2016-01-01

    The treatment of cancer is an important issue in both developing and developed countries. Clinical use of ultrasound in cancer is not only for the diagnosis but also for the treatment. Focused ultrasound surgery (FUS) is a noninvasive technique. By using the combination of high-intensity focused ultrasound (HIFU) and imaging method, FUS has the potential to ablate tumor lesions precisely. The main mechanisms of HIFU ablation involve mechanical and thermal effects. Recent advances in HIFU have...

  8. The feasibility and safety of high-intensity focused ultrasound combined with low-dose external beam radiotherapy as supplemental therapy for advanced prostate cancer following hormonal therapy

    OpenAIRE

    Wu, Rui-Yi; Wang, Guo-Min; Xu, Lei; ZHANG, BO-HENG; Xu, Ye-Qing; Zeng, Zhao-Chong; Chen, Bing

    2011-01-01

    The aim of this study was to investigate the feasibility and safety of high-intensity focused ultrasound (HIFU) combined with (+) low-dose external beam radiotherapy (LRT) as supplemental therapy for advanced prostate cancer (PCa) following hormonal therapy (HT). Our definition of HIFU+LRT refers to treating primary tumour lesions with HIFU in place of reduced field boost irradiation to the prostate, while retaining four-field box irradiation to the pelvis in conventional-dose external beam r...

  9. Clinical applications for magnetic resonance guided high intensity focused ultrasound (MRgHIFU): present and future

    International Nuclear Information System (INIS)

    It has been well known for decades that high intensity focused ultrasound (HIFU) generates heat in tissues resulting in coagulative necrosis. Implementation, however, has been slow, due to difficulties with finding an appropriate imaging modality that could not only guide treatment, but also provide real-time thermal feedback. These problems have been overcome with the newest magnetic resonance-guided high intensity focused ultrasound systems (MRgHIFU). With its superior spatial resolution enabling accurate image guidance coupled with its ability to provide real-time thermography during treatments, MRI is moving further into the realm of therapeutics for oncologic patient care. This article will discuss the implementation of an MR-guided HIFU system, current clinical indications and touch on future directions.

  10. High intensity focused ultrasound (HIFU as the alternative method of treatment of oncourological diseases

    Directory of Open Access Journals (Sweden)

    Blyumberg B.I.

    2012-12-01

    Full Text Available Increasing interest devoted to technology of high intensity focused ultrasound (high-intensity focused ultrasound, HIFU, basically, is explained by a wide spectrum of potential fields of application at minimum invasiveness of the given method. In oncourology HIFU is applied in prostate and kidney cancer. In case of tumors of renal parenchyma the given technique is being clinically tested, while HIFU is currently used in the practice of European oncourologists in treatment of prostate cancer. The majority of the references describing the results of HIFU application in prostate cancer is based on data of a number of clinical observations. It has been proved that HIFU is a possible method of treatment of highly — and moderate-differentiated tumors, and local relapses after remote radial therapy.

  11. Non-invasive estimation of thermal tissue properties by high-intensity focused ultrasound

    Science.gov (United States)

    Appanaboyina, Sunil; Partanen, Ari; Haemmerich, Dieter

    2013-02-01

    Magnetic Resonance guided High-intensity Focused Ultrasound (MR-HIFU) can be used to locally heat tissue while non-invasively monitoring tissue temperature via MR-based thermometry. The goal of this study was to investigate the use of a computational technique based on inverse heat-transfer modeling for the non-invasive measurement of thermal tissue properties from data collected using an MR-HIFU system.

  12. Laser-enhanced cavitation during high intensity focused ultrasound: An in vivo study

    Science.gov (United States)

    Cui, Huizhong; Zhang, Ti; Yang, Xinmai

    2013-04-01

    Laser-enhanced cavitation during high intensity focused ultrasound (HIFU) was studied in vivo using a small animal model. Laser light was employed to illuminate the sample concurrently with HIFU radiation. The resulting cavitation was detected with a passive cavitation detector. The in vivo measurements were made under different combinations of HIFU treatment depths, laser wavelengths, and HIFU durations. The results demonstrated that concurrent light illumination during HIFU has the potential to enhance cavitation effect by reducing cavitation threshold in vivo.

  13. High-intensity focused ultrasound to treat primary hyperparathyroidism: a feasibility study in four patients

    DEFF Research Database (Denmark)

    Kovatcheva, Roussanka D; Vlahov, Jordan D; Shinkov, Alexander D; Borissova, Anna-Maria; Hwang, Joo Ha; Arnaud, Françoise; Hegedüs, Laszlo

    2010-01-01

    Many patients with primary hyperparathyroidism either decline or are not candidates for surgical parathyroidectomy. There are drawbacks to medical therapy as well as percutaneous ethanol injection as alternative therapies for primary hyperparathyroidism. Therefore, in this pilot study, our aim wa...... to test the feasibility, safety, and efficacy of a newly developed noninvasive high-intensity focused ultrasound (HIFU) technique for the nonsurgical management of primary hyperparathyroidism....

  14. Efficacy of high-intensity focused ultrasound ablation for adenomyosis therapy and sexual life quality

    OpenAIRE

    Long, Ling; Chen, Jinyun; Xiong, Yu; Zou, Min; Deng, Yongbin; Chen, Li; WANG, ZHIBIAO

    2015-01-01

    Objective: The aim of this study was to evaluate the efficacy, safety and sexual life quality outcomes of ultrasound-guided high-intensity focused ultrasound (HIFU) ablations for the treatment of patients with symptomatic adenomyosis and uterine volumes >200 cm3. Methods: In our prospective clinical trial 47 patients with uterine volumes >200 cm3 and symptomatic adenomyosis were treated with single treatment sessions of ultrasound-guided HIFU ablations. Beside uterus and adenomyosis lesion si...

  15. New clinical application of high-intensity focused ultrasound: local control of synovial sarcoma

    OpenAIRE

    Hu, Xiaoye; CAI, HONGKE; Zhou, Meiqi; HE, HAIFEI; Tian, Wei; Hu, Yue; Chen, Lirong; Deng, Yongchuan

    2013-01-01

    High-intensity focused ultrasound (HIFU) is playing an increasingly important role in cancer therapy. Primary synovial sarcomas of the chest wall are extremely rare. We report the first case of noninvasive HIFU therapy for the control of synovial sarcoma. A 51-year-old man was diagnosed with spindle cell sarcoma on the left chest wall through lumpectomy. After four cycles of chemotherapy, local recurrence of the sarcoma was detected. Subsequent extended resection confirmed synovial sarcoma. A...

  16. High-Intensity Focused Ultrasound as Salvage Therapy for Patients With Recurrent Prostate Cancer After Radiotherapy

    OpenAIRE

    Song, Wan; Jung, U Seok; Suh, Yoon Seok; Jang, Hyun Jun; Sung, Hyun Hwan; Jeon, Hwang Gyun; Jeong, Byung Chang; Seo, Seong Il; Jeon, Seong Soo; Choi, Han Yong; Lee, Hyun Moo

    2014-01-01

    Purpose To evaluate the oncologic outcomes and postoperative complications of high-intensity focused ultrasound (HIFU) as a salvage therapy after external-beam radiotherapy (EBRT) failure in patients with prostate cancer. Materials and Methods Between February 2002 and August 2010, we retrospectively reviewed the medical records of all patients who underwent salvage HIFU for transrectal ultrasound-guided, biopsy-proven locally recurred prostate cancer after EBRT failure (by ASTRO definition: ...

  17. PATHOMORPHISM OF PROSTATE CANCER DURING HIGH-INTENSITY FOCUSED ULTRASOUND TREATMENT

    OpenAIRE

    R.N. Fomkin; E.S. Voronina; V.M. Popkov; G.N. Maslyakova; B. I. Blyumberg

    2014-01-01

    The purpose of the study was to evaluate the efficiency of prostate cancer (PC) treatment using high-intensity focused ultrasound (HIFU) on the basis of morphometric and immunohistochemical (IHC) analyses of postoperative prostate biopsy specimens. The study subjects were 40 patients with localized and locally advanced PC. The postoperative morphological analysis was made on the basis of standard hematoxylineosin staining and morphometric and IHC studies using the following antibodies: PCNA, ...

  18. High-Intensity Focused Ultrasound for Prostate Cancer: Long-Term Followup and Complications Rate

    OpenAIRE

    Umberto Maestroni; Francesco Dinale; Roberto Minari; Paolo Salsi; Francesco Ziglioli

    2012-01-01

    Introduction. As it is well known, High Intensity Focused Ultrasound (HIFU) is a minimally invasive procedure for prostate cancer. Many investigators reported their series of patients, demonstrating the effectiveness of the treatment. The most majority of Authors, however, do not report the side effects and the complications of the procedure, which is the aim of our study. The diagnosis and management of complications is discussed, and the oncologic outcome is reported in terms of quality of ...

  19. Histological changes in the human prostate after radiotherapy and salvage high intensity focused ultrasound

    OpenAIRE

    Chalasani, Venu; Martinez, Carlos H; Williams, Andrew K.; Kwan, Kevin; Chin, Joseph L.

    2010-01-01

    The histological changes (both macroscopic and microscopic) in the prostate following the combination of external beam radiotherapy and salvage high intensity focused ultrasound (HIFU) have not been previously described. This article describes the case of a 65-year-old male who presented with recurrent localized prostate cancer after undergoing external beam radiotherapy for low-risk prostate cancer. He was treated with salvage HIFU, and 4 weeks later presented with symptoms and signs consist...

  20. High intensity focused ultrasound vs. cryotherapy as primary treatment for prostate cancer

    OpenAIRE

    Ranjan, Pratyush; Saurabh, Gyan; Bansal, Rahul; Gupta, Amit

    2008-01-01

    Prostate cancer is one of the most commonly diagnosed cancers. Here, we will be discussing two upcoming techniques for its management. One is cryotherapy which has returned from oblivion after nearly 150 years armed with latest technology and looking as if its full potential has been recognized now. On the other hand is high intensity focused ultrasound (HIFU), the application of ultrasound to this field is relatively new and hence a lot of excitement and hope. We searched MEDLINE (PubMed 194...

  1. A Rectourethral Fistula due to Transrectal High-Intensity Focused Ultrasound Treatment: Diagnosis and Management

    OpenAIRE

    Valeria Fiaschetti; Guglielmo Manenti; Isabelle Di Poce; Maria Fornari; Aurora Ricci; Enrico Finazzi Agrò; Giovanni Simonetti

    2012-01-01

    Colovesical fistula (CVF) is an abnormal connection between the enteric and the urinary systems. The rectourethral fistula (RUF) is a possible but extremely rare complication of treatment of prostate cancer with “transrectal High-Intensity Focused Ultrasound (HIFU) treatment.” We present a case of CVF due to HIFU treatment of recurrent prostate cancer. The case was assessed with cystography completed with a pelvic CT scan—with MPR, MIP, and VR reconstruction—before emptying the bladder. Since...

  2. Urodynamic Evaluation after High-Intensity Focused Ultrasound for Patients with Prostate Cancer

    OpenAIRE

    Luigi Mearini; Elisabetta Nunzi; Silvia Giovannozzi; Luca Lepri; Carolina Lolli; Antonella Giannantoni

    2014-01-01

    This prospective study assesses the impact of high-intensity focused ultrasound (HIFU) on lower urinary tract by comparing pre- and postoperative symptoms and urodynamic changes. Thirty consecutive patients with clinically organ-confined prostate cancer underwent urodynamic study before HIFU and then at 3–6 months after surgery. Continence status and symptoms were analyzed by means of International Prostate Symptoms Score IPSS and International Index Erectile Function IIEF5. As a result, ther...

  3. Results of low threshold to biopsy following high-intensity focused ultrasound for localized prostate cancer

    OpenAIRE

    Richard L Haddad; Tania A Hossack; Woo, Henry H.

    2012-01-01

    Context: There are different treatment options for localized prostate cancer. The success of high-intensity focused ultrasound (HIFU) is based largely on biochemical prostate specific antigen (PSA) results. Aims: To evaluate the impact of using a low PSA threshold to perform prostate biopsies after HIFU in order to more accurately gauge treatment success. Settings and Design: Eleven patients underwent HIFU at Sydney Adventist Hospital in Sydney, 10 as primary and 1 as salvage therapy ...

  4. Adverse Events of Extracorporeal Ultrasound-Guided High Intensity Focused Ultrasound Therapy

    OpenAIRE

    Tinghe Yu; Jun Luo

    2011-01-01

    BACKGROUND: High-intensity focused ultrasound (HIFU) is considered to be an alternative to surgery. Extracorporeal ultrasound-guided HIFU (USgFU) has been clinically used to treat solid tumors. Preliminary trials in a small sample of a Western population suggested that this modality was safe. Most trials are performed in China thereby providing comprehensive data for understanding the safety profile. The aim of this study was to evaluate adverse events of USgFU therapy. METHODS AND FINDINGS: ...

  5. High-Intensity Focused Ultrasound (HIFU) in Uterine Fibroid Treatment: Review Study

    OpenAIRE

    MAHMOUD, MUSTAFA Z.; Alkhorayef, Mohammed; Alzimami, Khalid S.; Aljuhani, Manal Saud; Sulieman, Abdelmoneim

    2014-01-01

    Summary Background High-intensity focused ultrasound (HIFU) is a highly precise medical procedure used locally to heat and destroy diseased tissue through ablation. This study intended to review HIFU in uterine fibroid therapy, to evaluate the role of HIFU in the therapy of leiomyomas as well as to review the actual clinical activities in this field including efficacy and safety measures beside the published clinical literature. Material/Methods An inclusive literature review was carried out ...

  6. High intensity focused ultrasound treatment of small renal masses: Clinical effectiveness and technological advances

    OpenAIRE

    Nabi, G; Goodman, C; Melzer, A.

    2010-01-01

    The review summarises the technological advances in the application of high-intensity focused ultrasound for small renal masses presumed to be cancer including the systematic review of its clinical application. Current progress in the area of magnetic resonance image guided ultrasound ablation is also appraised. Specifically, organ tracking and real time monitoring of temperature changes during the treatment are discussed. Finally, areas of future research interest are outlined.

  7. Spatial chirp control of high-intensity 4D pulse focusing for laser-matter interactions

    Directory of Open Access Journals (Sweden)

    Durfee C.

    2013-11-01

    Full Text Available Spatial chirp can be manipulated to control the focusing conditions for materials processing. Our double-ABCD nonparaxial analysis helps to understand and exploit the mechanisms for intensity localization, pulse front tilt, and grating formation, and includes initial spectral phase and detuning of the wavelength crossing plane. We also present a novel method for creating high density, high intensity interference patterns with crossed beams that have no relative pulse front tilt.

  8. High-intensity focused ultrasound: advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology

    OpenAIRE

    Malietzis, G; Monzon, L.; Hand, J.; Wasan, H; Leen, E; Abel, M.; Muhammad, A; Price, P; Abel, P.

    2013-01-01

    High-intensity focused ultrasound (HIFU) is a rapidly maturing technology with diverse clinical applications. In the field of oncology, the use of HIFU to non-invasively cause tissue necrosis in a defined target, a technique known as focused ultrasound surgery (FUS), has considerable potential for tumour ablation. In this article, we outline the development and underlying principles of HIFU, overview the limitations and commercially available equipment for FUS, then summarise some of the rece...

  9. High intensity focused ultrasound as a tool for tissue engineering: Application to cartilage.

    Science.gov (United States)

    Nover, Adam B; Hou, Gary Y; Han, Yang; Wang, Shutao; O'Connell, Grace D; Ateshian, Gerard A; Konofagou, Elisa E; Hung, Clark T

    2016-02-01

    This article promotes the use of High Intensity Focused Ultrasound (HIFU) as a tool for affecting the local properties of tissue engineered constructs in vitro. HIFU is a low cost, non-invasive technique used for eliciting focal thermal elevations at variable depths within tissues. HIFU can be used to denature proteins within constructs, leading to decreased permeability and potentially increased local stiffness. Adverse cell viability effects remain restricted to the affected area. The methods described in this article are explored through the scope of articular cartilage tissue engineering and the fabrication of osteochondral constructs, but may be applied to the engineering of a variety of different tissues. PMID:26724968

  10. HIGH INTENSITY FOCUSED ULTRASOUND FOR TREATMENT UNRESECTABLE MALIGNANT TUMORS IN 75 PATIENTS

    Institute of Scientific and Technical Information of China (English)

    郑国强

    2004-01-01

    Objective: To study preliminary experience of high intensity focused ultrasound (HIFU) for unresectable malignant tumors in 75 patients. Methods: The clinical data of 75 patients with unresectable tumor was analyzed retrospectively. Results: Among 75 patients, ten out of 57 cases achieved good local control in short-term, 5 patients liver tumor, 4 patients with tumor in the chest wall and one patient with bone matestics. Seven patients had skin burn and 2 patients developed intestinal perforations. Conclusion: HIFU is a novel tool for local tumor treatment. HIFU treatment for patients with unresectable tumor in the chest wall is effective.

  11. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound

    Institute of Scientific and Technical Information of China (English)

    2010-01-01

    AIM:To investigate whether tumor debris created by high-intensity focused ultrasound(HIFU)could trigger antitumor immunity in a mouse hepatocellular carcinoma model. METHODS:Twenty C57BL/6J mice bearing H22 hepatocellular carcinoma were used to generate antitumor vaccines.Ten mice underwent HIFU ablation,and the remaining 10 mice received a sham-HIFU procedure with no ultrasound irradiation.Sixty normal mice were randomly divided into HIFU vaccine,tumor vaccine and control groups.These mice were immunized w...

  12. Evaluation of pulsed high intensity focused ultrasound exposures on metastasis in a murine model

    OpenAIRE

    Hancock, Hilary; Dreher, Matthew R.; Crawford, Nigel; Pollock, Claire B.; Shih, Jennifer; Wood, Bradford J.; Hunter, Kent; Frenkel, Victor

    2009-01-01

    High intensity focused ultrasound (HIFU) may be employed in two ways: continuous exposures for thermal ablation of tissue (>60°C), and pulsed-exposures for non-ablative effects, including low temperature hyperthermia (37–45°C), and non thermal effects (e.g. acoustic cavitation and radiation forces). Pulsed-HIFU effects may enhance the tissue's permeability for improved delivery of drugs and genes, for example, by opening up gaps between cells in the vasculature and parenchyma. Inducing these ...

  13. A focusable, convergent fast-electron beam from ultra-high-intensity laser-solid interactions

    CERN Document Server

    Scott, R H H

    2015-01-01

    A novel scheme for the creation of a convergent, or focussing, fast-electron beam generated from ultra-high-intensity laser-solid interactions is described. Self-consistent particle-in-cell simulations are used to demonstrate the efficacy of this scheme in two dimensions. It is shown that a beam of fast-electrons of energy 500 keV - 3 MeV propagates within a solid-density plasma, focussing at depth. The depth of focus of the fast-electron beam is controlled via the target dimensions and focussing optics.

  14. Distribution of temperature elevation caused by moving high-intensity focused ultrasound transducer

    Science.gov (United States)

    Kim, Jungsoon; Jung, Jihee; Kim, Moojoon; Ha, Kanglyeol; Lee, Eunghwa; Lee, Ilkwon

    2015-07-01

    Ultrasonic thermal treatment for dermatology has been developed using a small high-intensity focused ultrasound (HIFU) transducer. The transducer moves horizontally at a constant while it emits focused ultrasound because the treatment needs a high-temperature area in skin tissue over a wide range of depths. In this paper, a tissue-mimicking phantom made of carrageenan and a thermochromic film were adopted to examine the temperature distribution in the phantom noninvasively when the focused ultrasound was irradiated from the moving transducer. The dependence of the high-temperature area on the irradiated acoustic energy and on the movement interval of the HIFU was analyzed experimentally. The results will be useful in ensuring safety and estimating the remedial value of the treatment.

  15. MR-Guided High-Intensity Focused Ultrasound: Current Status of an Emerging Technology

    Energy Technology Data Exchange (ETDEWEB)

    Napoli, Alessandro, E-mail: napoli.alessandro@gmail.com; Anzidei, Michele, E-mail: michele.anzidei@gmail.com; Ciolina, Federica, E-mail: federica.ciolina@gmail.com; Marotta, Eugenio, E-mail: eugenio.marotta@gmail.com; Cavallo Marincola, Beatrice, E-mail: beatrice.cavalloamarincola@gmail.com; Brachetti, Giulia, E-mail: giuliabrachetti@gmail.com; Mare, Luisa Di, E-mail: luisadimare@gmail.com; Cartocci, Gaia, E-mail: gaia.cartocci@gmail.com; Boni, Fabrizio, E-mail: fabrizioboni00@gmail.com; Noce, Vincenzo, E-mail: vinc.noce@hotmail.it; Bertaccini, Luca, E-mail: lucaone84@libero.it; Catalano, Carlo, E-mail: carlo.catalano@uniroma1.it [Sapienza, University of Rome, Department of Radiological Sciences (Italy)

    2013-10-15

    The concept of ideal tumor surgery is to remove the neoplastic tissue without damaging adjacent normal structures. High-intensity focused ultrasound (HIFU) was developed in the 1940s as a viable thermal tissue ablation approach. In clinical practice, HIFU has been applied to treat a variety of solid benign and malignant lesions, including pancreas, liver, prostate, and breast carcinomas, soft tissue sarcomas, and uterine fibroids. More recently, magnetic resonance guidance has been applied for treatment monitoring during focused ultrasound procedures (magnetic resonance-guided focused ultrasound, MRgFUS). Intraoperative magnetic resonance imaging provides the best possible tumor extension and dynamic control of energy deposition using real-time magnetic resonance imaging thermometry. We introduce the fundamental principles and clinical indications of the MRgFUS technique; we also report different treatment options and personal outcomes.

  16. MR-guided high-intensity focused ultrasound: current status of an emerging technology.

    Science.gov (United States)

    Napoli, Alessandro; Anzidei, Michele; Ciolina, Federica; Marotta, Eugenio; Cavallo Marincola, Beatrice; Brachetti, Giulia; Di Mare, Luisa; Cartocci, Gaia; Boni, Fabrizio; Noce, Vincenzo; Bertaccini, Luca; Catalano, Carlo

    2013-10-01

    The concept of ideal tumor surgery is to remove the neoplastic tissue without damaging adjacent normal structures. High-intensity focused ultrasound (HIFU) was developed in the 1940s as a viable thermal tissue ablation approach. In clinical practice, HIFU has been applied to treat a variety of solid benign and malignant lesions, including pancreas, liver, prostate, and breast carcinomas, soft tissue sarcomas, and uterine fibroids. More recently, magnetic resonance guidance has been applied for treatment monitoring during focused ultrasound procedures (magnetic resonance-guided focused ultrasound, MRgFUS). Intraoperative magnetic resonance imaging provides the best possible tumor extension and dynamic control of energy deposition using real-time magnetic resonance imaging thermometry. We introduce the fundamental principles and clinical indications of the MRgFUS technique; we also report different treatment options and personal outcomes. PMID:23474917

  17. High-Intensity Focused Ultrasound (HIFU) in Localized Prostate Cancer Treatment

    International Nuclear Information System (INIS)

    High-intensity focused ultrasound (HIFU) applies high-intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue through ablation. This study intended to review HIFU to explain the fundamentals of HIFU, evaluate the evidence concerning the role of HIFU in the treatment of prostate cancer (PC), review the technologies used to perform HIFU and the published clinical literature regarding the procedure as a primary treatment for PC. Studies addressing HIFU in localized PC were identified in a search of internet scientific databases. The analysis of outcomes was limited to journal articles written in English and published between 2000 and 2013. HIFU is a non-invasive approach that uses a precisely delivered ultrasound energy to achieve tumor cell necrosis without radiation or surgical excision. In current urological oncology, HIFU is used clinically in the treatment of PC. Clinical research on HIFU therapy for localized PC began in the 1990s, and the majority of PC patients were treated with the Ablatherm device. HIFU treatment for localized PC can be considered as an alternative minimally invasive therapeutic modality for patients who are not candidates for radical prostatectomy. Patients with lower pre-HIFU PSA level and favourable pathologic Gleason score seem to present better oncologic outcomes. Future advances in technology and safety will undoubtedly expand the HIFU role in this indication as more of patient series are published, with a longer follow-up period

  18. Clinical Application of High-intensity Focused Ultrasound in Cancer Therapy.

    Science.gov (United States)

    Hsiao, Yi-Hsuan; Kuo, Shou-Jen; Tsai, Horng-Der; Chou, Ming-Chih; Yeh, Guang-Perng

    2016-01-01

    The treatment of cancer is an important issue in both developing and developed countries. Clinical use of ultrasound in cancer is not only for the diagnosis but also for the treatment. Focused ultrasound surgery (FUS) is a noninvasive technique. By using the combination of high-intensity focused ultrasound (HIFU) and imaging method, FUS has the potential to ablate tumor lesions precisely. The main mechanisms of HIFU ablation involve mechanical and thermal effects. Recent advances in HIFU have increased its popularity. Some promising results were achieved in managing various malignancies, including pancreas, prostate, liver, kidney, breast and bone. Other applications include brain tumor ablation and disruption of the blood-brain barrier. We aim at briefly outlining the clinical utility of FUS as a noninvasive technique for a variety of types of cancer treatment. PMID:26918034

  19. PRESAGE® as a new calibration method for high intensity focused ultrasound therapy

    International Nuclear Information System (INIS)

    High Intensity Focused ultrasound (HIFU) is a non-invasive cancer therapy that makes use of the mainly thermal effects of ultrasound to destroy tissue. In order to achieve reliable treatment planning, it is necessary to characterise the ultrasound source (transducer) and to understand how the wave propagates in tissue and the energy deposition in the focal region. This novel exploratory study investigated how HIFU affects PRESAGE®, an optical phantom used for radiotherapy dosimetry, which is potentially a rapid method of calibrating the transducer. Samples, of two different formulations, were exposed to focused ultrasound and imaged using Optical Computed Tomography. First results showed that, PRESAGE® changes colour on ultrasound exposure (darker green regions were observed) with the alterations being related to the acoustic power and sample composition. Future work will involve quantification of these alterations and understanding how to relate them to the mechanisms of action of HIFU

  20. Effect of acoustic streaming on tissue heating due to high-intensity focused ultrasound

    CERN Document Server

    Solovchuk, Maxim A; Thiriet, Marc; Lin, Win-Li

    2011-01-01

    The influences of blood vessels and focused location on temperature distribution during high-intensity focused ultrasound (HIFU) ablation of liver tumors is studied. A three-dimensional acoustics-thermal-fluid coupling model is employed to compute the temperature field in the hepatic cancerous region. The model is based on the linear Westervelt and bioheat equations as well as the nonlinear Navier-Stokes equations for the liver parenchyma and blood vessels. The effect of acoustic streaming is also taken into account in the present HIFU simulation study. Different blood vessel diameters and focal point locations were investigated. We found from this three-dimensional numerical study that in large blood vessels both the convective cooling and acoustic streaming can change considerably the temperature field and the thermal lesion near blood vessels. If the blood vessel is located within the beam width, both acoustic streaming and blood flow cooling effects should be taken into account. The predicted temperature ...

  1. Enhancement and quenching of high-intensity focused ultrasound cavitation activity via short frequency sweep gaps.

    Science.gov (United States)

    Hallez, Loïc; Lee, Judy; Touyeras, Francis; Nevers, Aymeric; Ashokkumar, Muthupandian; Hihn, Jean-Yves

    2016-03-01

    This letter reports on the use of frequency sweeps to probe acoustic cavitation activity generated by high-intensity focused ultrasound (HIFU). Unprecedented enhancement and quenching of HIFU cavitation activity were observed when short frequency sweep gaps were applied in negative and positive directions, respectively. It was revealed that irrespective of the frequency gap, it is the direction and frequency sweep rate that govern the cavitation activity. These effects are related to the response of bubbles generated by the starting frequency to the direction of the frequency sweep, and the influence of the sweep rate on growth and coalescence of bubbles, which in turn affects the active bubble population. These findings are relevant for the use of HIFU in chemical and therapeutic applications, where greater control of cavitation bubble population is critical. PMID:26584998

  2. Real-time feedback control for high-intensity focused ultrasound system using localized motion imaging

    Science.gov (United States)

    Sugiyama, Ryusuke; Kanazawa, Kengo; Seki, Mika; Azuma, Takashi; Sasaki, Akira; Takeuchi, Hideki; Fujiwara, Keisuke; Itani, Kazunori; Tamano, Satoshi; Yoshinaka, Kiyoshi; Takagi, Shu; Matsumoto, Yoichiro

    2015-07-01

    High-intensity focused ultrasound (HIFU) is one of the noninvasive treatment for tumors. Visualizing the treated area inside the human body is necessary to control the HIFU exposure. Localized motion imaging (LMI) using ultrasound to induce and detect tissue deformation is one technique to detect a change in tissue stiffness caused by thermal coagulation. In experiments with porcine liver, LMI has shown to detect deformation with less than 20% accuracy. We have developed a prototype feedback control system using real-time LMI. In this system, coagulation size was measured every 1 s and controlled to correspond to a targeted size. The typical size error was reduced to 14% from 35%. LMI displacements in normal and coagulated tissues were sufficiently different to discriminate between coagulated areas and noncoagulated ones after HIFU sonication and to visualize treated areas after HIFU treatment.

  3. Imaging informatics based on method of MR temperature measurement in high-intensity focused ultrasound

    Science.gov (United States)

    Chen, Xiangjiao; Zhang, Jianguo

    2014-03-01

    MR imaging has been used to perform imaging guided high-intensity focused ultrasound (HIFU) and meanwhile can also be used precisely to measure tissue temperature in theory. But in practice, the temperature environment and target are complex. Therefore, it is difficult to measure targeted temperature just by simply using the theory of numerical calculation based on MR image information. In this presentation, we presented new MR temperature measurement, based on imaging informatics, to measure the targeted tissue temperature in MR imaging guided HIFU therapeutic procedure. By heating up the water phantom experiments under HIFU, the new algorithm gives a satisfactory result compared with existing algorithm. Based on experimental data, we can see the accuracy increase 37.5% from 0.4048℃ up to 0.2530℃ when we choose new algorithms.

  4. High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer.

    Science.gov (United States)

    Wu, Feng

    2014-11-28

    The noninvasive ablation of pancreatic cancer with high intensity focused ultrasound (HIFU) energy is received increasingly widespread interest. With rapidly temperature rise to cytotoxic levels within the focal volume of ultrasound beams, HIFU can selectively ablate a targeted lesion of the pancreas without any damage to surrounding or overlying tissues. Preliminary studies suggest that this approach is technical safe and feasible, and can be used alone or in combination with systemic chemotherapy for the treatment of patients with locally advanced pancreatic cancer. It can effectively alleviate cancer-related abdominal pain, and may confer an additional survival benefit with few significant complications. This review provides a brief overview of HIFU, describes current clinical applications, summarizes characteristics of continuous and pulsed HIFU, and discusses future applications and challenges in the treatment of pancreatic cancer. PMID:25469016

  5. The FDA Perspective on Pre-Clinical Testing for High Intensity Focused Ultrasound Devices

    Science.gov (United States)

    Harris, Gerald R.

    2006-05-01

    In the U. S., the pre-market review of high intensity focused ultrasound (HIFU) devices is carried out under the authority of the 1976 Medical Device Amendments to the Food, Drug, and Cosmetic Act. Different regulatory mechanisms may apply depending on the complexity of the HIFU device and the indications for use, but in all cases pre-clinical testing is required. This testing typically includes ultrasound field characterization, thermal modeling and measurement, and may include demonstrating the accuracy of targeting and monitoring, if applicable. Because there are no guidance documents or standards for these tests at present, the U.S. Food and Drug Administration (FDA) welcomes working with interested parties to develop acceptable procedures that can be incorporated into the regulatory review process.

  6. Novel Non-invasive Treatment With High-intensity Focused Ultrasound (HIFU).

    Science.gov (United States)

    Marinova, M; Rauch, M; Schild, H H; Strunk, H M

    2016-02-01

    Ultrasound is not only used for diagnostic purposes but it also can be applied therapeutically so far that nowadays high-intensity focused ultrasound (HIFU) even represents a novel non-invasive treatment modality for various solid tumors. HIFU works by causing selectively deep tissue destruction of target lesions within the body without harming adjacent and overlying structures. In this article, we present an overview on both the mode of action and requirements for a HIFU treatment as well as on the safety and the current status of indications and possible applications with regard to benign and malignant gynecological diseases. Based on numerous studies and original articles, HIFU proved to be an effective and low-risk treatment option particularly for uterine fibroids and adenomyosis, but it also seems to be effective for breast fibroadenomas or even for breast cancer in special cases and other rare entities. PMID:26251996

  7. A Rectourethral Fistula due to Transrectal High-Intensity Focused Ultrasound Treatment: Diagnosis and Management

    Directory of Open Access Journals (Sweden)

    Valeria Fiaschetti

    2012-01-01

    Full Text Available Colovesical fistula (CVF is an abnormal connection between the enteric and the urinary systems. The rectourethral fistula (RUF is a possible but extremely rare complication of treatment of prostate cancer with “transrectal High-Intensity Focused Ultrasound (HIFU treatment.” We present a case of CVF due to HIFU treatment of recurrent prostate cancer. The case was assessed with cystography completed with a pelvic CT scan—with MPR, MIP, and VR reconstruction—before emptying the bladder. Since the CT scan confirmed that the fistula involved solely the urethra and excluded even a minimal involvement of the bladder, it was possible to employ a conservative treatment by positioning a Foley catheter of monthly duration, in order to allow the urethra to rest. Still today, after 6 months, the patient is in a good clinical condition and has not shown yet signs of a recurrence of the fistula.

  8. Clinical evaluation of high-intensity focused ultrasound in treating uterus myomas

    International Nuclear Information System (INIS)

    Objective: To explore the safety and efficacy of high-intensity focused ultrasound (HIFU) for the treatment of uterus myomas. Methods: HIFU was performed in 47 patients with symptomatic hysteromyoma, who had a childbearing history and were 26-59 years old. Postoperative follow-up was carried out. Clinical symptoms and the tumor's size were observed before and after the HIFU treatment. The results were compared with each other. Results: After HIFU treatment, the symptoms such as dysmenorrhea and hypermenorrhea were markedly improved. Some patients developed hematuria or lower limb pain, which was relieved after symptomatic management. The average volume of myoma before the treatment was (47.6 ± 24.1) cm3 and it was reduced to (17.7 ± 13.1) cm3 at 6 months after the treatment, the difference was statistically significant (P < 0.05). Conclusion: HIFU is a safe and effective treatment for uterus myomas. (authors)

  9. The Efficacy of High-Intensity Focused Ultrasound (HIFU) in Advanced Pancreatic Cancer

    Institute of Scientific and Technical Information of China (English)

    Bo Xie; Jiajun Ling; Weiming Zhang; Xueqin Huang; Jihua Zhen; Yanzhe Huang

    2008-01-01

    OBJECTIVE To observe the efficacy of high-intensity focused ultrasound (HIFU)in the treatment of late-stage pancreatic cancer.METHODS Sixteen patients with advanced pancreatic cancer received HIFU therapy.Evaluation of efficacy was made on the basis of changes in clinical symptoms and variations in the tumor echo and size.RESULTS Clinical symptoms such as pain were significantly alleviated,echo of the tumor was enhanced with B-US and the quality of life such as eating,sleeping and mental status was markedly improved;no serious complications were observed.CONCLUSION The use of HIFU in the treatment of advanced pancreatic cancer is feasible and safe.It is effective in killing the carcinoma cells and alleviaring pain.This technique may offer non-invasive therapy for the treatment of patients with late-stage pancreatic cancer.

  10. High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases.

    Science.gov (United States)

    Orgera, Gianluigi; Krokidis, Miltiadis; Monfardini, Lorenzo; Bonomo, Guido; Della Vigna, Paolo; Fazio, Nicola; Orsi, Franco

    2011-04-01

    We describe the use of ultrasound-guided high-intensity focused ultrasound (HIFU) for ablation of two pancreatic neuroendocrine tumours (NETs; insulinomas) in two inoperable young female patients. Both suffered from episodes of severe nightly hypoglycemia that was not efficiently controlled by medical treatment. After HIFU ablation, local disease control and symptom relief were achieved without postinterventional complications. The patients remained free of symptoms during 9-month follow-up. The lesions appeared to be decreased in volume, and there was decreased enhancing pattern in the multidetector computed tomography control (MDCT). HIFU is likely to be a valid alternative for symptoms control in patients with pancreatic NETs. However, currently the procedure should be reserved for inoperable patients for whom symptoms cannot be controlled by medical therapy. PMID:20521049

  11. Experimental ablation of the pancreas with high intensity focused ultrasound (HIFU in a porcine model

    Directory of Open Access Journals (Sweden)

    Biao Xie, Yu-Yuan Li, Lin Jia, Yu-Qiang Nie, Hong Du, Shu-Man Jiang

    2011-01-01

    Full Text Available The aim of this study was to determine the feasibility and safety of high intensity focused ultrasound's (HIFU in pancreatic diseases. Twelve pigs were divided into three groups. The pancreases of pigs in Group A were ablated directly with HIFU, but those in Group B and C ablated by extracorporeal HIFU. The pigs in Group C were sacrificed at day 7 after HIFU. Serological parameters were determined pre-operation and post-operation. The entire pancreas was removed for histological examination. Each animal tolerate the HIFU ablation well. The complete necrosis was observed in targeted regions. The margins of the necrotic regions were clearly delineated from the surrounding normal tissues. Infiltration of inflammatory cells and phorocytosis on the boundary were found in group C. Blood and urine amylase levels were relatively steady after HIFU. No acute pancreatitis or severe complications occurred. In conclusion, HIFU ablation on the pancreas was safe and effective in experimental pigs.

  12. Investigations on the heating effect of PE-LD induced by high-intensity focused ultrasound.

    Science.gov (United States)

    Oehm, Lukas; Bach, Sascha; Majschak, Jens-Peter

    2016-08-01

    High-intensity focused ultrasound is widely applied in tissue treatment as well as for heating of solid polymer materials. Previous studies investigating the heating effect in polymer materials utilized sound transmission through water or other fluids at low HIFU power. In this study, the ultrasonic transducer possesses a solid sound conductor made of aluminum and a high HIFU power of above 100W was applied to heat solid PE-LD samples. Temperature measurements were performed by calibrated non-invasive infrared thermal imaging. A strong heating effect with heating above melting temperature and evaporation temperature within less than 1s of irradiation was observed. Furthermore, the acoustic coupling defined by the force applied by the ultrasonic applicator to the polymer material was found to be fundamental to induce the heating effect. This investigation reveals HIFU for new applications in the field of polymer processing. PMID:27208613

  13. High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma

    Directory of Open Access Journals (Sweden)

    Lv W

    2016-05-01

    Full Text Available Wei Lv, Tao Yan, Guojin Wang, Wei Zhao, Tao Zhang, Dinghua Zhou Hepatobiliary Surgery Department, Second Artillery General Hospital, Xicheng District, Beijing, People’s Republic of China Objective: To investigate the therapeutic effect and safety of high-intensity focused ultrasound (HIFU therapy combined with gemcitabine in treating unresectable pancreatic carcinoma. Methods: The 45 patients suffering from pancreatic carcinoma were randomized into two groups. The patients in the experimental group (n=23 received HIFU in combination with gemcitabine and those in the control group (n=22 received gemcitabine alone. The effect and clinical benefit rates in the two groups were compared. The median survival time and 6-month and 12-month survival rates were calculated by Kaplan–Meier method and log-rank test. Results: The median survival time and 6-month survival rate were significantly higher in the experimental group than in the control group (8.91 months vs 5.53 months, 73.9% vs 40.9%, respectively P<0.05, but 12-month survival rate was not statistically different between the two groups (13.0% vs 4.5%, P>0.05. The clinical benefit rates in the experimental group and the control group were 69.6% and 36.3%, respectively (P<0.05. The pain remission rate in the experimental group was significantly higher than that in the control group (65.2% vs 31.8%, P<0.05. Conclusion: HIFU in combination with gemcitabine is better than gemcitabine alone. This combinatorial therapy may become a better and effective treatment for unresectable pancreatic carcinoma. Keywords: pancreatic carcinoma treatment, high-intensity focused ultrasound therapy, gemcitabine

  14. A random phased array device for delivery of high intensity focused ultrasound

    Energy Technology Data Exchange (ETDEWEB)

    Hand, J W [Radiological Sciences Unit, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS (United Kingdom); Shaw, A; Sadhoo, N; Rajagopal, S [Acoustics Group, National Physical Laboratory, Teddington TW11 0LW (United Kingdom); Dickinson, R J [Department of Bioengineering, Imperial College London, London SW7 2AZ (United Kingdom); Gavrilov, L R [N.N. Andreev Acoustics Institute, 117036 Moscow (Russian Federation)], E-mail: j.hand@imperial.ac.uk

    2009-10-07

    Randomized phased arrays can offer electronic steering of a single focus and simultaneous multiple foci concomitant with low levels of secondary maxima and are potentially useful as sources of high intensity focused ultrasound (HIFU). This work describes laboratory testing of a 1 MHz random phased array consisting of 254 elements on a spherical shell of radius of curvature 130 mm and diameter 170 mm. Acoustic output power and efficiency are measured for a range of input electrical powers, and field distributions for various single- and multiple-focus conditions are evaluated by a novel technique using an infrared camera to provide rapid imaging of temperature changes on the surface of an absorbing target. Experimental results show that the array can steer a single focus laterally to at least {+-}15 mm off axis and axially to more than {+-}15 mm from the centre of curvature of the array and patterns of four and five simultaneous foci {+-}10 mm laterally and axially whilst maintaining low intensity levels in secondary maxima away from the targeted area in good agreement with linear theoretical predictions. Experiments in which pork meat was thermally ablated indicate that contiguous lesions several cm{sup 3} in volume can be produced using the patterns of multiple foci.

  15. An image-guided high intensity focused ultrasound device for uterine fibroids treatment

    International Nuclear Information System (INIS)

    A high intensity focused ultrasound (HIFU) device was developed for treating uterine fibroid tumors. This prototype device enables image-guided therapy by aligning a commercially available abdominal ultrasound image probe to a vaginal HIFU transducer so the HIFU focus is in the image plane. The device was designed based on anatomical constraints of the female pelvic structures. HIFU was generated using a 3.5 MHz PZT-8 crystal, 25.4 mm in diameter, bonded to an aluminum lens. Computer simulations were performed to ensure that effective focusing was achievable at a fixed focal depth of 40 mm. Transducer efficiency was empirically determined to be 58%, and the half pressure maximum focal dimensions were 11 mm in length and 1.2 mm in width. A water-filled latex condom surrounding the transducer provided acoustic coupling, a stand-off, and allowed water circulation for transducer cooling. In vitro experiments in a tissue-mimicking gel phantom and in turkey breast demonstrated ultrasound image-guided lesion formation, or tissue necrosis, at the focus due to HIFU induced thermal and cavitation effects. The HIFU treatment site appeared as a hyperechoic spot on the ultrasound image at intensities above 1250 W/cm2. The results of in vitro experiments and in vivo ergonomic testing in six human volunteers indicated that the device has the potential of providing a nonsurgical approach for uterine fibroid treatment. Future in vivo studies in large animal models and fibroids patients are planned

  16. Numerical Simulation of Temperature Elevation in Soft Tissue by High Intensity Focused Ultrasound

    Science.gov (United States)

    Lee, Kang Il; Sim, Imbo; Kang, Gwan Suk; Choi, Min Joo

    In focused ultrasound surgery, high intensity focused ultrasound (HIFU) can be used to destroy pathological tissue deep inside the body without any damage to the surrounding normal tissue. This noninvasive technique has been used to treat malignant tumors of the liver, prostate, kidney, and benign breast tumors via a percutaneous or transrectal approach without the need for general anaesthesia. In the present study, a finite element method was used for the simulation of temperature elevation in soft tissue by HIFU. First, the HIFU field was modeled using the Westervelt equation for the propagation of finite-amplitude sound in a thermoviscous fluid in order to account for the effects of diffraction, absorption, and nonlinearity. Second, the Pennes bioheat transfer equation was used to predict the temperature elevation in soft tissue by HIFU. In order to verify the numerical simulation, the simulated temperature elevation at the focus in a tissue-mimicking phantom was compared with the measurements, using a concave focused transducer with a focal length of 62.6 mm, a radius of 35.0 mm, and a center frequency of 1.1 MHz.

  17. Acoustic characterization of high intensity focused ultrasound fields generated from a transmitter with a large aperture

    Science.gov (United States)

    Chen, Tao; Fan, Tingbo; Zhang, Wei; Qiu, Yuanyuan; Tu, Juan; Guo, Xiasheng; Zhang, Dong

    2014-03-01

    Prediction and measurement of the acoustic field emitted from a high intensity focused ultrasound (HIFU) is essential for the accurate ultrasonic treatment. In this study, the acoustic field generated from a strongly focused HIFU transmitter was characterized by a combined experiment and simulation method. The spheroidal beam equation (SBE) was utilized to describe the nonlinear sound propagation. The curve of the source pressure amplitude versus voltage excitation was determined by fitting the measured ratio of the second harmonic to the fundamental component of the focal waveform to the simulation result; finally, the acoustic pressure field generated by the strongly focused HIFU transmitter was predicted by using the SBE model. A commercial fiber optic probe hydrophone was utilized to measure the acoustic pressure field generated from a 1.1 MHz HIFU transmitter with a large half aperture angle of 30°. The maximum measured peak-to-peak pressure was up to 72 MPa. The validity of this combined approach was confirmed by the comparison between the measured results and the calculated ones. The results indicate that the current approach might be useful to describe the HIFU field. The results also suggest that this method is not valid for low excitations owing to low sensitivity of the second harmonic.

  18. Acoustic characterization of high intensity focused ultrasound fields generated from a transmitter with a large aperture

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Tao; Fan, Tingbo [Institute of Acoustics, Key Laboratory of Modern Acoustics, MOE, Nanjing University, Nanjing 210093 (China); Jiangsu Province Institute for Medical Equipment Testing, Nanjing 210012 (China); Zhang, Wei [Jiangsu Province Institute for Medical Equipment Testing, Nanjing 210012 (China); Qiu, Yuanyuan [Department of electronic information, Nantong University, Nantong 226019 (China); Tu, Juan, E-mail: juantu@nju.edu.cn, E-mail: dzhang@nju.edu.cn; Guo, Xiasheng [Institute of Acoustics, Key Laboratory of Modern Acoustics, MOE, Nanjing University, Nanjing 210093 (China); Zhang, Dong, E-mail: juantu@nju.edu.cn, E-mail: dzhang@nju.edu.cn [Institute of Acoustics, Key Laboratory of Modern Acoustics, MOE, Nanjing University, Nanjing 210093 (China); Institute of Acoustics, State Key Laboratory of Acoustics, Chinese Academy of Sciences, Beijing 100190 (China)

    2014-03-21

    Prediction and measurement of the acoustic field emitted from a high intensity focused ultrasound (HIFU) is essential for the accurate ultrasonic treatment. In this study, the acoustic field generated from a strongly focused HIFU transmitter was characterized by a combined experiment and simulation method. The spheroidal beam equation (SBE) was utilized to describe the nonlinear sound propagation. The curve of the source pressure amplitude versus voltage excitation was determined by fitting the measured ratio of the second harmonic to the fundamental component of the focal waveform to the simulation result; finally, the acoustic pressure field generated by the strongly focused HIFU transmitter was predicted by using the SBE model. A commercial fiber optic probe hydrophone was utilized to measure the acoustic pressure field generated from a 1.1 MHz HIFU transmitter with a large half aperture angle of 30°. The maximum measured peak-to-peak pressure was up to 72 MPa. The validity of this combined approach was confirmed by the comparison between the measured results and the calculated ones. The results indicate that the current approach might be useful to describe the HIFU field. The results also suggest that this method is not valid for low excitations owing to low sensitivity of the second harmonic.

  19. Noninvasive surgery of prostate tissue by high-intensity focused ultrasound: an updated report

    Science.gov (United States)

    Sanghvi, Narendra T.; Syrus, J.; Foster, Richard S.; Bihrle, Richard; Casey, Richard W.; Uchida, Toyoak

    2000-05-01

    High Intensity Focused Ultrasound (HIFU) has been clinically used for the treatment of benign prostatic hyperplasia (BPH) and it is experimentally applied for the treatment of localized prostate caner (PC). Recent advances in the transducer material and technology have permitted to combine the ultrasound visualization capability and HIFU on the same ceramic crystal. Also, the transducer efficiency has increased to a level that a smaller size intracavity probe can be made to produce sufficient acoustic power required for the focused ultrasound surgery of the prostate. Using this technology, 4 MHz mechanically scanning transrectal ultrasound probes has been designed. The transrectal probes are used with Sonablate (SB-200, manufactured by Focus Surgery, Inc., Indianapolis, IN) device. The SB-200 produces both transverse and longitudinal images of the prostate. The transverse and longitudinal images are used for selection of tissue volume, treatment planning and monitoring of tissue during the HIFU treatment cycle. The paper reviews the present operation of the device and recent clinical protocol that has improved efficiency, efficacy and safety of the device. The two years follow-up clinical results from the multi-site US Pilot Study (USPS) and The Male Health Centre are compared with the Kitasato-study (Kitasato School of Medicine, Sagamihara, Japan).

  20. Impact of preconditioning pulse on lesion formation during high-intensity focused ultrasound histotripsy.

    Science.gov (United States)

    Xu, Jin; Bigelow, Timothy A; Riesberg, Grant M

    2012-11-01

    Therapeutic applications with high-intensity focused ultrasound (HIFU) fall into two classifications-one using thermal effect for coagulation or ablation while generally avoiding cavitation and the other using cavitation-mediated mechanical effects while suppressing heating. Representative of the latter, histotripsy uses HIFU at low duty factor to create energetic bubble clouds inside tissue to liquefy a region and has the advantages in real-time monitoring and lesion fidelity to treatment planning. We explored the impact of a preconditioning/heating pulse on histotripsy lesion formation in porcine muscle samples. During sonication, a targeted square region 9 mm wide (lateral to the focal plane) was scanned in a raster pattern with a step size of 0.75 mm. The 20-s exposure at each treatment location consisted of a 5-s duration preconditioning burst at spatial-peak intensities from 0-1386 W/cm² followed by 5000 tone bursts at high intensity (with spatial-peak pulse-average intensity of 47.34 kW/cm², spatial-peak temporal-average intensity of 284 W/cm², peak compressional pressure of 102 MPa and peak rarefactional pressure of 17 MPa). The temperature increase for all exposures was measured using a thermal imager immediately after each exposure. Lesion volume increased with increasing amplitude of the preconditioning pulse until coagulation was observed, but lesion width/area did not change significantly with the amplitude. In addition, the lesion dimensions became smaller when the global tissue temperature was raised before applying the histotripsy pulsing sequence. Therefore, the benefit of the preconditioning pulse was not caused by global heating. PMID:22929656

  1. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis

    Energy Technology Data Exchange (ETDEWEB)

    Fan, Tien-Ying [State Key Laboratory of Ultrasound Engineering in Medicine, Department of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Zhang, Lian; Chen, Wenzhi [Clinical Center of Tumor Therapy of 2nd Affiliated Hospital of Chongqing Medical University, Chongqing 400010 (China); Liu, Yinjiang; He, Min; Huang, Xiu [State Key Laboratory of Ultrasound Engineering in Medicine, Department of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Orsi, Franco [Interventional Radiology Unit, European Institute of Oncology, 435 Via Ripamonti, 20141 Milan (Italy); Wang, Zhibiao, E-mail: wangzhibiao@haifu.com.cn [State Key Laboratory of Ultrasound Engineering in Medicine, Department of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Clinical Center of Tumor Therapy of 2nd Affiliated Hospital of Chongqing Medical University, Chongqing 400010 (China)

    2012-11-15

    Highlights: Black-Right-Pointing-Pointer We tested the feasibility of MRIgHIFU ablation for adenomyosis. Black-Right-Pointing-Pointer Patients were treated with MRIgHIFU under conscious sedation. Black-Right-Pointing-Pointer Patient symptoms were assessed using SSS and UFS-QOL. Black-Right-Pointing-Pointer The mean SSS and UFS-QOL showed significant improvements at follow up. Black-Right-Pointing-Pointer No serious complications were observed 62.5 {+-} 21.6. -- Abstract: Purpose: To test the feasibility of MRI-guided high intensity focused ultrasound ablation for adenomyosis. Materials and methods: Patients with symptomatic adenomyosis were treated with MRI-guided high intensity focused ultrasound (MRIgHIFU). Under conscious sedation, MRIgHIFU was performed by a clinical MRI-compatible focused ultrasound tumour therapeutic system (JM15100, Haifu{sup Registered-Sign} Technology Co. Ltd., Chongqing, China) which is combined with a 1.5 T MRI system (Magnetom Symphony, Siemens Healthcare, Erlangen, Germany). MRI was used to calculate the volume of the uterus and lesion. Non-perfused volume of the targeted lesions was evaluated immediately after MRIgHIFU. Patient symptoms were assessed using symptom severity score (SSS) and uterine fibroids symptoms and quality of life questionnaire (UFS-QOL). Results: Ten patients with mean age of 40.3 {+-} 4 years with an average lesion size of 56.9 {+-} 12.7 mm in diameter were treated. Non-perfused volume and the percentage of non-perfused volume obtained from contrast-enhanced T1 Magnetic resonance images immediately post-treatment were 66.6 {+-} 49.4 cm{sup 3} and 62.5 {+-} 21.6%, respectively. The mean SSS and UFS-QOL showed significant improvements of 25%, 16% and 25% at 3, 6 and 12 months follow up, respectively, to pre-treatment scores. No serious complications were observed. Conclusion: Based on the results from this study, MRIgHIFU treatment appears to be a safe and feasible modality to ablate adenomyosis lesion and

  2. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis

    International Nuclear Information System (INIS)

    Highlights: ► We tested the feasibility of MRIgHIFU ablation for adenomyosis. ► Patients were treated with MRIgHIFU under conscious sedation. ► Patient symptoms were assessed using SSS and UFS-QOL. ► The mean SSS and UFS-QOL showed significant improvements at follow up. ► No serious complications were observed 62.5 ± 21.6. -- Abstract: Purpose: To test the feasibility of MRI-guided high intensity focused ultrasound ablation for adenomyosis. Materials and methods: Patients with symptomatic adenomyosis were treated with MRI-guided high intensity focused ultrasound (MRIgHIFU). Under conscious sedation, MRIgHIFU was performed by a clinical MRI-compatible focused ultrasound tumour therapeutic system (JM15100, Haifu® Technology Co. Ltd., Chongqing, China) which is combined with a 1.5 T MRI system (Magnetom Symphony, Siemens Healthcare, Erlangen, Germany). MRI was used to calculate the volume of the uterus and lesion. Non-perfused volume of the targeted lesions was evaluated immediately after MRIgHIFU. Patient symptoms were assessed using symptom severity score (SSS) and uterine fibroids symptoms and quality of life questionnaire (UFS-QOL). Results: Ten patients with mean age of 40.3 ± 4 years with an average lesion size of 56.9 ± 12.7 mm in diameter were treated. Non-perfused volume and the percentage of non-perfused volume obtained from contrast-enhanced T1 Magnetic resonance images immediately post-treatment were 66.6 ± 49.4 cm3 and 62.5 ± 21.6%, respectively. The mean SSS and UFS-QOL showed significant improvements of 25%, 16% and 25% at 3, 6 and 12 months follow up, respectively, to pre-treatment scores. No serious complications were observed. Conclusion: Based on the results from this study, MRIgHIFU treatment appears to be a safe and feasible modality to ablate adenomyosis lesion and alleviate its symptoms.

  3. High-Intensity Focused Ultrasound (HIFU) in Uterine Fibroid Treatment: Review Study

    International Nuclear Information System (INIS)

    High-intensity focused ultrasound (HIFU) is a highly precise medical procedure used locally to heat and destroy diseased tissue through ablation. This study intended to review HIFU in uterine fibroid therapy, to evaluate the role of HIFU in the therapy of leiomyomas as well as to review the actual clinical activities in this field including efficacy and safety measures beside the published clinical literature. An inclusive literature review was carried out in order to review the scientific foundation, and how it resulted in the development of extracorporeal distinct devices. Studies addressing HIFU in leiomyomas were identified from a search of the Internet scientific databases. The analysis of literature was limited to journal articles written in English and published between 2000 and 2013. In current gynecologic oncology, HIFU is used clinically in the treatment of leiomyomas. Clinical research on HIFU therapy for leiomyomas began in the 1990s, and the majority of patients with leiomyomas were treated predominantly with HIFUNIT 9000 and prototype single focus ultrasound devices. HIFU is a non-invasive and highly effective standard treatment with a large indication range for all sizes of leiomyomas, associated with high efficacy, low operative morbidity and no systemic side effects. Uterine fibroid treatment using HIFU was effective and safe in treating symptomatic uterine fibroids. Few studies are available in the literature regarding uterine artery embolization (UAE). HIFU provides an excellent option to treat uterine fibroids

  4. A fast boundary element method for the scattering analysis of high-intensity focused ultrasound.

    Science.gov (United States)

    van 't Wout, Elwin; Gélat, Pierre; Betcke, Timo; Arridge, Simon

    2015-11-01

    High-intensity focused ultrasound (HIFU) techniques are promising modalities for the non-invasive treatment of cancer. For HIFU therapies of, e.g., liver cancer, one of the main challenges is the accurate focusing of the acoustic field inside a ribcage. Computational methods can play an important role in the patient-specific planning of these transcostal HIFU treatments. This requires the accurate modeling of acoustic scattering at ribcages. The use of a boundary element method (BEM) is an effective approach for this purpose because only the boundaries of the ribs have to be discretized instead of the standard approach to model the entire volume around the ribcage. This paper combines fast algorithms that improve the efficiency of BEM specifically for the high-frequency range necessary for transcostal HIFU applications. That is, a Galerkin discretized Burton-Miller formulation is used in combination with preconditioning and matrix compression techniques. In particular, quick convergence is achieved with the operator preconditioner that has been designed with on-surface radiation conditions for the high-frequency approximation of the Neumann-to-Dirichlet map. Realistic computations of acoustic scattering at 1 MHz on a human ribcage model demonstrate the effectiveness of this dedicated BEM algorithm for HIFU scattering analysis. PMID:26627749

  5. High intensity focused ultrasound ablation: A new therapeutic option for solid tumors

    Directory of Open Access Journals (Sweden)

    Orsi Franco

    2010-01-01

    Full Text Available Surgery has been the standard of care in selected cases with solid tumors. However, a majority of patients are unable to undergo surgical resection because of the tumor sites, advanced stages, or poor general condition. High intensity focused ultrasound (HIFU is a novel non-invasive technique that is capable of producing coagulative necrosis at a precise focal point within the body, without harming overlying and adjacent structures even within the path of the beam. Diagnostic ultrasound was the first imaging modality used for guiding HIFU ablation in the 1990s. Over the last decade, thousands of patients with uterine fibroids, liver cancer, breast cancer, pancreatic cancer, bone tumors, renal cancer have been treated with ultrasound imaging-guided HIFU (USgHIFU worldwide. This USgHIFU system [Chongqing Haifu (HIFU Tech Co., Ltd., Chongqing, China] was first equipped in Asia, now in Europe. Several research groups have demonstrated that HIFU is safe and effective in treating human solid tumors. In 2004, the magnetic resonance guided focused ultrasound surgery (MRgFUS was approved by the United States Food and Drug Administration (FDA for clinical treatments of uterine fibroids. We conclude that HIFU offers patients another choice when no other treatment available or when patients refused surgical operation. This technique may play a key role in future clinical practice.

  6. High-Intensity Focused Ultrasound Ablation of Uterine Fibroids - Potential Impact on Fertility and Pregnancy Outcome.

    Science.gov (United States)

    Bohlmann, M K; Hoellen, F; Hunold, P; David, M

    2014-02-01

    Laparoscopic myomectomy is regarded as the gold standard for women with symptomatic fibroids who wish to become pregnant. High-intensity focused ultrasound (HIFU or MRgFUS) ablation of uterine fibroids is also being discussed as a non-surgical, minimally invasive, therapeutic option. This review examines the available data on the impact of HIFU/MRgFUS on fertility and pregnancy, focusing particularly on potential direct side-effects of this type of intervention on ovaries, fallopian tubes and uterus and potential late effects on pregnancy and birth, based on the current literature. All pregnancies after HIFU/MRgFUS published to date (around 100 cases) were evaluated. The published case series suggest that HIFU/MRgFUS ablation has no impact on the rate of miscarriages or other obstetrical outcome parameters. Because no prospective studies exist which permit firm conclusions to be drawn on the impact of HIFU/MRgFUS on fertility and pregnancy outcome in women with symptomatic fibroids, this approach is currently only recommended for women with suspected fertility problems due to uterine fibroids who either decline surgery or who have an unacceptably high surgical risk. PMID:24741124

  7. High-intensity focused ultrasound treatment (HIFU) for the advanced pancreatic cancer

    Energy Technology Data Exchange (ETDEWEB)

    Song, In Ho; Jung, Seung Eun; Hahn, Seong Tai; Jang, Jin Hee; Cho, Se Hyun; Han, Joon Yeol; Kim, Jin Il; Lee, Ji Young; Sung, Choon Ho [St. Mary' Hospital, the Catholic University of Korea, Seoul (Korea, Republic of)

    2007-06-15

    We wanted to evaluate the levels of effect and safety of high-intensity focused ultrasound ablation (HIFU) for treating patients with advanced pancreatic cancer. Nineteen sessions of HIFU, with the patients under general anesthesia, were performed in 18 patients with advanced pancreatic cancer. The change of the gray-scale of the target lesion was analyzed during HIFU, and MRI was performed before and after HIFU. We assessed the extent of coagulative necorsis, the change of pain and the complications after HIFU. The change of tumor size and the survival of patients were also evaluated. The average size of tumor was 4 cm in diameter. Eighty nine percent of the target tumors showed increased echogenicity. On MRI, necrosis of the entire target tumor occurred in 79% of the patients. After treatment, effective pain relief was noted in 89% of the patients. There were no major complications. No size increase of the treated tumor was noted during 24 weeks of follow-up for 10 patients. Six patients among 12 patients who were available for follow-up are still alive and they are receiving chemotherapy. Six patients expired due to other disease or progression of metastasis. HIFU is a safe method without any major complications, and it is effective for inducing tumor necrosis and achieving pain control for patients with advanced pancreatic cancer.

  8. High-intensity focused ultrasound treatment (HIFU) for the advanced pancreatic cancer

    International Nuclear Information System (INIS)

    We wanted to evaluate the levels of effect and safety of high-intensity focused ultrasound ablation (HIFU) for treating patients with advanced pancreatic cancer. Nineteen sessions of HIFU, with the patients under general anesthesia, were performed in 18 patients with advanced pancreatic cancer. The change of the gray-scale of the target lesion was analyzed during HIFU, and MRI was performed before and after HIFU. We assessed the extent of coagulative necorsis, the change of pain and the complications after HIFU. The change of tumor size and the survival of patients were also evaluated. The average size of tumor was 4 cm in diameter. Eighty nine percent of the target tumors showed increased echogenicity. On MRI, necrosis of the entire target tumor occurred in 79% of the patients. After treatment, effective pain relief was noted in 89% of the patients. There were no major complications. No size increase of the treated tumor was noted during 24 weeks of follow-up for 10 patients. Six patients among 12 patients who were available for follow-up are still alive and they are receiving chemotherapy. Six patients expired due to other disease or progression of metastasis. HIFU is a safe method without any major complications, and it is effective for inducing tumor necrosis and achieving pain control for patients with advanced pancreatic cancer

  9. Enhancement of Small Molecule Delivery by Pulsed High-Intensity Focused Ultrasound: A Parameter Exploration.

    Science.gov (United States)

    Zhou, Yufeng; Wang, Yak-Nam; Farr, Navid; Zia, Jasmine; Chen, Hong; Ko, Bong Min; Khokhlova, Tatiana; Li, Tong; Hwang, Joo Ha

    2016-04-01

    Chemotherapeutic drug delivery is often ineffective within solid tumors, but increasing the drug dose would result in systemic toxicity. The use of high-intensity focused ultrasound (HIFU) has the potential to enhance penetration of small molecules. However, operation parameters need to be optimized before the use of chemotherapeutic drugs in vivo and translation to clinical trials. In this study, the effects of pulsed HIFU (pHIFU) parameters (spatial-average pulse-average intensity, duty factor and pulse repetition frequency) on the penetration as well as content of small molecules were evaluated in ex vivo porcine kidneys. Specific HIFU parameters resulted in more than 40 times greater Evans blue content and 3.5 times the penetration depth compared with untreated samples. When selected parameters were applied to porcine kidneys in vivo, a 2.3-fold increase in concentration was obtained after a 2-min exposure to pHIFU. Pulsed HIFU has been found to be an effective modality to enhance both the concentration and penetration depth of small molecules in tissue using the optimized HIFU parameters. Although, performed in normal tissue, this study has the promise of translation into tumor tissue. PMID:26803389

  10. Positioning device for MRI-guided high intensity focused ultrasound system

    Energy Technology Data Exchange (ETDEWEB)

    Damianou, Christakis [Frederick Institute of Technology (FIT), Limassol (Cyprus); MEDSONIC, LTD, Limassol (Cyprus); Ioannides, Kleanthis [Polikliniki Igia, Limassol (Cyprus); Milonas, Nicos [Frederick Institute of Technology (FIT), Limassol (Cyprus)

    2008-04-15

    A prototype magnetic resonance imaging (MRI)- compatible positioning device was used to move an MRI-guided high intensity focused ultrasound (HIFU) transducer. The positioning device has three user-controlled degrees of freedom that allow access to various targeted lesions. The positioning device was designed and fabricated using construction materials selected for compatibility with high magnetic fields and fast switching magnetic field gradients encountered inside MRI scanners. The positioning device incorporates only MRI compatible materials such as piezoelectric motors, plastic sheets, brass screws, plastic pulleys and timing belts. The HIFU/MRI system includes the multiple subsystems (a) HIFU system, (b) MR imaging, (c) Positioning device (robot) and associate drivers, (d) temperature measurement, (e) cavitation detection, (f) MRI compatible camera, and (g) Soft ware. The MRI compatibility of the system was successfully demonstrated in a clinical high-field MRI scanner. The ability of the robot to accurately move the transducer thus creating discrete and overlapping lesions in biological tissue was tested successfully. A simple, cost effective, portable positioning device has been developed which can be used in virtually any clinical MRI scanner since it can be sited on the scanner's table. The propagation of HIFU can use either a lateral or superior-inferior approach. Discrete and large lesions were created successfully with reproducible results. (orig.)

  11. Advances in MR image-guided high-intensity focused ultrasound therapy.

    Science.gov (United States)

    Kim, Young-sun

    2015-05-01

    The clinical role of magnetic resonance image-guided high-intensity focused ultrasound (MR-HIFU) is rapidly expanding due to its merit of non-invasiveness. MR thermometry based on a proton resonance frequency shift technique is able to accurately measure HIFU-induced temperature changes, which provides considerable advantages over ultrasonography-guided HIFU in terms of safety and therapeutic efficacy. Recent studies and the resulting technological advances in MR-HIFU such as MR thermometry for moving organs, MR-acoustic radiation force imaging, and a volumetric mild hyperthermia technique further will expand its clinical roles from mere ablation therapy to targeted drug delivery and chemo- or radio-sensitisation for cancer treatment. In this article, MR-HIFU therapy is comprehensively reviewed with an emphasis on the roles of MR imaging in HIFU therapy, techniques of MR monitoring, recent advances in clinical MR-HIFU systems, and potential future applications of MR-HIFU therapy. In addition, the pros and cons of MR-HIFU when compared with ultrasonography-guided HIFU are discussed. PMID:25373687

  12. Salvage High-intensity Focused Ultrasound for the Recurrent Prostate Cancer after Radiotherapy

    International Nuclear Information System (INIS)

    To investigate the use of minimally invasive high-intensity focused ultrasound (HIFU) as a salvage therapy in men with localized prostate cancer recurrence following external beam radiotherapy (EBRT), brachytherapy or proton therapy. A review of 20 cases treated using the Sonablate registered 500 HIFU device, between August 28, 2002 and September 1, 2009, was carried out. All men had presumed organ-confined, histologically confirmed recurrent prostate adenocarcinoma following radiation therapy. All men with presumed, organ-confined, recurrent disease following EBRT in 8 patients, brachytherapy in 7 patients or proton therapy in 5 patients treated with salvage HIFU were included. The patients were followed for a mean (range) of 16.0 (3-80) months. Biochemical disease-free survival (bDFS) rates in patients with low-intermediate and high risk groups were 86% and 50%, respectively. Side-effects included urethral stricture in 2 of the 16 patients (13%), urinary tract infection or dysuria syndrome in eight (26%), and urinary incontinence in one (6%). Recto-urethral fistula occurred in one patient (6%). Transrectal HIFU is an effective treatment for recurrence after radiotherapy especially in patients with low- and intermediate risk groups.

  13. Dynamic T2-mapping during magnetic resonance guided high intensity focused ultrasound ablation of bone marrow

    International Nuclear Information System (INIS)

    Focal bone tumor treatments include amputation, limb-sparing surgical excision with bone reconstruction, and high-dose external-beam radiation therapy. Magnetic resonance guided high intensity focused ultrasound (MR-HIFU) is an effective non-invasive thermotherapy for palliative management of bone metastases pain. MR thermometry (MRT) measures the proton resonance frequency shift (PRFS) of water molecules and produces accurate (2, since T2 increases linearly in fat during heating. T2-mapping using dual echo times during a dynamic turbo spin-echo pulse sequence enabled rapid measurement of T2. Calibration of T2-based thermal maps involved heating the marrow in a bovine femur and simultaneously measuring T2 and temperature with a thermocouple. A positive T2 temperature dependence in bone marrow of 20 ms/°C was observed. Dynamic T2-mapping should enable accurate temperature monitoring during MR-HIFU treatment of bone marrow and shows promise for improving the safety and reducing the invasiveness of pediatric bone tumor treatments.

  14. High-Intensity Focused Ultrasound for Prostate Cancer: Long-Term Followup and Complications Rate

    Directory of Open Access Journals (Sweden)

    Umberto Maestroni

    2012-01-01

    Full Text Available Introduction. As it is well known, High Intensity Focused Ultrasound (HIFU is a minimally invasive procedure for prostate cancer. Many investigators reported their series of patients, demonstrating the effectiveness of the treatment. The most majority of Authors, however, do not report the side effects and the complications of the procedure, which is the aim of our study. The diagnosis and management of complications is discussed, and the oncologic outcome is reported in terms of quality of life. Materials and Methods. We report our experience in 89 patients, low-, intermediate-, and high-risk patients according with D’Amico classification. All data collected along the study were analyzed, including side effects and complications of the procedure. Results. Our series demonstrates the effectiveness of the procedure, in line with larger series reported in literature by other investigators. The most important side effects are sexual function impairment and transient incontinence in a minority of cases. Minor complications are reported as well as rare cases of major complications, which can require surgical treatment.

  15. Salvage High-intensity Focused Ultrasound for the Recurrent Prostate Cancer after Radiotherapy

    Science.gov (United States)

    Shoji, S.; Nakano, M.; Omata, T.; Harano, Y.; Nagata, Y.; Usui, Y.; Terachi, T.; Uchida, T.

    2010-03-01

    To investigate the use of minimally invasive high-intensity focused ultrasound (HIFU) as a salvage therapy in men with localized prostate cancer recurrence following external beam radiotherapy (EBRT), brachytherapy or proton therapy. A review of 20 cases treated using the Sonablate® 500 HIFU device, between August 28, 2002 and September 1, 2009, was carried out. All men had presumed organ-confined, histologically confirmed recurrent prostate adenocarcinoma following radiation therapy. All men with presumed, organ-confined, recurrent disease following EBRT in 8 patients, brachytherapy in 7 patients or proton therapy in 5 patients treated with salvage HIFU were included. The patients were followed for a mean (range) of 16.0 (3-80) months. Biochemical disease-free survival (bDFS) rates in patients with low-intermediate and high risk groups were 86% and 50%, respectively. Side-effects included urethral stricture in 2 of the 16 patients (13%), urinary tract infection or dysuria syndrome in eight (26%), and urinary incontinence in one (6%). Recto-urethral fistula occurred in one patient (6%). Transrectal HIFU is an effective treatment for recurrence after radiotherapy especially in patients with low- and intermediate risk groups.

  16. PATHOMORPHISM OF PROSTATE CANCER DURING HIGH-INTENSITY FOCUSED ULTRASOUND TREATMENT

    Directory of Open Access Journals (Sweden)

    R. N. Fomkin

    2013-01-01

    Full Text Available The purpose of the study was to evaluate the efficiency of prostate cancer (PC treatment using high-intensity focused ultrasound (HIFU on the basis of morphometric and immunohistochemical (IHC analyses of postoperative prostate biopsy specimens. The study subjects were 40 patients with localized and locally advanced PC. The postoperative morphological analysis was made on the basis of standard hematoxylineosin staining and morphometric and IHC studies using the following antibodies: PCNA, Bcl-2, AMACR, Е-cadherin, and ANDR (Dako. Pre- and post-HIFU therapy histological examination of the routinely hematoxylin-eosin-stained specimens showed that the therapeutic pathomorphism of the tumor corresponded to grades III and IV. It was established that the IHC study should be used as an additional crite-rion for the efficiency of PC therapy after HIFU ablation. In spite of positive clinical, laboratory, instrumental, and objective changes, the patients with high AMACR and Bcl-2 levels and decreased Е-cadherin expression may be considered as a group at risk for prolonged malignant growth or recurrent PC.

  17. Urodynamic Evaluation after High-Intensity Focused Ultrasound for Patients with Prostate Cancer

    Directory of Open Access Journals (Sweden)

    Luigi Mearini

    2014-01-01

    Full Text Available This prospective study assesses the impact of high-intensity focused ultrasound (HIFU on lower urinary tract by comparing pre- and postoperative symptoms and urodynamic changes. Thirty consecutive patients with clinically organ-confined prostate cancer underwent urodynamic study before HIFU and then at 3–6 months after surgery. Continence status and symptoms were analyzed by means of International Prostate Symptoms Score IPSS and International Index Erectile Function IIEF5. As a result, there were a significant improvement in bladder outlet, maximum flow at uroflowmetry, and reduction in postvoid residual PVR at 6-month follow-up and a concomitant significant reduction of detrusor pressure at opening and at maximum flow. De novo overactive bladder and impaired bladder compliance were detected in 10% of patients at 3 months, with progressive improvement at longer follow-up. Baseline prostate volume and length of the procedure were predictors of 6-month IPSS score and continence status. In conclusion, following HIFU detrusor overactivity, decreased bladder compliance and urge incontinence represent de novo dysfunction due to prostate and bladder neck injury during surgery. However, urodynamic study shows a progressive improvement in all storage and voiding patterns at 6-month follow-up. Patients with high prostate volume and long procedure length suffered from irritative symptoms even at long term.

  18. High-Intensity Focused Ultrasound (HIFU) for the Treatment of Localized Prostate Cancer using Sonablate-500

    Science.gov (United States)

    Uchida, Toyoaki; Ohkusa, Hiroshi; Yamashita, Hideyuki; Nagata, Yoshihiro

    2005-03-01

    We evaluated 181 patients with localized prostate cancer treated with high-intensity focused ultrasound (HIFU) for biochemical disease-free rate, safety, morbidity and predictors of biochemical outcome. A total of 181 patients underwent HIFU with the Sonablate-500 and with at least 12 months of follow-up. Biochemical failure was defined according to the criteria recommended by the American Society for Therapeutic Radiology and Oncology Consensus Panel. The biochemical disease-free rates at 1, 3 and 5 years in all patients were 84%, 80% and 78%, respectively. The biochemical disease-free rates at 3 years for patients with pretreatment PSA less than 10 ng/ml, 10.01 to 20.0 ng/ml and more than 20.0 ng/ml were 94%, 75% and 35%, respectively (pHIFU therapy appears to be a safe and efficacious minimally invasive therapy for patients with localized prostate cancer, especially those with a pretreatment PSA level less than 20 ng/ml.

  19. High-intensity focused ultrasound for the treatment of solid tumor: Chinese clinical experience

    Science.gov (United States)

    Takeuchi, Akira; Zhang, Hong; Sun, Kun; Hasumura, Hiromi; Liu, Botao; Fu, Yurui; Yang, Zaocheng

    2006-05-01

    As a non-invasive modality, high-intensity focused ultrasound (HIFU) therapy has been received an interest for the treatment of solid tumor. There are some makers of HIFU for the equipment in China. The Sonic CZ901 is developed from the Mianyang stream that has a great advantage for guiding by color Doppler ultrasound imaging. For the research about possibility of this equipment, we evaluate the clinical usefulness to the solid tumor of HIFU treatment at Wujing general hospital in Beijing. We elucidate the result in 28 cases with benign and malignant tumor (Uterine myoma:16, Benign prostatic hypertrophy:5, Benign breast tumor:2, Breast cancer:1, Retroperitoneal tumor:1, Pheochromocytoma:1, Liver cancer: 2) . After 14˜90days, all cases show the reduction of tumor size (Max.3.2cm, Min.1.6cm, :Mean 2.2cm reduced), and the blood flow of tumor completely reduced in 7/23, partially reduced in16/23. Clinical symptoms disappeared in 7, clearly improved in 14, improved in 7. All treatments had no adverse event except for two cases of liver cancer. They felt an abdominal pain that controllable by medicine and it improved within 6hours. It is concluded that HIFU with guide by ultrasound imaging is very safe, painless and effective as the anti-tumor treatment.

  20. Analysis of clinical effect of high-intensity focused ultrasound on liver cancer

    Institute of Scientific and Technical Information of China (English)

    Chuan-Xing Li; Guo-Liang Xu; Zhen-You Jiang; Jian-Jun Li; Guang-Yu Luo; Hong-Bo Shan; Rong Zhang; Yin Li

    2004-01-01

    AIM: To evaluate the clinical effect of high-intensity focused ultrasound (HIFU) in the treatment of patients with liver cancer.METHODS: HIFU treatment was performed in 100 patients with liver cancer under general anesthesia and by a targeted ultrasound. Evaluation of efficacy was made on the basis of clinical symptoms, liver function tests, AFP,MRI or CT before and after the treatment.RESULTS: After HIFU treatment, clinical symptoms were relieved in 86.6%(71/82) of patients. The ascites disappeared in 6 patients. ALT (95±44) U/L and AST (114±58) U/L before HIFU treatment were reduced to normal in 83.3%(30/36) and 72.9%(35/48) patients,respectively, after the treatment. AFP was lowered by more than 50% in 65.3%(32/49) patients. After HIFU treatment,MRI or CT findings indicated coagulation necrosis and blood supply reduction or disappearance of tumor in the target region.CONCLUSION: HIFU can efficiently treat the patients with liver cancer. It will offer a significant noninvasive therapy for local treatment of liver tumor.

  1. PATHOMORPHISM OF PROSTATE CANCER DURING HIGH-INTENSITY FOCUSED ULTRASOUND TREATMENT

    Directory of Open Access Journals (Sweden)

    R. N. Fomkin

    2014-07-01

    Full Text Available The purpose of the study was to evaluate the efficiency of prostate cancer (PC treatment using high-intensity focused ultrasound (HIFU on the basis of morphometric and immunohistochemical (IHC analyses of postoperative prostate biopsy specimens. The study subjects were 40 patients with localized and locally advanced PC. The postoperative morphological analysis was made on the basis of standard hematoxylineosin staining and morphometric and IHC studies using the following antibodies: PCNA, Bcl-2, AMACR, Е-cadherin, and ANDR (Dako. Pre- and post-HIFU therapy histological examination of the routinely hematoxylin-eosin-stained specimens showed that the therapeutic pathomorphism of the tumor corresponded to grades III and IV. It was established that the IHC study should be used as an additional crite-rion for the efficiency of PC therapy after HIFU ablation. In spite of positive clinical, laboratory, instrumental, and objective changes, the patients with high AMACR and Bcl-2 levels and decreased Е-cadherin expression may be considered as a group at risk for prolonged malignant growth or recurrent PC.

  2. First Experience Of Application Of High-Intensity Focused Ultrasonic Ablation (Hifu In Prostate Cancer Treatment

    Directory of Open Access Journals (Sweden)

    A.V. Stativko

    2009-12-01

    Full Text Available The scientific article points out that 40 sessions of HIFU prostate ablation have been performed for estimation of clinical efficiency. Average frequency of influences presents 628±164 impulses; average volume of tissues subjected to influence during one procedure is 33,8±16,3 smi (132 % of prostate volume; average operation time constitutes 150 minutes (from 90 to 200 minutes. During the operation no complications have been occurred. In the first days after the session of HIFU there was a peak of PSA increase and then during 1,5-3 months there was decrease to the lowest index. Minimal PSA level was reached in 10-12 weeks after treatment and it constituted from 0,04 till 1,1 ngml depending on the disease state. Reduction of prostate volume occurred in average from the 30th day of postoperative period and lasted for 6 months, reaching in average 50 % from initial volume. Postoperative period varied from 10 till 16 days and constituted in average 12±0,8 days. Thus application of high-intensity focused ultrasonic ablation allows treating successfully various stages of prostate cancer with minimal number of side-effects and makes possible the early estimation of treatment efficiency

  3. Positioning device for MRI-guided high intensity focused ultrasound system

    International Nuclear Information System (INIS)

    A prototype magnetic resonance imaging (MRI)- compatible positioning device was used to move an MRI-guided high intensity focused ultrasound (HIFU) transducer. The positioning device has three user-controlled degrees of freedom that allow access to various targeted lesions. The positioning device was designed and fabricated using construction materials selected for compatibility with high magnetic fields and fast switching magnetic field gradients encountered inside MRI scanners. The positioning device incorporates only MRI compatible materials such as piezoelectric motors, plastic sheets, brass screws, plastic pulleys and timing belts. The HIFU/MRI system includes the multiple subsystems (a) HIFU system, (b) MR imaging, (c) Positioning device (robot) and associate drivers, (d) temperature measurement, (e) cavitation detection, (f) MRI compatible camera, and (g) Soft ware. The MRI compatibility of the system was successfully demonstrated in a clinical high-field MRI scanner. The ability of the robot to accurately move the transducer thus creating discrete and overlapping lesions in biological tissue was tested successfully. A simple, cost effective, portable positioning device has been developed which can be used in virtually any clinical MRI scanner since it can be sited on the scanner's table. The propagation of HIFU can use either a lateral or superior-inferior approach. Discrete and large lesions were created successfully with reproducible results. (orig.)

  4. Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: Preliminary results

    Energy Technology Data Exchange (ETDEWEB)

    Wang Yang [Department of Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853 (China); Wang Wei, E-mail: wangyang301301@yahoo.com.cn [Department of Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853 (China); Wang Longxia; Wang Junyan; Tang Jie [Department of Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853 (China)

    2011-07-15

    Purpose: To evaluate the safety and therapeutic efficacy of ultrasound (US)-guided high-intensity focused ultrasound (HIFU) ablation for the treatment of abdominal wall endometriosis (AWE). Materials and methods: Twenty-one consecutive patients with AWE were treated as outpatients by US-guided HIFU ablation under conscious sedation. The median size of the AWE was 2.4 cm (range 1.0-5.3 cm). An acoustic power of 200-420 W was used, intermittent HIFU exposure of 1 s was applied. Treatment was considered complete when the entire nodule and its nearby 1 cm margin become hyperechoic on US. Pain relief after HIFU ablation was observed and the treated nodule received serial US examinations during follow-up. Results: All AWE was successfully ablated after one session of HIFU ablation, the ablation time lasted for 5-48 min (median 13 min), no major complications occurred. The cyclic pain disappeared in all patients during a mean follow-up of 18.7 months (range 3-31 months). The treated nodules gradually shank over time, 16 nodules became unnoticeable on US during follow-up. Conclusion: US-guided HIFU ablation appears to be safe and effective for the treatment of AWE.

  5. High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy.

    Science.gov (United States)

    Copelan, Alexander; Hartman, Jason; Chehab, Monzer; Venkatesan, Aradhana M

    2015-12-01

    Image-guided high-intensity focused ultrasound (HIFU) is an innovative therapeutic technology, permitting extracorporeal or endocavitary delivery of targeted thermal ablation while minimizing injury to the surrounding structures. While ultrasound-guided HIFU was the original image-guided system, MR-guided HIFU has many inherent advantages, including superior depiction of anatomic detail and superb real-time thermometry during thermoablation sessions, and it has recently demonstrated promising results in the treatment of both benign and malignant tumors. HIFU has been employed in the management of prostate cancer, hepatocellular carcinoma, uterine leiomyomas, and breast tumors, and has been associated with success in limited studies for palliative pain management in pancreatic cancer and bone tumors. Nonthermal HIFU bioeffects, including immune system modulation and targeted drug/gene therapy, are currently being explored in the preclinical realm, with an emphasis on leveraging these therapeutic effects in the care of the oncology patient. Although still in its early stages, the wide spectrum of therapeutic capabilities of HIFU offers great potential in the field of image-guided oncologic therapy. PMID:26622104

  6. Pathological changes on human breast cancer specimens ablated in vitro with high-intensity focused ultrasound.

    Science.gov (United States)

    Niu, Lingchuan; Wang, Zhibiao; Zou, Wenbing; Zhang, Lian; Xiang, Like; Zhu, Hui; Chen, Wenzhi; Bai, Jin; Wu, Junru

    2010-09-01

    The purpose of this study was to evaluate the pathologic changes of human breast cancer specimens ablated with high-intensity focused ultrasound (HIFU) in vitro. Twenty specimens of pathologically confirmed breast cancer tissue were ablated with ultrasound-guided HIFU. The evaluation methods include histopathologic observation using hematoxylin-eosin staining, electron microscopic imaging, enzyme histochemical and immunohistochemical examination on tumor antigens. Vacuole-like structures in cytoplasm were observed by histopathologic observation but there were no significant changes in cell morphology and nucleus karyotype. Typical phenomena related to coagulation necrosis were observed in electron microscopic studies; the contour of cell structure was still preserved but the structures of cell (all kinds of organelles and nucleus) were damaged or disappeared. Acid phosphatase and succinate dehydrogenase staining showed that tumor cells were inactivated. In immunohistochemical evaluations, estrogen receptor, progesterone receptor, cerbB-2 and P53 expression changed from 85%, 82%, 75% and 80% in nonablation tissue to no expression in ablated tumor tissue, respectively. We, therefore, conclude that breast cancer cells appear normal contour immediately after ablation with HIFU under light microscopic but they were evaluated to be dead by electron microscopic imaging, enzyme histochemical and immunohistochemical examinations. PMID:20800171

  7. Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: Preliminary results

    International Nuclear Information System (INIS)

    Purpose: To evaluate the safety and therapeutic efficacy of ultrasound (US)-guided high-intensity focused ultrasound (HIFU) ablation for the treatment of abdominal wall endometriosis (AWE). Materials and methods: Twenty-one consecutive patients with AWE were treated as outpatients by US-guided HIFU ablation under conscious sedation. The median size of the AWE was 2.4 cm (range 1.0-5.3 cm). An acoustic power of 200-420 W was used, intermittent HIFU exposure of 1 s was applied. Treatment was considered complete when the entire nodule and its nearby 1 cm margin become hyperechoic on US. Pain relief after HIFU ablation was observed and the treated nodule received serial US examinations during follow-up. Results: All AWE was successfully ablated after one session of HIFU ablation, the ablation time lasted for 5-48 min (median 13 min), no major complications occurred. The cyclic pain disappeared in all patients during a mean follow-up of 18.7 months (range 3-31 months). The treated nodules gradually shank over time, 16 nodules became unnoticeable on US during follow-up. Conclusion: US-guided HIFU ablation appears to be safe and effective for the treatment of AWE.

  8. Treatment of murine tumors using acoustic droplet vaporization-enhanced high intensity focused ultrasound

    Science.gov (United States)

    Zhu, Meili; Jiang, Lixing; Fabiilli, Mario L.; Zhang, Aili; Fowlkes, J. Brian; Xu, Lisa X.

    2013-09-01

    High intensity focused ultrasound (HIFU) can be applied focally and noninvasively to thermally ablate solid tumors. Long treatment times are typically required for large tumors, which can expose patients to certain risks while potentially decreasing the therapeutic efficacy of the treatment. Acoustic droplet vaporization (ADV) is a promising modality that can enhance the efficacy of tumor treatment using HIFU. In this study, the therapeutic effects of combined HIFU and ADV was evaluated in mice bearing subcutaneously-implanted 4T1 tumors. Histological examination showed that the combination of HIFU and ADV generated a mean necrotic area in the tumor that was 2.9-fold larger than with HIFU alone. A significant enhancement of necrosis was found in the periphery of the tumor, where the blood supply was abundant. Seven days after treatment, the tumors treated with combined HIFU and ADV were 30-fold smaller in volume than tumors treated with HIFU alone. The study demonstrates the potential advantage of combining HIFU and ADV in tumor treatment.

  9. Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors

    Institute of Scientific and Technical Information of China (English)

    Jian-Jun Li; Guo-Liang Xu; Mo-Fa Gu; Guang-Yu Luo; Zhang Rong; Pei-Hong Wu; Jian-Chuan Xia

    2007-01-01

    AIM: To analyze the local and systemic complications of high intensity focused ultrasound (HIFU) for patients with recurrent and metastatic abdominal tumors.METHODS: From Aug 2001 to Aug 2004, 17 patients with recurrent and metastatic abdominal tumors were enrolled in this study. Real-time sonography was taken, and vital signs, liver and kidney function, skin burns, local reactions, and systemic effects were observed and recored before, during, and after HIFU. CT and MRI were also taken before and after HIFU.RESULTS: All 17 patients had skin burns and pAln in the treatment region; the next common complication was neurapraxia of the stomach and intestines to variable degrees. The other local and systemic complications were relatively rare. Severe complications were present in two patients; one developed a superior mesenteric artery infarction resulting in necrosis of the entire small intestines, and the other one suffered from a perforation in terminal ileum due to HIFU treatment.CONCLUSION: Although HIFU is a one of noninvasive treatments for the recurrent and metastatic abdominal tumors, there are still some common and severe complications which need serious consideration.

  10. Analgesic effect of high intensity focused ultrasound in patients with advanced pancreatic cancer

    Institute of Scientific and Technical Information of China (English)

    Xinjin Tan; Jian Chen; Li Ren; Ruilu Lin; Zailian Chen

    2013-01-01

    Objective:The aim of this study was to evaluate the analgesic ef ect of high intensity focused ultrasound (HIFU) in patients with advanced pancreatic cancer. Methods:A total of 106 patients with advanced pancreatic cancer accompanied by abdominal pain were treated by HIFU. Pain intensities and quantities of morphine consumption before and after treatment were observed and compared. Results:The average pain intensities before treatment, and at d3, d7 after treatment were 5.80 ± 2.14, 2.73 ± 2.68, 2.45 ± 2.43 respectively (P<0.01). Fifty-nine cases (55.7%) got to extremely ef ective, and 29 cases (27.4%) ef ective. Total ef icient rate was 83.0%. The average quantities of morphine consumption before and after treatment in the patients with grade III pain were 114.9 ± 132.5 mg, 16.8 ± 39.7 mg each person everyday respectively (P<0.01). Conclusion:HIFU can relieve pain suf ered by patients with pancreatic cancer ef ectively. It is a new adjuvant treatment for pancreatic cancer pain.

  11. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy

    Energy Technology Data Exchange (ETDEWEB)

    Voogt, M.J.; Mali, W.P.T.M.; Bosch, Maurice A.A.J. van den [University Medical Center Utrecht, Department of Radiology, Utrecht (Netherlands); Trillaud, H.; Frulio, N. [Hospital St. Andre, Department of Radiology, Bordeaux (France); Kim, Y.S.; Rhim, H.; Lim, H.K. [Sungkyunkwan University School of Medicine, Department of Radiology, Samsung Medical Center, Seoul (Korea, Republic of); Barkhausen, J.; Eckey, T. [University Hospital Schleswig-Holstein, Department of Radiology, Luebeck (Germany); Bartels, L.W.; Deckers, R. [University Medical Center Utrecht, Image Sciences Institute, Utrecht (Netherlands); Nieminen, H.J.; Soini, J.; Vaara, T.; Koehler, M.O. [Philips Healthcare, Vantaa (Finland); Mougenot, C. [Philips Healthcare, Toronto (Canada); Keserci, B. [Philips Healthcare, Seoul (Korea, Republic of); Sokka, S. [Philips Healthcare, Andover, MA (United States)

    2012-02-15

    The purpose of this prospective multicenter study was to assess the safety and technical feasibility of volumetric Magnetic Resonance-guided High Intensity Focused Ultrasound (MR-HIFU) ablation for treatment of patients with symptomatic uterine fibroids. Thirty-three patients with 36 fibroids were treated with volumetric MR-HIFU ablation. Treatment capability and technical feasibility were assessed by comparison of the Non-Perfused Volumes (NPVs) with MR thermal dose predicted treatment volumes. Safety was determined by evaluation of complications or adverse events and unintended lesions. Secondary endpoints were pain and discomfort scores, recovery time and length of hospital stay. The mean NPV calculated as a percentage of the total fibroid volume was 21.7%. Correlation between the predicted treatment volumes and NPVs was found to be very strong, with a correlation coefficient r of 0.87. All patients tolerated the treatment well and were treated on an outpatient basis. No serious adverse events were reported and recovery time to normal activities was 2.3 {+-} 1.8 days. This prospective multicenter study proved that volumetric MR-HIFU is safe and technically feasible for the treatment of symptomatic uterine fibroids. (orig.)

  12. Nonlinear 3-D simulation of high-intensity focused ultrasound therapy in the kidney

    CERN Document Server

    Suomi, Visa; Treeby, Bradley; Cleveland, Robin

    2016-01-01

    Kidney cancer is a severe disease which can be treated non-invasively using high-intensity focused ultrasound (HIFU) therapy. However, tissue in front of the transducer and the deep location of kidney can cause significant losses to the efficiency of the treatment. The effect of attenuation, refraction and reflection due to different tissue types on HIFU therapy of the kidney was studied using a nonlinear ultrasound simulation model. The geometry of the tissue was derived from a computed tomography (CT) dataset of a patient which had been segmented for water, bone, soft tissue, fat and kidney. The combined effect of inhomogeneous attenuation and sound-speed was found to result in an 11.0 dB drop in spatial peak-temporal average (SPTA) intensity in the kidney compared to pure water. The simulation without refraction effects showed a 6.3 dB decrease indicating that both attenuation and refraction contribute to the loss in focal intensity. The losses due to reflections at soft tissue interfaces were less than 0....

  13. Differential attenuation imaging for the characterization of high intensity focused ultrasound lesions.

    Science.gov (United States)

    Ribault, M; Chapelon, J Y; Cathignol, D; Gelet, A

    1998-07-01

    High intensity focused ultrasound (HIFU) is an effective technique for creating coagulative necrotic lesions in biological tissue, with a view to treating localized tumors. Although good results have already been obtained, notably in urology, current systems lack a real time monitoring system to check the efficacy of the treatment procedures. This study describes the development and assessment of a noninvasive system for making local measurements of attentuation variations during HIFU treatment procedures. An apparatus (Ablatherm, Edap-Technomed, France), combining a 2.5 MHz therapeutic transducer and a 5.5 MHz twin plane imaging probe (connected to an ultrasound scanner), was used to produce lesions. The rf signals needed to calculate the attenuation were recorded as outputs from the ultrasound scanner, before and after the high intensity firing sequences, which were performed on ten pieces of porcine liver. Each firing sequence involved producing a lesion volume comprising 42 individual lesions. A number of recordings were also made without producing lesions, in order to test the reproducibility of the measurements. The attenuation function was evaluated locally using the centroid and the multinarrowband methods. Initially, changes in the integrated attenuation alpha (mean attenuation in the 4-7 MHz range) and the attenuation slope beta were examined for the lesion volume. beta values did not vary significantly within this range, whereas alpha values varied significantly (in the region of 86% of the initial level) in comparison to measurements performed without forming lesions. The differential attenuation delta alpha (representing local variations in alpha) was subsequently used to generate images revealing the lesion areas. There was a strong similarity between these 'delta alpha images' and the lesion volumes defined by the operator. 'delta alpha images' offer several advantages over existing attenuation imaging techniques. Any problems related to the

  14. Shock-induced heating and millisecond boiling in gels and tissue due to high intensity focused ultrasound

    OpenAIRE

    Canney, Michael S.; Khokhlova, Vera A.; Bessonova, Olga V.; Bailey, Michael R.; Crum, Lawrence A.

    2009-01-01

    Nonlinear propagation causes high intensity ultrasound waves to distort and generate higher harmonics, which are more readily absorbed and converted to heat than the fundamental frequency. Although such nonlinear effects have previously been investigated and found not to significantly alter high intensity focused ultrasound (HIFU) treatments, two results reported here change this paradigm. One is that at clinically relevant intensity levels, HIFU waves not only become distorted but form shock...

  15. High-intensity focused ultrasound monitoring using harmonic motion imaging for focused ultrasound (HMIFU) under boiling or slow denaturation conditions.

    Science.gov (United States)

    Hou, Gary Y; Marquet, Fabrice; Wang, Shutao; Apostolakis, Iason-Zacharias; Konofagou, Elisa E

    2015-07-01

    Harmonic motion imaging for focused ultrasound (HMIFU) is a recently developed high-intensity focused ultrasound (HIFU) treatment monitoring method that utilizes an amplitude-modulated therapeutic ultrasound beam to induce an oscillatory radiation force at the HIFU focus and estimates the focal tissue displacement to monitor the HIFU thermal treatment. In this study, the performance of HMIFU under acoustic, thermal, and mechanical effects was investigated. The performance of HMIFU was assessed in ex vivo canine liver specimens (n = 13) under slow denaturation or boiling regimes. A passive cavitation detector (PCD) was used to assess the acoustic cavitation activity, and a bare-wire thermocouple was used to monitor the focal temperature change. During lesioning with slow denaturation, high quality displacements (correlation coefficient above 0.97) were observed under minimum cavitation noise, indicating the tissue initial-softening-then- stiffening property change. During HIFU with boiling, HMIFU monitored a consistent change in lesion-to-background displacement contrast (0.46 ± 0.37) despite the presence of strong cavitation noise due to boiling during lesion formation. Therefore, HMIFU effectively monitored softening-then-stiffening during lesioning under slow denaturation, and detected lesioning under boiling with a distinct change in displacement contrast under boiling in the presence of cavitation. In conclusion, HMIFU was shown under both boiling and slow denaturation regimes to be effective in HIFU monitoring and lesioning identification without being significantly affected by cavitation noise. PMID:26168177

  16. High intensity focused ultrasound (HIFU) focal spot localization using harmonic motion imaging (HMI)

    Science.gov (United States)

    Han, Yang; Hou, Gary Yi; Wang, Shutao; Konofagou, Elisa

    2015-08-01

    Several ultrasound-based imaging modalities have been proposed for image guidance and monitoring of high-intensity focused ultrasound (HIFU) treatment. However, accurate localization and characterization of the effective region of treatment (focal spot) remain important obstacles in the clinical implementation of HIFU ablation. Harmonic motion imaging for focused ultrasound (HMIFU) is a HIFU monitoring technique that utilizes radiation-force-induced localized oscillatory displacement. HMIFU has been shown to correctly identify the formation and extent of HIFU thermal ablation lesions. However a significant problem remains in identifying the location of the HIFU focus, which is necessary for treatment planning. In this study, the induced displacement was employed to localize the HIFU focal spot inside the tissue prior to treatment. Feasibility was shown with two separate systems. The 1D HMIFU system consisted of a HIFU transducer emitting an amplitude-modulated HIFU beam for mechanical excitation and a confocal single-element, pulse-echo transducer for simultaneous RF acquisition. The 2D HIFU system consists of a HIFU phased array, and a co-axial imaging phased array for simultaneous imaging. Initial feasibility was first performed on tissue-mimicking gelatin phantoms and the focal zone was defined as the region corresponding to the  -3dB full width at half maximum of the HMI displacement. Using the same parameters, in vitro experiments were performed in canine liver specimens to compare the defined focal zone with the lesion. In vitro measurements showed good agreement between the HMI predicted focal zone and the induced HIFU lesion location. HMIFU was experimentally shown to be capable of predicting and tracking the focal region in both phantoms and in vitro tissues. The accuracy of focal spot localization was evaluated by comparing with the lesion location in post-ablative tissues, with a R2 = 0.821 at p  HIFU focal spot without inducing thermal changes

  17. High intensity focused ultrasound (HIFU) focal spot localization using harmonic motion imaging (HMI).

    Science.gov (United States)

    Han, Yang; Hou, Gary Yi; Wang, Shutao; Konofagou, Elisa

    2015-08-01

    Several ultrasound-based imaging modalities have been proposed for image guidance and monitoring of high-intensity focused ultrasound (HIFU) treatment. However, accurate localization and characterization of the effective region of treatment (focal spot) remain important obstacles in the clinical implementation of HIFU ablation. Harmonic motion imaging for focused ultrasound (HMIFU) is a HIFU monitoring technique that utilizes radiation-force-induced localized oscillatory displacement. HMIFU has been shown to correctly identify the formation and extent of HIFU thermal ablation lesions. However a significant problem remains in identifying the location of the HIFU focus, which is necessary for treatment planning. In this study, the induced displacement was employed to localize the HIFU focal spot inside the tissue prior to treatment. Feasibility was shown with two separate systems. The 1D HMIFU system consisted of a HIFU transducer emitting an amplitude-modulated HIFU beam for mechanical excitation and a confocal single-element, pulse-echo transducer for simultaneous RF acquisition. The 2D HIFU system consists of a HIFU phased array, and a co-axial imaging phased array for simultaneous imaging. Initial feasibility was first performed on tissue-mimicking gelatin phantoms and the focal zone was defined as the region corresponding to the -3dB full width at half maximum of the HMI displacement. Using the same parameters, in vitro experiments were performed in canine liver specimens to compare the defined focal zone with the lesion. In vitro measurements showed good agreement between the HMI predicted focal zone and the induced HIFU lesion location. HMIFU was experimentally shown to be capable of predicting and tracking the focal region in both phantoms and in vitro tissues. The accuracy of focal spot localization was evaluated by comparing with the lesion location in post-ablative tissues, with a R(2) = 0.821 at p < 0.002 in the 2D HMI system. We demonstrated the

  18. Modelling the temperature evolution of bone under high intensity focused ultrasound

    Science.gov (United States)

    ten Eikelder, H. M. M.; Bošnački, D.; Elevelt, A.; Donato, K.; Di Tullio, A.; Breuer, B. J. T.; van Wijk, J. H.; van Dijk, E. V. M.; Modena, D.; Yeo, S. Y.; Grüll, H.

    2016-02-01

    Magnetic resonance-guided high intensity focused ultrasound (MR-HIFU) has been clinically shown to be effective for palliative pain management in patients suffering from skeletal metastasis. The underlying mechanism is supposed to be periosteal denervation caused by ablative temperatures reached through ultrasound heating of the cortex. The challenge is exact temperature control during sonication as MR-based thermometry approaches for bone tissue are currently not available. Thus, in contrast to the MR-HIFU ablation of soft tissue, a thermometry feedback to the HIFU is lacking, and the treatment of bone metastasis is entirely based on temperature information acquired in the soft tissue adjacent to the bone surface. However, heating of the adjacent tissue depends on the exact sonication protocol and requires extensive modelling to estimate the actual temperature of the cortex. Here we develop a computational model to calculate the spatial temperature evolution in bone and the adjacent tissue during sonication. First, a ray-tracing technique is used to compute the heat production in each spatial point serving as a source term for the second part, where the actual temperature is calculated as a function of space and time by solving the Pennes bio-heat equation. Importantly, our model includes shear waves that arise at the bone interface as well as all geometrical considerations of transducer and bone geometry. The model was compared with a theoretical approach based on the far field approximation and an MR-HIFU experiment using a bone phantom. Furthermore, we investigated the contribution of shear waves to the heat production and resulting temperatures in bone. The temperature evolution predicted by our model was in accordance with the far field approximation and agreed well with the experimental data obtained in phantoms. Our model allows the simulation of the HIFU treatments of bone metastasis in patients and can be extended to a planning tool prior to MR

  19. Efficacy and imaging characteristics of high intensity focused ultrasound in treatment of uterine fibroid

    Directory of Open Access Journals (Sweden)

    Yuan-yuan HUA

    2014-03-01

    Full Text Available Objective  To investigate the efficacy and imaging characteristics of high intensity focused ultrasound (HIFU in treatment of uterine fibroid. Methods  Forty seven patients with fifty three uterine fibroids were treated with HIFU from Jan. 2010 to Dec. 2012. UFS-QOL, a disease-specific symptom and health-related quality of life questionnaire for fibroid, enhanced magnetic resonance imaging (MRI, and Doppler ultrasound were performed before and 1, 3, 6, 12 months after the treatment. Scores of symptoms and UFS-QOL of patients, and the size of uterine fibroid detected by MRI and Doppler ultrasound were assessed to study the efficacy of the treatment. The relationship between the shrinkage of the uterine fibroid, and the imaging characteristics of the MRI and ultrasound were also assessed. Results  The symptoms in 38 patients were improved as reflected by the scores of symptoms and UFS-QOL after treatment with HIFU (P0.05. The low signal intensity in the target fibroids on MRI and the decrease of blood flow on Doppler ultrasound before the treatment were associated with the shrinkage of the fibroids. The more enhanced signal in MRI and the more blood flow in fibroids detected by Doppler ultrasound before treatment were, the less degree of shrinkage after the treatment was (P<0.05. The non-perfusion area in the fibroids increased if there was less enhanced signal on MRI before treatment or intensity change as monitored by real-time ultrasound (P<0.05. Conclusion  HIFU could reduce the fibroid volume and improve the patients' symptoms and life quality, and it may be used as an effective treatment for uterine fibroid. DOI: 10.11855/j.issn.0577-7402.2014.03.09

  20. Salvage high-intensity focused ultrasound for the recurrent prostate cancer after radiotherapy in Japan

    Science.gov (United States)

    Shoji, S.; Nakano, M.; Nagata, Y.; Uchida, T.

    2012-10-01

    Aim: to investigate the use of minimally invasive high-intensity focused ultrasound (HIFU) as a salvage therapy in men with localized prostate cancer recurrence following external beam radiotherapy (EBRT), brachytherapy or proton therapy. A review of 22 cases treated using the Sonablate® 500 HIFU device, between August 28, 2002 and April 1, 2010, was carried out. All men had presumed organ-confined, histologically confirmed recurrent prostate adenocarcinoma following radiation therapy. The mean (range) age was 65 (52-80) years with a mean PSA level before radiation therapy of 14.3 (5.7-118) ng/mL. The mean (range) period after radiation therapy to HIFU was 36 (4-96) months. All men with presumed, organ-confined, recurrent disease following EBRT in 14 patients, brachytherapy in 5 patients (4 patients with high-dose brachytherapy with In192 and 1 with low-dose brachytherapy with Au98) or proton therapy in 3 patients treated with salvage HIFU were included. The patients were followed for a mean (range) of 24 months. Biochemical disease-free survival (bDFS) rates in patients with low-, intermediate-and high risk groups were 100%, 86%, and 14%, respectively. All nine patients who received a post HIFU prostate biopsy showed no malignancy. Side-effects included urethral stricture in 4 of the 25 patients (16%) and urinary incontinence in 4 of the 25 patients (16%). Recto-urethral fistula occurred in one patient (4%). Salvage HIFU is a minimally invasive for patients with low-and intermediate risk group with comparable morbidity to other forms of salvage treatment.

  1. Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: A prospective study

    Energy Technology Data Exchange (ETDEWEB)

    Zhang, Xin [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Zou, Min; Zhang, Cai [Department of Obstetrics and Gynecology, Chongqing Haifu Hospital, Chongqing 401121 (China); He, Jia [Department of Obstetrics and Gynecology, Suining Central Hospital, Sichuan 629000 (China); Mao, Shihua [Department of Obstetrics and Gynecology, Three Gorges Central Hospital, Chongqing 404000 (China); Wu, Qingrong [Department of Obstetrics and Gynecology, Fuling Central Hospital, Chongqing 408099 (China); He, Min [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Department of Obstetrics and Gynecology, Suining Central Hospital, Sichuan 629000 (China); Wang, Jian [Department of Obstetrics and Gynecology, Chongqing Haifu Hospital, Chongqing 401121 (China); Department of Obstetrics and Gynecology, Three Gorges Central Hospital, Chongqing 404000 (China); Zhang, Ruitao [Department of Obstetrics and Gynecology, Chongqing Haifu Hospital, Chongqing 401121 (China); Department of Obstetrics and Gynecology, Fuling Central Hospital, Chongqing 408099 (China); Zhang, Lian, E-mail: lianwzhang@yahoo.com [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Department of Obstetrics and Gynecology, Chongqing Haifu Hospital, Chongqing 401121 (China)

    2014-09-15

    Objective: To investigate the effects of oxytocin on high-intensity focused ultrasound (HIFU) ablation for the treatment of adenomyosis. Materials and methods: Eighty-six patients with adenomyosis from three hospitals were randomly assigned to the oxytocin group or control group for HIFU treatment. During HIFU treatment, 80 units of oxytocin was added in 500 ml of 0.9% normal saline running at the rate of 2 ml/min (0.32 U/min) in the oxytocin group, while 0.9% normal saline was used in the control group. Both patients and HIFU operators were blinded to oxytocin or saline application. Treatment results, adverse effects were compared. Results: When using oxytocin, the non-perfused volume (NPV) ratio was 80.7 ± 11.6%, the energy-efficiency factor (EEF) was 8.1 ± 9.9 J/mm{sup 3}, and the sonication time required to ablate 1 cm{sup 3} was 30.0 ± 36.0 s/cm{sup 3}. When not using oxytocin, the non-perfused volume ratio was 70.8 ± 16.7%, the EEF was 15.8 ± 19.6 J/mm{sup 3}, and the sonication time required to ablate 1 cm{sup 3} was 58.2 ± 72.7 S/cm{sup 3}. Significant difference in the NPV ratio, EEF, and the sonication time required to ablate 1 cm{sup 3} between the two groups was observed. No oxytocin related adverse effects occurred. Conclusion: Oxytocin could significantly decrease the energy for ablating adenomyosis with HIFU, safely enhance the treatment efficiency.

  2. Investigation of therapy improvement using real-time photoacoustic imaging guided high intensity focused ultrasound

    Science.gov (United States)

    Cui, Huizhong

    There are a lot of risks in cancer treatment by invasive surgery, such as bleeding, wound infection, and long recovery time, etc. Therefore, there is great need for minimally- or non-invasive treatment. High intensity focused ultrasound (HIFU) is a rapidly growing and truly non-invasive technology. It has been widely used in therapeutic applications, such as rapid tissue heating and tissue ablation. With proper imaging guidance, HIFU treatment can be performed totally noninvasively. Currently, ultrasound imaging-guided HIFU has been extensively studied. However, ultrasound imaging guidance is less precise because of the relatively low imaging contrast, sensitivity, and specificity for noninvasive detection. In this study, we employed photoacoustic imaging (PAI) technique, which has been developed a novel promising imaging technique for early cancer detection, to guide HIFU treatment. The goal of this study is to investigate the feasibility of PAI to guide, monitor in real time and enhance the HIFU therapy. In this dissertation, as the first step, the integrated PAI and HIFU system had been shown to have the feasibility to guide HIFU both ex vivo and in vivo. Then, the system was improved and developed to a real-time PAI-guided HIFU system. It is demonstrated that the sensitivity of PA detection for HIFU lesion is very high and the saturation of PA signals can be used as the indicator for tissue coagulation. During the temperature measurement using this system, laser-enhanced HIFU heating was found. Thus, we further investigated the laser enhanced technique in both HIFU heating and pulsed HIFU thrombolysis. In the HIFU therapy, laser light was employed to illuminate the sample concurrently with HIFU radiation. The resulting cavitation was detected with a passive cavitation detector. We demonstrated that concurrent light illumination during HIFU has the potential to significantly enhance HIFU by reducing cavitation threshold.

  3. Thrombolysis using multi-frequency high intensity focused ultrasound at MHz range: an in vitro study

    Science.gov (United States)

    Suo, Dingjie; Guo, Sijia; Lin, Weili; Jiang, Xiaoning; Jing, Yun

    2015-09-01

    High intensity focused ultrasound (HIFU) based thrombolysis has emerged as a promising drug-free treatment approach for ischemic stroke. The large amount of acoustic power required by this approach, however, poses a critical challenge to the future clinical translation. In this study, multi-frequency acoustic waves at MHz range (near 1.5 MHz) were introduced as HIFU excitations to reduce the required power for treatment as well as the treatment time. In vitro bovine blood clots weighing around 150 mg were treated by single-frequency and multi-frequency HIFU. The pulse length was 2 ms for all experiments except the ones where the duty cycle was changed. It was found that dual-frequency thrombolysis efficiency was statistically better than single-frequency under the same acoustic power and excitation condition. When varying the acoustic power but fixing the duty cycle at 5%, it was found that dual-frequency ultrasound can save almost 30% power in order to achieve the same thrombolysis efficiency. In the experiment where the duty cycle was increased from 0.5% to 10%, it was shown that dual-frequency ultrasound can achieve the same thrombolysis efficiency with only half of the duty cycle of single-frequency. Dual-frequency ultrasound could also accelerate the thrombolysis by a factor of 2-4 as demonstrated in this study. No significant differences were found between dual-frequencies with different frequency differences (0.025, 0.05, and 0.1 MHz) and between dual-frequency and triple-frequency. The measured cavitation doses of dual-frequency and triple-frequency excitations were at about the same level but both were significantly higher than that of single-frequency.

  4. Reproducibility of Left Atrial Ablation with High Intensity Focused Ultrasound Energy in a Calf Model

    Science.gov (United States)

    Villamizar, Nestor R.; Crow, Jennifer H.; III, Valentino Piacentino; DiBernardo, Louis R.; Daneshmand, Mani A.; Bowles, Dawn E.; Groh, Mark A.; Milano, Carmelo A.

    2014-01-01

    Purpose Achieving transmural tissue ablation may be necessary for successful treatment of atrial fibrillation. The purpose of this study is to evaluate the reproducibility of transmural left atrial (LA) ablation using a high intensity focused ultrasound (HIFU) energy system in a calf model. Methods Nine heparinized bovines underwent a beating-heart LA ablation with a single application of the HIFU device. All animals were acutely sacrificed and the LA was fixed in formalin. Protocolized histological sections (5μm) were obtained throughout each lesion and prepared with Masson's Trichrome and Hematoxylin and Eosin staining. Measurements were performed on a total of 359 slides from the nine lesions. In addition, fresh LA from 18 unused human donor hearts that did not meet criteria for cardiac transplantation were measured at the site where the HIFU device is normally applied. Results Calf LA thickness ranged between 2.5 and 20.1 mm, with a mean of 9.10 mm. HIFU ablation consistently produced a 100% transmural lesion in LA thickness up to 6mm. In addition, a transmural lesion was observed in 91% of tissues that were up to 10 mm thick and in 85% up to 15 mm of thickness. Human LA thickness ranged between 1.2 to 6 mm, with a mean of 3.7 mm. Conclusions Calf LA thickness in this study was greater than human LA thickness. Human LA thickness is generally less than 6mm, and in this range HIFU ablation achieved 100% transmurality. These histological results may correlate with a high success rate of atrial fibrillation ablation using the HIFU system. PMID:20934725

  5. Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: A prospective study

    International Nuclear Information System (INIS)

    Objective: To investigate the effects of oxytocin on high-intensity focused ultrasound (HIFU) ablation for the treatment of adenomyosis. Materials and methods: Eighty-six patients with adenomyosis from three hospitals were randomly assigned to the oxytocin group or control group for HIFU treatment. During HIFU treatment, 80 units of oxytocin was added in 500 ml of 0.9% normal saline running at the rate of 2 ml/min (0.32 U/min) in the oxytocin group, while 0.9% normal saline was used in the control group. Both patients and HIFU operators were blinded to oxytocin or saline application. Treatment results, adverse effects were compared. Results: When using oxytocin, the non-perfused volume (NPV) ratio was 80.7 ± 11.6%, the energy-efficiency factor (EEF) was 8.1 ± 9.9 J/mm3, and the sonication time required to ablate 1 cm3 was 30.0 ± 36.0 s/cm3. When not using oxytocin, the non-perfused volume ratio was 70.8 ± 16.7%, the EEF was 15.8 ± 19.6 J/mm3, and the sonication time required to ablate 1 cm3 was 58.2 ± 72.7 S/cm3. Significant difference in the NPV ratio, EEF, and the sonication time required to ablate 1 cm3 between the two groups was observed. No oxytocin related adverse effects occurred. Conclusion: Oxytocin could significantly decrease the energy for ablating adenomyosis with HIFU, safely enhance the treatment efficiency

  6. Treatment time reduction through parameter optimization in magnetic resonance guided high intensity focused ultrasound treatments

    Science.gov (United States)

    Coon, Joshua

    Magnetic Resonance guided High Intensity Focused Ultrasound (MRgHIFU) treatments are a promising modality for cancer treatments in which a focused beam of ultrasound energy is used to kill tumor tissue. However, obstacles still exist to its widespread clinical implementation, including long treatment times. This research demonstrates reductions in treatment times through intelligent selection of the user-controllable parameters, including: the focal zone treatment path, focal zone size, focal zone spacing, and whether to treat one or several focal zone locations at any given time. Several treatments using various combinations of these parameters were simulated using a finite difference method to solve the Pennes bio-heat transfer equation for an ultrasonically heated tissue region with a wide range of acoustic, thermal, geometric, and tumor properties. The total treatment time was iteratively optimized using either a heuristic method or routines included in the Matlab software package, with constraints imposed for patient safety and treatment efficacy. The results demonstrate that large reductions in treatment time are possible through the intelligent selection of user-controllable treatment parameters. For the treatment path, treatment times are reduced by as much as an order of magnitude if the focal zones are arranged into stacks along the axial direction and a middle-front-back ordering is followed. For situations where normal tissue heating constraints are less stringent, these focal zones should have high levels of adjacency to further decrease treatment times; however, adjacency should be reduced in some cases where normal tissue constraints are more stringent. Also, the use of smaller, more concentrated focal zones produces shorter treatment times than larger, more diluted focal zones, a result verified in an agar phantom model. Further, focal zones should be packed using only a small amount of overlap in the axial direction and with a small gap in the

  7. A review of high intensity focused ultrasound in relation to the treatment of renal tumours and other malignancies.

    Science.gov (United States)

    Cranston, David

    2015-11-01

    For 60 years, high-intensity focused ultrasound (HIFU) has been the subject of interest for medical research. HIFU causes tissue necrosis in a very well defined area, at a variable distance from the transducer, through heating or cavitation. Over the past two decades, the use of high-intensity focused ultrasound has been investigated in many clinical settings. This review summarises recent advances made in the field of renal cancer in particular, and gives an overview on the use of the extracorporeal machines in the treatment of other malignant tumours. PMID:26070919

  8. Adverse events of extracorporeal ultrasound-guided high intensity focused ultrasound therapy.

    Directory of Open Access Journals (Sweden)

    Tinghe Yu

    Full Text Available BACKGROUND: High-intensity focused ultrasound (HIFU is considered to be an alternative to surgery. Extracorporeal ultrasound-guided HIFU (USgFU has been clinically used to treat solid tumors. Preliminary trials in a small sample of a Western population suggested that this modality was safe. Most trials are performed in China thereby providing comprehensive data for understanding the safety profile. The aim of this study was to evaluate adverse events of USgFU therapy. METHODS AND FINDINGS: Clinical data were searched in 2 Chinese databases. Adverse events of USgFU were summarized and compared with those of magnetic resonance-guided HIFU (MRgFU; for uterine, bone or breast tumor and transrectal ultrasound-guided HIFU (for prostate cancer or benign prostate hyperplasia. USgFU treatment was performed using 7 types of device. Side effects were evaluated in 13262 cases. There were fewer adverse events in benign lesions than in malignant lesions (11.81% vs. 21.65%, p<0.0001. Rates of adverse events greatly varied between the disease types (0-280%, p<0.0001 and between the applied HIFU devices in both malignant (10.58-44.38%, p<0.0001 and benign lesions (1.67-17.57%, p<0.0001. Chronological analysis did not demonstrate a decrease in the rate of adverse events. Based upon evaluable adverse events, incidences in USgFU were consistent with those in MRgFU or transrectal HIFU. Some side effects frequently occurred following transrectal HIFU were not reported in USgFU. Several events including intrahepatic metastasis, intraoperative high fever, and occlusions of the superior mesenteric artery should be of particular concern because they have not been previously noted. The types of adverse events suggested that they were ultrasonic lesions. CONCLUSION: The frequency of adverse events depended on the location of the lesion and the type of HIFU device; however, side effects of USgFU were not yet understood. USgFU did not decrease the incidence of adverse events

  9. A retrospective comparison of microwave ablation and high intensity focused ultrasound for treating symptomatic uterine fibroids

    Energy Technology Data Exchange (ETDEWEB)

    Zhao, Wen-Peng, E-mail: zwp215@163.com; Han, Zhi-Yu, E-mail: hanzhiyu301@hotmail.com; Zhang, Jing, E-mail: zjbch@sina.com; Liang, Ping, E-mail: liangping301@hotmail.com

    2015-03-15

    Highlights: •Both HIFU and PMWA are thermal ablation techniques and they all provide safe and reliable alternative treatment methods for uterine fibroids. •However, whether there are obvious difference between these two kinds of approaches in improving symptom, treatment time, ablation rate, regression rate and adverse events, until now, there are no clinical trials which have been performed to compare the therapeutic effects of HIFU and PMWA. •In this research, we retrospectively compare the results of these two treatment methods. •To our knowledge, our study is the first directly comparing long-term outcome after PMWA and HIFU in patients with uterine fibroids. -- Abstract: Objectives: To retrospectively compare the effectiveness and safety of percutaneous microwave ablation (PMWA) and ultrasound-guided high-intensity focused ultrasound (USgHIFU) for treating symptomatic uterine fibroids. Methods: Seventy-three women with symptomatic uterine fibroids who met the inclusion criteria were enrolled in our study from September 2012 to December 2013. Thirty-one patients with forty uterine fibroids underwent PMWA, and forty-two patients with fifty-one uterine fibroids underwent USgHIFU. A contrast-enhanced MRI was performed before and after treatment, and all patients were followed up for 6 months. Assessment endpoints included symptom severity scores (SSS), treatment time, ablation rate, fibroid regression rate and adverse events. Results: The mean age of the patients in our study was 35.4 ± 6.2 years (range, 21–49 years), and the median volume of uterine fibroids was 95.7 cm{sup 3} (60.3–131.5 cm{sup 3}). The ablation rate of uterine fibroids was 79.8 ± 18.2% and 77.1 ± 14.9% in the PMWA group and the USgHIFU group, respectively, and showed no significant difference between the groups. Changes in SSS after PMWA were similar in the PMWA group (47.7 pre-treatment vs. 29.9 post-treatment) and USgHIFU group (42.1 pre-treatment vs. 24.6 post-treatment). The

  10. Growth inhibition of high-intensity focused ultrasound on hepatic cancer in vivo

    Institute of Scientific and Technical Information of China (English)

    Xiu-Jie Wang; Shu-Lan Yuan; Yan-Rong Lu; Jie Zhang; Bo-Tao Liu; Wen-Fu Zeng; Yue-Ming He; Yu-Rui Fu

    2005-01-01

    AIM: To investigate the damaging effect of high-intensity focused ultrasound (HIFU) on cancer cells and the inhibitory effect on tumor growth.METHODS: Murine H22 hepatic cancer cells were treated with HIFU at the same intensity for different lengths of time and at different intensities for the same length of timein vitro, the dead cancer cells were determined by trypan blue staining. Two groups of cancer cells treated with HIFU at the lowest and highest intensity were inoculated into mice. Tumor masses were removed and weighed after 2 wk, tumor growth in each group was confirmed pathologically.RESULTS: The death rate of cancer cells treated with HIFU at 1 000 W/cm2 for 0.5, 1, 2, 4, 8, and 12 s was 3.11±1.21%, 13.37±2.56%, 38.84±3.68%, 47.22±5.76%,87.55±7.32%, and 94.33±8.11%, respectively. A positive relationship between the death rates of cancer ceils and the length of HIFU treatment time was found (r = 0.96,P<0.01). The death rate of cancer cells treated with HIFU at the intensity of 100, 200, 400, 600, 800, and 1 000 W/cm2 for 8 s was 26.31±3.26%, 31.00±3.87%, 41.97±5.86%,72.23±8.12%, 94.90±8.67%, and 99.30±9.18%,respectively. A positive relationship between the death rates of cancer cells and the intensities of HIFU treatment was confirmed (r = 0.98, P<0.01). The cancer cells treated with HIFU at 1 000 W/cm2 for 8 s were inoculated into mice ex vivo. The tumor inhibitory rate was 90.35%compared to the control (P<0.01). In the experimental group inoculated with the cancer cells treated with HIFU at 1 000 W/cm2 for 0.5 s, the tumor inhibitory rate was 22.9% (P<0.01). By pathological examination, tumor growth was confirmed in 8 out of 14 mice (57.14%, 8/14)inoculated with the cancer cells treated with HIFU at 1 000 W/cm2 for 8 s, which was significantly lower than that in the control (100%, 15/15, P<0.05).CONCLUSION: HIFU is effective on killing or damage of H22 hepatic cancer cellsin vitro and on inhibiting tumor growth in mice ex vivo.

  11. Advantage of annular focus generation by sector-vortex array in cavitation-enhanced high-intensity focused ultrasound treatment

    Science.gov (United States)

    Jimbo, Hayato; Takagi, Ryo; Taguchi, Kei; Yoshizawa, Shin; Umemura, Shin-ichiro

    2016-07-01

    High-intensity focused ultrasound (HIFU) is a noninvasive method for cancer treatment. One of the disadvantages of this method is that it has a long total treatment time because of the smallness of the treatment volume by a single exposure. To solve this problem, we have proposed a method of cavitation-enhanced heating, which utilized the heat generated by oscillating the cavitation bubbles, in combination with the method of lateral enlargement of a HIFU focal zone to minimize the surface volume ratio. In a previous study, focal spot scanning at multiple points was employed for the enlargement. This method involves nonlinear propagation and absorption due to the high spatial-peak temporal-peak (SPTP) intensity in addition to the cavitation-enhanced heating. However, it is difficult to predict the size and position of the coagulation volume because they are significantly affected by the nonlinear parameters of the tissue. In this study, a sector vortex method was employed to directly synthesize an annular focal pattern. Since this method can keep the SPTP intensity at a manageably low level, nonlinear propagation and absorption can be minimized. Experimental results demonstrate that the coagulation was generated only in the region where both the cavitation cloud and the heating ultrasound were matched. The proposed method will make the cavitation-enhanced HIFU treatment more accurate and predictable.

  12. Effects of magnetic resonance-guided high-intensity focused ultrasound ablation on bone mechanical properties and modeling

    NARCIS (Netherlands)

    Yeo, Sin Yuin; Arias Moreno, Andrés J; van Rietbergen, Bert; Ter Hoeve, Natalie D; van Diest, Paul J; Grüll, Holger

    2015-01-01

    BACKGROUND: Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) is a promising technique for palliative treatment of bone pain. In this study, the effects of MR-HIFU ablation on bone mechanics and modeling were investigated. METHODS: A total of 12 healthy rat femurs were ablated us

  13. Sampling strategies for subsampled segmented EPI PRF thermometry in MR guided high intensity focused ultrasound

    Energy Technology Data Exchange (ETDEWEB)

    Odéen, Henrik, E-mail: h.odeen@gmail.com; Diakite, Mahamadou [Department of Physics and Astronomy, University of Utah, Salt Lake City, Utah 84108 and Department of Radiology, University of Utah, Salt Lake City, Utah 84108 (United States); Todd, Nick; Minalga, Emilee; Payne, Allison; Parker, Dennis L. [Department of Radiology, University of Utah, Salt Lake City, Utah 84108 (United States)

    2014-09-15

    Purpose: To investigate k-space subsampling strategies to achieve fast, large field-of-view (FOV) temperature monitoring using segmented echo planar imaging (EPI) proton resonance frequency shift thermometry for MR guided high intensity focused ultrasound (MRgHIFU) applications. Methods: Five different k-space sampling approaches were investigated, varying sample spacing (equally vs nonequally spaced within the echo train), sampling density (variable sampling density in zero, one, and two dimensions), and utilizing sequential or centric sampling. Three of the schemes utilized sequential sampling with the sampling density varied in zero, one, and two dimensions, to investigate sampling the k-space center more frequently. Two of the schemes utilized centric sampling to acquire the k-space center with a longer echo time for improved phase measurements, and vary the sampling density in zero and two dimensions, respectively. Phantom experiments and a theoretical point spread function analysis were performed to investigate their performance. Variable density sampling in zero and two dimensions was also implemented in a non-EPI GRE pulse sequence for comparison. All subsampled data were reconstructed with a previously described temporally constrained reconstruction (TCR) algorithm. Results: The accuracy of each sampling strategy in measuring the temperature rise in the HIFU focal spot was measured in terms of the root-mean-square-error (RMSE) compared to fully sampled “truth.” For the schemes utilizing sequential sampling, the accuracy was found to improve with the dimensionality of the variable density sampling, giving values of 0.65 °C, 0.49 °C, and 0.35 °C for density variation in zero, one, and two dimensions, respectively. The schemes utilizing centric sampling were found to underestimate the temperature rise, with RMSE values of 1.05 °C and 1.31 °C, for variable density sampling in zero and two dimensions, respectively. Similar subsampling schemes

  14. Sampling strategies for subsampled segmented EPI PRF thermometry in MR guided high intensity focused ultrasound

    International Nuclear Information System (INIS)

    Purpose: To investigate k-space subsampling strategies to achieve fast, large field-of-view (FOV) temperature monitoring using segmented echo planar imaging (EPI) proton resonance frequency shift thermometry for MR guided high intensity focused ultrasound (MRgHIFU) applications. Methods: Five different k-space sampling approaches were investigated, varying sample spacing (equally vs nonequally spaced within the echo train), sampling density (variable sampling density in zero, one, and two dimensions), and utilizing sequential or centric sampling. Three of the schemes utilized sequential sampling with the sampling density varied in zero, one, and two dimensions, to investigate sampling the k-space center more frequently. Two of the schemes utilized centric sampling to acquire the k-space center with a longer echo time for improved phase measurements, and vary the sampling density in zero and two dimensions, respectively. Phantom experiments and a theoretical point spread function analysis were performed to investigate their performance. Variable density sampling in zero and two dimensions was also implemented in a non-EPI GRE pulse sequence for comparison. All subsampled data were reconstructed with a previously described temporally constrained reconstruction (TCR) algorithm. Results: The accuracy of each sampling strategy in measuring the temperature rise in the HIFU focal spot was measured in terms of the root-mean-square-error (RMSE) compared to fully sampled “truth.” For the schemes utilizing sequential sampling, the accuracy was found to improve with the dimensionality of the variable density sampling, giving values of 0.65 °C, 0.49 °C, and 0.35 °C for density variation in zero, one, and two dimensions, respectively. The schemes utilizing centric sampling were found to underestimate the temperature rise, with RMSE values of 1.05 °C and 1.31 °C, for variable density sampling in zero and two dimensions, respectively. Similar subsampling schemes

  15. SU-E-J-04: Integration of Interstitial High Intensity Therapeutic Ultrasound Applicators On a Clinical MRI-Guided High Intensity Focused Ultrasound Treatment Planning Software Platform

    International Nuclear Information System (INIS)

    Purpose: Interstitial high intensity therapeutic ultrasound (HITU) applicators can be used to ablate tissue percutaneously, allowing for minimally-invasive treatment without ionizing radiation [1,2]. The purpose of this study was to evaluate the feasibility and usability of combining multielement interstitial HITU applicators with a clinical magnetic resonance imaging (MRI)-guided focused ultrasound software platform. Methods: The Sonalleve software platform (Philips Healthcare, Vantaa, Finland) combines anatomical MRI for target selection and multi-planar MRI thermometry to provide real-time temperature information. The MRI-compatible interstitial US applicators (Acoustic MedSystems, Savoy, IL, USA) had 1–4 cylindrical US elements, each 1 cm long with either 180° or 360° of active surface. Each applicator (4 Fr diameter, enclosed within a 13 Fr flexible catheter) was inserted into a tissue-mimicking agar-silica phantom. Degassed water was circulated around the transducers for cooling and coupling. Based on the location of the applicator, a virtual transducer overlay was added to the software to assist targeting and to allow automatic thermometry slice placement. The phantom was sonicated at 7 MHz for 5 minutes with 6–8 W of acoustic power for each element. MR thermometry data were collected during and after sonication. Results: Preliminary testing indicated that the applicator location could be identified in the planning images and the transducer locations predicted within 1 mm accuracy using the overlay. Ablation zones (thermal dose ≥ 240 CEM43) for 2 active, adjacent US elements ranged from 18 mm × 24 mm (width × length) to 25 mm × 25 mm for the 6 W and 8 W sonications, respectively. Conclusion: The combination of interstitial HITU applicators and this software platform holds promise for novel approaches in minimally-invasive MRI-guided therapy, especially when bony structures or air-filled cavities may preclude extracorporeal HIFU.[1] Diederich et al

  16. SU-E-J-04: Integration of Interstitial High Intensity Therapeutic Ultrasound Applicators On a Clinical MRI-Guided High Intensity Focused Ultrasound Treatment Planning Software Platform

    Energy Technology Data Exchange (ETDEWEB)

    Ellens, N [Johns Hopkins University, Baltimore, Maryland (United States); Partanen, A [Philips Healthcare, Andover, Massachusetts (United States); Ghoshal, G; Burdette, E [Acoustic MedSystems Inc., Savoy, IL (United States); Farahani, K [National Cancer Institute, Bethesda, MD (United States)

    2015-06-15

    Purpose: Interstitial high intensity therapeutic ultrasound (HITU) applicators can be used to ablate tissue percutaneously, allowing for minimally-invasive treatment without ionizing radiation [1,2]. The purpose of this study was to evaluate the feasibility and usability of combining multielement interstitial HITU applicators with a clinical magnetic resonance imaging (MRI)-guided focused ultrasound software platform. Methods: The Sonalleve software platform (Philips Healthcare, Vantaa, Finland) combines anatomical MRI for target selection and multi-planar MRI thermometry to provide real-time temperature information. The MRI-compatible interstitial US applicators (Acoustic MedSystems, Savoy, IL, USA) had 1–4 cylindrical US elements, each 1 cm long with either 180° or 360° of active surface. Each applicator (4 Fr diameter, enclosed within a 13 Fr flexible catheter) was inserted into a tissue-mimicking agar-silica phantom. Degassed water was circulated around the transducers for cooling and coupling. Based on the location of the applicator, a virtual transducer overlay was added to the software to assist targeting and to allow automatic thermometry slice placement. The phantom was sonicated at 7 MHz for 5 minutes with 6–8 W of acoustic power for each element. MR thermometry data were collected during and after sonication. Results: Preliminary testing indicated that the applicator location could be identified in the planning images and the transducer locations predicted within 1 mm accuracy using the overlay. Ablation zones (thermal dose ≥ 240 CEM43) for 2 active, adjacent US elements ranged from 18 mm × 24 mm (width × length) to 25 mm × 25 mm for the 6 W and 8 W sonications, respectively. Conclusion: The combination of interstitial HITU applicators and this software platform holds promise for novel approaches in minimally-invasive MRI-guided therapy, especially when bony structures or air-filled cavities may preclude extracorporeal HIFU.[1] Diederich et al

  17. Investigation of Generation, Acceleration, Transport and Final Focusing of High-Intensity Heavy Ion Beams from Sources to Targets

    Energy Technology Data Exchange (ETDEWEB)

    Chiping Chen

    2006-10-26

    Under the auspices of the research grant, the Intense Beam Theoretical Research Goup at Massachusetts Institute of Technology's Plasma Science and Fusion Center made significant contributions in a number of important areas in the HIF and HEDP research, including: (a) Derivation of rms envelope equations and study of rms envelope dynamics for high-intensity heavy ion beams in a small-aperture AG focusing transport systems; (b) Identification of a new mechanism for chaotic particle motion, halo formation, and beam loss in high-intensity heavy ion beams in a small-aperture AG focusing systems; Development of elliptic beam theory; (d) Study of Physics Issues in the Neutralization Transport Experiment (NTX).

  18. Investigation of Generation, Acceleration, Transport and Final Focusing of High-Intensity Heavy Ion Beams from Sources to Targets

    International Nuclear Information System (INIS)

    Under the auspices of the research grant, the Intense Beam Theoretical Research Group at Massachusetts Institute of Technology's Plasma Science and Fusion Center made significant contributions in a number of important areas in the HIF and HEDP research, including: (a) Derivation of rms envelope equations and study of rms envelope dynamics for high-intensity heavy ion beams in a small-aperture AG focusing transport systems; (b) Identification of a new mechanism for chaotic particle motion, halo formation, and beam loss in high-intensity heavy ion beams in a small-aperture AG focusing systems; (c) Development of elliptic beam theory; and (d) Study of Physics Issues in the Neutralization Transport Experiment (NTX)

  19. The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus

    OpenAIRE

    Aubry, Jean-Francois; Pauly, Kim,; Moonen, Chrit; Haar, Gail Ter; Ries, Mario; Salomir, Rares; Sokka, Sham; Sekins, Kevin,; Shapira, Yerucham; Ye, Fangwei; Huff-Simonin, Heather; Eames, Matt; Hananel, Arik; Kassell, Neal; Napoli, Alessandro

    2013-01-01

    International audience Clinical use of high-intensity focused ultrasound (HIFU) under ultrasound or MR guidance as a non-invasive method for treating tumors is rapidly increasing. Tens of thousands of patients have been treated for uterine fibroid, benign prostate hyperplasia, bone metastases, or prostate cancer. Despite the methods' clinical potential, the liver is a particularly challenging organ for HIFU treatment due to the combined effect of respiratory-induced liver motion, partial b...

  20. High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis

    OpenAIRE

    Fouad Aoun; Ksenija Limani; Alexandre Peltier; Quentin Marcelis; Marc Zanaty; Alexandre Chamoun; Marc Vanden Bossche; Thierry Roumeguère; Roland van Velthoven

    2015-01-01

    Purpose. To evaluate postoperative morbidity and long term oncologic and functional outcomes of high intensity focused ultrasound (HIFU) compared to brachytherapy for the treatment of localized prostate cancer. Material and Methods. Patients treated by brachytherapy were matched 1 : 1 with patients who underwent HIFU. Differences in postoperative complications across the two groups were assessed using Wilcoxon's rank-sum or χ 2 test. Kaplan-Meier curves, log-rank tests, and Cox regression mod...

  1. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer

    OpenAIRE

    Pei-Hong Wu; Sheng Li

    2013-01-01

    Image-guided high-intensity focused ultrasound (HIFU) has been used for more than ten years, primarily in the treatment of liver and prostate cancers. HIFU has the advantages of precise cancer ablation and excellent protection of healthy tissue. Breast cancer is a common cancer in women. HIFU therapy, in combination with other therapies, has the potential to improve both oncologic and cosmetic outcomes for breast cancer patients by providing a curative therapy that conserves mammary shape. Cu...

  2. Single High Intensity Focused Ultrasound Session as a Whole Gland Primary Treatment for Clinically Localized Prostate Cancer: 10-Year Outcomes

    OpenAIRE

    Ksenija Limani; Fouad Aoun; Serge Holz; Marianne Paesmans; Alexandre Peltier; Roland van Velthoven

    2014-01-01

    Objectives. To assess the treatment outcomes of a single session of whole gland high intensity focused ultrasound (HIFU) for patients with localized prostate cancer (PCa). Methods. Response rates were defined using the Stuttgart and Phoenix criteria. Complications were graded according to the Clavien score. Results. At a median follow-up of 94months, 48 (44.4%) and 50 (46.3%) patients experienced biochemical recurrence for Phoenix and Stuttgart definition, respectively. The 5- and 10-year act...

  3. Preliminary safety and efficacy results with robotic high-intensity focused ultrasound : A single center Indian experience

    OpenAIRE

    Mishra, Shashikant; Sharma, Rajan; Garg, Chandra Prakash; Muthu, V.; Ganpule, Arvind; Sabnis, Ravindra B.; Desai, Mahesh R

    2011-01-01

    Background: There are no Indian data of high-intensity focused ultrasound (HIFU). Being an alternative, still experimental modality, reporting short-term safety outcome is paramount. Aims: This study was aimed at to assess the safety and short-term outcome in patients with prostate cancer treated by HIFU. Settings and Design: A retrospective study of case records of 30 patients undergoing HIFU between January 2008 to September 2010 was designed and conducted. Materials and Methods: The proced...

  4. High-Intensity Focused Ultrasound for the Treatment of Wrinkles and Skin Laxity in Seven Different Facial Areas

    OpenAIRE

    Park, Hyunchul; Kim, Eunjin; Kim, Jeongeun; Ro, Youngsuck; Ko, Jooyeon

    2015-01-01

    Background High-intensity focused ultrasound (HIFU) treatment has recently emerged in response to the increasing demand for noninvasive procedures for skin lifting and tightening. Objective This study was aimed at evaluating the clinical efficacy of and patient satisfaction with HIFU treatment for wrinkles and laxity in seven different areas of the face in Asian skin. Methods Twenty Korean patients with facial wrinkle and laxity were analyzed after a single session of HIFU treatment. Two inde...

  5. Evaluation of high intensity focused ultrasound ablation of prostate tumor with hyperpolarized 13C imaging biomarkers

    Science.gov (United States)

    Lee, Jessie E.; Diederich, Chris J.; Salgaonkar, Vasant A.; Bok, Robert; Taylor, Andrew G.; Kurhanewicz, John

    2015-03-01

    Real-time hyperpolarized (HP) 13C MR can be utilized during high-intensity focal ultrasound (HIFU) therapy to improve treatment delivery strategies, provide treatment verification, and thus reduce the need for more radical therapies for lowand intermediate-risk prostate cancers. The goal is to develop imaging biomarkers specific to thermal therapies of prostate cancer using HIFU, and to predict the success of thermal coagulation and identify tissues potentially sensitized to adjuvant treatment by sub-ablative hyperthermic heat doses. Mice with solid prostate tumors received HIFU treatment (5.6 MHz, 160W/cm2, 60 s), and the MR imaging follow-ups were performed on a wide-bore 14T microimaging system. 13C-labeled pyruvate and urea were used to monitor tumor metabolism and perfusion accordingly. After treatment, the ablated tumor tissue had a loss in metabolism and perfusion. In the regions receiving sub-ablative heat dose, a timedependent change in metabolism and perfusion was observed. The untreated regions behaved as a normal untreated TRAMP prostate tumor would. This promising preliminary study shows the potential of using 13C MR imaging as biomarkers of HIFU/thermal therapies.

  6. Focusing of short-pulse high-intensity laser-accelerated proton beams

    Science.gov (United States)

    Bartal, Teresa; Foord, Mark E.; Bellei, Claudio; Key, Michael H.; Flippo, Kirk A.; Gaillard, Sandrine A.; Offermann, Dustin T.; Patel, Pravesh K.; Jarrott, Leonard C.; Higginson, Drew P.; Roth, Markus; Otten, Anke; Kraus, Dominik; Stephens, Richard B.; McLean, Harry S.; Giraldez, Emilio M.; Wei, Mingsheng S.; Gautier, Donald C.; Beg, Farhat N.

    2012-02-01

    Recent progress in generating high-energy (>50MeV) protons from intense laser-matter interactions (1018-1021Wcm-2 refs , , , , , , ) has opened up new areas of research, with applications in radiography, oncology, astrophysics, medical imaging, high-energy-density physics, and ion-proton beam fast ignition. With the discovery of proton focusing with curved surfaces, rapid advances in these areas will be driven by improved focusing technologies. Here we report on the first investigation of the generation and focusing of a proton beam using a cone-shaped target. We clearly show that the focusing is strongly affected by the electric fields in the beam in both open and enclosed (cone) geometries, bending the trajectories near the axis. Also in the cone geometry, a sheath electric field effectively `channels' the proton beam through the cone tip, substantially improving the beam focusing properties. These results agree well with particle simulations and provide the physics basis for many future applications.

  7. Efficient generation of cavitation bubbles and reactive oxygen species using triggered high-intensity focused ultrasound sequence for sonodynamic treatment

    Science.gov (United States)

    Yasuda, Jun; Yoshizawa, Shin; Umemura, Shin-ichiro

    2016-07-01

    Sonodynamic treatment is a method of treating cancer using reactive oxygen species (ROS) generated by cavitation bubbles in collaboration with a sonosensitizer at a target tissue. In this treatment method, both localized ROS generation and ROS generation with high efficiency are important. In this study, a triggered high-intensity focused ultrasound (HIFU) sequence, which consists of a short, extremely high intensity pulse immediately followed by a long, moderate-intensity burst, was employed for the efficient generation of ROS. In experiments, a solution sealed in a chamber was exposed to a triggered HIFU sequence. Then, the distribution of generated ROS was observed by the luminol reaction, and the amount of generated ROS was quantified using KI method. As a result, the localized ROS generation was demonstrated by light emission from the luminol reaction. Moreover, it was demonstrated that the triggered HIFU sequence has higher efficiency of ROS generation by both the KI method and the luminol reaction emission.

  8. The role of acoustic nonlinearity in tissue heating behind the rib cage using high intensity focused ultrasound phased array

    OpenAIRE

    Yuldashev, Petr V.; Shmeleva, Svetlana M.; Ilyin, Sergey A.; Sapozhnikov, Oleg A.; Gavrilov, Leonid R.; Khokhlova, Vera A.

    2013-01-01

    The goal of this study was to investigate theoretically the effects of nonlinear propagation in a high intensity focused ultrasound (HIFU) field produced by a therapeutic phased array and the resultant heating of tissue behind a rib cage. Three configurations of focusing were simulated: in water, in water with ribs in the beam path, and in water with ribs backed by a layer of soft tissue. The Westervelt equation was used to model the nonlinear HIFU field and a 1 MHz phased array consisting of...

  9. Ellipsoidal plasma mirror focusing of high power laser pulses to ultra-high intensities

    Science.gov (United States)

    Wilson, R.; King, M.; Gray, R. J.; Carroll, D. C.; Dance, R. J.; Armstrong, C.; Hawkes, S. J.; Clarke, R. J.; Robertson, D. J.; Neely, D.; McKenna, P.

    2016-03-01

    The design and development of an ellipsoidal F/1 focusing plasma mirror capable of increasing the peak intensity achievable on petawatt level laser systems to >1022 W cm-2 is presented. A factor of 2.5 reduction in the focal spot size is achieved when compared to F/3 focusing with a conventional (solid state) optic. We find a factor of 3.6 enhancement in peak intensity, taking into account changes in plasma mirror reflectivity and focal spot quality. The sensitivity of the focusing plasma optic to misalignment is also investigated. It is demonstrated that an increase in the peak laser intensity from 3 ×1020 W cm-2 to 1021 W cm-2 results in a factor of 2 increase in the maximum energy of sheath-accelerated protons from a thin foil positioned at the focus of the intense laser light.

  10. WE-G-12A-01: High Intensity Focused Ultrasound Surgery and Therapy

    International Nuclear Information System (INIS)

    More and more emphasis is being made on alternatives to invasive surgery and the use of ionizing radiation to treat various diseases including cancer. Novel screening, diagnosis, treatment and monitoring of response to treatment are also hot areas of research and new clinical technologies. Ultrasound(US) has gained traction in all of the aforementioned areas of focus. Especially with recent advances in the use of ultrasound to noninvasively treat various diseases/organ systems. This session will focus on covering MR-guided focused ultrasound and the state of the art clinical applications, and the second speaker will survey the more cutting edge technologies e.g. Focused Ultrasound (FUS) mediated drug delivery, principles of cavitation and US guided FUS. Learning Objectives: Fundamental physics and physical limitations of US interaction with tissue and nanoparticles The alteration of tissue transport using focused ultrasound US control of nanoparticle drug carriers for targeted release The basic principles of MRI-guided focused ultrasound (MRgFUS) surgery and therapy the current state of the art clinical applications of MRgFUS requirements for quality assurance and treatment planning

  11. WE-G-12A-01: High Intensity Focused Ultrasound Surgery and Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Farahani, K [National Cancer Institute, Rockville, MD (United States); O' Neill, B [The Methodist Hospital Research Institute, Houston, TX (United States)

    2014-06-15

    More and more emphasis is being made on alternatives to invasive surgery and the use of ionizing radiation to treat various diseases including cancer. Novel screening, diagnosis, treatment and monitoring of response to treatment are also hot areas of research and new clinical technologies. Ultrasound(US) has gained traction in all of the aforementioned areas of focus. Especially with recent advances in the use of ultrasound to noninvasively treat various diseases/organ systems. This session will focus on covering MR-guided focused ultrasound and the state of the art clinical applications, and the second speaker will survey the more cutting edge technologies e.g. Focused Ultrasound (FUS) mediated drug delivery, principles of cavitation and US guided FUS. Learning Objectives: Fundamental physics and physical limitations of US interaction with tissue and nanoparticles The alteration of tissue transport using focused ultrasound US control of nanoparticle drug carriers for targeted release The basic principles of MRI-guided focused ultrasound (MRgFUS) surgery and therapy the current state of the art clinical applications of MRgFUS requirements for quality assurance and treatment planning.

  12. Generation and focusing of short pulse high intensity laser accelerated protons

    Science.gov (United States)

    Foord, Mark E.

    2011-10-01

    Much progress has recently been reported in generating MeV energy protons from intense laser-matter interactions, having potential applications in areas such as radiography, oncology, and ion-proton beam fast ignition. Experiments were conducted on the sub-ps LANL Trident laser, where we systematically investigated proton focusing and conversion efficiency from curved surface targets in both open and closed cone-shaped target geometries. We clearly show that the focusing is strongly affected by the electric fields in the beam, bending the trajectories near the axis. We also find that in the cone geometry, a sheath electric field effectively ``channels'' the proton beam through the cone tip, substantially improving the beam focusing properties. The far-field energy and angular distribution of the proton beam were measured using a mesh that images the beam onto a RCF detector. For the cone-shaped targets using a 300 μm-radius curved surface foil, a 60 μm diameter proton spot was determined. Proton generation and focusing were modeled using 2-D hybrid PIC simulations, which compared well with RCF data. The proton conversion efficiency varied strongly with the target geometry. Simulations indicate this is due to that charge flow on the structure and the coupling to the hot electrons and electric fields in the plasma. Work performed under US DOE contract DE-AC52-07NA27344

  13. Sub-array patterns of spherical-section phased array for high intensity focused ultrasound surgery

    Institute of Scientific and Technical Information of China (English)

    WANG Xiaodong; WANG Xufei; LU Mingzhu; WAN Mingxi

    2005-01-01

    The sub-array field patterns of spherical-section phased array were implemented for noninvasive ultrasound surgery of liver-tumor. The sub-array approach included field calculation, pseudo-inverse method and genetic algorithm. The sub-arrays uncovered by ribs according to scanned images normally emitted ultrasound. The results from different sub-arrays demonstrated quite satisfied acoustic performances, which included qualified focus size and intensity level for ultrasound surgery with single-focus and multi-foci patterns. Moreover, the patterns could decrease power accumulation on the ribs, and avoid damaging normal tissues. Thus the sub-array method provides a promising tool for phased array ultrasound propagating through strong obstacles like human rib cage, and it may broaden the therapeutic area, make the surgery safer and more flexible.

  14. 3-point support mechanical steering system for high intensity focused ultrasound

    International Nuclear Information System (INIS)

    We have developed a simple approach for mechanically scanning a focused bowl ultrasound (US) transducer for either hyperthermia or tissue ablation therapies called the 3-point support (3PS) mechanical steering technique. The scanning involves translation of the required 3D motion of the ultrasound transducer to the more manageable linear movement of three support rods. It is a cost-effective alternative, especially compared with electronic scanning and other previous implementations of mechanically scanned systems. The 3PS approach is particularly well suited for integration with our microwave breast imaging technique-the combination of which could be an effective, low-cost thermal therapy/monitoring approach. The results show that the US focus can be moved laterally in a spiral pattern 3 cm below the surface in a gel phantom and that similar patterns can be moved to multiple locations within the phantom volume in succession. The feasibility of simultaneously acquiring microwave thermal images is also demonstrated

  15. Compensating for bone interfaces and respiratory motion in high-intensity focused ultrasound.

    OpenAIRE

    Tanter, Mickaël; PERNOT, mathieu; Aubry, Jean-François; Montaldo, Gabriel; Marquet, Fabrice; Fink, Mathias

    2007-01-01

    Bursts of focused ultrasound energy a thousand times more intense than diagnostic ultrasound have become a non-invasive option for treating cancer, from breast to prostate or uterine fibroid, during the last decade. Despite this progress, many issues still need to be addressed. First, the distortions caused by defocusing obstacles, such as the skull or ribs, on the ultrasonic therapeutic beam are still being investigated. Multi-element transducer technology must be used in order to achieve su...

  16. Energy Loss of High Intensity Focused Proton Beams Penetrating Metal Foils

    Science.gov (United States)

    McGuffey, C.; Qiao, B.; Kim, J.; Beg, F. N.; Wei, M. S.; Evans, M.; Fitzsimmons, P.; Stephens, R. B.; Chen, S. N.; Fuchs, J.; Nilson, P. M.; Canning, D.; Mastrosimone, D.; Foord, M. E.

    2014-10-01

    Shortpulse-laser-driven intense ion beams are appealing for applications in probing and creating high energy density plasmas. Such a beam isochorically heats and rapidly ionizes any target it enters into warm dense matter with uncertain transport and stopping properties. Here we present experimental measurements taken with the 1.25 kJ, 10 ps OMEGA EP BL shortpulse laser of the proton and carbon spectra after passing through metal foils. The laser irradiated spherically curved C targets with intensity 4×1018 W/cm2, producing proton beams with 3 MeV slope temperature and a sharp low energy cutoff at 5 MeV which has not been observed on lower energy, shorter pulse intense lasers. The beam either diverged freely or was focused to estimated 1016 p +/cm2 ps by a surrounding structure before entering the metal foils (Al or Ag and a Cu tracer layer). The proton and ion spectra were altered by the foil depending on material and whether or not the beam was focused. Transverse proton radiography probed the target with ps temporal and 10 micron spatial resolution, indicating an electrostatic field on the foil may also have affected the beam. We present complementary particle-in-cell simulations of the beam generation and transport to the foils. This work was supported by the DOE/NNSA National Laser User Facility program, Contract DE-SC0001265.

  17. Three-axis MR-conditional robot for high-intensity focused ultrasound for treating prostate diseases transrectally

    OpenAIRE

    Yiallouras, Christos; Ioannides, Kleanthis; Dadakova, Tetiana; Pavlina, Matt; Bock, Michael; Damianou, Christakis

    2015-01-01

    Background A prototype magnetic resonance image (MRI)-conditional robot was developed for navigating a high-intensity focused ultrasound (HIFU) system in order to treat prostate cancer transrectally. Materials and methods The developed robotic device utilizes three PC-controlled axes: a linear axis for motion along the rectum, an angular axis for rotation in the rectum, and a linear axis to lift the robot up and down. Experiments with the system were performed in a 1.5-T MRI system using gel ...

  18. Adjuvant hormone therapy in patients undergoing high-intensity focused ultrasound therapy for locally advanced prostate cancer

    OpenAIRE

    A. I. Neimark; M. A. Tachalov; B. A. Neimark

    2014-01-01

    Objective: to evaluate the efficiency and safety of using the luteinizing hormone releasing hormone leuprorelin with the Atrigel delivery system in doses of 7.5, 22.5, and 45 mg as an adjuvant regimen in high- and moderate-risk cancer patients who have received high-intensity focused ultrasound (HIFU) therapy.Subjects and methods. Moderate- and high-risk locally advanced prostate cancer (PC) patients treated with HIFU (n = 28) and HIFU in combination with hormone therapy during 6 months (n = ...

  19. The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound

    International Nuclear Information System (INIS)

    Objective: To discuss the nursing measures for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization (TACE) and high intensive focus ultrasound(HIFU). Methods: During the period of Aug.2008-Aug. 2009, TACE together with HIFU were performed in 40 patients with hepatocellular carcinoma. The perioperative nursing measures were summarized. Results: During hospitalization no severe complications, such as dangerous infection, intestinal bleeding, etc. occurred in all patients. Conclusion: Correct and proper perioperative nursing care is of significant importance for the prevention of complications and for the therapeutic effectiveness. (authors)

  20. Smooth transverse and longitudinal focusing in high-intensity ion linacs

    International Nuclear Information System (INIS)

    We examine ion linac designs that start with a high energy radio- frequency quadrupole (RFQ) followed by either a drift-tube linac (DTL) or a coupled-cavity drift-tube linac (CCDTL). For high energies a conventional CCL follows the CCDTL. High RFQ output energy allows tailoring the transverse and longitudinal focusing strengths to match into the following structure. When the RFQ beam enters a higher frequency structure, the DTL or CCDTL starts with a low accelerating gradient and large negative synchronous phase. The gradient and phase both ramp up gradually to higher values. Other changes later in the machine are also gradual. Beam dynamics simulations show that these linacs require no separate matching sections. Applications include a cw 100 mA H+ beam from a 350-MHz, 6.7 MeV RFQ injecting a 700 MHz CCDTL and CCL; a 7% duty 28 mA H- beam from a 402.5 MHz RFQ and DTL injecting 805 MHz structures; a cw 135 mA D+ beam produced by a 175 MHz, 8 MeV RFQ and DTL; and a 2.4% duty, 80 mA H+ beam using a 433 MHz 10 MeV RFQ and a 1300 MHz CCDTL. The machines take advantage of the considerable flexibility of the CCDTL. Designs can use a variety of different transverse focusing lattices. Use of two coupling cavity orientations permits a constant period even when the number of drift tubes per cavity changes along the linac

  1. Feasibility of laser-integrated high intensity focused ultrasound (HIFU) treatment for bladder tumors: in vitro study (Conference Presentation)

    Science.gov (United States)

    Nguyen, Van Phuc; Park, Suhyun; Oh, Junghwan; Kang, Hyun Wook

    2016-02-01

    Previous studies have shown that photothemal therapy combined with high intensity focused ultrasound (HIFU) can provide a promising method to achieve rapid thermal coagulation during surgical procedures. The current study investigated the feasibility of the laser-integrated high intensity focused ultrasound (HIFU) application to treat bladder tumors by enhancing thermal effects and therapeutic depth in vitro. To generate thermal coagulation, a single element HIFU transducer with a central frequency of 2.0 MHz was used to transmit acoustic energy to 15 fresh porcine bladders injected with an artificial tumor (100 µl gelatin and hemoglobin solution) in vitro. Simultaneously, an 80-W 532-nm laser system was also implemented to induce thermal necrosis in the targeted tissue. The intensity of 570 W/cm2 at the focus of HIFU and laser energy of 0.9 W were applied to all the samples for 40 s. The temperature rise increased up to about 1.6 or 3 folds (i.e., ΔT=32±3.8 K for laser-integrated HIFU, ΔT=20±6.5 K for HIFU only, and ΔT=11±5.6 K for laser only). The estimated lesion depth also increased by 1.3 and 2 folds during the dual-thermal treatment, in comparison with the treatment by either HIFU or laser. The results indicated that the laser-integrated HIFU treatment can be an efficient hyperthermic method for tumor coagulation.

  2. High intensity focused ultrasound (HIFU) for treatment of T1/T2 prostate cancer

    Science.gov (United States)

    Sanghvi, N.; Gardner, T.; Koch, M.

    2003-04-01

    This FDA approved phase I/II clinical trial is to evaluate the safety and efficacy of the Sonablate device (Focus Surgery, Inc.) for the treatment of organ confined prostate cancer. 20 patients with biopsy proven prostate cancer, Gleason Prostate Symptom Score, International Impotence and Erectile Function score, and the SF-36 health survey. The mean patient age is 62.0, Gleason score of 6.18, PSA of 5.2, and prostate size 26.0 gm. Mean PSA results were 5.62, 44, 20, 1.68, 0.87, and 0.44 ng/ml at screening, 48-72 hours, 14 days, 30 days, 90 days and 180 days, respectively. There was one patient (9%) with a positive TRUS biopsy at 6 months, which resulted in a retreatment. There were no rectal injuries. Average pre-treatment IPSS, IIEF, and SF-36 scores were 9.55, 16.1, and 103.5. At the 30 day follow-up, they were 18.3, 3, and 97.4, respectively. HIFU is a minimally invasive modality that achieves complete prostatic ablation and is efficacious in the treatment of low-stage prostate cancer.

  3. Treatment of localised prostate cancer with transrectal high intensity focused ultrasound.

    Science.gov (United States)

    Chapelon, J Y; Ribault, M; Vernier, F; Souchon, R; Gelet, A

    1999-03-01

    With the advent of PSA dosing, an increasing number of prostate cancers are being detected at a local stage. Since 1989, our group has been developing a research project with the aim of establishing treatment of localised prostate cancer by means of HIFU. The treatment is performed transrectally, using ultrasound imaging guidance only. The quality of HIFU treatment depends on four factors: the intensity of the transmitted pulse, the exposure time, the signal frequency, and the time between two firing bursts. The lesions are created by a thermal effect. Their slightly conical form is due to the absorption of ultrasound by tissue, enhanced by cavitation bubbles. Results obtained since 1993 demonstrate that transrectally administered HIFU treatment achieves local control of localised prostate cancer in 80% of cases, with 70% complete success and 30% partial response. The use of an annular array probe with variable focus and frequency should significantly improve results in the future. Finally, real time visual display of the damaged tissue via differential imaging of the attenuation coefficient should give the surgeon an instant appreciation of the result of the sequence. It would thus be possible to repeat treatment of insufficiently covered zones in the same session. PMID:10099164

  4. Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model

    Science.gov (United States)

    Yu, Mi Hye; Kim, Hae Ri; Kim, Bo Ram; Park, Eun-Joo; Kim, Hoe Suk; Han, Joon Koo; Choi, Byung Ihn

    2016-01-01

    Objective To investigate whether high-intensity focused ultrasound (HIFU) combined with microbubbles enhances the therapeutic effects of chemotherapy. Materials and Methods A pancreatic cancer xenograft model was established using BALB/c nude mice and luciferase-expressing human pancreatic cancer cells. Mice were randomly assigned to five groups according to treatment: control (n = 10), gemcitabine alone (GEM; n = 12), HIFU with microbubbles (HIFU + MB, n = 11), combined HIFU and gemcitabine (HIGEM; n = 12), and HIGEM + MB (n = 13). After three weekly treatments, apoptosis rates were evaluated using the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay in two mice per group. Tumor volume and bioluminescence were monitored using high-resolution 3D ultrasound imaging and in vivo bioluminescence imaging for eight weeks in the remaining mice. Results The HIGEM + MB group showed significantly higher apoptosis rates than the other groups (p < 0.05) and exhibited the slowest tumor growth. From week 5, the tumor-volume-ratio relative to the baseline tumor volume was significantly lower in the HIGEM + MB group than in the control, GEM, and HIFU + MB groups (p < 0.05). Despite visible distinction, the HIGEM and HIGEM + MB groups showed no significant differences. Conclusion High-intensity focused ultrasound combined with microbubbles enhances the therapeutic effects of gemcitabine chemotherapy in a pancreatic cancer xenograft model. PMID:27587968

  5. Effects of cavitation-enhanced heating in high-intensity focused ultrasound treatment on shear wave imaging

    Science.gov (United States)

    Iwasaki, Ryosuke; Nagaoka, Ryo; Takagi, Ryo; Goto, Kota; Yoshizawa, Shin; Saijo, Yoshifumi; Umemura, Shin-ichiro

    2015-07-01

    High-intensity focused ultrasound (HIFU) therapy is a less invasive method of cancer treatment, in which ultrasound is generated outside the body and focused at the tumor tissue to be thermally coagulated. To enhance the safety, accuracy, and efficiency of HIFU therapy, “multiple-triggered HIFU” has been proposed as a method of cavitation-enhanced heating to shorten treatment time. In this study, we also propose shear wave elastography (SWE) to noninvasively monitor the cavitation-enhanced heating. Results show that the increase in shear wave velocity was observed in the coagulation area, but it was significantly slower when cavitation occurred. This suggests that the cavitation-enhanced heating requires a significantly longer cooling time before the accurate measurement of shear modulus than heating without generating bubbles.

  6. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU) in Treatment of Symptomatic Uterine Myomas

    International Nuclear Information System (INIS)

    Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) is a noninvasive technique for ablation therapy for uterine myomas, where focused ultrasound energy beam generates localized high temperature in the selected area and coagulates chosen tissue, leaving the skin and tissues in between unharmed. Magnetic resonance imaging enables accurate targeting for HIFU as well as temperature monitoring during treatment. MR guidance with 3D anatomical imaging provides reference data for treatment planning, while real-time temperature monitoring aids in controlling ablation process. This review provides basic information regarding methodology, clinical indications for this kind of treatment, expected outcome and patient management during MR-HIFU procedure. The aim of this work is to introduce a new, noninvasive treatment method for uterine leiomyomas and to present a comparison with other currently used methods

  7. Focused high-intensity proton beam from a lithium source by using an ExB stigmatic selector

    International Nuclear Information System (INIS)

    This article describes the design and operation of a system that produces a high-intensity proton beam. The system consists of a lithium proton source and an ExB stigmatic selector that produces a stigmatic proton beam at the mass focus. The protons are produced by bombarding electrons against a lithium surface. These protons are accelerated toward a special tilted-pole Wien filter (stigmatic selector), which eliminates astigmatism in the proton beam at the mass focus. The stigmatic ExB selector was also tested with electron beams, and their astigmatism was also eliminated. A classical ExB Wien filter with parallel poles (astigmatic selector) was used for comparison. The experimental spectral curves of both the proton current and the electron current, each using both types of selectors, are shown

  8. Effect of controlled offset of focal position in cavitation-enhanced high-intensity focused ultrasound treatment

    Science.gov (United States)

    Goto, Kota; Takagi, Ryo; Miyashita, Takuya; Jimbo, Hayato; Yoshizawa, Shin; Umemura, Shin-ichiro

    2015-07-01

    High-intensity focused ultrasound (HIFU) is a noninvasive treatment for tumors such as cancer. In this method, ultrasound is generated outside the body and focused to the target tissue. Therefore, physical and mental stresses on the patient are minimal. A drawback of the HIFU treatment is a long treatment time for a large tumor due to the small therapeutic volume by a single exposure. Enhancing the heating effect of ultrasound by cavitation bubbles may solve this problem. However, this is rather difficult because cavitation clouds tend to be formed backward from the focal point while ultrasonic intensity for heating is centered at the focal point. In this study, the focal points of the trigger pulses to generate cavitation were offset forward from those of the heating ultrasound to match the cavitation clouds with the heating patterns. Results suggest that the controlled offset of focal points makes the thermal coagulation more predictable.

  9. Analysis of Temperature Rise Induced by High-Intensity Focused Ultrasound in Tissue-Mimicking Gel Considering Cavitation Bubbles

    Science.gov (United States)

    Asai, Ayumu; Okano, Hiroki; Yoshizawa, Shin; Umemura, Shin-ichiro

    2013-07-01

    High-intensity focused ultrasound (HIFU) causes a selective temperature rise in tissue and is used as a noninvasive method for tumor treatment. However, there is a problem in that it typically takes several hours to treat a large tumor. The development of a highly efficient method is required to shorten the treatment time. It is known that cavitation bubbles generated by HIFU enhance HIFU heating. In this study, the enhancement of the heating effect by cavitation was estimated in a numerical simulation solving a bio-heat transfer equation (BHTE) by increasing the absorption coefficients in and out of the volume of cavitation bubbles. The absorption coefficients were obtained by a curve fitting the temperature rise near the focal point between experiment and simulation. The results show that cavitation bubbles caused the increase in ultrasonic absorption not only in but also near the volume of cavitation bubbles.

  10. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer

    Directory of Open Access Journals (Sweden)

    Pei-Hong Wu

    2013-08-01

    Full Text Available Image-guided high-intensity focused ultrasound (HIFU has been used for more than ten years, primarily in the treatment of liver and prostate cancers. HIFU has the advantages of precise cancer ablation and excellent protection of healthy tissue. Breast cancer is a common cancer in women. HIFU therapy, in combination with other therapies, has the potential to improve both oncologic and cosmetic outcomes for breast cancer patients by providing a curative therapy that conserves mammary shape. Currently, HIFU therapy is not commonly used in breast cancer treatment, and efforts to promote the application of HIFU is expected. In this article, we compare different image-guided models for HIFU and reviewed the status, drawbacks, and potential of HIFU therapy for breast cancer.

  11. Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report

    Science.gov (United States)

    Ungaro, Antonio; Orsi, Franco; Casadio, Chiara; Galdy, Salvatore; Spada, Francesca; Cella, Chiara Alessandra; Tonno, Clementina Di; Bonomo, Guido; Vigna, Paolo Della; Murgioni, Sabina; Frezza, Anna Maria; Fazio, Nicola

    2016-01-01

    We report a case of a 74-year-old man with a metastatic anaplastic pancreatic carcinoma (APC). After an early tumour progression on first-line chemotherapy with cisplatin and gemcitabine, even though it was badly tolerated, he was treated with a combination of systemic modified FOLFIRI and high-intensity focused ultrasound (HIFU) on the pancreatic mass. A tumour showing partial response with a clinical benefit was obtained. HIFU was preferred to radiotherapy because of its shorter course and minimal side effects, in order to improve the patient’s clinical conditions. The patient is currently on chemotherapy, asymptomatic with a good performance status. In referral centres, with specific expertise, HIFU could be safely and successfully combined with systemic chemotherapy for treatment of metastatic pancreatic carcinoma. PMID:27170835

  12. Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report.

    Science.gov (United States)

    Ungaro, Antonio; Orsi, Franco; Casadio, Chiara; Galdy, Salvatore; Spada, Francesca; Cella, Chiara Alessandra; Tonno, Clementina Di; Bonomo, Guido; Vigna, Paolo Della; Murgioni, Sabina; Frezza, Anna Maria; Fazio, Nicola

    2016-01-01

    We report a case of a 74-year-old man with a metastatic anaplastic pancreatic carcinoma (APC). After an early tumour progression on first-line chemotherapy with cisplatin and gemcitabine, even though it was badly tolerated, he was treated with a combination of systemic modified FOLFIRI and high-intensity focused ultrasound (HIFU) on the pancreatic mass. A tumour showing partial response with a clinical benefit was obtained. HIFU was preferred to radiotherapy because of its shorter course and minimal side effects, in order to improve the patient's clinical conditions. The patient is currently on chemotherapy, asymptomatic with a good performance status. In referral centres, with specific expertise, HIFU could be safely and successfully combined with systemic chemotherapy for treatment of metastatic pancreatic carcinoma. PMID:27170835

  13. Development of a strongly focusing high-intensity He(+) ion source for a confined alpha particle measurement at ITER.

    Science.gov (United States)

    Kisaki, M; Shinto, K; Kobuchi, T; Okamoto, A; Kitajima, S; Sasao, M; Tsumori, K; Nishiura, M; Kaneko, O; Matsuda, Y; Wada, M; Sakakita, H; Kiyama, S; Hirano, Y

    2008-02-01

    A strongly focusing high-intensity He(+) ion source has been designed and constructed as a beam source for a high-energy He(0) beam probe system for diagnosis of fusion produced alpha particles in the thermonuclear fusion plasmas. The He(+) beam was extracted from the ion source at an acceleration voltage of 18-35 kV. Temperature distributions of the beam target were observed with an IR camera. The 1/e-holding beam profile half-width was about 15 mm at optimum perveance (Perv) of 0.03 (I(beam)=2.4 A). A beam current about 3 A was achieved at an acceleration voltage of 26.7 kV with an arc power of 10 kW (Perv=0.023). PMID:18315239

  14. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer.

    Science.gov (United States)

    Li, Sheng; Wu, Pei-Hong

    2013-08-01

    Image-guided high-intensity focused ultrasound (HIFU) has been used for more than ten years, primarily in the treatment of liver and prostate cancers. HIFU has the advantages of precise cancer ablation and excellent protection of healthy tissue. Breast cancer is a common cancer in women. HIFU therapy, in combination with other therapies, has the potential to improve both oncologic and cosmetic outcomes for breast cancer patients by providing a curative therapy that conserves mammary shape. Currently, HIFU therapy is not commonly used in breast cancer treatment, and efforts to promote the application of HIFU is expected. In this article, we compare different image-guided models for HIFU and reviewed the status, drawbacks, and potential of HIFU therapy for breast cancer. PMID:23237221

  15. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer

    Institute of Scientific and Technical Information of China (English)

    Sheng Li; Pei-Hong Wu

    2013-01-01

    Image-guided high-intensity focused ultrasound (HIFU) has been used for more than ten years,primarily in the treatment of liver and prostate cancers.HIFU has the advantages of precise cancer ablation and excellent protection of healthy tissue.Breast cancer is a common cancer in women.HIFU therapy,in combination with other therapies,has the potential to improve both oncologic and cosmetic outcomes for breast cancer patients by providing a curative therapy that conserves mammary shape.Currently,HIFU therapy is not commonly used in breast cancer treatment,and efforts to promote the application of HIFU is expected.In this article,we compare different image-guided models for HIFU and reviewed the status,drawbacks,and potential of HIFU therapy for breast cancer.

  16. Full-wave nonlinear ultrasound simulation on distributed clusters with applications in high-intensity focused ultrasound

    CERN Document Server

    Jaros, Jiri; Treeby, Bradley E

    2014-01-01

    Model-based treatment planning and exposimetry for high-intensity focused ultrasound (HIFU) requires the numerical simulation of nonlinear ultrasound propagation through heterogeneous and absorbing media. This is a computationally demanding problem due to the large distances travelled by the ultrasound waves relative to the wavelength of the highest frequency harmonic. Here, the k-space pseudospectral method is used to solve a set of coupled partial differential equations equivalent to a generalised Westervelt equation. The model is implemented in C++ and parallelised using the message passing interface (MPI) for solving large-scale problems on distributed clusters. The domain is partitioned using a 1D slab decomposition, and global communication is performed using a sparse communication pattern. Operations in the spatial frequency domain are performed in transposed space to reduce the communication burden imposed by the 3D fast Fourier transform. The performance of the model is evaluated using grid sizes up ...

  17. Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: A review of safety and efficacy.

    Science.gov (United States)

    Zhang, Lian; Zhang, Wenyi; Orsi, Franco; Chen, Wenzhi; Wang, Zhibiao

    2015-05-01

    As a non-surgical treatment, high intensity focused ultrasound (HIFU) has received increasing interest for the treatment of gynaecological diseases over the last 10 years. Many studies have shown that HIFU is safe and effective in treating patients with uterine fibroids, adenomyosis, cervicitis or vulvar diseases. Both magnetic resonance imaging-guided HIFU (MRgHIFU) and ultrasound-guided HIFU (USgHIFU) can offer gynaecologists non-invasive techniques to treat patients with uterine benign diseases. Focused ultrasound therapy can also be used effectively to treat cervicitis and vulvar diseases. As gynaecologists gain more experience with this technology, the rate of severe adverse effects has been lowered with the development of this non-invasive technique. In this paper we review the literature available regarding the utilisation of magnetic resonance imaging-guided focused ultrasound/MRgHIFU or USgHIFU and new findings from our group in the treatment of gynaecological diseases: uterine fibroids, adenomyosis, cervicitis, vulvar diseases, caesarean scar pregnancies, and abdominal wall endometriosis. PMID:25609456

  18. Optimal transcostal high-intensity focused ultrasound with combined real-time 3D movement tracking and correction

    Science.gov (United States)

    Marquet, F.; Aubry, J. F.; Pernot, M.; Fink, M.; Tanter, M.

    2011-11-01

    Recent studies have demonstrated the feasibility of transcostal high intensity focused ultrasound (HIFU) treatment in liver. However, two factors limit thermal necrosis of the liver through the ribs: the energy deposition at focus is decreased by the respiratory movement of the liver and the energy deposition on the skin is increased by the presence of highly absorbing bone structures. Ex vivo ablations were conducted to validate the feasibility of a transcostal real-time 3D movement tracking and correction mode. Experiments were conducted through a chest phantom made of three human ribs immersed in water and were placed in front of a 300 element array working at 1 MHz. A binarized apodization law introduced recently in order to spare the rib cage during treatment has been extended here with real-time electronic steering of the beam. Thermal simulations have been conducted to determine the steering limits. In vivo 3D-movement detection was performed on pigs using an ultrasonic sequence. The maximum error on the transcostal motion detection was measured to be 0.09 ± 0.097 mm on the anterior-posterior axis. Finally, a complete sequence was developed combining real-time 3D transcostal movement correction and spiral trajectory of the HIFU beam, allowing the system to treat larger areas with optimized efficiency. Lesions as large as 1 cm in diameter have been produced at focus in excised liver, whereas no necroses could be obtained with the same emitted power without correcting the movement of the tissue sample.

  19. Influence of Skin and Subcutaneous Tissue on High-Intensity Focused Ultrasound Beam: Experimental Quantification and Numerical Modeling.

    Science.gov (United States)

    Grisey, Anthony; Heidmann, Marc; Letort, Veronique; Lafitte, Pauline; Yon, Sylvain

    2016-10-01

    High-intensity focused ultrasound (HIFU) enables the non-invasive thermal ablation of tumors. However, numerical simulations of the treatment remain complex and difficult to validate in clinically relevant situations. In this context, needle hydrophone measurements of the acoustic field downstream of seven rabbit tissue layers comprising skin, subcutaneous fat and muscle were performed in different geometrical configurations. Increasing curvature and thickness of the sample were found to decrease the focusing of the beam: typically, a curvature of 0.05 mm(-1) decreased the maximum pressure by 45% and doubled the focal area. A numerical model based on k-Wave Toolbox was found to be in very good agreement with the reported measurements. It was used to extrapolate the effect of the superficial tissues on peak positive and peak negative pressure at focus, which affects both cavitation and target heating. The shape of the interface was found to have a strong influence on the values, and it is therefore an important parameter to monitor or to control in the clinical practice. This also highlights the importance of modeling realistic configurations when designing treatment procedures. PMID:27471120

  20. Coagulation and ablation patterns of high-intensity focused ultrasound on a tissue-mimicking phantom and cadaveric skin.

    Science.gov (United States)

    Kim, Hee-Jin; Kim, Han Gu; Zheng, Zhenlong; Park, Hyoun Jun; Yoon, Jeung Hyun; Oh, Wook; Lee, Cheol Woo; Cho, Sung Bin

    2015-12-01

    High-intensity focused ultrasound (HIFU) can be applied noninvasively to create focused zones of tissue coagulation on various skin layers. We performed a comparative study of HIFU, evaluating patterns of focused tissue coagulation and ablation upon application thereof. A tissue-mimicking (TM) phantom was prepared with bovine serum albumin and polyacrylamide hydrogel to evaluate the geometric patterns of HIFU-induced thermal injury zones (TIZs) for five different HIFU devices. Additionally, for each device, we investigated histologic patterns of HIFU-induced coagulation and ablation in serial sections of cadaveric skin of the face and neck. All HIFU devices generated remarkable TIZs in the TM phantom, with different geometric values of coagulation for each device. Most of the TIZs seemed to be separated into two or more tiny parts. In cadaveric skin, characteristic patterns of HIFU-induced ablation and coagulation were noted along the mid to lower dermis at the focal penetration depth of 3 mm and along subcutaneous fat to the superficial musculoaponeurotic system or the platysma muscle of the neck at 4.5 mm. Additionally, remarkable pre-focal areas of tissue coagulation were observed in the upper and mid dermis at the focal penetration depth of 3 mm and mid to lower dermis at 4.5 mm. For five HIFU devices, we outlined various patterns of HIFU-induced TIZ formation along pre-focal, focal, and post-focal areas of TM phantom and cadaveric skin of the face and neck. PMID:26341380

  1. Characteristic Uptake Pattern of Bone Scintigraphy in Patients with Hepatocellular Carcinoma Following Treatment with High-Intensity Focused Ultrasound

    Energy Technology Data Exchange (ETDEWEB)

    Ma, Waihan; Ho, Waiyin; Lai, Andrew S. H.; Wong, Kwongkuen; Law, Martin [Queen Mary Hospital, Pokfulam (Hong Kong)

    2013-12-15

    This study retrospectively reviews the characteristic bone scintigraphic findings in 18 patients with hepatocellular carcinoma (HCC) following treatment with high-intensity focused ultrasound (HIFU). A potential complication of HIFU is damage to the tissues along the path of the ultrasound beam and structures superficial to the lesion of interest. Patients with hepatocellular carcinoma who underwent a bone scan between 1st December 2005 and 31st December 2011 were considered for this study. Among these patients, only those who had bone scans after the HIFU treatment were included. The time between HIFU treatment and bone scans, HIFU energy, HCC sites, tumour sizes and related radiological findings were evaluated. In total, 20 bone scans of 18 patients were reviewed. Of these scans, two patients were normal; three patients showed decreased uptake, four patients showed increased uptake and nine patients showed mixed uptakes of the bony tracer in their rib cages. The defects were located in the anterior, lateral, anterolateral or posterolateral aspects of the rib cage. The majority of those cold defects were in the right anterior rib cages. SPECT/CT was used to localise the decreased uptake in ribs. The magnetic resonance imaging in individual patients invariably showed ill-defined rim enhancement along the right chest wall, signifying chest wall injury. The results showed that tissue ablation using HIFU caused tissue injury along the pathway of high-intensity ultrasound beams. The harm to tissues is presented as photopenic area on the rib cages due to necrosis or hot spots due to rib fractures in the bone scan. Since these cold defects are subtle, they are easily overlooked or mistaken as aggressive bony metastasis.

  2. Characteristic Uptake Pattern of Bone Scintigraphy in Patients with Hepatocellular Carcinoma Following Treatment with High-Intensity Focused Ultrasound

    International Nuclear Information System (INIS)

    This study retrospectively reviews the characteristic bone scintigraphic findings in 18 patients with hepatocellular carcinoma (HCC) following treatment with high-intensity focused ultrasound (HIFU). A potential complication of HIFU is damage to the tissues along the path of the ultrasound beam and structures superficial to the lesion of interest. Patients with hepatocellular carcinoma who underwent a bone scan between 1st December 2005 and 31st December 2011 were considered for this study. Among these patients, only those who had bone scans after the HIFU treatment were included. The time between HIFU treatment and bone scans, HIFU energy, HCC sites, tumour sizes and related radiological findings were evaluated. In total, 20 bone scans of 18 patients were reviewed. Of these scans, two patients were normal; three patients showed decreased uptake, four patients showed increased uptake and nine patients showed mixed uptakes of the bony tracer in their rib cages. The defects were located in the anterior, lateral, anterolateral or posterolateral aspects of the rib cage. The majority of those cold defects were in the right anterior rib cages. SPECT/CT was used to localise the decreased uptake in ribs. The magnetic resonance imaging in individual patients invariably showed ill-defined rim enhancement along the right chest wall, signifying chest wall injury. The results showed that tissue ablation using HIFU caused tissue injury along the pathway of high-intensity ultrasound beams. The harm to tissues is presented as photopenic area on the rib cages due to necrosis or hot spots due to rib fractures in the bone scan. Since these cold defects are subtle, they are easily overlooked or mistaken as aggressive bony metastasis

  3. Shock-induced heating and millisecond boiling in gels and tissue due to high intensity focused ultrasound.

    Science.gov (United States)

    Canney, Michael S; Khokhlova, Vera A; Bessonova, Olga V; Bailey, Michael R; Crum, Lawrence A

    2010-02-01

    Nonlinear propagation causes high-intensity ultrasound waves to distort and generate higher harmonics, which are more readily absorbed and converted to heat than the fundamental frequency. Although such nonlinear effects have been investigated previously and found to not significantly alter high-intensity focused ultrasound (HIFU) treatments, two results reported here change this paradigm. One is that at clinically relevant intensity levels, HIFU waves not only become distorted but form shock waves in tissue. The other is that the generated shock waves heat the tissue to boiling in much less time than predicted for undistorted or weakly distorted waves. In this study, a 2-MHz HIFU source operating at peak intensities up to 25,000 W/cm(2) was used to heat transparent tissue-mimicking phantoms and ex vivo bovine liver samples. Initiation of boiling was detected using high-speed photography, a 20-MHz passive cavitation detector and fluctuation of the drive voltage at the HIFU source. The time to boil obtained experimentally was used to quantify heating rates and was compared with calculations using weak shock theory and the shock amplitudes obtained from nonlinear modeling and measurements with a fiber optic hydrophone. As observed experimentally and predicted by calculations, shocked focal waveforms produced boiling in as little as 3 ms and the time to initiate boiling was sensitive to small changes in HIFU output. Nonlinear heating as a result of shock waves is therefore important to HIFU, and clinicians should be aware of the potential for very rapid boiling because it alters treatments. PMID:20018433

  4. MR-guided high intensity focused ultrasound thermoablation under temperature mapping monitoring for the treatment of uterine fibroids

    International Nuclear Information System (INIS)

    Objective: To assess the feasibility and effectiveness of MR-guided high intensity focused ultrasound (MRgHIFU) thermoablation under temperature mapping monitoring for the treatment of uterine fibroids. Methods: MRgHIFU was carried out in 52 patients with a total of 61 uterine fibroids. The mean age was (39.6 ± 7.3) years (ranged between 23-56 years), and the average diameter of the fibroids was(6.1 ± 2.1) cm (ranged between 1.2-10.7 cm). This procedure was accomplished by a JM-HIFU system (Mode JM15100, Chongqing Haifu Technology Co., Ltd., China), in combination with a 1.5-Tesla MRI system (Avanto TIM, Siemens, Germany), which provided real-time guidance and temperature mapping. Contrast-enhanced MR imaging was performed both immediately and three months after MRgHIFU treatment in order to evaluate the efficacy of thermal ablation. The treatment time and adverse events were recorded. The percentage of ablation volume was calculated after the procedure. The changes in the size of the uterine fibroid and in the clinical symptoms three months after the procedure were evaluated. Results: The mean fibroid volume for each case before and three months after MRgHIFU treatment was (113.3 ± 87.7) cm3 and (58.1 ± 45.0) cm3 respectively(P 3 (ranged between 7.7-282.9 cm3) of fibroid volume was (19.8 ± 8.8) minutes. The mean energy of focused ultrasound delivered into the ablated fibroid tissue was (7.1 ± 6.7) J/mm3 (ranged between 0.9-32.1 J/mm3). The symptoms were relieved, the mean overall points decreased from (24.7 ± 4.8) to (16.7 ± 3.2) after therapy (P < 0.05). One patient experienced mild skin burn (small blisters), which subsided within two days. No other adverse events and complications were observed. Two patients got pregnant at three months after the treatment. Conclusion: MR-guided high intensity focused ultrasound treatment is a safe, effective and non-invasive technique for ablating uterine fibroids. A single thermoablation procedure is enough to make

  5. MR-Guided High-Intensity Focused Ultrasound Ablation of Breast Cancer with a Dedicated Breast Platform

    Energy Technology Data Exchange (ETDEWEB)

    Merckel, Laura G., E-mail: L.G.Merckel-2@umcutrecht.nl [University Medical Center Utrecht, Department of Radiology (Netherlands); Bartels, Lambertus W., E-mail: W.Bartels@umcutrecht.nl [University Medical Center Utrecht, Image Sciences Institute (Netherlands); Koehler, Max O., E-mail: max.kohler@philips.com [Philips Healthcare (Finland); Bongard, H. J. G. Desiree van den, E-mail: D.vandenBongard@umcutrecht.nl [University Medical Center Utrecht, Department of Radiotherapy (Netherlands); Deckers, Roel, E-mail: R.Deckers-2@umcutrecht.nl [University Medical Center Utrecht, Image Sciences Institute (Netherlands); Mali, Willem P. Th. M., E-mail: W.Mali@umcutrecht.nl [University Medical Center Utrecht, Department of Radiology (Netherlands); Binkert, Christoph A., E-mail: Christoph.Binkert@ksw.ch [Cantonal Hospital Winterthur, Department of Radiology (Switzerland); Moonen, Chrit T., E-mail: C.Moonen@umcutrecht.nl [University Medical Center Utrecht, Image Sciences Institute (Netherlands); Gilhuijs, Kenneth G. A., E-mail: K.G.A.Gilhuijs@umcutrecht.nl; Bosch, Maurice A. A. J. van den, E-mail: mbosch@umcutrecht.nl [University Medical Center Utrecht, Department of Radiology (Netherlands)

    2013-04-15

    Optimizing the treatment of breast cancer remains a major topic of interest. In current clinical practice, breast-conserving therapy is the standard of care for patients with localized breast cancer. Technological developments have fueled interest in less invasive breast cancer treatment. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) is a completely noninvasive ablation technique. Focused beams of ultrasound are used for ablation of the target lesion without disrupting the skin and subcutaneous tissues in the beam path. MRI is an excellent imaging method for tumor targeting, treatment monitoring, and evaluation of treatment results. The combination of HIFU and MR imaging offers an opportunity for image-guided ablation of breast cancer. Previous studies of MR-HIFU in breast cancer patients reported a limited efficacy, which hampered the clinical translation of this technique. These prior studies were performed without an MR-HIFU system specifically developed for breast cancer treatment. In this article, a novel and dedicated MR-HIFU breast platform is presented. This system has been designed for safe and effective MR-HIFU ablation of breast cancer. Furthermore, both clinical and technical challenges are discussed, which have to be solved before MR-HIFU ablation of breast cancer can be implemented in routine clinical practice.

  6. An improved tissue-mimicking polyacrylamide hydrogel phantom for visualizing thermal lesions with high-intensity focused ultrasound.

    Science.gov (United States)

    Guntur, Sitaramanjaneya Reddy; Choi, Min Joo

    2014-11-01

    A recipe was created to improve the tissue-mimicking (TM) bovine serum albumin (BSA) polyacrylamide hydrogel (PAG) reported in our previous study (Choi MJ, Guntur SR, Lee KI, Paeng DG, Coleman AJ. Ultrasound Med Biol 2013; 29:439-448). In that work, the concentration of acrylamide in TM BSA PAG was increased to make its attenuation coefficient the same as that of a tissue. However, this increase made the PAG stiffer and less homogeneous. In addition, the increase in acrylamide caused a significant increase in temperature over the denaturation threshold of BSA during polymerization, which required forced cooling so that the PAG did not become opaque at room temperature after polymerization. To eliminate those shortcomings, we substituted the increased acrylamide with a viscous polysaccharide liquid (corn syrup). The concentration of corn syrup was optimized to 20% (w/v, tested in the volume of 50 mL), so that the acoustic properties of the PAG would be close to those of human liver. The improved TM (iTM) BSA PAG constructed in this study had a speed of sound of 1588 ± 9 m/s, an attenuation coefficient of 0.51 ± 0.06 dB cm(-1) at 1 MHz and a backscattering coefficient of 0.22 ± 0.09 × 10(-3) sr(-1) cm(-1) MHz(-1). The density and acoustic impedance were 1057 kg/m(3) and 1.68 MRayl, respectively, and the non-linear parameter (B/A) was 5.9 ± 0.3. The thermal, optical and mechanical properties were almost the same as those of the BSA PAG (Lafon et al.2005). Experimental verification indicated that the thermal lesions visualized in the proposed iTM BSA PAG by high-intensity focused ultrasound were highly reproducible. In conclusion, iTM BSA PAG was proven to eliminate TM BSA PAG shortcomings effectively and is expected to be a promising test phantom for clinical high-intensity focused ultrasound device. PMID:25220272

  7. High-intensity focused ultrasound treatment for intra-abdominal desmoid tumors: a report of four cases.

    Science.gov (United States)

    Shi, Yulan; Huang, Yanqin; Zhou, Meiqi; Ying, Xiao; Hu, Xiaoye

    2016-04-01

    Desmoid tumors are rare clonal fibroblastic proliferations that can arise at abdominal or extra-abdominal sites. Complete surgical resection is the primary treatment for resectable desmoid tumors, but a high rate of local recurrence has been reported even after complete resection. For patients with a recurrent tumor, the goals of treatment are to control the recurrence, maintain quality of life, and prolong survival. Radiofrequency ablation, radiotherapy, chemotherapy, and other medical therapies can be used as alternative methods, but there are considerable controversies over the roles of these methods in the management of desmoid tumors. High-intensity focused ultrasound (HIFU) is a minimally invasive and effective method for treatment of solid tumors. We used HIFU to treat four patients with intra-abdominal desmoid tumors from June 2011 to September 2013. Post-procedural pain was seen in all patients. One patient had an intra-abdominal abscess and another suffered a slight injury to the femoral nerve. The patients were followed up for 19-46 months (mean 34 months) until April 2015. The tumor in one patient disappeared, and no tumor progression was observed in the other patients. PMID:27033872

  8. Radio Frequency Ultrasound Time Series Signal Analysis to Evaluate High-intensity Focused Ultrasound Lesion Formation Status in Tissue.

    Science.gov (United States)

    Mobasheri, Saeedeh; Behnam, Hamid; Rangraz, Parisa; Tavakkoli, Jahan

    2016-01-01

    High-intensity focused ultrasound (HIFU) is a novel treatment modality used by scientists and clinicians in the recent decades. This modality has had a great and significant success as a noninvasive surgery technique applicable in tissue ablation therapy and cancer treatment. In this study, radio frequency (RF) ultrasound signals were acquired and registered in three stages of before, during, and after HIFU exposures. Different features of RF time series signals including the sum of amplitude spectrum in the four quarters of the frequency range, the slope, and intercept of the best-fit line to the entire power spectrum and the Shannon entropy were utilized to distinguish between the HIFU-induced thermal lesion and the normal tissue. We also examined the RF data, frame by frame to identify exposure effects on the formation and characteristics of a HIFU thermal lesion at different time steps throughout the treatment. The results obtained showed that the spectrum frequency quarters and the slope and intercept of the best fit line to the entire power spectrum both increased two times during the HIFU exposures. The Shannon entropy, however, decreased after the exposures. In conclusion, different characteristics of RF time series signal possess promising features that can be used to characterize ablated and nonablated tissues and to distinguish them from each other in a quasi-quantitative fashion. PMID:27186536

  9. Thermal ablation produced using a surgical toroidal high-intensity focused ultrasound device is independent from hepatic inflow occlusion

    Energy Technology Data Exchange (ETDEWEB)

    Melodelima, D; N' Djin, W A; Favre-Cabrera, J; Parmentier, H; Rivoire, M; Chapelon, J Y [Inserm, U556, Lyon, F-69003 (France); Universite de Lyon, Lyon, F-69003 (France)

    2009-10-21

    In the liver, the efficacy of radiofrequency or high-intensity focused ultrasound (HIFU) ablation is impaired by blood perfusion. This can be overcome by hepatic inflow occlusion. Here we report the in vivo evaluation of ablations performed in the liver using a surgical toroidal HIFU device used during an open procedure with and without hepatic inflow occlusion. The HIFU device was composed of 256 toroidal-shaped emitters working at 3 MHz and an integrated ultrasound imaging probe working at 7.5 MHz. Using an intermittent Pringle maneuver (IPM), thermal ablations were created in three pigs with hepatic inflow occlusion (IPM group) and in three pigs with normal perfusion (NoIPM group). The ablations were studied on sonograms, macroscopically and microscopically 14 days after the treatment. In the NoIPM group, the average coagulated volume obtained after a 40 s exposure was 7.4 {+-} 3.8 cm{sup 3} (2.2-16.6). In the IPM group, the average ablated volume was 6.3 {+-} 2.9 cm{sup 3} (2.6-12.1). There was no significant difference between the two groups in terms of ablated volume (p = 0.25), diameter (p = 0.37) or depth (p = 0.61). Therefore, a toroidal-shaped HIFU device allows treatment in the liver that can be considered as independent from hepatic inflow occlusion.

  10. The Value of Proton Magnetic Resonance Spectroscopy in High-Intensity Focused Ultrasound Treatment of Experimental Liver Cancer

    Directory of Open Access Journals (Sweden)

    Zhuo-yue Tang

    2015-06-01

    Full Text Available High-intensity focused ultrasound (HIFU is a rapidly developing, non-invasive technique for local treatment of solid tumors that produce coagulative tumor necrosis. This study is aimed to investigate the feasibility of proton magnetic resonance spectroscopy (MRS on early assessing treatment of HIFU ablation in rabbit with VX2 liver tumor. HIFU ablation was performed on normal liver and VX2 tumor in rabbit, and MRS was performed on normal liver and VX2 tumor before and 2 days after 100% HIFU ablation or 80% ablation in tumor volume. Choline (Cho and choline/lipid (Cho/Lip ratios between complete and partial HIFU ablation of tumor were compared. Tissues were harvested and sequentially sliced to confirm the necrosis. In normal liver, the Cho value liver was not obviously changed after HIFU (P > .05, but the Cho/Lip ratio was decreased (P .05; however, the Cho value in partial ablation was still higher than that in normal liver before or in tumor after complete HIFU treatment due to the residual part of tumors, and Cho/Lip ratio is lower than that in complete HIFU treatment (P < .001. The changes in MRS parameters were consistent with histopathologic changes of the tumor tissues after treatment. MRS could differentiate the complete tumor necrosis from residual tumor tissue, when combined with magnetic resonance imaging. We conclude that MRS may be applied as an important, non-invasive biomarker for monitoring the thoroughness of HIFU ablation.

  11. A Bayesian approach for energy-based estimation of acoustic aberrations in high intensity focused ultrasound treatment

    CERN Document Server

    Hosseini, Bamdad; Pichardo, Samuel; Constanciel, Elodie; Drake, James M; Stockie, John M

    2016-01-01

    High intensity focused ultrasound is a non-invasive method for treatment of diseased tissue that uses a beam of ultrasound in order to generate heat within a small volume. A common challenge in application of this technique is that heterogeneity of the biological medium can defocus the ultrasound beam. In this study, the problem of refocusing the beam is reduced to the Bayesian inverse problem of estimating the acoustic aberration due to the biological tissue from acoustic radiative force imaging data. The solution to this problem is a posterior probability density on the aberration which is sampled using a Metropolis-within-Gibbs algorithm. The framework is tested using both a synthetic and experimental dataset. This new approach has the ability to obtain a good estimate of the aberrations from a small dataset, as little as 32 sonication tests, which can lead to significant speedup in the treatment process. Furthermore, this framework is very flexible and can work with a wide range of sonication tests and so...

  12. The dynamics of cavitation bubble clouds in high-intensity focused ultrasound field observed by high-speed photography

    Science.gov (United States)

    Li, Xiaojing; Chen, Hong; Wan, Mingxi

    2007-01-01

    High-speed photography is being considered as an effective technique to record the transient phenomena in medical field. This presentation summarizes our previous work of using high-speed photography in the observation of cavitation bubble clouds generated in high-intensity focused ultrasound (HIFU) field, aiming at the better understanding of the cavitation mechanism during the medical application of HIFU. A high-speed photography system synchronized with HIFU emission facilities was built up, and using this system we have investigated the dynamics of cavitation bubble clouds (i) in the whole HIFU free field; (ii) in the focal region of HIFU free field; and (iii) near the tissue surface in HIFU field. The spatial-temporal evolution of the bubble cloud and the characteristics of bubble cloud structures as well as the possible explanations to the recorded phenomena are reviewed. All the results we got elucidated that the highspeed camera is a potent tool to detect the cavitation phenomena in HIFU field.

  13. MRI methods for the evaluation of high intensity focused ultrasound tumor treatment: Current status and future needs.

    Science.gov (United States)

    Hectors, Stefanie J C G; Jacobs, Igor; Moonen, Chrit T W; Strijkers, Gustav J; Nicolay, Klaas

    2016-01-01

    Thermal ablation with high intensity focused ultrasound (HIFU) is an emerging noninvasive technique for the treatment of solid tumors. HIFU treatment of malignant tumors requires accurate treatment planning, monitoring and evaluation, which can be facilitated by performing the procedure in an MR-guided HIFU system. The MR-based evaluation of HIFU treatment is most often restricted to contrast-enhanced T1 -weighted imaging, while it has been shown that the non-perfused volume may not reflect the extent of nonviable tumor tissue after HIFU treatment. There are multiple studies in which more advanced MRI methods were assessed for their suitability for the evaluation of HIFU treatment. While several of these methods seem promising regarding their sensitivity to HIFU-induced tissue changes, there is still ample room for improvement of MRI protocols for HIFU treatment evaluation. In this review article, we describe the major acute and delayed effects of HIFU treatment. For each effect, the MRI methods that have been-or could be-used to detect the associated tissue changes are described. In addition, the potential value of multiparametric MRI for the evaluation of HIFU treatment is discussed. The review ends with a discussion on future directions for the MRI-based evaluation of HIFU treatment. PMID:26096859

  14. Management of Respiratory Motion in Extracorporeal High-Intensity Focused Ultrasound Treatment in Upper Abdominal Organs: Current Status and Perspectives

    Energy Technology Data Exchange (ETDEWEB)

    Muller, A., E-mail: arnaud.muller@chu-lyon.fr [Centre Hospitalier Lyon Sud, Service de Radiologie, Hospices Civils de Lyon (France); Petrusca, L.; Auboiroux, V. [University of Geneva, Department of Radiology, Faculty of Medicine (Switzerland); Valette, P. J. [Centre Hospitalier Lyon Sud, Service de Radiologie, Hospices Civils de Lyon (France); Salomir, R. [University of Geneva, Department of Radiology, Faculty of Medicine (Switzerland); Cotton, F. [Centre Hospitalier Lyon Sud, Service de Radiologie, Hospices Civils de Lyon (France)

    2013-12-15

    Extracorporeal high-intensity focused ultrasound (HIFU) is a minimally invasive therapy considered with increased interest for the ablation of small tumors in deeply located organs while sparing surrounding critical tissues. A multitude of preclinical and clinical studies have showed the feasibility of the method; however, concurrently they showed several obstacles, among which the management of respiratory motion of abdominal organs is at the forefront. The aim of this review is to describe the different methods that have been proposed for managing respiratory motion and to identify their advantages and weaknesses. First, we specify the characteristics of respiratory motion for the liver, kidneys, and pancreas and the problems it causes during HIFU planning, treatment, and monitoring. Second, we make an inventory of the preclinical and clinical approaches used to overcome the problem of organ motion. Third, we analyze their respective benefits and drawbacks to identify the remaining physical, technological, and clinical challenges. We thereby consider the outlook of motion compensation techniques and those that would be the most suitable for clinical use, particularly under magnetic resonance thermometry monitoring.

  15. Transarterial infusion chemotherapy combined with high intensity focused ultrasound for the treatment of pancreatic carcinomas: a clinical study

    International Nuclear Information System (INIS)

    Objective: To assess the clinical value of transarterial infusion chemotherapy combined with high intensity focused ultrasound (HIFU) for the treatment of pancreatic carcinomas. Methods: A total of 64 patients with inoperable pancreatic carcinomas were randomly divided into study group (n=32) and control group (n=32). Transarterial infusion chemotherapy combined with HIFU was employed in patients of study group, while simple transarterial infusion chemotherapy was conducted in patients of control group. The effective rate, the clinical benefit rate (CBR), the occurrence of side effect and the survival time of the two groups were recorded. The results were compared between the two groups. Results: The effective rate (PR + MR), the median survival time and the one-year survival rate of the study group were 55.56%, 13.0 months and 68.75% respectively, while the effective rate (PR + MR), the median survival time and the one-year survival rate of the control group were 28.57%, 9.0 months and 43.75% respectively. Both the effective rate and the one-year survival rate of the study group were significantly higher than those of the control group (P<0.05). Conclusion: Compared with pure transarterial infusion chemotherapy, transarterial infusion chemotherapy combined with HIFU can significantly improve the short-term efficacy and increase the one-year survival rate for patients with advanced pancreatic carcinomas. (authors)

  16. Adjuvant hormone therapy in patients undergoing high-intensity focused ultrasound therapy for locally advanced prostate cancer

    Directory of Open Access Journals (Sweden)

    A. I. Neimark

    2014-01-01

    Full Text Available Objective: to evaluate the efficiency and safety of using the luteinizing hormone releasing hormone leuprorelin with the Atrigel delivery system in doses of 7.5, 22.5, and 45 mg as an adjuvant regimen in high- and moderate-risk cancer patients who have received high-intensity focused ultrasound (HIFU therapy.Subjects and methods. Moderate- and high-risk locally advanced prostate cancer (PC patients treated with HIFU (n = 28 and HIFU in combination with hormone therapy during 6 months (n = 31 were examined.Results. The investigation has shown that leuprorelin acetate monotherapy used within 6 months after HIFU therapy can achieve the highest reduction in prostate-specific antigen levels and positively affect the symptoms of the disease. HIFU in combination with androgen deprivation substantially diminishes the clinical manifestations of the disease and improves quality of life in HIFU-treated patients with PC, by reducing the degree of infravesical obstruction (according to uroflowmetric findings and IPSS scores, and causes a decrease in prostate volume as compared to those who have undergone HIFU only. Treatment with leuprorelin having the Atrigel delivery system has demonstrated the low incidence of adverse reactions and good tolerability.

  17. Role of Focal Therapy with High-Intensity Focused Ultrasound in the Management of Clinically Localized Prostate Cancer.

    Science.gov (United States)

    Kuru, Timur H; van Essen, Julius; Pfister, David; Porres, Daniel

    2015-01-01

    Overtreatment of prostate cancer (PC) remains one of the main burdens in uro-oncology. Focal therapy may be a reasonable alternative with less side effects and morbidity. Application of high-intensity focused ultrasound (HIFU) induces immediate and irreversible coagulation. The treatment leads to consecutive necrosis with sharply delineated margins, making HIFU a promising tool for the focal therapy of localized PC. Unlike radiation, the treatment leaves no collateral damage outside of the heated tissue, allowing repeated use of HIFU, if necessary. In case of non-organ-confined relapse, additional radical salvage therapy can be performed. This review gives an overview of the existing evidence on focal HIFU. Today, 3 HIFU devices are approved for the treatment of localized PC: Sonablate™, Ablatherm™ and the FocalOne™ device. In summary, the first published results of focal HIFU are promising. The quality of life and potency of the patients are well preserved. Therefore, HIFU treatment, and especially focal ablation of tumor foci, seems to be a safe alternative to standard treatment, with low side effects. The oncologic results seem satisfactory but need further follow-up to validate this practice of PC control. PMID:26632846

  18. High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis.

    Science.gov (United States)

    Aoun, Fouad; Limani, Ksenija; Peltier, Alexandre; Marcelis, Quentin; Zanaty, Marc; Chamoun, Alexandre; Vanden Bossche, Marc; Roumeguère, Thierry; van Velthoven, Roland

    2015-01-01

    Purpose. To evaluate postoperative morbidity and long term oncologic and functional outcomes of high intensity focused ultrasound (HIFU) compared to brachytherapy for the treatment of localized prostate cancer. Material and Methods. Patients treated by brachytherapy were matched 1 : 1 with patients who underwent HIFU. Differences in postoperative complications across the two groups were assessed using Wilcoxon's rank-sum or χ (2) test. Kaplan-Meier curves, log-rank tests, and Cox regression models were constructed to assess differences in survival rates between the two groups. Results. Brachytherapy was significantly associated with lower voiding LUTS and less frequent acute urinary retention (p HIFU cohort and 44 months (13-89 months) in the brachytherapy cohort. Median time to achieve PSA nadir was statistically shorter in the HIFU. Biochemical recurrence-free survival rate was significantly higher in the brachytherapy cohort compared to HIFU cohort (68.5% versus 53%, p cancer specific, and overall survivals was observed between the two groups. Conclusion. HIFU and brachytherapy are safe with no significant difference in cancer specific survival on long term oncologic follow-up. Nonetheless, a randomized controlled trial is needed to confirm these results. PMID:26357511

  19. Adjuvant hormone therapy in patients undergoing high-intensity focused ultrasound therapy for locally advanced prostate cancer

    Directory of Open Access Journals (Sweden)

    A. I. Neimark

    2014-11-01

    Full Text Available Objective: to evaluate the efficiency and safety of using the luteinizing hormone releasing hormone leuprorelin with the Atrigel delivery system in doses of 7.5, 22.5, and 45 mg as an adjuvant regimen in high- and moderate-risk cancer patients who have received high-intensity focused ultrasound (HIFU therapy.Subjects and methods. Moderate- and high-risk locally advanced prostate cancer (PC patients treated with HIFU (n = 28 and HIFU in combination with hormone therapy during 6 months (n = 31 were examined.Results. The investigation has shown that leuprorelin acetate monotherapy used within 6 months after HIFU therapy can achieve the highest reduction in prostate-specific antigen levels and positively affect the symptoms of the disease. HIFU in combination with androgen deprivation substantially diminishes the clinical manifestations of the disease and improves quality of life in HIFU-treated patients with PC, by reducing the degree of infravesical obstruction (according to uroflowmetric findings and IPSS scores, and causes a decrease in prostate volume as compared to those who have undergone HIFU only. Treatment with leuprorelin having the Atrigel delivery system has demonstrated the low incidence of adverse reactions and good tolerability.

  20. High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis

    Directory of Open Access Journals (Sweden)

    Fouad Aoun

    2015-01-01

    Full Text Available Purpose. To evaluate postoperative morbidity and long term oncologic and functional outcomes of high intensity focused ultrasound (HIFU compared to brachytherapy for the treatment of localized prostate cancer. Material and Methods. Patients treated by brachytherapy were matched 1 : 1 with patients who underwent HIFU. Differences in postoperative complications across the two groups were assessed using Wilcoxon’s rank-sum or χ2 test. Kaplan-Meier curves, log-rank tests, and Cox regression models were constructed to assess differences in survival rates between the two groups. Results. Brachytherapy was significantly associated with lower voiding LUTS and less frequent acute urinary retention (p<0.05. Median oncologic follow-up was 83 months (13–123 months in the HIFU cohort and 44 months (13–89 months in the brachytherapy cohort. Median time to achieve PSA nadir was statistically shorter in the HIFU. Biochemical recurrence-free survival rate was significantly higher in the brachytherapy cohort compared to HIFU cohort (68.5% versus 53%, p<0.05. No statistically significant difference in metastasis-free, cancer specific, and overall survivals was observed between the two groups. Conclusion. HIFU and brachytherapy are safe with no significant difference in cancer specific survival on long term oncologic follow-up. Nonetheless, a randomized controlled trial is needed to confirm these results.

  1. High-Intensity Focused Ultrasound (HIFU) Using Sonablate-500 for the Treatment of Localized Prostate Cancer: 6-year experience

    Science.gov (United States)

    Uchida, Toyoaki; Shoji, Sunao; Nagata, Yoshihiro

    2006-05-01

    We evaluated 281 patients of localized prostate cancer treated with high-intensity focused ultrasound (HIFU) for biochemical disease-free rate, safety, morbidity and predictors of biochemical outcome. A total of 281 patients underwent HIFU with the use of Sonablate-500 and with at least 12 months of follow-up. Biochemical failure was defined according to the criteria recommended by the American Society for Therapeutic Radiology and Oncology Consensus Panel. The biochemical disease-free rates at 1, 3 and 5 years in all patients were 78%, 74% and 72%, respectively. The biochemical disease-free rates at 5 years for patients with pretreatment PSA less than 10 ng/ml, 10.01 to 20.0 ng/ml and more than 20.0 ng/ml were 88%, 70% and 17%, respectively (pHIFU therapy appears to be a safe and efficacious minimally invasive therapy for patients with localized prostate cancer, especially those with a pretreatment PSA level less than 20 ng/ml.

  2. Single High Intensity Focused Ultrasound Session as a Whole Gland Primary Treatment for Clinically Localized Prostate Cancer: 10-Year Outcomes

    Directory of Open Access Journals (Sweden)

    Ksenija Limani

    2014-01-01

    Full Text Available Objectives. To assess the treatment outcomes of a single session of whole gland high intensity focused ultrasound (HIFU for patients with localized prostate cancer (PCa. Methods. Response rates were defined using the Stuttgart and Phoenix criteria. Complications were graded according to the Clavien score. Results. At a median follow-up of 94months, 48 (44.4% and 50 (46.3% patients experienced biochemical recurrence for Phoenix and Stuttgart definition, respectively. The 5- and 10-year actuarial biochemical recurrence free survival rates were 57% and 40%, respectively. The 10-year overall survival rate, cancer specific survival rate, and metastasis free survival rate were 72%, 90%, and 70%, respectively. Preoperative high risk category, Gleason score, preoperative PSA, and postoperative nadir PSA were independent predictors of oncological failure. 24.5% of patients had self-resolving LUTS, 18.2% had urinary tract infection, and 18.2% had acute urinary retention. A grade 3b complication occurred in 27 patients. Pad-free continence rate was 87.9% and the erectile dysfunction rate was 30.8%. Conclusion. Single session HIFU can be alternative therapy for patients with low risk PCa. Patients with intermediate risk should be informed about the need of multiple sessions of HIFU and/or adjuvant treatments and HIFU performed very poorly in high risk patients.

  3. The efficacy of high-intensity, focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva.

    Science.gov (United States)

    Zhou, W; Zhu, L; Zhou, H; Shen, K; Lang, J; Cui, Q; Shi, H

    2016-01-01

    Non-neoplastic epithelial disorders of the vulva (NNEDV) are common types of vulval lesions. Although corticosteroids represent a first-line treatment for NNEDV, concerns exist about the safety associated with long-term topical corticosteroid use. Recently, several clinical trials have identified high-intensity focused ultrasound (HIFU) as a promising treatment modality for NNEDV. The aim of this multi-center, randomized, controlled clinical trial was to investigate the efficacy of HIFU therapy in women with NNEDV based on histological alterations. We enrolled patients who were clinically diagnosed with NNEDV. They were randomized into 2 treatment groups: 1) halcinonide for 3 months or 2) HIFU once. A total of 123 patients were biopsied both prior to and after the therapy, and 62 and 61 patients were assigned to the HIFU and halcinonide groups, respectively. The histological changes were then analyzed. After the treatments, the therapeutic effects were observed in both groups. Comparing the diagnosis and alterations in lichenoid and sclerotic patterns and in chronic inflammation, we found statistically significant differences. Furthermore, when compared with the halcinonide group, the HIFU group exhibited enhanced curative effects that were statistically significant (P = 0.039). Based on the histological evidence from this randomized, controlled trial, HIFU represents an effective method for the treatment of NNEDV. PMID:27188744

  4. An ex vivo human lung model for ultrasound-guided high-intensity focused ultrasound therapy using lung flooding.

    Science.gov (United States)

    Wolfram, Frank; Reichenbach, Jürgen R; Lesser, Thomas G

    2014-03-01

    The usability of an ex vivo human lung model for ablation of lung cancer tissue with high-intensity focused ultrasound (HIFU) is described. Lung lobes were flooded with saline, with no gas remaining after complete atelectasis. The tumor was delineated sono-morphologically. Speed of sound, tissue density and ultrasound attenuation were measured for flooded lung and different pulmonary cancer tissues. The acoustic impedance of lung cancer tissue (1.6-1.9 mega-Rayleighs) was higher than that of water, as was its attenuation coefficient (0.31-0.44 dB/cm/MHz) compared with that of the flooded lung (0.12 dB/cm/MHz). After application of HIFU, the temperature in centrally located lung cancer surrounded by the flooded lung increased as high as 80°C, which is sufficient for treatment. On the basis of these preliminary results, ultrasound-guided HIFU ablation of lung cancer, by lung flooding with saline, appears feasible and should be explored in future clinical studies. PMID:24412177

  5. Preliminary Experience Using Extracorporeal High-Intensity Focused Ultrasound For The Treatment Of Kidney And Liver Tumours

    Science.gov (United States)

    Illing, Rowland O.; Kennedy, James E.; Wu, Feng; ter Haar, Gail R.; Phillips, Rachel R.; Protheroe, Andrew S.; Middleton, Mark R.; Cranston, David W.

    2005-03-01

    High-intensity focused ultrasound (HIFU) provides a potentially non-invasive alternative to conventional therapies. We have been using the extracorporeal ultrasound-guided Model-JC Tumor Therapy System (HAIFU™ Technology Co, China) in clinical trials to evaluate the safety and feasibility of treating renal and liver tumours. 30 patients have been treated (22 liver and 8 kidney tumours), all of whom were available for adverse event reporting. Of the 22 liver tumours, 20 are evaluable for response to treatment; 14 were followed up with magnetic resonance imaging (MRI) alone, and 6 with both MRI and histological resection. Evidence of ablation was seen in 20/20 (100%) cases radiologically, and 6/6 (100%) cases histologically. Of the 8 kidney tumours treated, 7 are evaluable; 2 were followed up with MRI alone, and 5 with both MRI and histological resection. Evidence of ablation was seen in 4/7 (57%) radiologically and 1/5 (20%) histologically. Mild, moderate or severe transient pain was reported by 16 (53%), 7 (23%) and 1 (3%) patients, respectively. Superficial skin toxicity was seen in 7 patients (23%). Renal function was unaffected, and all patients were fit for discharge from hospital the day after treatment. Early results show that this technique is feasible, and carries a low morbidity.

  6. Radio Frequency Ultrasound Time Series Signal Analysis to Evaluate High-intensity Focused Ultrasound Lesion Formation Status in Tissue

    Science.gov (United States)

    Mobasheri, Saeedeh; Behnam, Hamid; Rangraz, Parisa; Tavakkoli, Jahan

    2016-01-01

    High-intensity focused ultrasound (HIFU) is a novel treatment modality used by scientists and clinicians in the recent decades. This modality has had a great and significant success as a noninvasive surgery technique applicable in tissue ablation therapy and cancer treatment. In this study, radio frequency (RF) ultrasound signals were acquired and registered in three stages of before, during, and after HIFU exposures. Different features of RF time series signals including the sum of amplitude spectrum in the four quarters of the frequency range, the slope, and intercept of the best-fit line to the entire power spectrum and the Shannon entropy were utilized to distinguish between the HIFU-induced thermal lesion and the normal tissue. We also examined the RF data, frame by frame to identify exposure effects on the formation and characteristics of a HIFU thermal lesion at different time steps throughout the treatment. The results obtained showed that the spectrum frequency quarters and the slope and intercept of the best fit line to the entire power spectrum both increased two times during the HIFU exposures. The Shannon entropy, however, decreased after the exposures. In conclusion, different characteristics of RF time series signal possess promising features that can be used to characterize ablated and nonablated tissues and to distinguish them from each other in a quasi-quantitative fashion.

  7. Dependence of ablative ability of high-intensity focused ultrasound cavitation-based histotripsy on mechanical properties of agar.

    Science.gov (United States)

    Xu, Jin; Bigelow, Timothy A; Davis, Gabriel; Avendano, Alex; Shrotriya, Pranav; Bergler, Kevin; Hu, Zhong

    2014-12-01

    Cavitation-based histotripsy uses high-intensity focused ultrasound at low duty factor to create bubble clouds inside tissue to liquefy a region, and provides better fidelity to planned lesion coordinates and the ability to perform real-time monitoring. The goal of this study was to identify the most important mechanical properties for predicting lesion dimensions, among these three: Young's modulus, bending strength, and fracture toughness. Lesions were generated inside tissue-mimicking agar, and correlations were examined between the mechanical properties and the lesion dimensions, quantified by lesion volume and by the width and length of the equivalent bubble cluster. Histotripsy was applied to agar samples with varied properties. A cuboid of 4.5 mm width (lateral to focal plane) and 6 mm depth (along beam axis) was scanned in a raster pattern with respective step sizes of 0.75 and 3 mm. The exposure at each treatment location was either 15, 30, or 60 s. Results showed that only Young's modulus influenced histotripsy's ablative ability and was significantly correlated with lesion volume and bubble cluster dimensions. The other two properties had negligible effects on lesion formation. Also, exposure time differentially affected the width and depth of the bubble cluster volume. PMID:25480051

  8. Ultrasonograpy of VX-2 Liver Tumor in Rabbit Treated by High Intensity Focused Ultrasound Combined with Microbubble Contrast Agent

    Science.gov (United States)

    Xiaojuan, Ji; Jinqing, Li; Zhibiao, Wang; Jianzhong, Zou; Wenzhi, Chen; Jin, Bai

    2007-05-01

    Objective: To assess the value of sonographic appearance and to investigate the sonographic character of VX-2 liver tumor in rabbit treated by high intensity focused ultrasound (HIFU) combined with microbubble contrast agent. Methods: Forty-five rabbits bearing VX-2 tumors were randomly averagely assigned into three groups. In group A irradiation was sustained until the target region became hyperechoic. In group B therapy was stopped as soon as hyperecho occurred, and in group C irradiation time was prolonged to ensure the occurrence of coagulation necrosis. Results: Exposure duration for tumors treated purely with HIFU was the longest, whilst the use of microbubble contrast agent combined with HIFU shortened the exposure duration significantly. The gross examination and ultrasonogram coagulation necrosis area measurements correlated strongly (r=0.986,P<0.05) in the microbubble-enhanced HIFU group. Conclusion: It was feasible to enhance HIFU therapy with microbubble contrast agent. The characteristic change in the ultrasound images made it possible to assess the enhanced HIFU therapeutic efficacy in order to adjust the treatment program.

  9. High-Intensity Focused Ultrasound in the Treatment of Hepatic Metastases from Colorectal Cancer of 18 Patients

    Institute of Scientific and Technical Information of China (English)

    HuiZhu; WenzhiChen; FengWu; KequanLi; JianzhongZou; ZhibiaoWang

    2004-01-01

    OBJECTIVE To evaluate the safety and effectiveness of treatment of hepatic metastases from colorectal cancer using high-intensity focused ultrasound (HIFU). METHODS Thirty-one lesions in 18 patients with hepatic metastases from colorectal cancer after colectomy were treated with HIFU therapy. The vital signs, function of the vital organs, complications and pathological outcome were studied using imaging examinations such as CT or MRI. RESULTS The vital signs of all patients remained stable and their liver and kidney functions normal. Two of the 18 patients were not followed-up. After a mean follow-up of 16.1 months (6-38 months), 13 survived. The survival rates at the 12th and 18th months were 83.3% and 66.7%, respectively. The median survival rate was 16 months. Among the 25 lesions followed-up, 17 shrank over 50%, 5 grew new metastases and superficial degree II skin injury occurred in 8. CONCLUSION HIFU is a safe, effective and non-invasive option for the treatment of hepatic metastases from colorectal cancer.

  10. Management of Respiratory Motion in Extracorporeal High-Intensity Focused Ultrasound Treatment in Upper Abdominal Organs: Current Status and Perspectives

    International Nuclear Information System (INIS)

    Extracorporeal high-intensity focused ultrasound (HIFU) is a minimally invasive therapy considered with increased interest for the ablation of small tumors in deeply located organs while sparing surrounding critical tissues. A multitude of preclinical and clinical studies have showed the feasibility of the method; however, concurrently they showed several obstacles, among which the management of respiratory motion of abdominal organs is at the forefront. The aim of this review is to describe the different methods that have been proposed for managing respiratory motion and to identify their advantages and weaknesses. First, we specify the characteristics of respiratory motion for the liver, kidneys, and pancreas and the problems it causes during HIFU planning, treatment, and monitoring. Second, we make an inventory of the preclinical and clinical approaches used to overcome the problem of organ motion. Third, we analyze their respective benefits and drawbacks to identify the remaining physical, technological, and clinical challenges. We thereby consider the outlook of motion compensation techniques and those that would be the most suitable for clinical use, particularly under magnetic resonance thermometry monitoring

  11. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study.

    Science.gov (United States)

    Gong, Chunmei; Yang, Bin; Shi, Yarong; Liu, Zhongqiong; Wan, Lili; Zhang, Hong; Jiang, Denghua; Zhang, Lian

    2016-08-01

    Objectives The aim of this study was to investigate factors affecting ablative efficiency of high intensity focused ultrasound (HIFU) for adenomyosis. Materials and methods In all, 245 patients with adenomyosis who underwent ultrasound guided HIFU (USgHIFU) were retrospectively reviewed. All patients underwent dynamic contrast-enhanced magnetic resonance imaging (MRI) before and after HIFU treatment. The non-perfused volume (NPV) ratio, energy efficiency factor (EEF) and greyscale change were set as dependent variables, while the factors possibly affecting ablation efficiency were set as independent variables. These variables were used to build multiple regression models. Results A total of 245 patients with adenomyosis successfully completed HIFU treatment. Enhancement type on T1 weighted image (WI), abdominal wall thickness, volume of adenomyotic lesion, the number of hyperintense points, location of the uterus, and location of adenomyosis all had a linear relationship with the NPV ratio. Distance from skin to the adenomyotic lesion's ventral side, enhancement type on T1WI, volume of adenomyotic lesion, abdominal wall thickness, and signal intensity on T2WI all had a linear relationship with EEF. Location of the uterus and abdominal wall thickness also both had a linear relationship with greyscale change. Conclusion The enhancement type on T1WI, signal intensity on T2WI, volume of adenomyosis, location of the uterus and adenomyosis, number of hyperintense points, abdominal wall thickness, and distance from the skin to the adenomyotic lesion's ventral side can all be used as predictors of HIFU for adenomyosis. PMID:27385316

  12. Targeted Vessel Ablation for More Efficient Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids

    Energy Technology Data Exchange (ETDEWEB)

    Voogt, Marianne J., E-mail: m.voogt@umcutrecht.nl [University Medical Center Utrecht, Department of Radiology (Netherlands); Stralen, Marijn van [University Medical Center Utrecht, Image Sciences Institute (Netherlands); Ikink, Marlijne E. [University Medical Center Utrecht, Department of Radiology (Netherlands); Deckers, Roel; Vincken, Koen L.; Bartels, Lambertus W. [University Medical Center Utrecht, Image Sciences Institute (Netherlands); Mali, Willem P. Th. M.; Bosch, Maurice A. A. J. van den [University Medical Center Utrecht, Department of Radiology (Netherlands)

    2012-10-15

    Purpose: To report the first clinical experience with targeted vessel ablation during magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) treatment of symptomatic uterine fibroids. Methods: Pretreatment T1-weighted contrast-enhanced magnetic resonance angiography was used to create a detailed map of the uterine arteries and feeding branches to the fibroids. A three-dimensional overlay of the magnetic resonance angiography images was registered on 3D T2-weighted pretreatment imaging data. Treatment was focused primarily on locations where supplying vessels entered the fibroid. Patients were followed 6 months after treatment with a questionnaire to assess symptoms and quality of life (Uterine Fibroid Symptom and Quality of Life) and magnetic resonance imaging to quantify shrinkage of fibroid volumes. Results: In two patients, three fibroids were treated with targeted vessel ablation during MR-HIFU. The treatments resulted in almost total fibroid devascularization with nonperfused volume to total fibroid volume ratios of 84, 68, and 86%, respectively, of treated fibroids. The predicted ablated volumes during MR-HIFU in patients 1 and 2 were 45, 40, and 82 ml, respectively, while the nonperfused volumes determined immediately after treatment were 195, 92, and 190 ml respectively, which is 4.3 (patient 1) and 2.3 (patient 2) times higher than expected based on the thermal dose distribution. Fibroid-related symptoms reduced after treatment, and quality of life improved. Fibroid volume reduction ranged 31-59% at 6 months after treatment. Conclusion: Targeted vessel ablation during MR-HIFU allowed nearly complete fibroid ablation in both patients. This technique may enhance the use of MR-HIFU for fibroid treatment in clinical practice.

  13. Non-invasive magnetic resonance-guided high intensity focused ultrasound ablation of a vascular malformation in the lower extremity : a case report

    OpenAIRE

    van Breugel, Marjolein; Nijenhuis, Robbert J; Ries, Mario G.; Toorop, RJ; Vonken, EPA; Wijlemans, JW; van den Bosch, Maurice A. A. J.

    2015-01-01

    INTRODUCTION: Therapy of choice for symptomatic vascular malformations consists of surgery, sclerotherapy, or embolization. However, these techniques are invasive with possible complications and require hospitalization. We present a novel non-invasive technique, i.e., magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation, for the treatment of a vascular malformation in a patient. This technique applies high-intensity sound waves transcutaneously to the body and is ful...

  14. The feasibility and safety of high-intensity focused ultrasound combined with low-dose external beam radiotherapy as supplemental therapy for advanced prostate cancer following hormonal therapy

    Institute of Scientific and Technical Information of China (English)

    Rui-Yi Wu; Guo-Min Wang; Lei Xu; Bo-Heng Zhang; Ye-Qing Xu; Zhao-Chong Zeng; Bing Chen

    2011-01-01

    The aim of this study was to investigate the feasibility and safety of high-intensity focused ultrasound (HIFU) combined with (+) low-dose external beam radiotherapy (LRT) as supplemental therapy for advanced prostate cancer (PCa) following hormonal therapy (HT). Our definition of HIFU+LRT refers to treating primary tumour lesions with HIFU in place of reduced field boost irradiation to the prostate, while retaining four-field box irradiation to the pelvis in conventional-dose external beam radiotherapy (CRT). We performed a prospective, controlled and non-randomized study on 120 patients with advanced PCa after HT who received HIFU, CRT, HIFU+LRT and HT alone, respectively. CT/MR imaging showed the primary tumours and pelvic lymph node metastases visibly shrank or even disappeared after HIFU+LRT treatment. There were significant differences among four groups with regard to overall survival (OS) and disease-specific survival (DSS) curves (P=0.018 and 0.015). Further comparison between each pair of groups suggested that the long-term DSS of the HIFU+LRT group was higher than those of the other three groups, but there was no significant difference between the HIFU+LRT group and the CRT group. Multivariable Cox's proportional hazard model showed that both HIFU+LRT and CRT were independently associated with DSS (P=0.001 and 0.035) and had protective effects with regard to the risk of death. Compared with CRT, HIFU+LRT significantly decreased incidences of radiation-related late gastrointestinal (GI) and genitourinary (GU) toxicity grade ≥II. In conclusion, long-term survival of patients with advanced PCa benefited from strengthening local control of primary tumour and regional lymph node metastases after HT. As an alternative to CRT, HIFU+LRT showed good efficacy and better safety.

  15. Use of high-intensity focused ultrasound in the treatment of both benign and malignant prostatic disease

    Science.gov (United States)

    Kernen, Kenneth M.; Miles, Brian J.

    2000-05-01

    Prostate cancer, the most common malignancy in men in the United States, accounts for more than 29% of all male cancers diagnosed and 13% of all cancer deaths. This translates into approximately 200,000 men diagnosed and 37,000 men who will die from the disease this year in this country. A significant number of patients ultimately choose external beam radiation or interstitial radioactive implants (brachytherapy) combined with external beam radiotherapy as their primary treatment. Approximately 25 - 35% of external beam irradiation patients and 20 - 30% of interstitial implants combined with external beam radiotherapy will fail within 10 years. The treatment options for patients with localized radiorecurrent disease include watchful waiting, endocrine therapy, salvage radiotherapy, and salvage radical prostatectomy, cryotherapy and now high intensity focused ultrasound therapy (HIFU). Although some studies regarding watchful waiting demonstrated comparable results to formal treatment for early prostate cancer, other studies have shown metastatic and mortality rates that are significantly higher, and that radiorecurrent patients would have even greater rates of metastasis and progression to death. Prostate cancer cure by means of endocrine therapy is highly unlikely and its role is still one of palliation with a side effect profile which includes hot flashes, osteoporosis, fatigue, loss of muscle mass, anemia, loss of libido and potency. The role of salvage radiotherapy may offer local control, however long term efficacy has yet to be determined. In a recent series, only 50% of the patients were controlled for a mean of four years with salvage radiotherapy. Salvage prostatectomy has the advantage of providing excellent local control and even a cure if the cancer is confined to the prostate or within the surrounding periprostatic tissue. Historically, salvage prostatectomy is technically demanding and fraught with higher complications. In one large series

  16. Midterm Results after Uterine Artery Embolization Versus MR-Guided High-Intensity Focused Ultrasound Treatment for Symptomatic Uterine Fibroids

    Energy Technology Data Exchange (ETDEWEB)

    Froeling, V., E-mail: vera.froeling@charite.de; Meckelburg, K., E-mail: katrin.meckelburg@charite.de; Scheurig-Muenkler, C., E-mail: christian.scheurig-muenkler@charite.de; Schreiter, N. F., E-mail: nils.schreiter@charite.de; Kamp, J., E-mail: julia.kamp@charite.de; Maurer, M. H., E-mail: martin.maurer@charite.de; Beck, A., E-mail: alexander.beck@charite.de; Hamm, B., E-mail: bernd.hamm@charite.de; Kroencke, T. J., E-mail: Thomas.kroencke@charite.de [Charite-Universitaetsmedizin Berlin, Department of Radiology (Germany)

    2013-12-15

    Purpose: To compare the rate of reintervention and midterm changes in symptom severity (SS) and Total health-related quality of life (HRQoL) scores after uterine artery embolization (UAE) and magnetic resonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids. Methods: Eighty women (median age 38.3 years), equally eligible for MR-g HIFU and UAE who underwent one of both treatments between 2002 and 2009 at our institution, were included. The primary end point of the study was defined as the rate of reintervention after both therapies. The secondary outcome was defined as changes in SS and Total HRQoL scores after treatment. SS and Total HRQoL scores before treatment and at midterm follow-up (median 13.3 months) were assessed by the uterine fibroid symptom and quality-of-life questionnaire (UFS-QoL) and compared. Results: The rate of reintervention was significantly lower after UAE than after MR-g HIFU (p = 0.002). After both treatments, SS and Total HRQoL scores improved significantly from baseline to follow-up (UAE: p < 0.001, p < 0.001; MR-g HIFU: p = 0.002, p < 0.001). Total HRQoL scores were significantly higher after UAE than after MR-g HIFU (p = 0.032). Changes in the SS scores did not differ significantly for both treatments (p = 0.061). Conclusion: UAE and MR-g HIFU significantly improved the health-related quality of life of women with symptomatic uterine fibroids. After UAE, the change in Total HRQoL score improvement was significantly better, and a significantly lower rate of reintervention was observed.

  17. Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer

    International Nuclear Information System (INIS)

    The objective of this study was to evaluate health-related quality of life (HRQOL) after salvage high-intensity focused ultrasound (HIFU) for locally radiorecurrent prostate cancer (PCa). Since June 2006 we have treated 61 patients consecutively by salvage HIFU. All patients were offered the University of California, Los Angeles Prostate Cancer Index (UCLA-PCI) questionnaire at baseline and at follow-up. Scores ranged from 0 (worst) to 100 (best). Clinically significant changes were defined as a minimum difference of 10 points between the baseline score and the score at follow-up. Fifty-seven patients (93%) had evaluable data at baseline, compared with 46 (75%) after treatment. The mean time lapse between HIFU treatment and questionnaire response was 17.5 months (range 6-29 months). The mean score for urinary function decreased from 79.7±12.1 prior to HIFU to 67.4±17.8 after HIFU (P<0.001). The mean score for sexual function decreased from 32.1±24.1 prior to HIFU to 17.2±17.0 after HIFU (P<0.001). There were no significant effects on bowel function. There was a significant reduction in the mean score for Physical HRQOL, but the mean score for Mental HRQOL was did not change significantly. Treatment of localized radiorecurrent PCa by salvage HIFU is associated with clinically significant reductions in urinary and sexual function domains after a mean follow-up of 17.5 months. (author)

  18. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.

    Science.gov (United States)

    Kim, Hyun Ryoung; You, Dong Gil; Park, Sang-Jun; Choi, Kyu-Sil; Um, Wooram; Kim, Jae-Hun; Park, Jae Hyung; Kim, Young-Sun

    2016-05-01

    Monitoring of drug release from a heat-activated liposome carrier provides an opportunity for real-time control of drug delivery and allows prediction of the therapeutic effect. We have developed short-chain elastin-like polypeptide-incorporating thermosensitive liposomes (STLs). Here, we report the development of STL encapsulating gadobenate dimeglumine (Gd-BOPTA), a MRI contrast agent, and doxorubicin (Dox) (Gd-Dox-STL). The Dox release profile from Gd-Dox-STL was comparable to Gd-Dox-LTSL; however, the serum stability of Gd-Dox-STL was much higher than Gd-Dox-LTSL. MRI studies showed that the difference in T1 relaxation time between 37 and 42 °C for Gd-Dox-STL was larger than the difference for Gd-Dox-LTSL. Although relaxivity for both liposomes at 42 °C was similar, the relaxivity of Gd-Dox-STL at 37 °C was 2.5-fold lower than that of Gd-Dox-LTSL. This was likely due to Gd-BOPTA leakage from the LTSL because of low stability at 37 °C. Pharmacokinetic studies showed plasma half-lives of 4.85 and 1.95 h for Gd-Dox-STL and Gd-Dox-LTSL, respectively, consistent with in vitro stability data. In vivo MRI experiments demonstrated corelease of Dox and Gd-BOPTA from STL under mild hyperthermia induced by high-intensity focused ultrasound (HIFU), which suggests STL is a promising tumor selective formulation when coupled with MR-guided HIFU. PMID:26998616

  19. Characterization of lesion formation and bubble activities during high-intensity focused ultrasound ablation using temperature-derived parameters

    Science.gov (United States)

    Hsiao, Yi-Sing; Kumon, Ronald E.; Deng, Cheri X.

    2013-09-01

    Successful high-intensity focused ultrasound (HIFU) thermal tissue ablation relies on accurate information of the tissue temperature and tissue status. Often temperature measurements are used to predict and monitor the ablation process. In this study, we conducted HIFU ablation experiments with ex vivo porcine myocardium tissue specimens to identify changes in temperature associated with tissue coagulation and bubble/cavity formation. Using infrared (IR) thermography and synchronized bright-field imaging with HIFU applied near the tissue surface, parameters derived from the spatiotemporal evolution of temperature were correlated with HIFU-induced lesion formation and overheating, of which the latter typically results in cavity generation and/or tissue dehydration. Emissivity of porcine myocardium was first measured to be 0.857 ± 0.006 (n = 3). HIFU outcomes were classified into non-ablative, normal lesion, and overheated lesion. A marked increase in the rate of temperature change during HIFU application was observed with lesion formation. A criterion using the maximum normalized second time derivative of temperature change provided 99.1% accuracy for lesion identification with a 0.05 s-1 threshold. Asymmetric temperature distribution on the tissue surface was observed to correlate with overheating and/or bubble generation. A criterion using the maximum displacement of the spatial location of the peak temperature provided 90.9% accuracy to identify overheated lesion with a 0.16 mm threshold. Spatiotemporal evolution of temperature obtained using IR imaging allowed determination of the critical cumulative equivalent minutes at 43 °C (CEM43) for lesion formation to be 170 min. Similar temperature characteristics indicative of lesion formation and overheating were identified for subsurface HIFU ablation. These results suggest that parameters derived from temperature changes during HIFU application are associated with irreversible changes in tissue and may provide

  20. Dynamic T{sub 2}-mapping during magnetic resonance guided high intensity focused ultrasound ablation of bone marrow

    Energy Technology Data Exchange (ETDEWEB)

    Waspe, Adam C.; Looi, Thomas; Mougenot, Charles; Amaral, Joao; Temple, Michael; Sivaloganathan, Siv; Drake, James M. [Centre for Image Guided Innovation and Therapeutic Intervention, The Hospital for Sick Children, Toronto, ON, M5G 1X8 (Canada); Philips Healthcare Canada, Markham, ON, L6C 2S3 (Canada); Centre for Image Guided Innovation and Therapeutic Intervention, The Hospital for Sick Children, Toronto, ON, M5G 1X8 (Canada); Department of Applied Mathematics, University of Waterloo, Waterloo, ON, N2L 3G1 (Canada); Centre for Image Guided Innovation and Therapeutic Intervention, The Hospital for Sick Children, Toronto, ON, M5G 1X8 (Canada)

    2012-11-28

    Focal bone tumor treatments include amputation, limb-sparing surgical excision with bone reconstruction, and high-dose external-beam radiation therapy. Magnetic resonance guided high intensity focused ultrasound (MR-HIFU) is an effective non-invasive thermotherapy for palliative management of bone metastases pain. MR thermometry (MRT) measures the proton resonance frequency shift (PRFS) of water molecules and produces accurate (<1 Degree-Sign C) and dynamic (<5s) thermal maps in soft tissues. PRFS-MRT is ineffective in fatty tissues such as yellow bone marrow and, since accurate temperature measurements are required in the bone to ensure adequate thermal dose, MR-HIFU is not indicated for primary bone tumor treatments. Magnetic relaxation times are sensitive to lipid temperature and we hypothesize that bone marrow temperature can be determined accurately by measuring changes in T{sub 2}, since T{sub 2} increases linearly in fat during heating. T{sub 2}-mapping using dual echo times during a dynamic turbo spin-echo pulse sequence enabled rapid measurement of T{sub 2}. Calibration of T{sub 2}-based thermal maps involved heating the marrow in a bovine femur and simultaneously measuring T{sub 2} and temperature with a thermocouple. A positive T{sub 2} temperature dependence in bone marrow of 20 ms/ Degree-Sign C was observed. Dynamic T{sub 2}-mapping should enable accurate temperature monitoring during MR-HIFU treatment of bone marrow and shows promise for improving the safety and reducing the invasiveness of pediatric bone tumor treatments.

  1. Twelve years' experience with high-intensity focused ultrasound (HIFU) using sonablate™ devices for the treatment of localized prostate cancer

    Science.gov (United States)

    Uchida, Toyoaki; Nakano, Muyura; Shoji, Sunao; Nagata, Yoshihiro; Usui, Yukio; Terachi, Toshiro

    2012-10-01

    To report on the long-term results of high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. Patients with clinical Stage T1c-T3N0M0, biopsy proven, localized prostate cancer, with a serum prostate specific antigen (PSA) level of HIFU using the Sonablate™ (S) device and were required to have a minimal follow-up of 2 years after the last HIFU session to be included in this analysis. Four different generation HIFU devices, S200, S500, S500 version 4 and S500 TCM, have been used for this study. Biochemical failure was defined according to the Phoenix definition (PSA nadir+2ng/ml). Seven hundred and fifty-three men with prostate cancer were included. The patients were divided into two groups: in the Former group, 421 patients were treated with S200 and 500 from 1990 to 2005; in the Latter group, 332 patients were treated with S500 ver. 4 and TCM from 2005 to 2009. The mean age, PSA, Gleason score, operation time, and follow-up period in the Former and Latter groups were 68 and 67 years, 11.3 and 9.7 ng/ml, 6.2 and 6.6, 167 and 101 min, and 49 and 38 months, respectively. The biochemical disease-free rate (BDFR) in the groups at 5 years was, respectively, 67% and 53%, and was 50% at 10 years in the Former group (pprostate biopsy rate in the Former and Latter groups was 81% and 93%, respectively. Postoperative erectile dysfunction was noted in 45%, 38%, and 24% of patients at 6 months, 12 months, and 2 years after HIFU. The results after long-term follow-up have indicated that HIFU is an efficient and safe treatment for patients with localized prostate cancer, especially low-and intermediate-risk patients.

  2. Postoperative monitoring of prostate-specific antigen (PSA after treatment with high-intensive focused ultrasound (HIFU

    Directory of Open Access Journals (Sweden)

    Blyumberg B.I.

    2012-12-01

    Full Text Available Research objective: to estimate efficiency of treatment of prostate cancer using high-intensive focused ultrasound on the basis of laboratory analysis of postoperative level prostate-specific antigen (PSA. Objects of research. Objects of research consisted of 110 patients treated in urological clinic of Hospital n.a. S. R. Mirotvortsev (Saratov State Medical University during the period February, 2009 — March, 2012. Patients took 110 sessions of primary operative treatment of prostate cancer by HIFU therapy method. Technique and research methods. Concentration of PSA in blood changed in all patients every 1,5 month within 6 months after operation, irrespective of its kind (including after repeated HIFU, further — after every 3 month till one year, and later on after 6 months. We were guided by references of the International Consensus, which considers PSA level more than 0,5 ng/ml in blood after 3 months of treatment to be unsatisfactory result. We also headed for PSA level before treatment and oncological risk degree. Results. Median nadir formed 0,5 ng/ml PSA by 3 months after treatment. Patients demonstrated different indicators of PSA dynamics depending on oncological risk, stage and hormonal therapy management. Patients with low oncological risk had initially lower PSA concentration, further PSA concentration reached nadir level faster. At patients with widespread forms of prostate cancer accurate dependence of PSA concentration according to prevalence of process was traced. Time of PSA nadir amount did not differ and was marked as 12-14 weeks on average. At patients received hormonal therapy, lower value of PSA nadir was marked. The conclusion. Monitoring of PSA concentration (PSA nadir by 3 months, dynamics of PSA concentration change is of great importance in early revealing of relapse after prostate HIFU therapy. High level of PSA nadir and PSA growth according to time period are important prognostic factors.

  3. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging

    Energy Technology Data Exchange (ETDEWEB)

    Zhao, Wen-Peng, E-mail: zwp215@163.com [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Chen, Jin-Yun, E-mail: chenjinyun2006@126.com [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Zhang, Lian, E-mail: zhangl@haifu.com.cn [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Clinical Center for Tumor Therapy of 2nd Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Chongqing 400010 (China); Li, Quan, E-mail: 1013283493@qq.com [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Qin, Juan, E-mail: ant000999@163.com [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); and others

    2013-01-15

    Purpose: To retrospectively investigate whether uterine fibroids with hyperintense on pretreatment T2-weighted magnetic resonance imaging (MRI) could be treated with ultrasound-guided high intensity focused ultrasound (USgHIFU). Materials and methods: 282 patients with 282 symptomatic uterine fibroids who underwent USgHIFU treatment were retrospectively analyzed. Based on the signal intensity of T2-weighted MRI, uterine fibroids were classified as hypointense, isointense and hyperintense. Hyperintense fibroids were subjectively further subdivided into heterogeneous hyperintense, slightly homogeneous hyperintense and markedly homogeneous hyperintense based on the signal intensity of fibroid relative to myometrium and endometrium on T2-weighted MRI. Enhanced MRI was performed within one month after HIFU treatment. Non-perfused volume (NPV, indicative of successful ablation) ratio, treatment time, treatment efficiency, energy effect ratio and adverse events were recorded. Results: The median volume of uterine fibroids was 70.3 cm{sup 3} (interquartile range, 41.1–132.5 cm{sup 3}). The average NPV ratio, defined as non-perfused volume divided by the fibroid volume after HIFU treatment, was 76.8 ± 19.0% (range, 0–100%) in the 282 patients. It was 86.3 ± 11.9% (range, 40.9–100.0%) in the group with hypointense fibroids, 77.1 ± 16.5% (range, 32.2–100.0%) in isointense fibroids, and 67.6 ± 23.9% (range, 0–100.0%) in hyperintense fibroids. The lowest NPV ratio, lowest treatment efficiency, more treatment time, more sonication energy and pain scores were observed in the slightly homogeneous hyperintense fibroids, and the NPV ratio was 55.8 ± 26.7% (range, 0–83.9%) in this subgroup. Conclusion: Based on our results, the heterogeneous and markedly homogeneous hyperintense fibroids were suitable for USgHIFU, and only the slightly homogeneous hyperintense fibroids should be excluded.

  4. Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: Utility of contrast-enhanced ultrasonography

    Energy Technology Data Exchange (ETDEWEB)

    Zhou Xiaodong [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China)]. E-mail: zhouxd@fmmu.edu.cn; Ren Xiaolong [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China)]. E-mail: renxiaolong70@hotmail.com; Zhang Jun [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); He Guangbin [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); Zheng Minjuan [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); Tian Xue [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); Li Li [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); Zhu Ting [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); Zhang Min [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); Wang Lei [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China); Luo Wen [Department of Ultrasonography, Xijing Hospital, Fourth Military Medical University, No. 17 West Changle Road, Xi' an 710032 (China)

    2007-05-15

    Purpose: To assess the utility of contrast-enhanced ultrasonography (ceUS) in the assessment of the therapeutic response to high intensity focused ultrasound (HIFU) ablation in patients with uterine fibroid. Materials and methods: Sixty-four patients with a total of 64 uterine fibroids (mean: 5.3 {+-} 1.2 cm; range: 3.2-8.9 cm) treated with HIFU ablation under the ultrasound guidance were evaluated with ceUS after receiving an intravenous bolus injection of a microbubble contrast agent (SonoVue) within 1 week after intervention. We obtained serial ceUS images during the time period from beginning to 5 min after the initiation of the bolus contrast injection. All of the patients underwent a contrast enhanced MRI (ceMRI) and ultrasound guided needle puncture biopsy within 1 week after HIFU ablation. And as a follow-up, all of the patients underwent US at 1, 3, 6 and 12 months after HIFU treatment. The volume change was observed and compared to pre- and post-HIFU ablation. The results of the ceUS were compared with those of the ceMRI in terms of the presence or absence of residual unablated tumor and pathologic change in the treated lesions. Results: On ceUS, diagnostic accuracy was 100%, while residual unablated tumors were found in three uterine fibroids (4.7%) and failed treatment was found in eight uterine fibroids (12.5%). All the 11 fibroids were subjected to additional HIFU ablation. Of the 58 ablated fibroids without residual tumors on both the ceUS and ceMRI after the HIFU ablation, the volumes of all the fibroids decreased in different degrees during the 1 year follow-up USs. And histologic examinations confirmed findings of necrotic and viable tumor tissue, respectively. Conclusion: CEUS is potentially useful for evaluating the early therapeutic effect of percutaneous HIFU ablation for uterine fibroids.

  5. Precision control of lesions by high-intensity focused ultrasound cavitation-based histotripsy through varying pulse duration.

    Science.gov (United States)

    Xu, Jin; Bigelow, Timothy A; Nagaraju, Ravindra

    2013-07-01

    The goal of this experimental study was to explore the feasibility of acquiring controllable precision through varying pulse duration for lesions generated by cavitation-based histotripsy. Histotripsy uses high-intensity focused ultrasound (HIFU) at low duty factor to create energetic bubble clouds inside tissue to liquefy a region. It uses cavitation-mediated mechanical effects while minimizing heating, and has the advantages of real-time monitoring and lesion fidelity to treatment planning. In our study, histotripsy was applied to three groups of tissue-mimicking agar samples of different stiffnesses (29.4 ± 5.3, 44.8 ± 5.9, and 66.4 ± 7.1 kPa). B-mode imaging was used first to quantify bubble cluster dimensions in both water and agar. Then, a 4.5-mm-wide square (lateral to the focal plane) was scanned in a raster pattern with a step size of 0.75 mm in agar histotripsy experiments to estimate equivalent bubble cluster dimensions based on the histotripsyinduced damage. The 15-s exposure at each treatment location comprised 5000 sine-wave tone bursts at a spatial-peak pulseaverage intensity of 41.1 kW/cm2, with peak compressional and rarefactional pressures of 102 and 17 MPa, respectively. The results showed that bubble cluster width and length increased with pulse duration and decreased with agar stiffness. Therefore, a significant improvement in histotripsy precision could be achieved by reducing the pulse duration. PMID:25004507

  6. Enhanced Ablation of High Intensity Focused Ultrasound with Microbubbles: An Experimental Study on Rabbit Hepatic VX2 Tumors

    International Nuclear Information System (INIS)

    Purpose: This study was designed to assess the enhanced effect of high intensity focused ultrasound (HIFU) ablation with microbubbles on rabbit hepatic VX2 tumors and to compare the detection sensitivity of CEUS and CECT to determine the residual viable tissue after ablation of HIFU. Methods: Forty rabbits with hepatic VX2 tumors were randomly separated into two groups (20 animals per group) before HIFU ablation. A bolus of 0.2 mL of saline or a microbubble-based ultrasound (US) contrast agent was injected intravenously to group I rabbits and group II rabbits, respectively. The HIFU ablation procedure was started 15 s after the injection. Tumors were examined with grayscale contrast-enhanced ultrasound (CEUS) and contrast-enhanced computed tomography (CECT) immediately before and after HIFU ablation. Histopathologic assessment was performed immediately after treatment imaging. Results: Before ablation, intense contrast enhancement during arterial phase was observed at the whole tumors or the periphery of the tumors by CEUS and CECT. Lower HIFU energy was used in group II than in group I (P < 0.001). Histopathologic assessment revealed local residual viable tumor tissues due to incomplete ablation in 47.4% (9/19) of tumors in group I and 10% (2/20) of tumors in group II (P < 0.05). The concordance rate of CEUS (90.9%) with histopathology on residual tumor detection was higher than that of CECT (27.3%, P < 0.05). Conclusions: Introduction of the microbubble agent enhances HIFU therapeutic efficacy. CEUS proves to have high sensitivity in assessment of residual viable rabbit VX2 tumor after HIFU.

  7. Concurrent Chemotherapy and Pulsed High-Intensity Focused Ultrasound Therapy for the Treatment of Unresectable Pancreatic Cancer: Initial Experiences

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Jae Young; Choi, Byung Ihn; Ryu, Ji Kon; Kim, Yong Tae; Kim, Se Hyung; Han, Joon Koo [Seoul National University Hospital, Seoul (Korea, Republic of); Hwang, Joo Ha [University of Washington Medical Center, Seattle (United States)

    2011-04-15

    This study was performed to evaluate the potential clinical value of concurrent chemotherapy and pulsed high intensity focused ultrasound (HIFU) therapy (CCHT), as well as the safety of pulsed HIFU, for the treatment of unresectable pancreatic cancer. Twelve patients were treated with HIFU from October 2008 to May 2010, and three of them underwent CCHT as the main treatment (the CCHT group). The overall survival (OS), the time to tumor progression (TTP), the complications and the current performance status in the CCHT and non-CCHT groups were analyzed. Nine patients in the non-CCHT group were evaluated to determine why CCHT could not be performed more than twice. The OS of the three patients in the CCHT group was 26.0, 21.6 and 10.8 months, respectively, from the time of diagnosis. Two of them were alive at the time of preparing this manuscript with an excellent performance status, and one of them underwent a surgical resection one year after the initiation of CCHT. The TTP of the three patients in the CCHT group was 13.4, 11.5 and 9.9 months, respectively. The median OS and TTP of the non-CCHT group were 10.3 months and 4.4 months, respectively. The main reasons why the nine patients of the non-CCHT group failed to undergo CCHT more than twice were as follows: pancreatitis (n = 1), intolerance of the pain during treatment (n = 4), palliative use of HIFU for pain relief (n = 1) and a poor physical condition due to disease progression (n = 3). No major complications were encountered except one case of pancreatitis. This study shows that CCHT is a potentially effective and safe modality for the treatment of unresectable pancreatic cancer

  8. Locally recurrent prostate cancer after initial radiation therapy: Early salvage high-intensity focused ultrasound improves oncologic outcomes

    International Nuclear Information System (INIS)

    Purpose: To evaluate pre-operative prognostic risk factors to predict oncologic outcome of Salvage High-Intensity Focused Ultrasound (S-HIFU) for radiorecurrent prostate cancer (PCa). Methods and materials: A total of 290 men with biopsy-confirmed locally radiorecurrent PCa, underwent S-HIFU. D’Amico risk group before external beam radiotherapy (EBRT), Prostate Specific Antigen (PSA), estimated Gleason score prior HIFU and post HIFU biopsies were analyzed for predictive utility of local cancer control, cancer-specific, metastasis free, and progression free survival rates (PFSR). Results: Local cancer control with negative biopsy results was obtained in 81% of the 208 patients who underwent post-S-HIFU biopsies. Median PSA nadir was 0.14 ng/ml and 127 patients did not require androgen deprivation therapy (ADT). The mean follow up was 48 months for cancer-specific survival rates. The cancer-specific and metastasis-free survival rates at 7 years were 80% and 79.6% respectively. The PFSR was significantly influenced by: the pre-HIFU PSA level (hazard ratio (HR): 1.09, 95% CI 1.04–1.13), a Gleason score ⩾8 versus ⩽6 (HR: 1.17, 95% CI 1.03–1.3), and a previous ADT (HR: 1.28, 95% CI 1.09–1.46). The rates of recto-urethral fistula (0.4%) and grade II/III incontinence (19.5%) indicate significant reduction in serious side effects with use of dedicated post-radiation acoustic parameters compared with standard parameters. Conclusion: S-HIFU is an effective curative option for radiorecurrent PCa with acceptable morbidity for localized radiorecurrent PCa, but should be initiated early following EBRT failure. Use of prognostic risk factors can optimize patient selection.

  9. Non-invasive Measurement of Thermal Diffusivity Using High-Intensity Focused Ultrasound and Through-Transmission Ultrasonic Imaging.

    Science.gov (United States)

    Yeshurun, Lilach; Azhari, Haim

    2016-01-01

    Thermal diffusivity at the site ablated by high-intensity focused ultrasound (HIFU) plays an important role in the final therapeutic outcome, as it influences the temperature's spatial and temporal distribution. Moreover, as tissue thermal diffusivity is different in tumors as compared with normal tissue, it could also potentially be used as a new source of imaging contrast. The aim of this study was to examine the feasibility of combining through-transmission ultrasonic imaging and HIFU to estimate thermal diffusivity non-invasively. The concept was initially evaluated using a computer simulation. Then it was experimentally tested on phantoms made of agar and ex vivo porcine fat. A computerized imaging system combined with a HIFU system was used to heat the phantoms to temperatures below 42°C to avoid irreversible damage. Through-transmission scanning provided the time-of-flight values in a region of interest during its cooling process. The time-of-flight values were consequently converted into mean values of speed of sound. Using the speed-of-sound profiles along with the developed model, we estimated the changes in temperature profiles over time. These changes in temperature profiles were then used to calculate the corresponding thermal diffusivity of the studied specimen. Thermal diffusivity for porcine fat was found to be lower by one order of magnitude than that obtained for agar (0.313×10(-7)m(2)/s vs. 4.83×10(-7)m(2)/s, respectively, p < 0.041). The fact that there is a substantial difference between agar and fat implies that non-invasive all-ultrasound thermal diffusivity mapping is feasible. The suggested method may particularly be suitable for breast scanning. PMID:26489364

  10. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging

    International Nuclear Information System (INIS)

    Purpose: To retrospectively investigate whether uterine fibroids with hyperintense on pretreatment T2-weighted magnetic resonance imaging (MRI) could be treated with ultrasound-guided high intensity focused ultrasound (USgHIFU). Materials and methods: 282 patients with 282 symptomatic uterine fibroids who underwent USgHIFU treatment were retrospectively analyzed. Based on the signal intensity of T2-weighted MRI, uterine fibroids were classified as hypointense, isointense and hyperintense. Hyperintense fibroids were subjectively further subdivided into heterogeneous hyperintense, slightly homogeneous hyperintense and markedly homogeneous hyperintense based on the signal intensity of fibroid relative to myometrium and endometrium on T2-weighted MRI. Enhanced MRI was performed within one month after HIFU treatment. Non-perfused volume (NPV, indicative of successful ablation) ratio, treatment time, treatment efficiency, energy effect ratio and adverse events were recorded. Results: The median volume of uterine fibroids was 70.3 cm3 (interquartile range, 41.1–132.5 cm3). The average NPV ratio, defined as non-perfused volume divided by the fibroid volume after HIFU treatment, was 76.8 ± 19.0% (range, 0–100%) in the 282 patients. It was 86.3 ± 11.9% (range, 40.9–100.0%) in the group with hypointense fibroids, 77.1 ± 16.5% (range, 32.2–100.0%) in isointense fibroids, and 67.6 ± 23.9% (range, 0–100.0%) in hyperintense fibroids. The lowest NPV ratio, lowest treatment efficiency, more treatment time, more sonication energy and pain scores were observed in the slightly homogeneous hyperintense fibroids, and the NPV ratio was 55.8 ± 26.7% (range, 0–83.9%) in this subgroup. Conclusion: Based on our results, the heterogeneous and markedly homogeneous hyperintense fibroids were suitable for USgHIFU, and only the slightly homogeneous hyperintense fibroids should be excluded

  11. A modeling-based assessment of acousto-optic sensing for monitoring high-intensity focused ultrasound lesion formation

    Science.gov (United States)

    Adams, Matthew Tyler

    Real-time acousto-optic (AO) sensing---a dual-wave modality that combines ultrasound with diffuse light to probe the optical properties of turbid media---has been demonstrated to non-invasively detect changes in ex vivo tissue optical properties during high-intensity focused ultrasound (HIFU) exposure. The AO signal indicates the onset of lesion formation and predicts resulting lesion volumes. Although proof-of-concept experiments have been successful, many of the underlying parameters and mechanisms affecting thermally induced optical property changes and the AO detectability of HIFU lesion formation are not well understood. In thesis, a numerical simulation was developed to model the AO sensing process and capture the relevant acoustic, thermal, and optical transport processes. The simulation required data that described how optical properties changed with heating. Experiments were carried out where excised chicken breast was exposed to thermal bath heating and changes in the optical absorption and scattering spectra (500 nm--1100 nm) were measured using a scanning spectrophotometer and an integrating sphere assembly. Results showed that the standard thermal dose model currently used for guiding HIFU treatments needs to be adjusted to describe thermally induced optical property changes. To model the entire AO process, coupled models were used for ultrasound propagation, tissue heating, and diffusive light transport. The angular spectrum method was used to model the acoustic field from the HIFU source. Spatial-temporal temperature elevations induced by the absorption of ultrasound were modeled using a finite-difference time-domain solution to the Pennes bioheat equation. The thermal dose model was then used to determine optical properties based on the temperature history. The diffuse optical field in the tissue was then calculated using a GPU-accelerated Monte Carlo algorithm, which accounted for light-sound interactions and AO signal detection. The simulation was

  12. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: Role of partial rib resection

    Energy Technology Data Exchange (ETDEWEB)

    Zhu Hui; Zhou Kun; Zhang Lian; Jin Chengbin; Peng Song; Yang Wei; Li Kequan; Su Haibing [Clinical Center for Tumor Therapy of 2nd Hospital of Chongqing University of Medical Sciences, Chongqing 400010 (China); Chen Wenzhi [Clinical Center for Tumor Therapy of 2nd Hospital of Chongqing University of Medical Sciences, Chongqing 400010 (China); State Key Laboratory, Department of Biomedical Engineering, Chongqing University of Medical Sciences, Chongqing 400037 (China); Bai Jin; Wu Feng [State Key Laboratory, Department of Biomedical Engineering, Chongqing University of Medical Sciences, Chongqing 400037 (China); National Engineering and Research Center for Ultrasound Medicine, Chongqing 401121 (China); Wang, Zhibiao [Clinical Center for Tumor Therapy of 2nd Hospital of Chongqing University of Medical Sciences, Chongqing 400010 (China); State Key Laboratory, Department of Biomedical Engineering, Chongqing University of Medical Sciences, Chongqing 400037 (China); National Engineering and Research Center for Ultrasound Medicine, Chongqing 401121 (China)], E-mail: wangzhibiao@haifu.com.cn

    2009-10-15

    Objective: It has long been known that high intensity focused ultrasound (HIFU) can kill tissue through coagulative necrosis. However, it is only in recent years that practical clinical applications are becoming possible. Since the ribs have strong reflections to ultrasonic beams, they may affect the deposition of ultrasound energy, decreasing the efficacy of HIFU treatment and increasing the chance of adverse events when the intra-abdominal tumours concealed by ribs are treated. The aim of this study was to evaluate the influence of partial rib resection on the efficacy and safety of HIFU treatment. Methods: This prospective study was approved by the ethics committee at Chongqing University of Medical Sciences. An informed consent form was obtained from each patient and family member. A total of 16 patients with hepatocellular carcinoma (HCC), consisting of 13 males and 3 females, were studied. All patients had the successful HIFU treatment. To create a better acoustic pathway for HIFU treatment, all of the 16 patients had the ribs that shield the tumour mass to be removed. Magnetic resonance imaging (MRI) was used to evaluate the efficacy of HIFU treatment. Results: Sixteen cases had 23 nodules, including 12 cases with a single nodule, 1 case with 2 nodules, 3 cases with 3 nodules. The mean diameter of tumours was 7.0 {+-} 2.1 cm (5-10 cm). According to TNM classification, 9 patients were diagnosed as stage II, 4 patients were stage III, and 3 patients were stage IV. Follow-up imaging showed an absence of tumour blood supply and shrinkage of all treated lesions. The survival rates at 1, 2, 3, 4, and 5 years were 100%, 83.3%, 69.4%, 55.6%, and 55.6%, respectively. No serious complications were observed in the patients treated with HIFU. Conclusion: Partial rib resection can create a better acoustic pathway of HIFU therapy. Even though it is an invasive treatment, this measure offers patients an improved prospect of complete tumour ablation when no other treatment

  13. An Experimental Study of High Intensity Focused Ultrasound on Pig's Pancreas and the Early Clinical Experience on Pancreatic Cancer

    Science.gov (United States)

    Xiong, LiuLin; Huang, XiaoBo; Yao, SongSen; Yu, JinSheng; Hwang, JooHa; Fei, XingBo; Yu, QiuHong; Xue, WeiCheng; Zheng, ZhuYing; Wang, XiaoFeng

    2007-05-01

    Objective: To investigate the feasibility and safety of high intensity focused ultrasound (HIFU) treatment of in vivo pig pancreases, and to evaluate the safety and efficacy of HIFU in the clinical treatment of pancreatic cancer in humans. Methods: HIFU was performed in 12 domestic pig pancreases in vivo with varying acoustic energies. The safety of HIFU treatments was assessed by necropsy. The pathology and microstructure of the treated pancreases were evaluated using standard histology and transmission electron microscopy. Following the animal studies 62 patients with advanced pancreas cancer were treated with 250 - 420 W of acoustic power. There were 3 patients with stage II, 23 patients with stage III, and 36 patients with stage IV disease. Results: In animal studies, precise regions of coagulation necrosis were identified on pathology in 8 specimens that were treated with 420 W or 645 W acoustic power. Treatment effects were unable to be identified in 4 specimens treated with 300˜340 W acoustic power; however, damages to the cells microstructure and apoptosis were identified on electron microscopy. Damage to the stomach and colon were seen in some animals treated with 645 W. In the clinical treatments in humans the following were seen: local tumor control: complete response (CR) 0%, partial response (PR) 17.7%, no change (NC) 54.8%, progressive disease (PD) 27.5%. Pain relief was achieved in 87.1% of patients. The median survival for stage II and III patients was 11.2 months and median survival for stage IV patients was 5.6 months. The total median survival was 8.6 months. The survival rate at 1 year was as follows: stage II and III 42.3%, stage IV 5.6%. The survival rate at 2 years was as follows: stage II and III 15.4%, stage IV 0%. There were no severe complications or adverse events related to HIFU therapy seen in any of the patients treated. Conclusions: This study supports the feasibility of HIFU in the treatment of pancreatic cancer. The clinical

  14. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: Role of partial rib resection

    International Nuclear Information System (INIS)

    Objective: It has long been known that high intensity focused ultrasound (HIFU) can kill tissue through coagulative necrosis. However, it is only in recent years that practical clinical applications are becoming possible. Since the ribs have strong reflections to ultrasonic beams, they may affect the deposition of ultrasound energy, decreasing the efficacy of HIFU treatment and increasing the chance of adverse events when the intra-abdominal tumours concealed by ribs are treated. The aim of this study was to evaluate the influence of partial rib resection on the efficacy and safety of HIFU treatment. Methods: This prospective study was approved by the ethics committee at Chongqing University of Medical Sciences. An informed consent form was obtained from each patient and family member. A total of 16 patients with hepatocellular carcinoma (HCC), consisting of 13 males and 3 females, were studied. All patients had the successful HIFU treatment. To create a better acoustic pathway for HIFU treatment, all of the 16 patients had the ribs that shield the tumour mass to be removed. Magnetic resonance imaging (MRI) was used to evaluate the efficacy of HIFU treatment. Results: Sixteen cases had 23 nodules, including 12 cases with a single nodule, 1 case with 2 nodules, 3 cases with 3 nodules. The mean diameter of tumours was 7.0 ± 2.1 cm (5-10 cm). According to TNM classification, 9 patients were diagnosed as stage II, 4 patients were stage III, and 3 patients were stage IV. Follow-up imaging showed an absence of tumour blood supply and shrinkage of all treated lesions. The survival rates at 1, 2, 3, 4, and 5 years were 100%, 83.3%, 69.4%, 55.6%, and 55.6%, respectively. No serious complications were observed in the patients treated with HIFU. Conclusion: Partial rib resection can create a better acoustic pathway of HIFU therapy. Even though it is an invasive treatment, this measure offers patients an improved prospect of complete tumour ablation when no other treatment is

  15. Focusing and transport of high-intensity multi-MeV proton bunches from a compact laser-driven source

    Science.gov (United States)

    Busold, S.; Schumacher, D.; Deppert, O.; Brabetz, C.; Frydrych, S.; Kroll, F.; Joost, M.; Al-Omari, H.; Blažević, A.; Zielbauer, B.; Hofmann, I.; Bagnoud, V.; Cowan, T. E.; Roth, M.

    2013-10-01

    Laser ion acceleration provides for compact, high-intensity ion sources in the multi-MeV range. Using a pulsed high-field solenoid, for the first time high-intensity laser-accelerated proton bunches could be selected from the continuous exponential spectrum and delivered to large distances, containing more than 109 particles in a narrow energy interval around a central energy of 9.4 MeV and showing ≤30mrad envelope divergence. The bunches of only a few nanoseconds bunch duration were characterized 2.2 m behind the laser-plasma source with respect to arrival time, energy width, and intensity as well as spatial and temporal bunch profile.

  16. Histological evaluation of high-intensity focused ultrasound with lower-intensity focused ultrasound pre-exposure on the treatment of rabbit VX2 liver tumors

    International Nuclear Information System (INIS)

    This study was to evaluate the effect of pre-exposure lower-intensity focused ultrasound(US), or LIFU, in high-intensity focused ultrasound(HIFU) ablation of rabbit VX2 liver tumors . Liver VX2 tumor models were established in 30 rabbits, which were divided randomly into two groups. The liver tumors of rabbits in Group A underwent single HIFU ablation; those in Group B were given LIFU exposure before HIFU treatment. Five rabbits from each of the two groups were sacrificed at 0 hours, 3 days, and 7 days after HIFU ablation. Tissue samples that included targeted and short-range sounding (s-RS, within 5 mm of the targeted) and far-range sounding (f-RS, more than 5 mm of the targeted) tissues were observed using light microscope and transmission electron microscopy. The histological examination indicated that not only the targeted tumor cells became irreversible damage, but also the short-range sounding tumors were severely damaged by the HIFU with LIFU pre-exposure in group B. It is concluded that LIFU pre-exposure can enhance the effects of HIFU ablation on the destruction of cell ultrastructures and can enlarge the region of HIFU ablation.

  17. Histological evaluation of high-intensity focused ultrasound with lower-intensity focused ultrasound pre-exposure on the treatment of rabbit VX2 liver tumors

    Energy Technology Data Exchange (ETDEWEB)

    Zou Hairong; Zou Jianzhong; Wang Yan; Ou Xia [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key laboratory of Ultrasound in Medicine and Engineering, Department of Biomedical Engineering, Chongqing Medical (China)

    2012-10-03

    This study was to evaluate the effect of pre-exposure lower-intensity focused ultrasound(US), or LIFU, in high-intensity focused ultrasound(HIFU) ablation of rabbit VX2 liver tumors . Liver VX2 tumor models were established in 30 rabbits, which were divided randomly into two groups. The liver tumors of rabbits in Group A underwent single HIFU ablation; those in Group B were given LIFU exposure before HIFU treatment. Five rabbits from each of the two groups were sacrificed at 0 hours, 3 days, and 7 days after HIFU ablation. Tissue samples that included targeted and short-range sounding (s-RS, within 5 mm of the targeted) and far-range sounding (f-RS, more than 5 mm of the targeted) tissues were observed using light microscope and transmission electron microscopy. The histological examination indicated that not only the targeted tumor cells became irreversible damage, but also the short-range sounding tumors were severely damaged by the HIFU with LIFU pre-exposure in group B. It is concluded that LIFU pre-exposure can enhance the effects of HIFU ablation on the destruction of cell ultrastructures and can enlarge the region of HIFU ablation.

  18. MR Thermometry Analysis of Sonication Accuracy and Safety Margin of Volumetric MR Imaging-guided High-Intensity Focused Ultrasound Ablation of Symptomatic Uterine Fibroids

    NARCIS (Netherlands)

    Kim, Young-sun; Trillaud, Herve; Rhim, Hyunchul; Lim, Hyo K.; Mali, Willem; Voogt, Marianne; Barkhausen, Jorg; Eckey, Thomas; Kohler, Max O.; Keserci, Bilgin; Mougenot, Charles; Sokka, Shunmugavelu D.; Soini, Jouko; Nieminen, Heikki J.

    2012-01-01

    Purpose: To evaluate the accuracy of the size and location of the ablation zone produced by volumetric magnetic resonance (MR) imaging-guided high-intensity focused ultrasound ablation of uterine fibroids on the basis of MR thermometric analysis and to assess the effects of a feedback control techni

  19. Photoacoustic detection and optical spectroscopy of high-intensity focused ultrasound-induced thermal lesions in biologic tissue

    International Nuclear Information System (INIS)

    Purpose: The aims of this study are: (a) to investigate the capability of photoacoustic (PA) method in detecting high-intensity focused ultrasound (HIFU) treatments in muscle tissuesin vitro; and (b) to determine the optical properties of HIFU-treated and native tissues in order to assist in the interpretation of the observed contrast in PA detection of HIFU treatments. Methods: A single-element, spherically concaved HIFU transducer with a centre frequency of 1 MHz was utilized to create thermal lesions in chicken breast tissuesin vitro. To investigate the detectability of HIFU treatments photoacoustically, PA detection was performed at 720 and 845 nm on seven HIFU-treated tissue samples. Within each tissue sample, PA signals were acquired from 22 locations equally divided between two regions of interest within two volumes in tissue – a HIFU-treated volume and an untreated volume. Optical spectroscopy was then carried out on 10 HIFU-treated chicken breast specimens in the wavelength range of 500–900 nm, in 1-nm increments, using a spectrophotometer with an integrating sphere attachment. The authors’ optical spectroscopy raw data (total transmittance and diffuse reflectance) were used to obtain the optical absorption and reduced scattering coefficients of HIFU-induced thermal lesions and native tissues by employing the inverse adding-doubling method. The aforementioned interaction coefficients were subsequently used to calculate the effective attenuation coefficient and light penetration depth of HIFU-treated and native tissues in the wavelength range of 500–900 nm. Results: HIFU-treated tissues produced greater PA signals than native tissues at 720 and 845 nm. At 720 nm, the averaged ratio of the peak-to-peak PA signal amplitude of HIFU-treated tissue to that of native tissue was 3.68 ± 0.25 (mean ± standard error of the mean). At 845 nm, the averaged ratio of the peak-to-peak PA signal amplitude of HIFU-treated tissue to that of native tissue was 3.75

  20. Photoacoustic detection and optical spectroscopy of high-intensity focused ultrasound-induced thermal lesions in biologic tissue

    Energy Technology Data Exchange (ETDEWEB)

    Alhamami, Mosa; Kolios, Michael C.; Tavakkoli, Jahan, E-mail: jtavakkoli@ryerson.ca [Department of Physics, Ryerson University, 350 Victoria Street, Toronto, Ontario M5B 2K3 (Canada)

    2014-05-15

    Purpose: The aims of this study are: (a) to investigate the capability of photoacoustic (PA) method in detecting high-intensity focused ultrasound (HIFU) treatments in muscle tissuesin vitro; and (b) to determine the optical properties of HIFU-treated and native tissues in order to assist in the interpretation of the observed contrast in PA detection of HIFU treatments. Methods: A single-element, spherically concaved HIFU transducer with a centre frequency of 1 MHz was utilized to create thermal lesions in chicken breast tissuesin vitro. To investigate the detectability of HIFU treatments photoacoustically, PA detection was performed at 720 and 845 nm on seven HIFU-treated tissue samples. Within each tissue sample, PA signals were acquired from 22 locations equally divided between two regions of interest within two volumes in tissue – a HIFU-treated volume and an untreated volume. Optical spectroscopy was then carried out on 10 HIFU-treated chicken breast specimens in the wavelength range of 500–900 nm, in 1-nm increments, using a spectrophotometer with an integrating sphere attachment. The authors’ optical spectroscopy raw data (total transmittance and diffuse reflectance) were used to obtain the optical absorption and reduced scattering coefficients of HIFU-induced thermal lesions and native tissues by employing the inverse adding-doubling method. The aforementioned interaction coefficients were subsequently used to calculate the effective attenuation coefficient and light penetration depth of HIFU-treated and native tissues in the wavelength range of 500–900 nm. Results: HIFU-treated tissues produced greater PA signals than native tissues at 720 and 845 nm. At 720 nm, the averaged ratio of the peak-to-peak PA signal amplitude of HIFU-treated tissue to that of native tissue was 3.68 ± 0.25 (mean ± standard error of the mean). At 845 nm, the averaged ratio of the peak-to-peak PA signal amplitude of HIFU-treated tissue to that of native tissue was 3.75

  1. Real-time Monitoring of High Intensity Focused Ultrasound (HIFU) Ablation of In Vitro Canine Livers Using Harmonic Motion Imaging for Focused Ultrasound (HMIFU).

    Science.gov (United States)

    Grondin, Julien; Payen, Thomas; Wang, Shutao; Konofagou, Elisa E

    2015-01-01

    Harmonic Motion Imaging for Focused Ultrasound (HMIFU) is a technique that can perform and monitor high-intensity focused ultrasound (HIFU) ablation. An oscillatory motion is generated at the focus of a 93-element and 4.5 MHz center frequency HIFU transducer by applying a 25 Hz amplitude-modulated signal using a function generator. A 64-element and 2.5 MHz imaging transducer with 68kPa peak pressure is confocally placed at the center of the HIFU transducer to acquire the radio-frequency (RF) channel data. In this protocol, real-time monitoring of thermal ablation using HIFU with an acoustic power of 7 W on canine livers in vitro is described. HIFU treatment is applied on the tissue during 2 min and the ablated region is imaged in real-time using diverging or plane wave imaging up to 1,000 frames/second. The matrix of RF channel data is multiplied by a sparse matrix for image reconstruction. The reconstructed field of view is of 90° for diverging wave and 20 mm for plane wave imaging and the data are sampled at 80 MHz. The reconstruction is performed on a Graphical Processing Unit (GPU) in order to image in real-time at a 4.5 display frame rate. 1-D normalized cross-correlation of the reconstructed RF data is used to estimate axial displacements in the focal region. The magnitude of the peak-to-peak displacement at the focal depth decreases during the thermal ablation which denotes stiffening of the tissue due to the formation of a lesion. The displacement signal-to-noise ratio (SNRd) at the focal area for plane wave was 1.4 times higher than for diverging wave showing that plane wave imaging appears to produce better displacement maps quality for HMIFU than diverging wave imaging. PMID:26556647

  2. High intensity circular proton accelerators

    International Nuclear Information System (INIS)

    Circular machines suitable for the acceleration of high intensity proton beams include cyclotrons, FFAG accelerators, and strong-focusing synchrotrons. This paper discusses considerations affecting the design of such machines for high intensity, especially space charge effects and the role of beam brightness in multistage accelerators. Current plans for building a new generation of high intensity 'kaon factories' are reviewed. 47 refs

  3. Generalized Courant-Snyder Theory and Kapchinskij-Vladimirskij Distribution For High-intensity Beams In A Coupled Transverse Focusing Lattice

    Energy Technology Data Exchange (ETDEWEB)

    Hong QIn, Ronald Davidson

    2011-07-18

    The Courant-Snyder (CS) theory and the Kapchinskij-Vladimirskij (KV) distribution for high-intensity beams in a uncoupled focusing lattice are generalized to the case of coupled transverse dynamics. The envelope function is generalized to an envelope matrix, and the envelope equation becomes a matrix envelope equation with matrix operations that are non-commutative. In an uncoupled lattice, the KV distribution function, first analyzed in 1959, is the only known exact solution of the nonlinear Vlasov-Maxwell equations for high-intensity beams including self-fields in a self-consistent manner. The KV solution is generalized to high-intensity beams in a coupled transverse lattice using the generalized CS invariant. This solution projects to a rotating, pulsating elliptical beam in transverse configuration space. The fully self-consistent solution reduces the nonlinear Vlasov-Maxwell equations to a nonlinear matrix ordinary differential equation for the envelope matrix, which determines the geometry of the pulsating and rotating beam ellipse. These results provide us with a new theoretical tool to investigate the dynamics of high-intensity beams in a coupled transverse lattice. A strongly coupled lattice, a so-called N-rolling lattice, is studied as an example. It is found that strong coupling does not deteriorate the beam quality. Instead, the coupling induces beam rotation, and reduces beam pulsation.

  4. Generalized Courant-Snyder Theory and Kapchinskij-Vladimirskij Distribution For High-intensity Beams In A Coupled Transverse Focusing Lattice

    International Nuclear Information System (INIS)

    The Courant-Snyder (CS) theory and the Kapchinskij-Vladimirskij (KV) distribution for high-intensity beams in a uncoupled focusing lattice are generalized to the case of coupled transverse dynamics. The envelope function is generalized to an envelope matrix, and the envelope equation becomes a matrix envelope equation with matrix operations that are non-commutative. In an uncoupled lattice, the KV distribution function, first analyzed in 1959, is the only known exact solution of the nonlinear Vlasov-Maxwell equations for high-intensity beams including self-fields in a self-consistent manner. The KV solution is generalized to high-intensity beams in a coupled transverse lattice using the generalized CS invariant. This solution projects to a rotating, pulsating elliptical beam in transverse configuration space. The fully self-consistent solution reduces the nonlinear Vlasov-Maxwell equations to a nonlinear matrix ordinary differential equation for the envelope matrix, which determines the geometry of the pulsating and rotating beam ellipse. These results provide us with a new theoretical tool to investigate the dynamics of high-intensity beams in a coupled transverse lattice. A strongly coupled lattice, a so-called N-rolling lattice, is studied as an example. It is found that strong coupling does not deteriorate the beam quality. Instead, the coupling induces beam rotation, and reduces beam pulsation.

  5. Multi-parametric monitoring and assessment of high-intensity focused ultrasound (HIFU) boiling by harmonic motion imaging for focused ultrasound (HMIFU): an ex vivo feasibility study

    International Nuclear Information System (INIS)

    Harmonic motion imaging for focused ultrasound (HMIFU) is a recently developed high-intensity focused ultrasound (HIFU) treatment monitoring method with feasibilities demonstrated in vitro and in vivo. Here, a multi-parametric study is performed to investigate both elastic and acoustics-independent viscoelastic tissue changes using the Harmonic Motion Imaging (HMI) displacement, axial compressive strain and change in relative phase shift during high energy HIFU treatment with tissue boiling. Forty three (n = 43) thermal lesions were formed in ex vivo canine liver specimens (n = 28). Two-dimensional (2D) transverse HMI displacement maps were also obtained before and after lesion formation. The same method was repeated in 10 s, 20 s and 30 s HIFU durations at three different acoustic powers of 8, 10, and 11 W, which were selected and verified as treatment parameters capable of inducing boiling using both thermocouple and passive cavitation detection (PCD) measurements. Although a steady decrease in the displacement, compressive strain, and relative change in the focal phase shift (Δϕ) were obtained in numerous cases, indicating an overall increase in relative stiffness, the study outcomes also showed that during boiling, a reverse lesion-to-background displacement contrast was detected, indicating potential change in tissue absorption, geometrical change and/or, mechanical gelatification or pulverization. Following treatment, corresponding 2D HMI displacement images of the thermal lesions also mapped consistent discrepancy in the lesion-to-background displacement contrast. Despite the expectedly chaotic changes in acoustic properties with boiling, the relative change in phase shift showed a consistent decrease, indicating its robustness to monitor biomechanical properties independent of the acoustic property changes throughout the HIFU treatment. In addition, the 2D HMI displacement images confirmed and indicated the increase in the thermal lesion size with

  6. Multi-parametric monitoring and assessment of high-intensity focused ultrasound (HIFU) boiling by harmonic motion imaging for focused ultrasound (HMIFU): an ex vivo feasibility study

    Science.gov (United States)

    Hou, Gary Y.; Marquet, Fabrice; Wang, Shutao; Konofagou, Elisa E.

    2014-03-01

    Harmonic motion imaging for focused ultrasound (HMIFU) is a recently developed high-intensity focused ultrasound (HIFU) treatment monitoring method with feasibilities demonstrated in vitro and in vivo. Here, a multi-parametric study is performed to investigate both elastic and acoustics-independent viscoelastic tissue changes using the Harmonic Motion Imaging (HMI) displacement, axial compressive strain and change in relative phase shift during high energy HIFU treatment with tissue boiling. Forty three (n = 43) thermal lesions were formed in ex vivo canine liver specimens (n = 28). Two-dimensional (2D) transverse HMI displacement maps were also obtained before and after lesion formation. The same method was repeated in 10 s, 20 s and 30 s HIFU durations at three different acoustic powers of 8, 10, and 11 W, which were selected and verified as treatment parameters capable of inducing boiling using both thermocouple and passive cavitation detection (PCD) measurements. Although a steady decrease in the displacement, compressive strain, and relative change in the focal phase shift (Δϕ) were obtained in numerous cases, indicating an overall increase in relative stiffness, the study outcomes also showed that during boiling, a reverse lesion-to-background displacement contrast was detected, indicating potential change in tissue absorption, geometrical change and/or, mechanical gelatification or pulverization. Following treatment, corresponding 2D HMI displacement images of the thermal lesions also mapped consistent discrepancy in the lesion-to-background displacement contrast. Despite the expectedly chaotic changes in acoustic properties with boiling, the relative change in phase shift showed a consistent decrease, indicating its robustness to monitor biomechanical properties independent of the acoustic property changes throughout the HIFU treatment. In addition, the 2D HMI displacement images confirmed and indicated the increase in the thermal lesion size with

  7. MRI monitoring of lesions created at temperature below the boiling point and of lesions created above the boiling point using high intensity focused ultrasound

    OpenAIRE

    Damianou, C.; Ioannides, K.; Hadjisavvas, V.; Mylonas, N.; Couppis, A.; Iosif, D.; Kyriacou, P. A.

    2010-01-01

    Magnetic Resonance Imaging (MRI) was utilized to monitor lesions created at temperature below the boiling point and lesions created at temperature above the boiling point using High Intensity Focused Ultrasound (HIFU) in freshly excised kidney, liver and brain and in vivo rabbit kidney and brain. T2-weighted fast spin echo (FSE) was proven as an excellent MRI sequence that can detect lesions with temperature above the boiling point in kidney. This advantage is attributed to the significant di...

  8. Single application of high-intensity focused ultrasound as primary therapy of localized prostate cancer: Treatment-related predictors of biochemical outcomes

    OpenAIRE

    Dietrich Pfeiffer; Juergen Berger; Andreas Gross

    2015-01-01

    Objective: Recent reports on high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer suggest that preoperative risk groups of tumor recurrence are strong predictors of oncological outcomes. The purpose of this study is to determine the prognostic significance of treatment-related factors in relation to patient characteristics for biochemical outcomes after HIFU. Methods: This retrospective single-center study included patients treated from December 2002 to December ...

  9. A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.

    OpenAIRE

    Dickinson, L.; Ahmed, H. U.; Kirkham, A; Allen, C.; Freeman, A; Barber, J; Hindley, R; Leslie, T.; Ogden, C.; Persad, R; Winkler, M.H.; Emberton, M; on behalf of the INDEX Study Group

    2013-01-01

    Introduction Focal therapy offers the possibility of cancer control, without the side effect profile of radical therapies. Early single centre prospective development studies using high intensity focused ultrasound (HIFU) have demonstrated encouraging genitourinary functional preservation and short-term cancer control. Large multi-centre trials are required to evaluate medium-term cancer control and reproduce functional recovery. We describe the study design of an investigator-led UK multi-ce...

  10. Comparison of Transrectal Prostate Biopsy Results with Histology of Transurethral Resection of the Prostate in Men Undergoing High-Intensity Focused Ultrasound

    OpenAIRE

    Rogenhofer, Sebastian; Walter, Bernhard; Hartmann, Arndt; Wieland, Walter Ferdinand; Mueller, S.C.; Blana, Andreas

    2014-01-01

    Introduction: The aim of our study was to evaluate the significance of transurethral resection of the prostate (TURP) to detect prostate cancer (PCa). A comparison was performed of the TURP specimens of patients undergoing high-intensity focused ultrasound (HIFU) with the core biopsies. Materials and Methods: TURP before undergoing HIFU therapy was performed in 106 patients without neoadjuvant treatment. The resected tissue was subjected to histopathological evaluation...

  11. Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: Review of technical incidents and morbidity after 5 years of use

    OpenAIRE

    RIPERT, Thomas; AZEMAR, Marie Dominique; MENARD, Johann; BAYOUD, Younes; Messaoudi, Rabah; Duval, François; Staerman, Frédéric

    2010-01-01

    Abstract OBJECTIVE To report on technical incidents, and early and late complications, occurring on high-intensity focused ultrasound (HIFU) treatment of patients with localized prostate cancer. PATIENTS AND METHODS We performed a retrospective review of patients who were treated by Ablatherm? in our centre. We recorded all technical incidents, treatment discontinuations, and early (< 1 month) and late complications. RESULTS A total of 74 HIFU procedures were perfor...

  12. Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: Effect of Bowel Interposition on Procedure Feasibility and a Unique Bowel Displacement Technique

    OpenAIRE

    Young-Sun Kim; Hyo Keun Lim; Hyunchul Rhim

    2016-01-01

    Purpose To evaluate the effect of bowel interposition on assessing procedure feasibility, and the usefulness and limiting conditions of bowel displacement techniques in magnetic resonance imaging-guided high-intensity focused ultrasound (MR-HIFU) ablation of uterine fibroids. Materials and Methods Institutional review board approved this study. A total of 375 screening MR exams and 206 MR-HIFU ablations for symptomatic uterine fibroids performed between August 2010 and March 2015 were retrosp...

  13. Potential enhancement of intravenous nano-hydroxyapatite in high-intensity focused ultrasound ablation for treating hepatocellular carcinoma in a rabbit model

    OpenAIRE

    Liu, Liping; XIAO, ZIWEN; XIAO, YANBING; WANG, ZHIBIAO; Li, Faqi; LI, MAOPING; PENG, XIAOQIONG

    2014-01-01

    The aim of the present study was to evaluate the safety and efficiency of an intravenously delivered nano-hydroxyapatite (Nano-HA) solution into a rabbit model (Oryctolagus cuniculus) to determine the potential enhancement of high-intensity focused ultrasound (HIFU) for the ablation of hepatocellular carcinoma (HCC) in liver tissue. The present study clearly indicated that the intravenous delivery of large quantities of Nano-HA into the body of the rabbit model over relatively short periods o...

  14. High intensity hadron accelerators

    International Nuclear Information System (INIS)

    In this paper we give an introductory discussion of high intensity hadron accelerators with special emphasis on the high intensity feature. The topics selected for this discussion are: Types of acclerator - The principal actions of an accelerator are to confine and to accelerate a particle beam. Focusing - This is a discussion of the confinement of single particles. Intensity limitations - These are related to confinement of intense beams of particles. Power economics - Considerations related to acceleration of intense beams of particles. Heavy ion kinematics - The adaptation of accelerators to accelerate all types of heavy ions

  15. Dynamics of high-energy proton beam acceleration and focusing from hemisphere-cone targets by high-intensity lasers.

    Science.gov (United States)

    Qiao, B; Foord, M E; Wei, M S; Stephens, R B; Key, M H; McLean, H; Patel, P K; Beg, F N

    2013-01-01

    Acceleration and focusing of high-energy proton beams from fast-ignition (FI) -related hemisphere-cone assembled targets have been numerically studied by hybrid particle-in-cell simulations and compared with those from planar-foil and open-hemisphere targets. The whole physical process including the laser-plasma interaction has been self-consistently modeled for 15 ps, at which time the protons reach asymptotic motion. It is found that the achievable focus of proton beams is limited by the thermal pressure gradients in the co-moving hot electrons, which induce a transverse defocusing electric field that bends proton trajectories near the axis. For the advanced hemisphere-cone target, the flow of hot electrons along the cone wall induces a local transverse focusing sheath field, resulting in a clear enhancement in proton focusing; however, it leads to a significant loss of longitudinal sheath potential, reducing the total conversion efficiency from laser to protons. PMID:23410447

  16. Annular and Cylindrical Phased Array Geometries for Transrectal High-Intensity Focused Ultrasound (HIFU) using PZT and Piezocomposite Materials

    Science.gov (United States)

    Seip, Ralf; Chen, Wohsing; Carlson, Roy; Frizzell, Leon; Warren, Gary; Smith, Nadine; Saleh, Khaldon; Gerber, Gene; Shung, Kirk; Guo, Hongkai; Sanghvi, Narendra T.

    2005-03-01

    This paper presents engineering progress and the latest in-vitro and in-vivo results obtained with a 4.0 MHz, 20 element, PZT annular transrectal HIFU array and several 4.0 MHz, 211 element, PZT and piezocomposite cylindrical transrectal HIFU arrays for the treatment of prostate cancer. The geometries of both arrays were designed and analyzed to steer the HIFU beams to the desired sites in the prostate volume using multi-channel electronic drivers, with the intent to increase treatment efficiency and reliability for the next generation of HIFU systems. The annular array is able to focus in depth from 25 mm to 50 mm, generate total acoustic powers in excess of 60W, and has been integrated into a modified Sonablate®500 HIFU system capable of controlling such an applicator through custom treatment planning and execution software. Both PZT- and piezocomposite cylindrical arrays were constructed and their characteristics were compared for the transrectal applications. These arrays have been installed into appropriate transducer housings, and have undergone characterization tests to determine their total acoustic power output, focusing range (in depth and laterally), focus quality, efficiency, and comparison tests to determine the material and technology of choice (PZT or piezocomposite) for intra-cavity HIFU applications. Array descriptions, characterization results, in-vitro and in-vivo results, and an overview of their intended use through the application software is shown.

  17. MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment

    International Nuclear Information System (INIS)

    The purpose of this study is to evaluate the efficacy of the enhancement of docetaxel by pulsed focused ultrasound (pFUS) in combination with radiotherapy (RT) for treatment of prostate cancer in vivo. LNCaP cells were grown in the prostates of male nude mice. When the tumors reached a designated volume by MRI, tumor bearing mice were randomly divided into seven groups (n = 5): (1) pFUS alone; (2) RT alone; (3) docetaxel alone; (4) docetaxel + pFUS; (5) docetaxel + RT; (6) docetaxel + pFUS + RT, and (7) control. MR-guided pFUS treatment was performed using a focused ultrasound treatment system (InSightec ExAblate 2000) with a 1.5T GE MR scanner. Animals were treated once with pFUS, docetaxel, RT or their combinations. Docetaxel was given by i.v. injection at 5 mg kg−1 before pFUS. RT was given 2 Gy after pFUS. Animals were euthanized 4 weeks after treatment. Tumor volumes were measured on MRI at 1 and 4 weeks post-treatment. Results showed that triple combination therapies of docetaxel, pFUS and RT provided the most significant tumor growth inhibition among all groups, which may have potential for the treatment of prostate cancer due to an improved therapeutic ratio. (paper)

  18. Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapy

    OpenAIRE

    KOMURA, KAZUMASA; Inamoto, Teruo; Takai, Tomoaki; Uchimoto, Taizo; Saito, Kenkichi; Tanda, Naoki; Kono, Junko; Minami, Koichiro; Uehara, Hirohumi; Fujisue, Yutaka; Takahara, Kiyoshi; Hirano, Hajime; Nomi, Hayahito; WATSUJI, TOSHIKAZU; Kiyama, Satoshi

    2013-01-01

    Purpose To investigate the treatment outcomes of a single-session high-intensity focused ultrasound (HIFU) using the Sonablate® for patients with localized prostate cancer. Methods Biochemical failure was defined according to the Stuttgart definition [a rise of 1.2 ng/ml or more above the nadir prostate-specific antigen (PSA)] and the Phoenix definition (a rise of 2 ng/ml or more above the nadir PSA). Disease-free survival rate was defined using the Phoenix criteria and positive follow-up bio...

  19. First Clinical Experience of Intra-Operative High Intensity Focused Ultrasound in Patients with Colorectal Liver Metastases: A Phase I-IIa Study

    OpenAIRE

    Aurélien Dupré; David Melodelima; David Pérol; Yao Chen; Jérémy Vincenot; Jean-Yves Chapelon; Michel Rivoire

    2015-01-01

    Background Surgery is the only curative treatment in patients with colorectal liver metastases (CLM), but only 10–20% of patients are eligible. High Intensity Focused Ultrasound (HIFU) technology is of proven value in several indications, notably prostate cancer. Its intra-operative use in patients with CLM has not previously been studied. Preclinical work suggested the safety and feasibility of a new HIFU device capable of ablating volumes of up to 2cm x 2cm in a few seconds. Methods We cond...

  20. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly: a feasibility study with 10 years follow-up

    OpenAIRE

    Amine B. El Fegoun; Eric Barret; Dominique Prapotnich; Shawn Soon; Xavier Cathelineau; François Rozet; Marc Galiano; Rafael Sanchez-Salas; Guy Vallancien

    2011-01-01

    PURPOSE: To evaluate the long-term efficacy of prostate cancer control and complication rates, in the elderly, after focal therapy with high-intensity focused ultrasound (HIFU). MATERIALS AND METHODS: Between June 1997 and March 2000, patients with localized prostate cancer were included into a focal therapy protocol. Inclusion criteria were: PSA < 10 ng/mL, < 3 positive biopsies with only 1 lobe involved, clinical stage < T2a, Gleason score < 7 (3+4), negative CT scan and bone scan. Hemi-abl...

  1. Use of shock-wave heating for faster and safer ablation of tissue volumes in high intensity focused ultrasound therapy

    Science.gov (United States)

    Khokhlova, V.; Yuldashev, P.; Sinilshchikov, I.; Partanen, A.; Khokhlova, T.; Farr, N.; Kreider, W.; Maxwell, A.; Sapozhnikov, O.

    2015-10-01

    Simulation of enhanced heating of clinically relevant tissue volumes using nonlinear ultrasound waves generated by a multi-element HIFU phased array were conducted based on the combined Westervelt and bio-heat equations. A spatial spectral approach using the fast Fourier transform algorithm and a corresponding analytic solution to the bioheat equation were used to optimize temperature modeling in tissue. Localized shock-wave heating within a much larger treated tissue volume and short, single HIFU pulses within a much longer overall exposure time were accounted for in the algorithm. Separation of processes with different time and spatial scales made the calculations faster and more accurate. With the proposed method it was shown that for the same time-average power, the use of high peak power pulsing schemes that produce high-amplitude shocks at the focus result in faster tissue heating compared to harmonic, continuous-wave sonications. Nonlinear effects can significantly accelerate volumetric heating while also permitting greater spatial control to reduce the impact on surrounding tissues. Such studies can be further used to test and optimize various steering trajectories of shock-wave sonications for faster and more controlled treatment of tissue volumes.

  2. Treatment of Urethral/Bladder Neck Stricture After High-Intensity Focused Ultrasound for Prostate Cancer With Holmium: Yttrium-Aluminium-Garnet Laser

    Science.gov (United States)

    Cho, Won Jin; Kim, Tae Heon; Lee, Hyo Serk; Chung, Jin Woo; Lee, Ha Na

    2013-01-01

    Purpose To evaluate the efficacy and safety of the Holmium: yttrium-aluminium-garnet (YAG) laser for the treatment of urethral/bladder neck strictures after high-intensity focused ultrasound for prostate cancer. Methods Between February 2007 and July 2010, Holmium: YAG laser urethrotomies were performed in eleven patients for bladder neck strictures or prostatic urethral strictures. The laser was used with a 550-µm fiber at 2 J and frequency 30 to 50 Hz. The medical records were retrospectively reviewed for medical history, perioperative and postoperative data, uroflowmetry, International Prostate Symptoms Score/quality of life, and stricture recurrence. Results At a median follow-up of 12.0 months (range, 4 to 35 months), the mean postoperative maximal flow rate and residual volume were improved significantly (Plaser treatment subsequently required artificial urinary sphincter implantation and reported satisfaction without developing any recurrent strictures or artificial urinary sphincter erosion. All patients exhibited well-healed strictures and could void without difficulty. Conclusions Holmium: YAG laser therapy represents a safe, effective and minimally invasive treatment for urethral/bladder neck strictures occurring secondary to high-intensity focused ultrasound for prostate cancer. PMID:23610708

  3. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus

    Energy Technology Data Exchange (ETDEWEB)

    Zhang Lian; Chen Wenzhi [Clinical Center for Tumour Therapy of 2nd Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing 400010 (China); Liu Yinjiang; Hu Xiao [National Engineering Research Center of Ultrasound Medicine, Chongqing 400010 (China); Zhou Kun [Clinical Center for Tumour Therapy of 2nd Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing 400010 (China); Chen Li [National Engineering Research Center of Ultrasound Medicine, Chongqing 400010 (China); Peng Song; Zhu Hui [Clinical Center for Tumour Therapy of 2nd Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing 400010 (China); Zou Huiling [National Engineering Research Center of Ultrasound Medicine, Chongqing 400010 (China); Bai Jin [Institute of Ultrasound Engineering in Medicine of Chongqing University of Medical Sciences, Chongqing 400016 (China); Wang Zhibiao [Clinical Center for Tumour Therapy of 2nd Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing 400010 (China); National Engineering Research Center of Ultrasound Medicine, Chongqing 400010 (China); Institute of Ultrasound Engineering in Medicine of Chongqing University of Medical Sciences, Chongqing 400016 (China)], E-mail: wangzhibiao@haifu.com.cn

    2010-02-15

    Purpose: To prospectively evaluate the feasibility of magnetic resonance (MR) imaging-guided high intensity focused ultrasound (HIFU) therapeutic ablation of uterine fibroids in patients with bowel lies anterior to uterus. Materials and methods: Twenty-one patients with 23 uterine fibroids underwent MR imaging-guided high intensity focused ultrasound treatment, with a mean age of 39.4 {+-} 6.9 (20-49) years, with fibroids average measuring 6.0 {+-} 1.6 (range, 2.9-9.5) cm in diameter. After being compressed with a degassed water balloon on abdominal wall, MR imaging-guided high intensity focused ultrasound treatment was performed under conscious sedation by using fentanyl and midazolam. This procedure was performed by a Haifu JM focused ultrasound tumour therapeutic system (JM2.5C, Chongqing Haifu Technology Co., Ltd., China), in combination with a 1.5-Tesla MRI system (Symphony, Siemens, Germany), which provides real-time guidance and control. Contrast-enhanced MR imaging was performed to evaluate the efficacy of thermal ablation immediately and 3 months after HIFU treatment. The treatment time and adverse events were recorded. Results: The mean fibroid volume was 97.0 {+-} 78.3 (range, 12.7-318.3) cm{sup 3}. According to the treatment plan, an average 75.0 {+-} 11.4% (range, 37.8-92.4%) of the fibroid volume was treated. The mean fibroid volume immediately after HIFU was 109.7 {+-} 93.1 (range, 11.9-389.6) cm{sup 3}, slightly enlarged because of edema. The average non-perfused volume was 83.3 {+-} 71.7 (range, 7.7-282.9) cm{sup 3}, the average fractional ablation, which was defined as non-perfused volume divided by the fibroid volume immediately after HIFU treatment, was 76.9 {+-} 18.7% (range, 21.0-97.0%). There were no statistically significant differences between the treatment volume and the non-perfused volume. Follow-up magnetic resonance imaging (MRI) at 3 months obtained in 12 patients, the fibroid volume decreased by 31.4 {+-} 29.3% (range, -1.9 to 60

  4. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus

    International Nuclear Information System (INIS)

    Purpose: To prospectively evaluate the feasibility of magnetic resonance (MR) imaging-guided high intensity focused ultrasound (HIFU) therapeutic ablation of uterine fibroids in patients with bowel lies anterior to uterus. Materials and methods: Twenty-one patients with 23 uterine fibroids underwent MR imaging-guided high intensity focused ultrasound treatment, with a mean age of 39.4 ± 6.9 (20-49) years, with fibroids average measuring 6.0 ± 1.6 (range, 2.9-9.5) cm in diameter. After being compressed with a degassed water balloon on abdominal wall, MR imaging-guided high intensity focused ultrasound treatment was performed under conscious sedation by using fentanyl and midazolam. This procedure was performed by a Haifu JM focused ultrasound tumour therapeutic system (JM2.5C, Chongqing Haifu Technology Co., Ltd., China), in combination with a 1.5-Tesla MRI system (Symphony, Siemens, Germany), which provides real-time guidance and control. Contrast-enhanced MR imaging was performed to evaluate the efficacy of thermal ablation immediately and 3 months after HIFU treatment. The treatment time and adverse events were recorded. Results: The mean fibroid volume was 97.0 ± 78.3 (range, 12.7-318.3) cm3. According to the treatment plan, an average 75.0 ± 11.4% (range, 37.8-92.4%) of the fibroid volume was treated. The mean fibroid volume immediately after HIFU was 109.7 ± 93.1 (range, 11.9-389.6) cm3, slightly enlarged because of edema. The average non-perfused volume was 83.3 ± 71.7 (range, 7.7-282.9) cm3, the average fractional ablation, which was defined as non-perfused volume divided by the fibroid volume immediately after HIFU treatment, was 76.9 ± 18.7% (range, 21.0-97.0%). There were no statistically significant differences between the treatment volume and the non-perfused volume. Follow-up magnetic resonance imaging (MRI) at 3 months obtained in 12 patients, the fibroid volume decreased by 31.4 ± 29.3% (range, -1.9 to 60.0%) in average, with paired t

  5. High intensity focused ultrasound (HIFU) plus percutaneous transarterial chemo-embolization (TACE) in the treatment of malignant tumors: preliminary experience of clinical application

    International Nuclear Information System (INIS)

    Objective: To evaluate the clinical effect of High intensity focused ultrasound (HIFU) combined with percutaneous transarterial Chemoembolization (TACE) in the treatment of malignant tumors. Methods: 19 patients suffering from several typical malignant tumors received the treatment of HIFU combined TAE/TACE. Evaluation was made on the clinical symptom, B-mode ultrasound, liver function test, serum AFP and MRI scan. Results: During HIFU, remarkable increased echogenicity of the tumor was revealed by realtime US. In post-procedural patients, decreased serum AFP, reduced tumor blood supply and necrosis of the mass were observed. De-bulking effect on the tumor was revealed in several patients. Conclusions: HIFU is an effective treatment of solid malignant tumors. Synergic effects take place in the HIFU combined with TACE, in which lipiodol may play an important role in the synergic effects

  6. Tip-sensitive all-silica fiber-optic Fabry-Perot ultrasonic hydrophone for charactering high intensity focused ultrasound fields

    Science.gov (United States)

    Wang, D. H.; Jia, P. G.; Wang, S. J.; Zhao, C. L.; Zeng, D. P.; Wang, H.; Li, F. Q.

    2013-07-01

    This Letter reports on a tip-sensitive all-silica fiber-optic Fabry-Perot (TAFOFP) ultrasonic hydrophone for measuring high intensity focused ultrasound (HIFU) fields. The all-silica fiber-optic structure ensures that the TAFOFP ultrasonic hydrophone can withstand HIFU fields and the tip-sensitive configuration ensures that the TAFOFP ultrasonic hydrophone can achieve a high spatial resolution of 125 μm. The experimental results have shown that the TAFOFP ultrasonic hydrophone could stably measure the peak positive ultrasonic pressure as high as 4.34 MPa, and the measured ultrasonic pressure distributions of the HIFU field by the fabricated TAFOFP ultrasonic hydrophone agreed well with those by the piezoceramic needle hydrophone.

  7. A study of occurrence rates of Electromagnetic Interference (EMI) to aircraft with a focus on HIRF (external) High Intensity Radiated Fields

    Science.gov (United States)

    Shooman, Martin L.

    1994-01-01

    This report presents the methodology and results of a subjective study done by Polytechnic University to investigate Electromagnetic Interference (EMI) events on aircraft. The results cover various types of EMI from on-board aircraft systems, passenger carry-on devices, and externally generated disturbances. The focus of the study, however, was on externally generated EMI, termed High Intensity Radiated Fields (HIRF), from radars, radio and television transmitters, and other man-made emitters of electromagnetic energy. The study methodology used an anonymous questionnaire distributed to experts to gather the data. This method is known as the Delphi or Consensus Estimation technique. The questionnaire was sent to an expert population of 230 and there were 57 respondents. Details of the questionnaire, a few anecdotes, and the statistical results of the study are presented.

  8. High-Intensity Focused Ultrasound (HIFU) Using Sonablate® Devices for the Treatment of Benign Prostatic Hyperplasia and Localized Prostate Cancer: 18-year experience

    Science.gov (United States)

    Uchida, Toyoaki

    2011-09-01

    From 1993 to 2010, we have treated 156 patients benign prostatic hyperplasia (BPH) and 1,052 patients localized prostate cancer high-intensity focused ultrasound (HIFU). Four different HIFU devices, SonablateR-200, SonablateR-500, SonablateR-500 version 4 and Sonablate® TCM, have been used for this study. Clinical outcome of HIFU for BPH did not show any superior effects to transurethral resection of the prostate, laser surgery or transurethral vapolization of the prostate. However, HIFU appears to be a safe and minimally invasive therapy for patients with localized prostate cancer, especially low- and intermediate-risk patients. The rate of clinical outcome has significantly improved over the years due to technical improvements in the device.

  9. Relativistic self-focusing of ultra-high intensity X-ray laser beams in warm quantum plasma with upward density profile

    International Nuclear Information System (INIS)

    The results of a numerical study of high-intensity X-ray laser beam interaction with warm quantum plasma (WQP) are presented. By means of an upward ramp density profile combined with quantum factors specially the Fermi velocity, we have demonstrated significant relativistic self-focusing (RSF) of a Gaussian electromagnetic beam in the WQP where the Fermi temperature term in the dielectric function is important. For this purpose, we have considered the quantum hydrodynamics model that modifies refractive index of inhomogeneous WQPs with the inclusion of quantum correction through the quantum statistical and diffraction effects in the relativistic regime. Also, to better illustration of the physical difference between warm and cold quantum plasmas and their effect on the RSF, we have derived the envelope equation governing the spot size of X-ray laser beam in Q-plasmas. In addition to the upward ramp density profile, we have found that the quantum effects would be caused much higher oscillation and better focusing of X-ray laser beam in the WQP compared to that of cold quantum case. Our computational results reveal the importance of the use of electrons density profile and Fermi speed in enhancing self-focusing of laser beam

  10. Experimental study with high intensity focused ultrasound in swine vulva%高强度聚焦超声致香猪外阴损伤的研究

    Institute of Scientific and Technical Information of China (English)

    阮祥燕; 顾美礼; 王智彪

    2000-01-01

    目的 观察高强度聚焦超声(HIFU)对香猪外阴的损伤作用及愈合过程,旨在为外阴营养不良探索新的治疗方法.方法 对5只小型香猪的外阴进行HIFU(频率9.84 MHz,声强1 109 W/cm2)连续扫描定位损伤.HIFU辐照后即刻、3 d、7 d、14 d、21 d、30 d行彩超、病理检查,动态监测其损伤变化情况.结果 HIFU可准确定位损伤靶区组织,其相临表面皮肤组织不受损伤.HIFU后靶区超声影像学变化与病理学变化一致.结论 HIFU损伤猪外阴安全有效,为临床外阴营养不良的治疗提供了实验依据;彩超可监测HIFU致外阴治疗的情况.%Objective In order to explore a new method for the treatment of human vulva dystrophy,swine vulva were treated with high intensity focused ultrasound(HIFU).Methods A 9.84 MHz high intensity focused ultrasound at an intensity of 1 109 W/cm2 with continuous exposure was applied in 5 female swine.After HIFU lesions developed,the outcomes were assessed by color ultrasound and the pathological examination immediately and on day 3,7.14,21 and 30.Results HIFU was competent for damaging precisely the target tissue of the vulva and disrupting irreversibly the cellular structure in the focal region leaving the intact surface skin of the target region.A change of ultrasound in the focused region was coincident with that of the pathology.Conclusions HIFU has the powerful effect of accurately destroying vulva tissue and keeping the surface skin intact.The results provided an experimental basis for the clinical treatment of vulva dystrophy.Color ultrasound will become a useful tool in monitoring the outcome after HIFU treatment.

  11. Elimination of therapeutic ultrasound noise from pre-beamformed RF data in ultrasound imaging for ultrasound-guided high-intensity focused ultrasound treatment

    Science.gov (United States)

    Takagi, Ryo; Goto, Kota; Jimbo, Hayato; Matsuura, Keiko; Iwasaki, Ryosuke; Umemura, Shin-ichiro; Yoshizawa, Shin

    2015-07-01

    In conventional ultrasonic monitoring of high-intensity focused ultrasound (HIFU) treatment, a significant interval between consecutive HIFU shots is set for monitoring target tissue to avoid the interference of HIFU noise with RF echo signals. Thus, it is difficult to detect changes in tissue on the order of milliseconds, which are required to dynamically control the HIFU exposure. In this study, a new filtering method to eliminate the HIFU noise in the RF signals before beamforming is proposed. The CW response was estimated from RF signals with no pulse response to the imaging exposure, and the estimated CW response was subtracted from the entire RF signal to selectively eliminate the HIFU noise for each channel of the array probe before dynamic focusing was applied. The HIFU noise was selectively eliminated by this method when it existed. The results imply that the proposed filtering method is useful for true real-time detection of changes in tissue due to thermal coagulation during HIFU exposure.

  12. Comparative study of temperature measurements in ex vivo swine muscle and a tissue-mimicking material during high intensity focused ultrasound exposures

    International Nuclear Information System (INIS)

    Tissue-mimicking materials (TMMs) can provide a convenient, stable, and reproducible means for testing high intensity focused ultrasound (HIFU) devices. When TMMs containing thermal sensors are used to measure ultrasound-induced temperature rise, it is important that measurement results reasonably represent those that occur in biological tissue. Therefore the aim of this paper is to compare the thermal behavior of the TMM under HIFU exposure to that of ex vivo tissue. This was accomplished using both a previously developed TMM and fresh ex vivo swine muscle that were instrumented with bare 50 µm thin wire thermocouples. HIFU at 825 kHz was focused at the thermocouple junction. 30 s exposures of increasing peak negative pressure (1 to 5 MPa) were applied and the temperature profile during and after sonication was recorded. B-mode imaging was used to monitor bubble activity during sonication. If bubble formation was noted during the sonication, the sonication was repeated at the same pressure levels two more times at 20 min intervals. Temperature traces obtained at various pressure levels demonstrated similar types of heating profiles in both the tissue and TMM, the exact nature of which depended on whether bubbles formed during the HIFU exposure. The onset of bubble activity occurred at lower ultrasonic pressures in the TMM, but the basic temperature rise features due to HIFU exposure were essentially the same for both materials. (paper)

  13. The role of acoustic nonlinearity in tissue heating behind a rib cage using a high-intensity focused ultrasound phased array

    Science.gov (United States)

    Yuldashev, Petr V.; Shmeleva, Svetlana M.; Ilyin, Sergey A.; Sapozhnikov, Oleg A.; Gavrilov, Leonid R.; Khokhlova, Vera A.

    2013-04-01

    The goal of this study was to investigate theoretically the effects of nonlinear propagation in a high-intensity focused ultrasound (HIFU) field produced by a therapeutic phased array and the resultant heating of tissue behind a rib cage. Three configurations of focusing were simulated: in water, in water with ribs in the beam path and in water with ribs backed by a layer of soft tissue. The Westervelt equation was used to model the nonlinear HIFU field, and a 1 MHz phased array consisting of 254 circular elements was used as a boundary condition to the model. The temperature rise in tissue was modelled using the bioheat equation, and thermally necrosed volumes were calculated using the thermal dose formulation. The shapes of lesions predicted by the modelling were compared with those previously obtained in in vitro experiments at low-power sonications. Intensity levels at the face of the array elements that corresponded to the formation of high-amplitude shock fronts in the focal region were determined as 10 W cm-2 in the free field in water and 40 W cm-2 in the presence of ribs. It was shown that exposures with shocks provided a substantial increase in tissue heating, and its better spatial localization in the main focal region only. The relative effects of overheating ribs and splitting of the focus due to the periodic structure of the ribs were therefore reduced. These results suggest that utilizing nonlinear propagation and shock formation effects can be beneficial for inducing confined HIFU lesions when irradiating through obstructions such as ribs. Design of compact therapeutic arrays to provide maximum power outputs with lower intensity levels at the elements is necessary to achieve shock wave regimes for clinically relevant sonication depths in tissue.

  14. Harmonic motion imaging for abdominal tumor detection and high-intensity focused ultrasound ablation monitoring: an in vivo feasibility study in a transgenic mouse model of pancreatic cancer.

    Science.gov (United States)

    Chen, Hong; Hou, Gary Y; Han, Yang; Payen, Thomas; Palermo, Carmine F; Olive, Kenneth P; Konofagou, Elisa E

    2015-09-01

    Harmonic motion imaging (HMI) is a radiationforce- based elasticity imaging technique that tracks oscillatory tissue displacements induced by sinusoidal ultrasonic radiation force to assess the resulting oscillatory displacement denoting the underlying tissue stiffness. The objective of this study was to evaluate the feasibility of HMI in pancreatic tumor detection and high-intensity focused ultrasound (HIFU) treatment monitoring. The HMI system consisted of a focused ultrasound transducer, which generated sinusoidal radiation force to induce oscillatory tissue motion at 50 Hz, and a diagnostic ultrasound transducer, which detected the axial tissue displacements based on acquired radio-frequency signals using a 1-D cross-correlation algorithm. For pancreatic tumor detection, HMI images were generated for pancreatic tumors in transgenic mice and normal pancreases in wild-type mice. The obtained HMI images showed a high contrast between normal and malignant pancreases with an average peak-to-peak HMI displacement ratio of 3.2. Histological analysis showed that no tissue damage was associated with HMI when it was used for the sole purpose of elasticity imaging. For pancreatic tumor ablation monitoring, the focused ultrasound transducer was operated at a higher acoustic power and longer pulse length than that used in tumor detection to simultaneously induce HIFU thermal ablation and oscillatory tissue displacements, allowing HMI monitoring without interrupting tumor ablation. HMI monitoring of HIFU ablation found significant decreases in the peak-to-peak HMI displacements before and after HIFU ablation with a reduction rate ranging from 15.8% to 57.0%. The formation of thermal lesions after HIFU exposure was confirmed by histological analysis. This study demonstrated the feasibility of HMI in abdominal tumor detection and HIFU ablation monitoring. PMID:26415128

  15. Effective Strategy of the Combination of High-Intensity Focused Ultrasound and Transarterial Chemoembolization for Improving Outcome of Unresectable and Metastatic Hepatoblastoma: a Retrospective Cohort Study

    Directory of Open Access Journals (Sweden)

    Bailin Chen

    2014-12-01

    Full Text Available The combination of high-intensity focused ultrasound (HIFU and transarterial chemoembolization (TACE has been experimentally performed in a variety of malignant tumors, and its validity has not yet been evaluated for hepatoblastoma (HB. We evaluated the disease-response rate, resection rate, and toxicity in children with unresectable or metastatic HB (stage III and stage IV HB after sequential treatment with TACE plus HIFU in a controlled clinical trial. The 35 patients with unresectable or metastatic HB were nonrandomly assigned to HIFU ablation (n = 12 or C5V chemotherapy (n = 23. The rates of complete resection, tumor response, and treatment toxicity were evaluated for both regimens. Nine patients who received C5V and 10 patients who received TACE plus HIFU became operable (P = .02. The 3-year event-free survival and overall survival rates were 43.03% and 56.68% in the C5V group and 38.57% and 57.86% in the TACE plus HIFU group, respectively. Acute grade 3 or 4 adverse events, including neutropenia, thrombocytopenia, and anemia, were more frequent in patients treated with C5V therapy than in patients receiving TACE plus HIFU. HIFU ablation achieved a higher rate of complete resection and a lower rate of severe complications compared with C5V treatment in children with advanced HB (Chinese Clinical Trials Registry No. ChiCTR-PRCH-08000182.

  16. Effect of High-Intensity Focused Ultrasound on Drug Release from Doxorubicin-Loaded PEGylated Liposomes and Therapeutic Effect in Colorectal Cancer Murine Models.

    Science.gov (United States)

    Jeong, Hwan-Seok; Hwang, Hyosook; Oh, Phil-Sun; Kim, Eun-Mi; Lee, Tai Kyoung; Kim, Minjoo; Kim, Hyeon Soo; Lim, Seok Tae; Sohn, Myung-Hee; Jeong, Hwan-Jeong

    2016-04-01

    The goal of the study described here was to evaluate the use of high-intensity focused ultrasound (HIFU) in drug release and its application in cancer therapy. HIFU was set to minimize hyperthermia, particularly non-specific hyperthermia, of exposed areas. An in vitro temperature-sensitive hydrogel phantom model determined the parameters of HIFU under mild condition settings (spatial average temporal average intensity [ISATA] = 83.35 W/cm(2)). PEGylated liposomal indocyanine green (LCLP-ICG) and PEGylated liposomal doxorubicin (LCLP-Dox) were prepared with the same mole ratio to allow direct comparison of drug release in vitro and in vivo. We induced drug release with HIFU treatment using LCLP-ICG coupled with optical imaging in vitro and in vivo. The size distribution changes in LCLP-ICG in vitro and fluorescence intensity changes in ICG after intra-tumoral injection of LCLP-ICG into CT26 solid tumors in vivo followed by HIFU confirmed the feasibility of the system. We validated the therapeutic effect of HIFU treatment of the CT26 mouse tumor model. The tumor growth rate was significantly reduced (p HIFU treatment, and the chemotherapy of the CT26 solid tumors was found to be highly efficient. PMID:26795498

  17. MR thermometry analysis program for laser- or high-intensity focused ultrasound (HIFU)-induced heating at a clinical MR scanner

    Science.gov (United States)

    Kim, Eun Ju; Jeong, Kiyoung; Oh, Seung Jae; Kim, Daehong; Park, Eun Hae; Lee, Young Han; Suh, Jin-Suck

    2014-12-01

    Magnetic resonance (MR) thermometry is a noninvasive method for monitoring local temperature change during thermal therapy. In this study, a MR temperature analysis program was established for a laser with gold nanorods (GNRs) and high-intensity focused ultrasound (HIFU)-induced heating MR thermometry. The MR temperature map was reconstructed using the water proton resonance frequency (PRF) method. The temperature-sensitive phase difference was acquired by using complex number subtraction instead of direct phase subtraction in order to avoid another phase unwrapping process. A temperature map-analyzing program was developed and implemented in IDL (Interactive Data Language) for effective temperature monitoring. This one program was applied to two different heating devices at a clinical MR scanner. All images were acquired with the fast spoiled gradient echo (fSPGR) pulse sequence on a 3.0 T GE Discovery MR750 scanner with an 8-channel knee array coil or with a home-built small surface coil. The analyzed temperature values were confirmed by using values simultaneously measured with an optical temperature probe (R2 = 0.996). The temperature change in small samples induced by a laser or by HIFU was analyzed by using a raw data, that consisted of complex numbers. This study shows that our MR thermometry analysis program can be used for thermal therapy study with a laser or HIFU at a clinical MR scanner. It can also be applied to temperature monitoring for any other thermal therapy based on the PRF method.

  18. The use of high-intensity focused ultrasound as a novel treatment for painful conditions-a description and narrative review of the literature.

    Science.gov (United States)

    Brown, M R D; Farquhar-Smith, P; Williams, J E; ter Haar, G; deSouza, N M

    2015-10-01

    High-intensity focused ultrasound (HIFU) is a non-invasive technique that allows a small, well-circumscribed thermal lesion to be generated within a tissue target. Tissue destruction occurs due to direct heating within the lesion and the mechanical effects of acoustic cavitation. HIFU has been used in a broad range of clinical applications, including the treatment of malignancies, uterine fibroids and cardiac arrhythmias. Interest in the use of the technique to treat pain has recently increased. A number of painful conditions have been successfully treated, including musculoskeletal degeneration, bone metastases and neuropathic pain. The exact mechanism by which HIFU results in analgesia remains poorly understood, but it is thought to be due to localised denervation of tissue targets and/or neuromodulatory effects. The majority of studies conducted investigating the use of HIFU in pain are still at an early stage, although initial results are encouraging. Further research is indicated to improve our understanding of the mechanisms underlying this treatment and to fully establish its efficacy; however, it is likely that HIFU will play a role in pain management in the future. This narrative review provides a synthesis of the recent, salient clinical and basic science research related to this topic and gives a general introduction to the mechanisms by which HIFU exerts its effects. PMID:26385662

  19. [Diagnosis and treatment of local recurrence of prostate cancer using hystoscanning and high-intensity focused ultrasound in patients after radical prostatectomy].

    Science.gov (United States)

    Glybochko, P V; Aliaev, Iu G; Krupinov, G E; Rapoport, L M; Amosov, A V; Bezrukov, E A; Novichkov, N D; Lachinov, É L; Ganzha, T M; Obukhov, A A; Lerner, Iu V

    2014-01-01

    The study was aimed to the improvement of the diagnosis and treatment of patients with prostate cancer (PC). The study included 46 patients with recurrent prostate cancer after radical prostatectomy (RPE). The examination included contrast enhanced magnetic resonance imaging (endorectal coil 1.5T) and hystoscanning. All patients had local recurrence confirmed by the morphologically results of transrectal biopsy of the area of vesicourethral anastomosis. All patients underwent high-intensity focused ultrasound (HIFU). Before RPE, protate volume ranged from 21 to 102 cm3. The median age was 62 (46-68) years. PSA levels before a HIFU session ranged from 0.4 to 18 ng/ml. Nadir PSA level after 3 months of follow up was 0.1 ng/ml. Five-year disease-free survival in patients with locally recurrent prostate cancer after HIFU in the group of low cancer risk was 10 (81%), moderate risk--18 (57%), high risk--12 (42%). Contrast enhanced magnetic resonance imaging and hystoscanning are highly informative methods for diagnosis of local recurrence after radical prostatectomy, and HIFU can be categorized as highly effective treatment. PMID:25807764

  20. An optimum method for pulsed high intensity focused ultrasound treatment of large volumes using the InSightec ExAblate (registered) 2000 system

    International Nuclear Information System (INIS)

    Pulsed high intensity focused ultrasound (pHIFU) is a method for delivering ultrasound to tissue while avoiding high temperatures. The technique has been suggested for non-destructively enhancing local uptake of drugs. Side effects include thermal necrosis; therefore, real-time monitoring of tissue temperature is advantageous. This paper outlines a method for improving the treatment efficiency of pHIFU using the MR image-guided InSightec ExAblate (registered) 2000 system, an ultrasound system integrated into a whole body human MRI scanner with the ability to measure temperature at the treatment location in near real time. Thermal measurements obtained during treatment of a tissue phantom were used to determine appropriate heating parameters, and compared to in vivo treatment of rabbit muscle. Optimization of the treatment procedure and ultrasound transducer steering patterns was then conducted with the goal of minimizing treatment time while avoiding overheating. The optimization was performed on the basis of approximate solutions to the standard bioheat equation. The commercial system software of the Exablate (registered) system was modified to assist in this optimization. Depending on the size of the treatment volume, the presented results demonstrate that it is possible to use the technique described to cut treatment times significantly, up to one-third of that required by the current standard treatment cycle.

  1. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population.

    Science.gov (United States)

    Illing, R O; Kennedy, J E; Wu, F; ter Haar, G R; Protheroe, A S; Friend, P J; Gleeson, F V; Cranston, D W; Phillips, R R; Middleton, M R

    2005-10-17

    High-intensity focused ultrasound (HIFU) provides a potential noninvasive alternative to conventional therapies. We report our preliminary experience from clinical trials designed to evaluate the safety and feasibility of a novel, extracorporeal HIFU device for the treatment of liver and kidney tumours in a Western population. The extracorporeal, ultrasound-guided Model-JC Tumor Therapy System (HAIFU Technology Company, China) has been used to treat 30 patients according to four trial protocols. Patients with hepatic or renal tumours underwent a single therapeutic HIFU session under general anaesthesia. Magnetic resonance imaging 12 days after treatment provided assessment of response. The patients were subdivided into those followed up with further imaging alone or those undergoing surgical resection of their tumours, which enabled both radiological and histological assessment. HIFU exposure resulted in discrete zones of ablation in 25 of 27 evaluable patients (93%). Ablation of liver tumours was achieved more consistently than for kidney tumours (100 vs 67%, assessed radiologically). The adverse event profile was favourable when compared to more invasive techniques. HIFU treatment of liver and kidney tumours in a Western population is both safe and feasible. These findings have significant implications for future noninvasive image-guided tumour ablation. PMID:16189519

  2. Ultrasound-Guided Transesophageal High-Intensity Focused Ultrasound Cardiac Ablation in a Beating Heart: A Pilot Feasibility Study in Pigs.

    Science.gov (United States)

    Bessiere, Francis; N'djin, W Apoutou; Colas, Elodie Constanciel; Chavrier, Françoise; Greillier, Paul; Chapelon, Jean Yves; Chevalier, Philippe; Lafon, Cyril

    2016-08-01

    Catheter ablation for the treatment of arrhythmia is associated with significant complications and often-repeated procedures. Consequently, a less invasive and more efficient technique is required. Because high-intensity focused ultrasound (HIFU) enables the generation of precise thermal ablations in deep-seated tissues without harming the tissues in the propagation path, it has the potential to be used as a new ablation technique. A system capable of delivering HIFU into the heart by a transesophageal route using ultrasound (US) imaging guidance was developed and tested in vivo in six male pigs. HIFU exposures were performed on atria and ventricles. At the time of autopsy, visual inspection identified thermal lesions in the targeted areas in three of the animals. These lesions were confirmed by histologic analysis (mean size: 5.5 mm(2) × 11 mm(2)). No esophageal thermal injury was observed. One animal presented with bradycardia due to an atrio-ventricular block, which provides real-time confirmation of an interaction between HIFU and the electrical circuits of the heart. Thus, US-guided HIFU has the potential to minimally invasively create myocardial lesions without an intra-cardiac device. PMID:27158083

  3. Volumetric MR-Guided High-Intensity Focused Ultrasound with Direct Skin Cooling for the Treatment of Symptomatic Uterine Fibroids: Proof-of-Concept Study

    Directory of Open Access Journals (Sweden)

    Marlijne E. Ikink

    2015-01-01

    Full Text Available Objective. To prospectively assess the safety and technical feasibility of volumetric magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU ablation with direct skin cooling (DISC during treatment of uterine fibroids. Methods. In this proof-of-concept study, eight patients were consecutively selected for clinical MR-HIFU ablation of uterine fibroids with the use of an additional DISC device to maintain a constant temperature (T≈20°C at the interface between the HIFU table top and the skin. Technical feasibility was verified by successful completion of MR-HIFU ablation. Contrast-enhanced T1-weighted MRI was used to measure the treatment effect (nonperfused volume (NPV ratio. Safety was evaluated by recording of adverse events (AEs within 30 days’ follow-up. Results. All MR-HIFU treatments were successfully completed in an outpatient setting. The median NPV ratio was 0.56 (IQR [0.27–0.72]. Immediately after treatment, two patients experienced coldness related discomfort which resolved at the same day. No serious (device-related AEs were reported. Specifically, no skin burns, cold injuries, or subcutaneous edema were observed. Conclusion. This study showed that it is safe and technically feasible to complete a volumetric MR-HIFU ablation with DISC. This technique may reduce the risk of thermal injury to the abdominal wall during MR-HIFU ablation of uterine fibroids. This trial is registered with NTR4189.

  4. Real-Time Monitoring and Quantitative Evaluation of Cavitation Bubbles Induced by High Intensity Focused Ultrasound Using B-Mode Imaging

    Science.gov (United States)

    Yu, Jie; Chen, Chu-Yi; Chen, Gong; Guo, Xia-Sheng; Ma, Yong; Tu, Juan; Zhang, Dong

    2014-03-01

    A software-based method is proposed to eliminate the flooding interference strips in B-mode images, and to evaluate the cavitation bubbles generated during high intensity focused ultrasound (HIFU) exposures. In vitro tissue phantoms are exposed to 1.12 MHz HIFU pulses with a fixed 100 Hz pulse repetition frequency. HIFU-induced cavitation bubbles are detected as hyperechoic regions in B-mode images. The temporal evolution of cavitation bubbles, generated by HIFU pulses with varying driving amplitude and pulse length, is analyzed by measuring the time-varying area of the hyperechoic region. The results show that: first, it is feasible to monitor HIFU-induced cavitation bubble activity in real-time using B-mode imaging; second, more cavitation bubbles can be generated with higher acoustic energy delivered; third, the hyperechoic region is observed to shrink gradually after ceasing the HIFU pulses, which indicates the dissolution of cavitation bubbles. This work will be helpful for developing an effective tool to realize real-time monitoring and quantitative evaluation of HIFU-induced cavitation bubble activity using a current commercialized B-mode machine.

  5. Elucidation of the role of biological factors and device design in cerebral NIRS using an in vivo hematoma model based on high-intensity focused ultrasound

    Science.gov (United States)

    Wang, Jianting; Huang, Stanley; Myers, Matthew; Chen, Yu; Welle, Cristin; Pfefer, Joshua

    2016-03-01

    Near-Infrared Spectroscopy (NIRS) is an emerging medical countermeasure for rapid, field detection of hematomas caused by traumatic brain injury (TBI). Bench and animal tests to determine NIRS sensitivity and specificity are needed. However, current animal models involving non-invasively induced, localized neural damage are limited. We investigated an in vivo murine hematoma model in which cerebral hemorrhage was induced noninvasively by high-intensity focused ultrasound (HIFU) with calibrated positioning and parameters. To characterize the morphology of induced hematomas, we used skull-intact histological evaluation. A multi-wavelength fiber-optic NIRS system with three source-detector separation distances was used to detect hematoma A 1.1 MHz transducer produced consistent small-to-medium hematoma localized to a single hemisphere, along with bruising of the scalp, with a low mortality rate. A 220 kHz transducer produced larger, more diffuse hematomas, with higher variability in size and a correspondingly higher mortality rate. No skin bruising or blood accumulation between the skin and skull was observed following injury application with the 220 kHz transducer. Histological analysis showed higher sensitivity for larger hematomas (>4x4 mm2). NIRS optical density change after HIFU was able to detect all hematomas, with sensitivity dependent on wavelength and separation distance. While improvements in methods for validating cerebral blood distribution are needed, the HIFU hematoma model provided useful insights that will inform development of biologically relevant, performance test methods for cerebral NIRS systems.

  6. Modulation of the interstitial fluid pressure by high intensity focused ultrasound as a way to alter local fluid and solute movement: insights from a mathematical model

    International Nuclear Information System (INIS)

    High intensity focused ultrasound (HIFU) operated in thermal mode has been reported to reduce interstitial fluid pressure and improve the penetration of large macromolecules and nanoparticles in tumor and normal tissue. Little is understood about how the interstitial fluid pressure and velocity as well as the interstitial macromolecule transport are affected by HIFU exposure. A mathematical model is presented here which sheds light on the initial biophysical changes brought about HIFU. Our continuum model treats tissue as an effective poro-elastic material that reacts to elevated temperatures with a rapid drop in interstitial elastic modulus. Using parameters from the literature, the model is extrapolated to derive information on the effect in tumors, and to predict its impact on the convective and diffusive transport of macromolecular drugs. The model is first solved using an analytical approximation with step-wise changes at each boundary, and then solved numerically starting from a Gaussian beam approximation of the ultrasound treatment. Our results indicate that HIFU causes a rapid drop in interstitial fluid pressure that may be exploited to facilitate convection of macromolecules from vasculature to the exposed region. However, following a short recovery period in which the interstitial fluid pressure is normalized, transport returns to normal and the advantages disappear over time. The results indicate that this effect is strongest for the delivery of large molecules and nanoparticles that are in the circulation at the time of treatment. The model may be easily applied to more complex situations involving effects on vascular permeability and diffusion. (paper)

  7. Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: Prognostic value of prostate MRI

    International Nuclear Information System (INIS)

    Aim: To assess the prognostic value of magnetic resonance imaging (MRI) before salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after external-beam radiotherapy (EBRT). Materials and methods: Forty-six patients who underwent prostate MRI before salvage HIFU for locally recurrent prostate cancer after EBRT were retrospectively studied. HIFU failure was defined as a prostate-specific antigen (PSA) value >nadir + 2 ng/ml (Phoenix criteria) or positive follow-up biopsy or initiation of any other salvage therapy. The following prognostic parameters were assessed: neoadjuvant hormone therapy, clinical stage and Gleason score of recurrence, PSA level and velocity at HIFU treatment, and six MRI-derived parameters (prostate volume, tumour volume, extracapsular extension, seminal vesicle invasion, tumour extension into the apex or anterior to the urethra). Results: Two factors were significant independent predictors of salvage HIFU failure: the PSA level at HIFU treatment (p < 0.012; risk ratio: 1.15, 95% CI: 1.03–1.29) and the tumour extension anterior to the urethra, as assessed by MRI (p = 0.046, risk ratio: 2.51, 95% CI: 1.02–6.16). Conclusion: The location of cancer recurrence anterior to the urethra on MRI is an independent significant predictor of salvage HIFU failure for locally recurrent prostate cancer after EBRT. Therefore, MRI may be useful for patient selection before post-EBRT salvage HIFU ablation

  8. Suitability of a tumour-mimicking material for the evaluation of high-intensity focused ultrasound ablation under magnetic resonance guidance

    Science.gov (United States)

    Pichardo, S.; Kivinen, J.; Melodelima, D.; Curiel, L.

    2013-04-01

    This study tests the suitability of a tumour-mimic for targeting magnetic resonance (MR)-guided high-intensity focused ultrasound (HIFU). An agarose-based tumour-mimic was injected as a warm solution that polymerized in tissue. Thermal characteristics and acoustic absorption of the mimic were observed within the values reported for tissues. The relaxation times at 3T were 1679 ± 15 ms for T1 and 41 ± 1 ms for T2. The mimic was clearly visible on in vivo images. With lower contrast the tumour-mimic was visible on T2-weighted images, where it was possible to detect the ablated tissue surrounding the mimic after sonications. HIFU sonications were performed to induce thermal ablation on and around the mimic using a Sonalleve system (Philips). MR thermometry maps were performed during HIFU. The average temperature when the sonication was done at the tumour-mimic was 67.6 ± 8.0 °C in vitro and 67.6 ± 5.0 °C in vivo. The average temperature for sonications at tissues was 68.4 ± 8.7 °C in vitro (liver) and 66.0 ± 2.6 °C in vivo (muscle), with no significant difference between tissue and tumour-mimic (p > 0.05). The tumour-mimic behaviour when using MR-guided HIFU was similar to tissues, showing that this mimic can be used as an alternative to tumour models for validating MR-guided HIFU devices targeting.

  9. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: Long-term results

    Energy Technology Data Exchange (ETDEWEB)

    Froeling, V., E-mail: Vera.Froeling@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); Meckelburg, K., E-mail: Katrin.Meckelburg@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); Schreiter, N.F., E-mail: Nils.Schreiter@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); Scheurig-Muenkler, C., E-mail: Christian.Scheurig@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); Kamp, J., E-mail: Julia.Kamp@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); Maurer, M.H., E-mail: Martin.Maurer@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); Beck, A., E-mail: Alexander.Beck@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); Hamm, B., E-mail: Bernd.Hamm@charite.de [Department of Radiology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin (Germany); and others

    2013-12-01

    Objectives: To compare the long-term outcome after uterine artery embolization (UAE) versus magnetic resonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids. Methods: Seventy-seven women (median age, 39.3 years; range, 29.2–52.2 years) with symptomatic uterine fibroids, equally eligible for UAE and MR-g HIFU based on our exclusion criteria underwent treatment (UAE, N = 41; MR-g HIFU, N = 36) from 2002 to 2009 at our institution. Symptom severity (SS) and total health-related quality of life (Total HRQoL) scores were assessed by the uterine fibroid symptom and quality of life (UFS-QoL) questionnaire before treatment and at long-term follow-up after UAE (median 61.9 months) and after MR-g HIFU (median: 60.7 months). Re-intervention rates were assessed for each therapy and compared. Results: Re-intervention was significantly lower after UAE (12.2%) than after MR-g HIFU (66.7%) at long-term follow-up (p < 0.001). After UAE changes in SS (50 pre-treatment vs. 6.3 post-treatment) and Total HRQoL (57.8 pre-treatment vs. 100 post-treatment) were significantly better than changes in SS (42.2 pre-treatment vs. 26.6 post-treatment) and Total HRQoL score (66.4 pre-treatment vs. 87.9 post-treatment) after MR-g HIFU (p = 0.019 and 0.049 respectively). Conclusions: Improvement of SS and Total HRQoL scores was significantly better after UAE resulting in a significant lower re-intervention rate compared to MR-g HIFU.

  10. Retrospective analysis of high intensity focused ultrasound combined with S-1 in the treatment of metastatic pancreatic cancer after failure of gemcitabine.

    Science.gov (United States)

    Li, Xiaoping; Wang, Kun; Zheng, Leizhen; Meng, Zhiqiang

    2016-01-01

    The purpose of this study was to verify the efficacy and safety of high intensity focused ultrasound therapy (HIFU) combined with S-1 in the treatment of metastatic pancreatic cancer after failure of gemcitabine (GEM). In total, 120 patients with GEM-refractory PC who received HIFU and S-1 between Aug 2012 and December 2014 were randomly assigned to 2 groups. The patients in group A (n = 61) received HIFU in combination with S-1 and those in group B (n = 59) were given S-1 alone. S-1 was administered orally twice a day on days 1-14. Cycles were repeated every 21 days. The follow up time was 3~19 months in both groups. The median overall survival (OS) time and progression free survival (PFS) were analysed by Kaplan-Meier method and Logrank test. The pain remission rate of the two groups was compared by χ(2) test. Patient characteristics and prognostic factors were compared. Patient characteristics did not significantly differ between the 2 groups. Median OS was significantly longer in group A (10.3 months) than in group B (6.6 months, P = 0.000). Median PFS was also significantly longer in group A than in group B (5.1 months vs 2.3 months, P = 0.000). Meanwhile, the pain remission rate was markedly higher in group A than in group B (57% vs. 20%, P = 0.000). There were mild side effects and no significant difference was observed between the two groups. The treatment effect was independently associated with a good outcome. HIFU in combination with S-1 might be effective and well tolerated as salvage chemotherapy in the treatment for metastatic pancreatic cancer. PMID:27073725

  11. Comparison of the synergistic effect of lipid nanobubbles and SonoVue microbubbles for high intensity focused ultrasound thermal ablation of tumors

    Science.gov (United States)

    Yao, Yuanzhi; Yang, Ke; Cao, Yang; Zhou, Xuan; Xu, Jinshun; Liu, Jianxin; Wang, Qi

    2016-01-01

    Microbubbles (MBs) are considered as an important enhancer for high intensity focused ultrasound (HIFU) treatment of benign or malignant tumors. Recently, different sizes of gas-filled bubbles have been investigated to improve the therapeutic efficiency of HIFU thermal ablation and reduce side effects associated with ultrasound power and irradiation time. However, nanobubbles (NBs) as an ultrasound contrast agent for synergistic therapy of HIFU thermal ablation remain controversial due to their small nano-size in diameter. In this study, phospholipid-shell and gas-core NBs with a narrow size range of 500–600 nm were developed. The synergistic effect of NBs for HIFU thermal ablation was carefully studied both in excised bovine livers and in breast tumor models of rabbits, and made a critical comparison with that of commercial SonoVue microbubbles (SonoVue MBs). In addition, the pathological changes of the targeted area in tumor tissue after HIFU ablation were further investigated. Phosphate buffer saline (PBS) was used as the control. Under the same HIFU parameters, the quantitative echo intensity of B-mode ultrasound image and the volume of coagulative necrosis in lipid NBs groups were significantly higher and larger than that in PBS groups, but could not be demonstrated a difference to that in SonoVue MBs groups both ex vivo and in vivo. These results showed that the synergistic effect of lipid NBs for HIFU thermal ablation were similar with that of SonoVue MBs, and further indicate that lipid NBs could potentially become an enhancer for HIFU thermal ablation of tumors. PMID:26925336

  12. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma: Utility of contrast-enhanced MRI and diffusion-weighted imaging

    Energy Technology Data Exchange (ETDEWEB)

    Zhang Yuanyuan; Zhao Jiannong [Department of Radiology, Second Affiliated Hospital, Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, Chongqing 400010 (China); Guo Dajing, E-mail: guodaj@163.com [Department of Radiology, Second Affiliated Hospital, Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, Chongqing 400010 (China); Zhong Weijia [Department of Radiology, Second Affiliated Hospital, Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, Chongqing 400010 (China); Ran Lifen [Clinical Center for Tumor Therapy, Second Affiliated Hospital, Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, Chongqing 400010 (China)

    2011-09-15

    Objective: To explore the significance of contrast-enhanced MRI (CE-MRI) and diffusion-weighted imaging (DWI) in evaluating the short-term response of high intensity focused ultrasound (HIFU) ablation for primary hepatic carcinoma (PHC). Methods: Thirty-nine lesions in the livers of 27 patients were performed HIFU ablation. Conventional MRI sequences, CE-MRI and DWI were performed 1 week before HIFU and 1 week, 3 months after the therapy, respectively. The short-term responses of HIFU for all lesions were evaluated with MRI. Results: 28 of the 39 lesions (28/39, 71.8%) showed complete necrosis with no enhancement 1 week and 3 months after HIFU. The apparent diffusion coefficient (ADC) values 1 week and 3 months after HIFU were significantly higher than those 1 week before treatment (p < 0.05). The tumor recurrence was detected in 7 of the 39 lesions (7/39, 17.9%) which had no significant enhancement 1 week after HIFU. On the 3 months follow-up, focal nodules were found on the inner aspects of the treated areas. The ADC values had no significant difference between 1 week before and after treatment (p > 0.05), however, they were significantly higher 3 months after HIFU (p < 0.05). The tumor residuals were detected in 4 of the 39 lesions (4/39, 10.3%) showing enhancement 1 week after treatment and increased size 3 months after HIFU. The ADC values had no significant difference among 1 week before HIFU, 1 week and 3 months after treatment (p > 0.05). Conclusion: CE-MRI and DWI can be employed to evaluate the short-term response of HIFU ablation for PHC and to guide the patient management.

  13. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation.

    Science.gov (United States)

    Kim, Young-Sun; Lee, Jeong-Won; Choi, Chel Hun; Kim, Byoung-Gie; Bae, Duk-Soo; Rhim, Hyunchul; Lim, Hyo Keun

    2016-03-01

    Purpose To evaluate the relationships between T2 signal intensity and semiquantitative perfusion magnetic resonance (MR) parameters of uterine fibroids in patients who were screened for MR-guided high-intensity focused ultrasound (HIFU) ablation. Materials and Methods Institutional review board approval was granted, and informed consents were waived. One hundred seventy most symptom-relevant, nondegenerated uterine fibroids (mean diameter, 7.3 cm; range, 3.0-17.2 cm) in 170 women (mean age, 43.5 years; range, 24-56 years) undergoing screening MR examinations for MR-guided HIFU ablation from October 2009 to April 2014 were retrospectively analyzed. Fibroid signal intensity was assessed as the ratio of the fibroid T2 signal intensity to that of skeletal muscle. Parameters of semiquantitative perfusion MR imaging obtained during screening MR examination (peak enhancement, percentage of relative peak enhancement, time to peak [in seconds], wash-in rate [per seconds], and washout rate [per seconds]) were investigated to assess their relationships with T2 signal ratio by using multiple linear regression analysis. Correlations between T2 signal intensity and independently significant perfusion parameters were then evaluated according to fibroid type by using Spearman correlation test. Results Multiple linear regression analysis revealed that relative peak enhancement showed an independently significant correlation with T2 signal ratio (Β = 0.004, P HIFU ablation, the T2 signal intensity of nondegenerated uterine fibroids showed an independently significant positive correlation with relative peak enhancement in most cases, except those of submucosal intracavitary or type III fibroids. (©) RSNA, 2015. PMID:26313526

  14. First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.

    Directory of Open Access Journals (Sweden)

    Aurélien Dupré

    Full Text Available Surgery is the only curative treatment in patients with colorectal liver metastases (CLM, but only 10-20% of patients are eligible. High Intensity Focused Ultrasound (HIFU technology is of proven value in several indications, notably prostate cancer. Its intra-operative use in patients with CLM has not previously been studied. Preclinical work suggested the safety and feasibility of a new HIFU device capable of ablating volumes of up to 2cm x 2cm in a few seconds.We conducted a prospective, single-centre phase I-IIa trial. HIFU was delivered immediately before scheduled hepatectomy. To demonstrate the safety and efficacy of rapidly ablating liver parenchyma, ablations were performed on healthy tissue within the areas scheduled for resection.In total, 30 ablations were carried out in 15 patients. These ablations were all generated within 40 seconds and on average measured 27.5mm x 21.0mm. The phase I study (n = 6 showed that use of the HIFU device was feasible and safe and did not damage neighbouring tissue. The phase IIa study (n = 9 showed both that the area of ablation could be precisely targeted on a previously implanted metallic mark (used to represent a major anatomical structure and that ablations could be undertaken deliberately to avoid such a mark. Ablations were achieved with a precision of 1-2 mm.HIFU was feasible, safe and effective in ablating areas of liver scheduled for resection. The next stage is a phase IIb study which will attempt ablation of small metastases with a 5 mm margin, again prior to planned resection.ClinicalTrials.govNCT01489787.

  15. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly: a feasibility study with 10 years follow-up

    Directory of Open Access Journals (Sweden)

    Amine B. El Fegoun

    2011-04-01

    Full Text Available PURPOSE: To evaluate the long-term efficacy of prostate cancer control and complication rates, in the elderly, after focal therapy with high-intensity focused ultrasound (HIFU. MATERIALS AND METHODS: Between June 1997 and March 2000, patients with localized prostate cancer were included into a focal therapy protocol. Inclusion criteria were: PSA < 10 ng/mL, < 3 positive biopsies with only 1 lobe involved, clinical stage < T2a, Gleason score < 7 (3+4, negative CT scan and bone scan. Hemi-ablation of the prostate was performed with the Ablatherm(R device. Survival, complication rates and urinary continence were evaluated. Control biopsies were performed at 1 year. Treatment failure was defined as a positive biopsy or need for salvage therapy. RESULTS: Twelve patients with a mean age 70 years were included. Median follow-up was 10 years. Control prostate biopsies were negative in 11/12 (91% patients. Overall survival was 83% (10/12 and cancer specific survival was 100% at 10 years. Two patients died from other causes. Recurrence free survival was 90% (95% CI; 0.71-1 at 5 years, and 38% (95% CI; 0.04-0.73 at 10 years. Five patients had salvage therapy with repeat HIFU (n = 1 or hormonal therapy (n = 4 and all salvage patients were alive at 10 years. No patients developed lymph node or bone metastasis. No patients suffered from urinary incontinence. International Prostate Symptom Score was stable at 1 year. Complications included two urinary tract infections and one episode of acute urinary retention. CONCLUSIONS: Hemi-prostate ablation with HIFU can be safely performed in selected elderly patients with adequate long-term cancer control and low complication rates. Results from larger prospective studies using improved imaging techniques and extensive biopsy protocols are awaited.

  16. High-intensity focused ultrasound (HIFU) using Sonablate{trade mark, serif} devices for the treatment of localized prostate cancer: 13-year experience

    Science.gov (United States)

    Uchida, Toyoaki; Tomonaga, Tetsuro; Shoji, Sunao; Kim, Hakushi; Nagata, Yoshihiro

    2012-11-01

    To report on the long-term results of high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. Eight hundred and eighty-four men with prostate cancer treated with Sonablate® (SB) devices were included. All patients were followed for more than 2 years. The patients were divided into three groups: in the first group, 419 patients were treated with SB200/500 from 1999 to 2006; in the second group, 263 patients were treated with SB 500 ver. 4 from 2005 to 2009: in the third group, 202 patients were treated with SB 500 TCM from 2007 up to present. Biochemical failure was defined according to the Phoenix definition (PSA nadir + 2 ng/ml). The mean age, PSA, Gleason score, operation time, and follow-up period in each group were 68, 66 and 67 years, 11.2, 9.7 and 9.3 ng/ml, 6.2, 6.6 and 6.7, 167, 101 and 106 min, and 56, 48 and 36 months, respectively. The biochemical disease-free rate (bDFR) in each group at 5 years was, respectively, 54%, 61% and 84%, and was 50% at 10 years in the SB200/500 group (pprostate biopsy rates in 3 groups were 81%, 92% and 88%, respectively. As post HIFU complications, urethral stricture, acute epididymitis and urinary incontinence were noted in 18.0%, 6.2% and 1.9%, respectively. Rectourethral fistula was occurred in 0.6% in the first HIFU cases, Postoperative erectile dysfunction was noted in 27% of patients at 2 years after HIFU. HIFU therapy appears to be minimally invasive, efficacious, and safe for patients with localized prostate cancer. Technological advances as well as cultural and economic vectors have caused a shift from to minimally invasive techniques.

  17. HematoPorphyrin Monomethyl Ether polymer contrast agent for ultrasound/photoacoustic dual-modality imaging-guided synergistic high intensity focused ultrasound (HIFU) therapy.

    Science.gov (United States)

    Yan, Sijing; Lu, Min; Ding, Xiaoya; Chen, Fei; He, Xuemei; Xu, Chunyan; Zhou, Hang; Wang, Qi; Hao, Lan; Zou, Jianzhong

    2016-01-01

    This study is to prepare a hematoporphyrin monomethyl ether (HMME)-loaded poly(lactic-co-glycolic acid) (PLGA) microcapsules (HMME/PLGA), which could not only function as efficient contrast agent for ultrasound (US)/photoacoustic (PA) imaging, but also as a synergistic agent for high intensity focused ultrasound (HIFU) ablation. Sonosensitizer HMME nanoparticles were integrated into PLGA microcapsules with the double emulsion evaporation method. After characterization, the cell-killing and cell proliferation-inhibiting effects of HMME/PLGA microcapsules on ovarian cancer SKOV3 cells were assessed. The US/PA imaging-enhancing effects and synergistic effects on HIFU were evaluated both in vitro and in vivo. HMME/PLGA microcapsules were highly dispersed with well-defined spherical morphology (357 ± 0.72 nm in diameter, PDI = 0.932). Encapsulation efficiency and drug-loading efficiency were 58.33 ± 0.95% and 4.73 ± 0.15%, respectively. The HMME/PLGA microcapsules remarkably killed the SKOV3 cells and inhibited the cell proliferation, significantly enhanced the US/PA imaging results and greatly enhanced the HIFU ablation effects on ovarian cancer in nude mice by the HMME-mediated sono-dynamic chemistry therapy (SDT). HMME/PLGA microcapsules represent a potential multifunctional contrast agent for HIFU diagnosis and treatment, which might provide a novel strategy for the highly efficient imaging-guided non-invasive HIFU synergistic therapy for cancers by SDT in clinic. PMID:27535093

  18. Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: Effect of Bowel Interposition on Procedure Feasibility and a Unique Bowel Displacement Technique.

    Directory of Open Access Journals (Sweden)

    Young-Sun Kim

    Full Text Available To evaluate the effect of bowel interposition on assessing procedure feasibility, and the usefulness and limiting conditions of bowel displacement techniques in magnetic resonance imaging-guided high-intensity focused ultrasound (MR-HIFU ablation of uterine fibroids.Institutional review board approved this study. A total of 375 screening MR exams and 206 MR-HIFU ablations for symptomatic uterine fibroids performed between August 2010 and March 2015 were retrospectively analyzed. The effect of bowel interposition on procedure feasibility was assessed by comparing pass rates in periods before and after adopting a unique bowel displacement technique (bladder filling, rectal filling and subsequent bladder emptying; BRB maneuver. Risk factors for BRB failure were evaluated using logistic regression analysis.Overall pass rates of pre- and post-BRB periods were 59.0% (98/166 and 71.7% (150/209, and in bowel-interposed cases they were 14.6% (7/48 and 76.4% (55/72, respectively. BRB maneuver was technically successful in 81.7% (49/60. Through-the-bladder sonication was effective in eight of eleven BRB failure cases, thus MR-HIFU could be initiated in 95.0% (57/60. A small uterus on treatment day was the only significant risk factor for BRB failure (B = 0.111, P = 0.017.The BRB maneuver greatly reduces the fraction of patients deemed ineligible for MR-HIFU ablation of uterine fibroids due to interposed bowels, although care is needed when the uterus is small.

  19. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent

    Energy Technology Data Exchange (ETDEWEB)

    Numata, Kazushi, E-mail: kz-numa@urahp.yokohama-cu.ac.j [Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa 232-0024 (Japan); Fukuda, Hiroyuki; Ohto, Masao; Itou, Ryu [Department of Internal Medicine, Naruto General Hospital, 167 Naruto, Sanbu, Chiba 289-1326 (Japan); Nozaki, Akito; Kondou, Masaaki; Morimoto, Manabu [Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa 232-0024 (Japan); Karasawa, Eii [Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashi Kaigan-cho, Atami, Shizuoka 413-0012 (Japan); Tanaka, Katsuaki [Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa 232-0024 (Japan)

    2010-08-15

    Objective: We performed contrast-enhanced three-dimensional sonography (CE 3D US) with a perflubutane-based contrast agent to immediately evaluate the completeness of ablation of small hepatocellular carcinoma (HCC) lesions by extracorporeal high-intensity focused ultrasound (HIFU). Subjects and methods: Twenty-one HCC lesions were treated by a single ultrasound-guided HIFU ablation session, and CE 3D US was performed before, immediately after, and 1 week, and 1 month after HIFU, and contrast-enhanced CT (CE CT) or contrast-enhanced MRI (CE MRI) was performed before HIFU, 1 week and 1 month after HIFU, and during the follow-up period. Results: Immediately and 1 month after HIFU, 17 lesions were evaluated as adequately ablated by CE 3D US, and the other 4 lesions as residual tumors. One month after HIFU, 18 were evaluated as adequately ablated by CE CT or CE MRI, and the other 3 as residual tumors. The evaluation by CE 3D US immediately after HIFU and by CE CT or CE MRI 1 month after HIFU was concordant with 20 lesions. The kappa value for agreement between the findings of CE 3D US and other modalities by two blinded observers was 0.83. When the 1-month CE CT or CE MRI findings were used as the reference standard, the sensitivity, specificity, and accuracy of CE 3D US immediately after HIFU for the diagnosis of the adequate ablation were 100%, 75%, and 95%, respectively. Conclusion: CE 3D US appears to be a useful method for immediate evaluation of therapeutic efficacy of HIFU ablation of HCC lesions.

  20. Clinical utility of a microbubble-enhancing contrast (“SonoVue”) in treatment of uterine fibroids with high intensity focused ultrasound: A retrospective study

    Energy Technology Data Exchange (ETDEWEB)

    Peng, Song [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, Department of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Non-invasive and Minimally Invasive Therapeutic Research Center for Uterine Benign Diseases of Chongqing, Chongqing 401121 (China); Xiong, Yu [Department of Obstetrics of Chongqing Haifu Hospital, Chongqing 401121 (China); Non-invasive and Minimally Invasive Therapeutic Research Center for Uterine Benign Diseases of Chongqing, Chongqing 401121 (China); Li, Kequan [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, Department of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Non-invasive and Minimally Invasive Therapeutic Research Center for Uterine Benign Diseases of Chongqing, Chongqing 401121 (China); He, Min [Department of Obstetrics of Chongqing Haifu Hospital, Chongqing 401121 (China); Department of Obstetrics and Gynecology, Suining Central Hospital, Sichuan 629000 (China); Deng, Yongbin; Chen, Li; Zou, Min [Department of Obstetrics of Chongqing Haifu Hospital, Chongqing 401121 (China); Chen, Wenzhi; Wang, Zhibiao [State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, Department of Biomedical Engineering, Chongqing Medical University, Chongqing 400016 (China); Non-invasive and Minimally Invasive Therapeutic Research Center for Uterine Benign Diseases of Chongqing, Chongqing 401121 (China); He, Jia, E-mail: hejia0820@sina.com.cn [Department of Obstetrics and Gynecology, Suining Central Hospital, Sichuan 629000 (China); and others

    2012-12-15

    Purpose: To evaluate the clinical value of the contrast agent SonoVue in the treatment of uterine fibroids with ultrasound-guided high intensity focused ultrasound (HIFU) therapeutic ablation. Materials and Methods: A total of 291 patients with solitary uterine fibroid from three centers were treated with ultrasound-guided HIFU. Among them, 129 patients from Suining Central Hospital of Sichuan were treated without using SonoVue. 162 patients from the First Hospital of Chongqing Medical University and Chongqing Haifu Hospital were treated with using SonoVue before, during and after HIFU procedure to assess the extent of HIFU. Results: The non-perfused volume (indicative of successful ablation) was observed in all treated uterine fibroids immediately after HIFU ablation; median fractional ablation, defined as non-perfused volume divided by the fibroid volume immediately after HIFU treatment, was 86.0% (range, 28.8–100.0%) in the group with using SonoVue, and 83.0% (8.7–100.0%) without SonoVue. The rate of massive gray scale changes was higher with SonoVue than without the agent. The sonication time to achieve massive gray scale changes was shorter with SonoVue than without. The sonication time for ablating 1 cm{sup 3} of fibroid volume was significantly shorter with using SonoVue than without. No major complications were observed in any patients. Conclusions: Based on our results, SonoVue may enhance the outcome of HIFU ablation and can be used to assess the extent of treatment.

  1. Contrast-enhanced ultrasound for evaluation of high-intensity focused ultrasound treatment of benign uterine diseases: retrospective analysis of contrast safety.

    Science.gov (United States)

    Cheng, Chong-Qing; Zhang, Rui-Tao; Xiong, Yu; Chen, Li; Wang, Jian; Huang, Guo-Hua; Li, Ke-Quan; Zhang, Lian; Bai, Jin

    2015-04-01

    As a noninvasive treatment technique, ultrasound-guided high-intensity focused ultrasound (HIFU) has been considered as a routine treatment for uterine fibroids and adenomyosis in China. Contrast-enhanced ultrasound (CEUS) has been proposed as another option to assess the treatment efficacy during HIFU treatment. The aim of this investigation is to evaluate the adverse effects of HIFU ablation for benign uterine diseases in a group of patients studied with ultrasound contrast agent (UCA), in comparison with a group of patients not exposed to UCA. From November 2010 to December 2013, 2604 patients with benign uterine diseases were treated with HIFU. Among them, 1300 patients were exposed to an UCA, whereas 1304 patients were not.During HIFU procedure, the incidences of leg pain, sacral/buttock pain, groin pain, treatment area pain, and the discomfort "hot" sensation on skin were higher in the patients who were exposed to SonoVue (Bracco, Milan, Italy) than those who were not (20.5% vs 11.7%, 52.5% vs 42.3%, 6.5% vs 4.5%, 68.9% vs 55.4%, and 48.1% vs 42.9%, respectively). Among the postoperative adverse effects, the incidence of lower abdominal pain was significantly higher in patients who were exposed to an UCA than those who were not (51.2% vs 39.9%, P < 0.05). Two patients who were exposed to an UCA had acute renal function failure.In conclusion, UCA may increase the incidences of some common HIFU-related adverse effects during HIFU treatment for benign uterine diseases, but most of which were acceptable and self-limited. After HIFU treatment, renal function should be monitored in patients with a history of hypertension or taking nonsteroidal anti-inflammatory drugs. PMID:25906100

  2. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent

    International Nuclear Information System (INIS)

    Objective: We performed contrast-enhanced three-dimensional sonography (CE 3D US) with a perflubutane-based contrast agent to immediately evaluate the completeness of ablation of small hepatocellular carcinoma (HCC) lesions by extracorporeal high-intensity focused ultrasound (HIFU). Subjects and methods: Twenty-one HCC lesions were treated by a single ultrasound-guided HIFU ablation session, and CE 3D US was performed before, immediately after, and 1 week, and 1 month after HIFU, and contrast-enhanced CT (CE CT) or contrast-enhanced MRI (CE MRI) was performed before HIFU, 1 week and 1 month after HIFU, and during the follow-up period. Results: Immediately and 1 month after HIFU, 17 lesions were evaluated as adequately ablated by CE 3D US, and the other 4 lesions as residual tumors. One month after HIFU, 18 were evaluated as adequately ablated by CE CT or CE MRI, and the other 3 as residual tumors. The evaluation by CE 3D US immediately after HIFU and by CE CT or CE MRI 1 month after HIFU was concordant with 20 lesions. The kappa value for agreement between the findings of CE 3D US and other modalities by two blinded observers was 0.83. When the 1-month CE CT or CE MRI findings were used as the reference standard, the sensitivity, specificity, and accuracy of CE 3D US immediately after HIFU for the diagnosis of the adequate ablation were 100%, 75%, and 95%, respectively. Conclusion: CE 3D US appears to be a useful method for immediate evaluation of therapeutic efficacy of HIFU ablation of HCC lesions.

  3. Feasibility Study on MR-Guided High-Intensity Focused Ultrasound Ablation of Sciatic Nerve in a Swine Model: Preliminary Results

    International Nuclear Information System (INIS)

    IntroductionSpastic patients often seek neurolysis, the permanent destruction of the sciatic nerve, for better pain management. MRI-guided high-intensity focused ultrasound (MRgHIFU) may serve as a noninvasive alternative to the prevailing, more intrusive techniques. This in vivo acute study is aimed at performing sciatic nerve neurolysis using a clinical MRgHIFU system.MethodsThe HIFU ablation of sciatic nerves was performed in swine (n = 5) using a HIFU system integrated with a 3 T MRI scanner. Acute lesions were confirmed using T1-weighted contrast-enhanced (CE) MRI and histopathology using hematoxylin and eosin staining. The animals were euthanized immediately following post-ablation imaging.ResultsReddening and mild thickening of the nerve and pallor of the adjacent muscle were seen in all animals. The HIFU-treated sections of the nerves displayed nuclear pyknosis of Schwann cells, vascular hyperemia, perineural edema, hyalinization of the collagenous stroma of the nerve, myelin sheet swelling, and loss of axons. Ablations were visible on CE MRI. Non-perfused volume of the lesions (5.8–64.6 cc) linearly correlated with estimated lethal thermal dose volume (4.7–34.2 cc). Skin burn adjacent to the largest ablated zone was observed in the first animal. Bilateral treatment time ranged from 55 to 138 min, and preparation time required 2 h on average.ConclusionThe acute pilot study in swine demonstrated the feasibility of a noninvasive neurolysis of the sciatic nerve using a clinical MRgHIFU system. Results revealed that acute HIFU nerve lesions were detectable on CE MRI, gross pathology, and histology

  4. Portable high-intensity focused ultrasound system with 3D electronic steering, real-time cavitation monitoring, and 3D image reconstruction algorithms: a preclinical study in pigs

    Energy Technology Data Exchange (ETDEWEB)

    Choi, Jin Woo; Lee, Jae Young; Hwang, Eui Jin; Hwang, In Pyeong; Woo, Sung Min; Lee, Chang Joo; Park, Eun Joo; Choi, Byung Ihn [Dept. of Radiology and Institute of Radiation Medicine, Seoul National University Hospital, Seoul (Korea, Republic of)

    2014-10-15

    The aim of this study was to evaluate the safety and accuracy of a new portable ultrasonography-guided high-intensity focused ultrasound (USg-HIFU) system with a 3-dimensional (3D) electronic steering transducer, a simultaneous ablation and imaging module, real-time cavitation monitoring, and 3D image reconstruction algorithms. To address the accuracy of the transducer, hydrophones in a water chamber were used to assess the generation of sonic fields. An animal study was also performed in five pigs by ablating in vivo thighs by single-point sonication (n=10) or volume sonication (n=10) and ex vivo kidneys by single-point sonication (n=10). Histological and statistical analyses were performed. In the hydrophone study, peak voltages were detected within 1.0 mm from the targets on the y- and z-axes and within 2.0-mm intervals along the x-axis (z-axis, direction of ultrasound propagation; y- and x-axes, perpendicular to the direction of ultrasound propagation). Twenty-nine of 30 HIFU sessions successfully created ablations at the target. The in vivo porcine thigh study showed only a small discrepancy (width, 0.5-1.1 mm; length, 3.0 mm) between the planning ultrasonograms and the pathological specimens. Inordinate thermal damage was not observed in the adjacent tissues or sonic pathways in the in vivo thigh and ex vivo kidney studies. Our study suggests that this new USg-HIFU system may be a safe and accurate technique for ablating soft tissues and encapsulated organs.

  5. Feasibility Study on MR-Guided High-Intensity Focused Ultrasound Ablation of Sciatic Nerve in a Swine Model: Preliminary Results

    Energy Technology Data Exchange (ETDEWEB)

    Kaye, Elena A., E-mail: kayee@mskcc.org [Memorial Sloan Kettering Cancer Center, Department of Medical Physics (United States); Gutta, Narendra Babu, E-mail: gnbabu.aiims@gmail.com [Memorial Sloan Kettering Cancer Center, Department of Radiology (United States); Monette, Sebastien, E-mail: monettes@mskcc.org [The Rockefeller University, Tri-Institutional Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College (United States); Gulati, Amitabh, E-mail: gulatia@mskcc.org; Loh, Jeffrey, E-mail: jeffreyloh@gmail.com [Memorial Sloan Kettering Cancer Center, Department of Anesthesiology-Critical Care (United States); Srimathveeravalli, Govindarajan, E-mail: srimaths@mskcc.org [Memorial Sloan Kettering Cancer Center, Department of Radiology (United States); Ezell, Paula C., E-mail: paula.ezell@intusurg.com [The Rockefeller University, Tri-Institutional Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College (United States); Erinjeri, Joseph P., E-mail: erinjerj@mskcc.org; Solomon, Stephen B., E-mail: solomons@mskcc.org; Maybody, Majid, E-mail: maybodym@mskcc.org [Memorial Sloan Kettering Cancer Center, Department of Radiology (United States)

    2015-08-15

    IntroductionSpastic patients often seek neurolysis, the permanent destruction of the sciatic nerve, for better pain management. MRI-guided high-intensity focused ultrasound (MRgHIFU) may serve as a noninvasive alternative to the prevailing, more intrusive techniques. This in vivo acute study is aimed at performing sciatic nerve neurolysis using a clinical MRgHIFU system.MethodsThe HIFU ablation of sciatic nerves was performed in swine (n = 5) using a HIFU system integrated with a 3 T MRI scanner. Acute lesions were confirmed using T1-weighted contrast-enhanced (CE) MRI and histopathology using hematoxylin and eosin staining. The animals were euthanized immediately following post-ablation imaging.ResultsReddening and mild thickening of the nerve and pallor of the adjacent muscle were seen in all animals. The HIFU-treated sections of the nerves displayed nuclear pyknosis of Schwann cells, vascular hyperemia, perineural edema, hyalinization of the collagenous stroma of the nerve, myelin sheet swelling, and loss of axons. Ablations were visible on CE MRI. Non-perfused volume of the lesions (5.8–64.6 cc) linearly correlated with estimated lethal thermal dose volume (4.7–34.2 cc). Skin burn adjacent to the largest ablated zone was observed in the first animal. Bilateral treatment time ranged from 55 to 138 min, and preparation time required 2 h on average.ConclusionThe acute pilot study in swine demonstrated the feasibility of a noninvasive neurolysis of the sciatic nerve using a clinical MRgHIFU system. Results revealed that acute HIFU nerve lesions were detectable on CE MRI, gross pathology, and histology.

  6. Clinical utility of a microbubble-enhancing contrast (“SonoVue”) in treatment of uterine fibroids with high intensity focused ultrasound: A retrospective study

    International Nuclear Information System (INIS)

    Purpose: To evaluate the clinical value of the contrast agent SonoVue in the treatment of uterine fibroids with ultrasound-guided high intensity focused ultrasound (HIFU) therapeutic ablation. Materials and Methods: A total of 291 patients with solitary uterine fibroid from three centers were treated with ultrasound-guided HIFU. Among them, 129 patients from Suining Central Hospital of Sichuan were treated without using SonoVue. 162 patients from the First Hospital of Chongqing Medical University and Chongqing Haifu Hospital were treated with using SonoVue before, during and after HIFU procedure to assess the extent of HIFU. Results: The non-perfused volume (indicative of successful ablation) was observed in all treated uterine fibroids immediately after HIFU ablation; median fractional ablation, defined as non-perfused volume divided by the fibroid volume immediately after HIFU treatment, was 86.0% (range, 28.8–100.0%) in the group with using SonoVue, and 83.0% (8.7–100.0%) without SonoVue. The rate of massive gray scale changes was higher with SonoVue than without the agent. The sonication time to achieve massive gray scale changes was shorter with SonoVue than without. The sonication time for ablating 1 cm3 of fibroid volume was significantly shorter with using SonoVue than without. No major complications were observed in any patients. Conclusions: Based on our results, SonoVue may enhance the outcome of HIFU ablation and can be used to assess the extent of treatment.

  7. High-Intensity Focused Ultrasound for the Treatment of Localized and Locally Advanced Hormone-Resistant Prostate Cancer: 2,5 Year Outcome

    Science.gov (United States)

    Solovov, V. A.; Dvoynikov, S. Y.; Vozdvizhenskiy, M. O.

    2011-09-01

    Introduction & Objectives: High-Intensity Focused Ultrasound (HIFU) has been shown to be a successful treatment for localised prostate cancer (PC). Here we have explored the effectiveness of the HIFU treatment for hormone-resistant prostate cancer (HRPC). Materials & Methods: 341 patients were treated in our center between September 2007 and December 2009; all of them showed treatment failure following hormone ablation. The median time before hormone-resistance was 20 (3-48) months. In the group with localised PC: number of patients 237, Gleason score ≤7, stage T1-2N0M0, age 69 (60-89) years, mean PSA before treatment 40,0 (5,8-92,9) ng/ml, mean prostate volume—39,3 (28-92) cc; in the group with locally advanced PC: number of patients 104, Gleason score ≤9, stage T2-3N0M0, age 72 (52-83) years, PSA before treatment 30,3 (20,1-60) ng/ml, mean prostate volume—41,2 (25-198) cc. HIFU was delivered under spinal anesthesia using the Ablatherm HIFU device (EDAP, France). Pre HIFU transurethral resection of the prostate (TURP) was performed for all patients. Mean follow-up time 18 months (3-30). Results: The median PSA level 12 months after HIFU treatment was 0,04 (0-2,24) ng/ml—localised PC, and for locally advanced disease—0,05 (0-48,4) ng/ml, at 18 months after HIFU treatment this was 0,2 (0,02-2,0) ng/ml for localised PC, and for locally advanced disease 0,18 (0,04-7,45) ng/ml. Patients with localised PC has 4,5% recurrence, those with locally advanced PC 20%. Kaplan-Meir analyses of the total group indicated that the risk of recurrence after 1 year follow-up was 10%, the risk of recurrence was 19% after 2 years of follow-up. Conclusions: Our initial experience shows that ultrasound ablation is safe, minimally invasive and effective as a treatment for localised and locally advanced hormone-resistant prostate cancer.

  8. Spatial-temporal three-dimensional ultrasound plane-by-plane active cavitation mapping for high-intensity focused ultrasound in free field and pulsatile flow.

    Science.gov (United States)

    Ding, Ting; Hu, Hong; Bai, Chen; Guo, Shifang; Yang, Miao; Wang, Supin; Wan, Mingxi

    2016-07-01

    Cavitation plays important roles in almost all high-intensity focused ultrasound (HIFU) applications. However, current two-dimensional (2D) cavitation mapping could only provide cavitation activity in one plane. This study proposed a three-dimensional (3D) ultrasound plane-by-plane active cavitation mapping (3D-UPACM) for HIFU in free field and pulsatile flow. The acquisition of channel-domain raw radio-frequency (RF) data in 3D space was performed by sequential plane-by-plane 2D ultrafast active cavitation mapping. Between two adjacent unit locations, there was a waiting time to make cavitation nuclei distribution of the liquid back to the original state. The 3D cavitation map equivalent to the one detected at one time and over the entire volume could be reconstructed by Marching Cube algorithm. Minimum variance (MV) adaptive beamforming was combined with coherence factor (CF) weighting (MVCF) or compressive sensing (CS) method (MVCS) to process the raw RF data for improved beamforming or more rapid data processing. The feasibility of 3D-UPACM was demonstrated in tap-water and a phantom vessel with pulsatile flow. The time interval between temporal evolutions of cavitation bubble cloud could be several microseconds. MVCF beamformer had a signal-to-noise ratio (SNR) at 14.17dB higher, lateral and axial resolution at 2.88times and 1.88times, respectively, which were compared with those of B-mode active cavitation mapping. MVCS beamformer had only 14.94% time penalty of that of MVCF beamformer. This 3D-UPACM technique employs the linear array of a current ultrasound diagnosis system rather than a 2D array transducer to decrease the cost of the instrument. Moreover, although the application is limited by the requirement for a gassy fluid medium or a constant supply of new cavitation nuclei that allows replenishment of nuclei between HIFU exposures, this technique may exhibit a useful tool in 3D cavitation mapping for HIFU with high speed, precision and resolution

  9. Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis: A Retrospective Study.

    Science.gov (United States)

    Liu, Xin; Wang, Wei; Wang, Yang; Wang, Yuexiang; Li, Qiuyang; Tang, Jie

    2016-01-01

    The long-term outcomes of ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation treatment for adenomyosis and the relevant factors affecting the durability of symptom relief were assessed in this study.A total of 230 women with adenomyosis who were treated with USgHIFU ablation between January 2007 and December 2013 were retrospectively analyzed. The contrast-enhanced ultrasonography (CEUS) was performed immediately after the treatment to evaluate the ablation effect, and the nonperfused volume (NPV) ratio was then calculated. Regular follow-up was conducted and the visual analog scale (VAS) score was used to assess the changes in dysmenorrhea. The effect of treatment was evaluated after an average follow-up length of 3 months and the factors affecting clinical success and symptom relapse were identified.Of the 230 treated patients, 208 (90.4%) were followed up regularly, with a median follow-up length of 40 months (range, 18-94 months). Mean value of the NPV ratio calculated immediately after the treatment was 57.4 ± 24.4%. Varying degrees of symptomatic relief of dysmenorrhea based on the VAS scores were observed in 173 (83.2%) patients and 71.0% of the patients were asymptomatic during follow-up. Women with higher NPV ratio (OR = 0.964, 95% CI = 0.947-0.982, P = 0.000) and older age (OR = 0.342, 95% CI = 0.143-0.819, P = 0.016) were more likely to achieve clinical success. Dysmenorrhea recurred in 45 (26%) out of 173 cases; the median recurrence time was 12 months after treatment. The lower BMI (OR = 1.221, 95% CI = 1.079-1.381, P = 0.001) and the higher acoustic power (OR = 0.992, 95% CI = 0.986-0.998, P = 0.007) were associated with less risk of relapse. Twelve of the 14 patients who were retreated by USgHIFU ablation after experiencing dysmenorrhea recurrence achieved clinical success.USgHIFU ablation is an effective uterus-conserving treatment for symptomatic adenomyosis with an acceptable

  10. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: Long-term follow-up and clinical analysis

    International Nuclear Information System (INIS)

    Objective: High-intensity focused ultrasound (HIFU) combined with transarterial chemoembolization (TACE) has been used to treat unresectable HCC, but its long-term effects and major prognostic factors remain to be determined. The purpose of this study was to assess its long-term effects and find major prognostic factors to help us select eligible patients in the future. Methods: 73 patients with unresectable HCC received follow-up after HIFU + TACE. The variables of sex, age, AFP level, liver function, tumor location, tumor number, tumor size, TNM staging (5th edition), TNM staging (6th edition), portal vein invasion, ultrasonic pathway of HIFU, TACE session and ablation response were evaluated by univariate analysis. Those variables with significant difference were assessed by multivariate analysis. Results: The mean follow-up time was 11.7 ± 11.1 months (range, 1–60 months). The median survival time and overall survival rates of 1, 2, 3-year were 12 months, 49.1%, 18.8%, 8.4%, respectively. 45.2% patients achieved complete ablation. At the end of follow-up, 51 patients (69.9%) died from tumor progression (27 patients), liver function failure (18 patients), hemorrhage of upper digestive tract (3 patients) and infection (3 patients). 1 with liver abscess, 2 with serious skin burns and 2 with rib fracture were observed after HIFU. On univariate analysis, age (P = 0.017), tumor size (P = 0.000), tumor number (P = 0.039), the 5th edition of TNM staging (P = 0.023), portal vein invasion (P = 0.02) and ablation response (P = 0.000) had significant difference. On multivariate analysis, ablation response (P = 0.001) and tumor size (P = 0.013) were major prognostic factors. Conclusion: HIFU combined with TACE is a safe method with a low rate of severe complications. As major prognostic factors, ablation response and tumor size may help us predict the survival and select eligible patients clinically.

  11. High intensity hadron accelerators

    International Nuclear Information System (INIS)

    This rapporteur report consists mainly of two parts. Part I is an abridged review of the status of all High Intensity Hadron Accelerator projects in the world in semi-tabulated form for quick reference and comparison. Part II is a brief discussion of the salient features of the different technologies involved. The discussion is based mainly on my personal experiences and opinions, tempered, I hope, by the discussions I participated in in the various parallel sessions of the workshop. In addition, appended at the end is my evaluation and expression of the merits of high intensity hadron accelerators as research facilities for nuclear and particle physics

  12. High-intensity accelerators

    International Nuclear Information System (INIS)

    The design of high-intensity accelerators is described, using examples of machines being built at the Los Alamos National Laboratory. The major design problem with these accelerators is associated with control of beam loss when accelerator intensity is increased. Beam dynamics, beam loss, and the radio-frequency quadrupole structure are discussed in the first part of the chapter followed by an explanation of plans to achieve high-intensity operation in three projects: the Fusion Material Irradiation Tests (a joint effort with the Hanford Development Laboratory in Richland, Washington), the Proton Storage Ring (an addition to the LAMPF accelerator), and the Racetrack Microtron Project

  13. Opto-acoustic diagnostics of the thermal action of high-intensity focused ultrasound on biological tissues: the possibility of its applications and model experiments

    International Nuclear Information System (INIS)

    The possibility of using the opto-acoustic (OA) method for monitoring high-intensity ultrasonic therapy is studied. The optical properties of raw and boiled liver samples used as the undamaged model tissue and tissue destroyed by ultrasound, respectively, are measured. Experiments are performed with samples consisting of several alternating layers of raw and boiled liver of different thickness. The position and transverse size of the thermal lesion were determined from the temporal shape of the OA signals. The results of measurements are compared with the real size and position of the thermal lesion determined from the subsequent cuts of the sample. It is shown that the OA method permits the diagnostics of variations in biological tissues upon ultrasonic therapy. (special issue devoted to multiple radiation scattering in random media)

  14. Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer

    OpenAIRE

    Inamoto, Teruo; KOMURA, KAZUMASA; WATSUJI, TOSHIKAZU; Azuma, Haruhito

    2011-01-01

    Objectives: To determine the incidence and magnitude of the rapid increase in the serum PSA (riPSA) level after high-intensity focused ultrasound (HIFU) therapy for prostate cancer, and its correlation with clinical factors. Methods: A total of 176 patients with localized prostate cancer underwent HIFU therapy. Serum riPSA was determined on the basis of the same criteria as those for “PSA bounce”, ie, an increase of ≥0.2 ng/ml with a spontaneous return to the prebounce level or lower. Patient...

  15. Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up

    OpenAIRE

    Horiuchi, Akira; Muto, Satoru; Horie, Shigeo

    2016-01-01

    Background To evaluate the efficacy of holmium laser enucleation of the prostate (HoLEP) followed by high-intensity focused ultrasound (HIFU) for patients with huge prostate adenoma and localized prostate cancer (CaP) and compare the morbidity and efficacy results with those observed in a similar population treated only with HIFU for a follow-up period of up to 5 years. Methods The present retrospective study included 30 CaP patients who underwent HIFU alone and 10 patients who underwent HoLE...

  16. An Evaluation of Hemi-Ablation Therapy Using High-Intensity Focused Ultrasound in the Treatment of Localized Adenocarcinoma of the Prostate

    Science.gov (United States)

    Ahmed, Hashim Uddin; Freeman, Alex; Allen, Clare; Kirkham, Alex; Illing, Rowland; Emberton, Mark

    2007-05-01

    The current choice for men with localised prostate cancer lies between active surveillance and radical therapy. The best evidence for the difference between these two extremes of care is 5% in terms of cancer-related absolute mortality at 8 years. It is generally accepted that this small difference will decrease for men diagnosed in the PSA-era. Therein lays a dilemma for men. If they choose active surveillance they accept anxiety of living with a cancer diagnosis and risk of under-treatment in the long term. On the other hand, radical therapy carries significant toxicity (incontinence, impotence, rectal problems) because it treats the whole gland and damages surrounding structures in up to half of men. With increasing PSA screening practices men are diagnosed younger with lower risk disease — early stage, lower Gleason grade and lower volume of cancer. Many have unifocal or unilateral disease. We propose a new concept whereby only the tumour focus and a margin of normal tissue is treated. With emerging techniques that can accurately localise tumour in the gland and technology that can treat to within millimetre accuracy, focal therapy of prostate cancer is now possible. By treating focally, the psychological burden of active surveillance is avoided. Equally, it is proposed that toxicity will decrease whilst at the same time retaining effective cancer control.

  17. Ten-year Biochemical Disease-free Survival After High-intensity Focused Ultrasound (HIFU) for Localized Prostate Cancer: Comparison with Four Different Generation Devices

    International Nuclear Information System (INIS)

    HIFU has been recognized as a minimally invasive treatment option for localized prostate cancer. The purpose of the study was to assess with a long-term outcome of HIFU for prostate cancer. From January 1999, a total of 657 patients who had HIFU with at least 2 year follow-up were treated with four different types of Sonablate registered (Focus Surgery, Indianapolis, USA) devices. Thirty-three patients were treated with Sonablate registered 200 (S200) from 1999 to 2001, 406 patients with Sonablate registered 500 (S500) from 2001 to 2005, 200 patients with Sonablate registered 500 version 4 (V4) from 2005-2008 and 19 patients with Sonablate registered 500 TCM (TCM) from 2007. Biochemical disease-free survival rate (bDFS) in all patients was 59% in 8 years. bDFS in 8 years in patients with S200 and S500 groups were 55% and 56%, and bDFS in 4 and 2 years in patients with V4 and TCM group were 72% and 84%, respectively. bDFS in low, intermediate, and high risk groups were 75%, 54%, and 43% in S200/S500 and 93%, 72%, and 58% in V4/TCM group. Negative prostate biopsy rate after HIFU was 97% in S200, 79% in S500, 94% in V4 and 100% in TCM group. HIFU as primary therapy for prostate cancer is indicated in patients with low- and intermediate-risk (T1-T2b N0M0 disease, a Gleason score of ≤7, a PSA level of <20 ng/mL) and a prostate volume of less than 40 mL. The rate of clinical outcome has significantly improved over the years due to technical improvements in the device.

  18. Ten-year Biochemical Disease-free Survival After High-intensity Focused Ultrasound (HIFU) for Localized Prostate Cancer: Comparison with Four Different Generation Devices

    Science.gov (United States)

    Uchida, T.; Nakano, M.; Shoji, S.; Omata, T.; Harano, Y.; Nagata, Y.; Usui, Y.; Terachi, T.

    2010-03-01

    HIFU has been recognized as a minimally invasive treatment option for localized prostate cancer. The purpose of the study was to assess with a long-term outcome of HIFU for prostate cancer. From January 1999, a total of 657 patients who had HIFU with at least 2 year follow-up were treated with four different types of Sonablate® (Focus Surgery, Indianapolis, USA) devices. Thirty-three patients were treated with Sonablate® 200 (S200) from 1999 to 2001, 406 patients with Sonablate® 500 (S500) from 2001 to 2005, 200 patients with Sonablate® 500 version 4 (V4) from 2005-2008 and 19 patients with Sonablate® 500 TCM (TCM) from 2007. Biochemical disease-free survival rate (bDFS) in all patients was 59% in 8 years. bDFS in 8 years in patients with S200 and S500 groups were 55% and 56%, and bDFS in 4 and 2 years in patients with V4 and TCM group were 72% and 84%, respectively. bDFS in low, intermediate, and high risk groups were 75%, 54%, and 43% in S200/S500 and 93%, 72%, and 58% in V4/TCM group. Negative prostate biopsy rate after HIFU was 97% in S200, 79% in S500, 94% in V4 and 100% in TCM group. HIFU as primary therapy for prostate cancer is indicated in patients with low- and intermediate-risk (T1-T2b N0M0 disease, a Gleason score of ⩽7, a PSA level of prostate volume of less than 40 mL. The rate of clinical outcome has significantly improved over the years due to technical improvements in the device.

  19. High-intensity, focused ultrasonic fields

    DEFF Research Database (Denmark)

    Jensen, Leif Bjørnø

    1988-01-01

    The use of extracorporeal shock wave lithotripsy (ESWL) for disintegration of body stones has increased considerably during recent years. A worldwide activity in this field is reflected in a growing number of international publications and in the development and manufacturing of several ESWL...... machines marketed by companies in Germany and France, in particular. Two main types of ESWL systems are prevailing, the spark gap-based and the piezoelectric disk-based systems. This paper is introduced by a brief reconsideration of the features of pressure waves in water produced by an electrical...... discharge across a spark gap emphasizing the parameters of significance to pressure wave amplitude and time course. Moreover, a comparison is presented of results obtained using various theoretical models—including the KZK equation—for the calculation of pressure waveform parameters, spatial pressure...

  20. 高强度聚焦超声治疗子宫腺肌瘤疗效分析%Clinical study onuterine leiomymata treated by high intensity focused ultrasound

    Institute of Scientific and Technical Information of China (English)

    玛依努尔; 孙海燕; 李丽; 黄淑华; 王伟; 陈红香

    2008-01-01

    Objective To evaluate the clinical effect and safety of high intensity focused ultrasotmd(HIFU) for treating the uterine leiomyomata. Methods The patients with uterine leiomyornata who had born children were chosen as the eandidates, The high intensity focused ultrasound tumor therapeutic system was applied to focus the extraeorporeal ultrasound inside the uterine lieomyomata. The real-time two-dimensional ultrasonography was used to guide the location of the focal field and monitor the ablating procedure. The uterus ultrasonography, myomx related signs,syrnptoms were performed for follow-up before and after HIFU treatment. Results Among 65 eases who accepted the HIFU ablation,95% of them showed short-term or long-term effect. 5 % of them showed no effect. Conclusion HIFU is a safe and effective method for the treatment of uterine leiomyomata.%目的 探讨高强度聚焦超声(HIFU)治疗子宫腺肌瘤的疗效及安全性.方法 选择已生育的育龄期妇女为治疗对象,在B超定位并实时监视卞,采用HIFU治疗子宫腺肌瘤65例.定期随访观察患者临床症状、体征、瘤体内超声影像学变化及不良反应.结果 65例患者有效率为95%.结论 HIFU治疗子宫腺肌瘤安全有效,可作为一种无创伤治疗子宫腺肌瘤新方法.

  1. Treating Principle of High-intensity Focus Ultrasound Knife and Nursing Point in Use%高强度超声聚焦刀治疗原理和护理要点

    Institute of Scientific and Technical Information of China (English)

    吉铁凤

    2008-01-01

    高强度聚焦超声(high-intensity focused ultrasound,HI—FU)又称为聚焦超声刀,是一种非侵入性局部治疗实体肿瘤的新技术,为我国率先研制成功并投入临床应用,为临床实体瘤介入治疗开辟了一条新的途径。随着临床应用的逐渐广泛,对护理的要求也不断提高,我们回顾现有的研究结果,总结如下。

  2. 磁共振导航高强度聚焦超声的临床应用及进展%Clinical application and progresses of MR-guided high intensity focused ultrasound

    Institute of Scientific and Technical Information of China (English)

    许永华

    2011-01-01

    磁共振导航高强度聚焦超声(MRgHIFU)是基于磁共振导航下解剖定位、实时测温和高强度聚焦超声组合的无创治疗方法,相对于外科手术更具优势.该技术已在临床应用于子宫肌瘤、子宫腺肌症、乳腺肿瘤、疼痛性骨转移、前列腺癌、肝肿瘤、脑肿瘤的消融治疗,而在功能性神经外科治疗和急性脑血管意外治疗领域中的临床前研究也在进行之中.本文对MRgHIFU的治疗原理、临床应用现状及进展进行综述.%Based on the combination of anatomical location by MR guidance, real-time temperature mapping and high intensity focused ultrasound, non-invasive MR-guided high intensity focused ultrasound (MRgHIFU) has shown comparative advantages that superior to surgery in the treatment of some tumor and non-tumor diseases, such as ablating uterine fibroids, adenomyosis, breast tumors, bone metastasis, prostate cancer, hepatic carcinoma and cerebral tumor in clinical practice. Meanwhile, preclinical studies for functional neurosurgery and acute stroke treatment are in progress. The therapeutic principles, clinical applications and progresses of MRgHIFU were reviewed in this article.

  3. Enhancement of Blood–Brain Barrier Permeability and Delivery of Antisense Oligonucleotides or Plasmid DNA to the Brain by the Combination of Bubble Liposomes and High-Intensity Focused Ultrasound

    Directory of Open Access Journals (Sweden)

    Yoichi Negishi

    2015-09-01

    Full Text Available The blood–brain barrier (BBB is a major obstacle that prevents therapeutic drugs or genes from being delivered to the central nervous system. Therefore, it is important to develop methods to enhance the permeability of the BBB. We have developed echo-contrast gas (C3F8 entrapping liposomes (Bubble liposomes, BLs that can work as a gene delivery tool in combination with ultrasound (US exposure. Here, we studied whether the permeability of the BBB can be enhanced by the combination of BLs and high-intensity focused ultrasound (HIFU. Mice were intravenously injected with Evans blue (EB. BLs were subsequently injected, and the right hemispheres were exposed to HIFU. As a result, the accumulation of EB in the HIFU-exposed brain hemispheres was increased over that observed in the non-HIFU-exposed hemispheres, depending on the intensity and the duration of the HIFU. Similarly, the combination of BLs and HIFU allowed fluorescent-labeled antisense oligonucleotides to be delivered into the HIFU-exposed left hemispheres of the treated mice. Furthermore, a firefly luciferase-expressing plasmid DNA was delivered to the brain by the combination method of BLs and HIFU, which resulted in the increased gene expression in the brain at the focused-US exposure site. These results suggest that the method of combining BLs and HIFU together serves as a useful means for accelerating the permeability of BBB and thereby enabling antisense oligonucleotides or genes to be delivered to the focused brain site.

  4. HIFU测温中的多通道相位合成技术研究%Research on Combining Phase Image from Multi-channel RF Coils in High-Intensity Focused Ultrasound

    Institute of Scientific and Technical Information of China (English)

    陈相教; 孙健永; 张建国

    2015-01-01

    近年来,肿瘤热疗研究主要集中在使用高强度聚焦超声(High Intensity Focused Ultrasound,HIFU)来完成高温消融。治疗过程中利用磁共振测温技术进行无创测温。基于质子共振频率化学位移方法[1](Proton Resonance Frequency,PRF)是磁共振测温普遍使用的方法。为保证实时和精确的要求,需要进行多通道相位合成。通过对多通道的相位差进行加权平均线性组合,有效提高了测温精度。%Recent years, tumor hyperthermia studies focused on the use of HIFU to complete the high temperature ablation. During hyperthermia,noninvasive temperature measurement is realized by using magnetic resonance temperature measurement technology. PRF is a commonly used method in magnetic resonance temperature measurement. In order to guarantee the real-time and precision requirements, we need to combine phase images from multi-channel coils. In this paper, we use weighted average linear combination to deal with phase difference of multi channel, effectively improving the accuracy of temperature.

  5. Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model

    Science.gov (United States)

    Huisman, Merel; Staruch, Robert M.; Ladouceur-Wodzak, Michelle; van den Bosch, Maurice A.; Burns, Dennis K.; Chhabra, Avneesh; Chopra, Rajiv

    2015-01-01

    Purpose Ultrasound (US)-guided high intensity focused ultrasound (HIFU) has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic resonance (MR)-imaging guidance may overcome these limitations and MR-guided HIFU (MR-HIFU) has been used successfully for other clinical indications. The primary purpose of this study was to evaluate the feasibility of utilizing 3D MR neurography to identify and guide ablation of peripheral nerves using a clinical MR-HIFU system. Methods Volumetric MR-HIFU was used to induce lesions in the peripheral nerves of the lower limbs in three pigs. Diffusion-prep MR neurography and T1-weighted images were utilized to identify the target, plan treatment and immediate post-treatment evaluation. For each treatment, one 8 or 12 mm diameter treatment cell was used (sonication duration 20 s and 36 s, power 160–300 W). Peripheral nerves were extracted HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired, and may also have potential for post-treatment verification of thermal lesions without contrast injection. PMID:26659073

  6. 高强度聚焦超声在前列腺癌治疗中的应用%High Intensity Focused Ultrasound for the Treatment of Prostate Cancer

    Institute of Scientific and Technical Information of China (English)

    童亮; 吕军

    2011-01-01

    Some early researches suggest that high intensity focused ultrasound ( HIFU ) is effective on selected patients with prostate cancers. Two devices are currently used for the treatment of prostate cancer with HIFU: Sonablate ( USA ) and Ab-latherm ( France ) . The outcomes [ ie, biochemical free survival rate ( BFSR ), prostate special antigen ( PSA ) and negative postoperative prostate biopsies ] achieved for primary - care prostate cancer patients are very satisfactory. Moreover, HIFU is a potential treatment for local recurrence after radiation failure.%一些早期的研究报道显示,对于选择性的前列腺癌患者,高强度聚焦超声(HIFU)是一种有效的治疗方法.目前有两种设备用于前列腺癌的HIFU治疗,即美国生产的Sonablate设备和法国生产的Ablatherm设备.一些研究初步发现HIFU对前列腺癌患者的治疗结果(如生化无病生存率、前列腺特异性抗原、术后前列腺穿刺活检阴性)良好.另外,对于前列腺癌放射治疗后局部复发的患者,HIFU是潜在的治疗方式.本文就HIFU在前列腺癌治疗中的应用进展进行综述.

  7. 高强度聚焦超声治疗特殊前列腺癌的现状及进展%Current status and progress of high intensity focused ultrasound for special prostate cancer

    Institute of Scientific and Technical Information of China (English)

    李欣; 周崑

    2014-01-01

    前列腺癌现烧成为危害男性健康的常见泌尿系统肿瘤之一,我国前列腺癌的发病率不断上升.前列腺癌的治疗肉成为目前的热门话题.高强度聚焦超声(high intensity focused ultrasound, HIFU)是一种将超声聚焦形成高能量的焦域从而杀灭靶组织新技术.HIFU在一些报道中已单独用来治疗早期局限性前列腺癌,疗效确切.同时,HIFU对于几种特殊的前列腺癌,如激素非依赖性前列腺癌、放疗后复发前列腺癌以及HIFU治疗后复发的前列腺癌也起到了一定的作用.

  8. Feasibility of real-time treatment feedback using novel filter for eliminating therapeutic ultrasound noise with high-speed ultrasonic imaging in ultrasound-guided high-intensity focused ultrasound treatment

    Science.gov (United States)

    Takagi, Ryo; Jimbo, Hayato; Iwasaki, Ryosuke; Tomiyasu, Kentaro; Yoshizawa, Shin; Umemura, Shin-ichiro

    2016-07-01

    In the conventional ultrasonic monitoring of high-intensity focused ultrasound (HIFU) treatment, a significant interval between HIFU shots is required when monitoring target tissue to avoid interference between HIFU noise and RF echo signals. In our previous study, a new filtering method to eliminate only HIFU noise while maintaining tissue signals intact was proposed, and it was shown that the thermal coagulation could be detected during simultaneous HIFU irradiation through off-line processing. In this study, the filtering method and a real-time coagulation detection algorithm were implemented in an ultrasound imaging system, whose use for sequential exposure with multiple foci was demonstrated similarly to a commercial HIFU ablation system. The coagulation was automatically detected by the proposed method during real-time simultaneous HIFU irradiation, and the HIFU exposure time was controlled according to the changes in the tissue. The results imply that ultrasonic monitoring with the filtering and detection methods is useful for true real-time detection of changes in the tissue due to thermal coagulation during HIFU exposure.

  9. Can sample treatments based on advanced oxidation processes assisted by high-intensity focused ultrasound be used for toxic arsenic determination in human urine by flow-injection hydride-generation atomic absorption spectrometry?

    Science.gov (United States)

    Correia, A; Galesio, M; Santos, H; Rial-Otero, R; Lodeiro, C; Oehmen, A; Conceição, Antonio C L; Capelo, J L

    2007-05-15

    Two advanced oxidation processes (AOPs), based on high-intensity focused ultrasound (HIFU), namely, KMnO(4)/HCl/HIFU and H(2)O(2)/HCl/HIFU are studied and compared for the determination of toxic arsenic in human urine [As(III)+As(V)+MMA+DMA] by flow-injection hydride-generation atomic absorption spectrometry (FI-HG-AAS). The KMnO(4)/HCl/HIFU procedure was found to be adequate for organic matter degradation in human urine. l-cysteine (letra minuscula) was used for As reduction to the trivalent state. The new procedure was assessed with seven urines certified in different As species. Results revealed that with KMnO(4)/HCl/HIFU plus l-cysteine the toxic arsenic can be accurately measured in human urine whilst the H(2)O(2)/HCl/HIFU procedure underestimates toxic As. DMA and MMA degradation in urine were observed, due to the effects of the ultrasonic field. Recoveries for As(III), As(V), MMA and DMA were within the certified ranges. Arsenobetaine was not degraded by the AOPs. The new procedure adheres well to the principles of analytical minimalism: (i) low reagent consumption, (ii) low reagent concentration, (iii) low waste production and (iv) low amount of time required for sample preparation and analysis. PMID:19071711

  10. 磁共振引导高强度聚焦超声治疗子宫肌瘤临床研究%Clinical research of treatment of uterine fibroids by MR-guided high intensity focused ;ultrasound

    Institute of Scientific and Technical Information of China (English)

    陈军臣; 许永华; 王智彪; 陈文直

    2014-01-01

    Magnetic resonance guided high intensity focused ultrasound (MRgHIFU) employs MRI’s function such as accurate anatomical guidance and real-time temperature mapping for monitoring HIFU to accumulate ultrasound energy at the focal region, which would result in the temperature elevate in the targeted tissues for ablation without injures of the structures around the focus and at acoustic path. In this paper, the mechanism of MRgHIFU treatment of uterine fibroids, temperature mapping technology, clinical indications and contraindications, therapeutic efficacy and complications, and the advantages and disadvantages were reviewed.%磁共振引导高强度聚焦超声(MRgHIFU)利用 MRI 准确解剖定位引导及实时温度监测功能和高强度聚焦超声波,从体外将超声能量聚集于治疗靶区使其温度瞬间升高,选择性灭活体内某特定区域病灶,而对病灶周围及声通道上的组织结构无损害或损害很少。本文对 MRgHIFU治疗子宫肌瘤的作用机制、温度监控技术、临床治疗适应证和禁忌证、治疗疗效和并发症及其优势和不足进行综述。

  11. A boost for KAON

    International Nuclear Information System (INIS)

    Earlier this year, a report by a specially-formed subcommittee of the US Nuclear Science Advisory Committee gave an important boost to the proposal to build a high intensity particle beam 'factory' at the Canadian TRIUMF laboratory in Vancouver. (orig./HSI).

  12. Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids

    Energy Technology Data Exchange (ETDEWEB)

    Ikink, Marlijne E.; Voogt, Marianne J.; Bosch, Maurice A.A.J. van den; Nijenhuis, Robbert J. [University Medical Center Utrecht, Department of Radiology, Utrecht (Netherlands); Keserci, Bilgin [Samsung Medical Center, High-intensity Focused Ultrasound (HIFU) Center, Seoul (Korea, Republic of); Philips Healthcare, Advanced Science and Development, Seoul (Korea, Republic of); Kim, Young-sun [Samsung Medical Center, High-intensity Focused Ultrasound (HIFU) Center, Seoul (Korea, Republic of); Samsung Medical Center, Sunkyunkwan University, Department of Radiology and Center for Imaging Science, Seoul (Korea, Republic of); Vincken, Koen L.; Bartels, Lambertus W. [University Medical Center Utrecht, Department of Radiology and Image Sciences Institute, Utrecht (Netherlands)

    2014-09-15

    To assess the value of diffusion-weighted magnetic resonance imaging (DWI) and apparent diffusion coefficient (ADC) mapping using different b-value combinations for treatment evaluation after magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) of uterine fibroids. Fifty-six patients with 67 uterine fibroids were treated with volumetric MR-HIFU. Pre-treatment and post-treatment images were obtained using contrast-enhanced T1-weighted MRI (CE-T1WI) and DWI using b = 0, 200, 400, 600, 800 s/mm{sup 2}. ADC maps were generated using subsets of b-values to investigate the effects of tissue ablation on water diffusion and perfusion in fibroids treated with MR-HIFU. Four combinations of b-values were used: (1) all b-values; (2) b = 0, 200 s/mm{sup 2}; (3) b = 400, 600, 800 s/mm{sup 2}; and (4) b = 0, 800 s/mm{sup 2}. Using the lowest b-values (0 and 200 s/mm{sup 2}), the mean ADC value in the ablated tissue reduced significantly (p < 0.001) compared with baseline. Calculating the ADC value with the highest b-values (400, 600, 800 s/mm{sup 2}), the ADC increased significantly (p < 0.001) post-treatment. ADC maps calculated with the lowest b-values resulted in the best visual agreement of non-perfused fibroid tissue detected on CE images. Other b-value combinations and normal myometrium showed no difference in ADC after MR-HIFU treatment. A decrease in contrast agent uptake within the ablated region on CE-T1WI was correlated to a significantly decreased ADC when b = 0 and 200 s/mm{sup 2} were used. (orig.)

  13. Nursing Care in the Treatment of Prostatic Cancer by High Intensive Focused Ultrasound%高强度聚焦超声治疗前列腺癌的护理

    Institute of Scientific and Technical Information of China (English)

    徐瑞英; 李水英; 王杭; 徐叶青; 王国民

    2003-01-01

    目的:探讨高强度聚焦超声(high intensive focused ultrasound,HIFU)治疗前列腺癌的护理要点.方法:前列腺癌患者15例,HIFU治疗时均为坐位,每次治疗时间为50~60min.超声发射强度1000W,持续发射时间150~200ms,间隔150~200ms,发射次数50次.治疗过程中加强对患者的心理安慰,减少其焦虑心理.每次治疗结束仔细观察臀部皮肤有无破溃及烧伤.结果:13例(13/15,88%)完成整个疗程.3例治疗后出现臀周皮肤红肿,1例出现臀周皮肤起泡脱落现象.经口服抗生素,局部应用药物后好转.2例治疗过程中出现治疗部位剧烈疼痛,应用静脉止痛药后好转.15例均获随访,治疗后1月PSA值均降至正常(<4ng/ml).结论:HIFU是治疗前列腺癌的有效方法.治疗过程中,良好的护理是产生良好疗效的重要因素之一.注意患者的心理治疗并避免局部皮肤烧灼或压迫后破溃是HIFU治疗护理工作中的重要环节.

  14. 高强度超声聚能系统治疗激素难治性前列腺癌临床疗效观察%High-intensity focused ultrasound in treatment of hormone-refractory prostate cancer

    Institute of Scientific and Technical Information of China (English)

    赵永斌; 胡卫列; 吕军; 邓志雄; 张利朝; 邱晓拂; 肖远松; 刘俊; 张长征

    2008-01-01

    目的:探讨经直肠高强度聚焦超声(high-intensity focused ultrasound,HIFU)治疗激素难治性前列腺癌的有效性及安全性.方法:采用美国Focus Surgery公司生产的第三代HIFU Sonablate-500型治疗仪,对22例激素难治性前列腺癌患者进行治疗.根据直肠指检和经直肠前列腺B超检查前列腺肿块大小、血清PSA、ECT骨扫描等将疗效分为完全反应(CR)、部分反应(PR)、病情稳定(SD)、病情恶化(PD).主观症状根据骨痛、排尿异常、血尿等症状的变化分为症状消失、症状改善、症状平稳、症状加剧.结果:经HIFU治疗,CR 6例,占27.3%(6/22);PR 11例,占50.0%(11/22);SD 4例,占18.2%(4/22);PD1例,占4.5%(1/22).总有效率(CR+PR)达到77.3%(17/22).主观症状消失9例,占40.9%(9/22);症状改善6例,占27.3%(6/22);症状稳定3例,占13.6%(3/22);症状加剧4例,占18.2%(4/22).主观症状总改善率(症状消失+症状改善)达到68.2%(15/22).3例伴有血尿者均控制良好.术后并发症:3例发生附睾炎,无尿道狭窄、尿失禁、阳痿、尿道直肠瘘并发症发生.结论:HIFU对激素难治性前列腺癌的治疗有效、安全,为微创治疗激素难治性前列腺癌提供了新的途径.

  15. The Advance in the Clinical and Experimental Studies of High-IntensityFocused Ultrasound for Cancer Treatment%超声聚焦治疗肿瘤的临床和实验研究进展

    Institute of Scientific and Technical Information of China (English)

    王修杰; 李幼平

    2001-01-01

    超声聚焦(HIFU)由换能器发射的超声波组成,该高强度聚焦超声波主要通过热效应及其他机理引起组织损伤。用HIFU处理过的肿瘤组织表现为热细胞毒坏死和纤维化,导致肿瘤生长抑制。因此,HIFU是以高新技术为基础,微创治疗肿瘤的手段之一,且无放射毒副作用。目前已有多种肿瘤用HIFU治疗的研究报道,如:前列腺癌、肝癌、肾肿瘤、膀胱癌、乳腺癌和脑肿瘤等,其中一些肿瘤在临床和实验研究中获得了有效控制肿瘤生长的疗效,尤其是前列腺癌。虽然HIFU作为一种治疗肿瘤的微创外科技术由于其卫生经济、病人易接受、死亡率低而引起了人们的极大关注,但其用于治疗人类肿瘤的可行性及其机理有待进一步研究证实。%High-intensity focused ultrasound (HIFU) consists of focused ultrasound waves emitted from a transducer that are potential of inducing tissue damage. By means of this themal effect and other mechanisms, HIFU treated tumor tissues showed direct thermal cytotoxic necrosis and fibrosis, which lead to inhibition of tumor growth. Therefore, HIFU was thought to be a new sophisticated high-technology based, minimally invasive treatment option for some cancers, which allows radiation-free treatment. Until now there are many kinds of tumors, such as tumors of prostate, liver, kidney, bladder, breast and brain, especially the prostate cancers treated with HIFU. Some of which showed effective tumor growth controlled clinically and experimentally. Although HIFU as one of the ~ninimally invasive surgical techniques for cancer treatment is of great interest today, particularly for reasons of health economics, patient acceptability and reduced mortality. The feasibility and mechanisms of HIFU for treatment of human cancers need to be confirmed further.

  16. Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU: Pilot Study in a Swine Model.

    Directory of Open Access Journals (Sweden)

    Merel Huisman

    Full Text Available Ultrasound (US-guided high intensity focused ultrasound (HIFU has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic resonance (MR-imaging guidance may overcome these limitations and MR-guided HIFU (MR-HIFU has been used successfully for other clinical indications. The primary purpose of this study was to evaluate the feasibility of utilizing 3D MR neurography to identify and guide ablation of peripheral nerves using a clinical MR-HIFU system.Volumetric MR-HIFU was used to induce lesions in the peripheral nerves of the lower limbs in three pigs. Diffusion-prep MR neurography and T1-weighted images were utilized to identify the target, plan treatment and immediate post-treatment evaluation. For each treatment, one 8 or 12 mm diameter treatment cell was used (sonication duration 20 s and 36 s, power 160-300 W. Peripheral nerves were extracted < 3 hours after treatment. Ablation dimensions were calculated from thermal maps, post-contrast MRI and macroscopy. Histological analysis included standard H&E staining, Masson's trichrome and toluidine blue staining.All targeted peripheral nerves were identifiable on MR neurography and T1-weighted images and could be accurately ablated with a single exposure of focused ultrasound, with peak temperatures of 60.3 to 85.7°C. The lesion dimensions as measured on MR neurography were similar to the lesion dimensions as measured on CE-T1, thermal dose maps, and macroscopy. Histology indicated major hyperacute peripheral nerve damage, mostly confined to the location targeted for ablation.Our preliminary results indicate that targeted peripheral nerve ablation is feasible with MR-HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired, and may also have potential for post

  17. The rise of high intensity focused ultrasound (HIFU) non-invasive therapy for solid tumors%高强聚焦超声(HIFU)无创治疗肿瘤技术的崛起

    Institute of Scientific and Technical Information of China (English)

    冯若; 朱辉; 李发琪; 苏海兵; 陈迅

    2011-01-01

    20世纪40年代,美国学者首次提出了高强聚焦超声治疗技术的概念,并进行了初步的工程和临床研究.70、80年代间,治疗肿瘤的温热疗法曾盛行一时.90年代之后,高强聚焦超声外科肿瘤治疗技术在国际上重新崛起,我国率先推出了大型高强聚焦超声肿瘤治疗系统,并成功地应用于临床治疗乳腺癌、骨肿瘤、肝癌等多种实体肿瘤.迄今,该"JC型高强聚焦超声肿瘤治疗系统"已出口到英国、意大利、西班牙、日本、韩国等许多欧亚国家,在诸如欧洲肿瘤治疗中心等20多个医疗中心运行,治疗肿瘤患者达数万例.我国持续保持着引领世界超声无创治疗技术发展的领先地位.%In the 40 years of last centry American scientists put forward a concep of high intensity focused ultrasound (HIFU) therapeutic technique and had done some technical and clinical studies. Since 90 years the HIFU surgery technique treating tumors anew rised abruptly in the world. China firstly put out a comprehensive HIFU tumor treating sistem and successfully treated many solid tumors such as breast cancer, bone tumor, liver cancer etc.. Now the treating sistem has already exported to England, Italy,Spain, Japan, Colea etc. and treated tens thousands tumor patients. In the field of noninvasive ultrasound treating tumor technique China has continually kept the leading position in the world.

  18. High Intensity Focused Ultrasound Ablation for Uterine Fibroids in Patients with Retroposition of Uterus%高强度聚焦超声消融治疗子宫后位肌瘤的临床研究

    Institute of Scientific and Technical Information of China (English)

    鄢利梅; 何佳; 黄国华; 何敏; 黎克全; 张炼

    2012-01-01

    Objective To investigate the therapeutic effectiveness and safety of ultrasound-guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids in patients with retroposition of uterus. Methods 45 fibroids in 32 patients with anteposition of uterus and 37 fibroids in 24 patients with retroposition of uterus were treated with USgHIFU. MRI was used to assess treatment response. Adverse effects were recorded. Results MRI showed the average fractional ablation was (88. 7 + 7. 0)% in patients with anteposition of uterus,(84. 8 + 13. 8)% in patients with retroposition of uterus. During HIFU procedure, more patients with retroposition of the uterus complained sacral pain than those with anteposition of the uterus (95. 8% vs 50. 0%). Conclusions USgHIFU is safe and effective in ablating uterine fibroids in patients with retroposition of uterus.%目的 研究实时超声监控的超声消融治疗后位子宫子宫肌瘤的有效性及安全性.方法 前位子宫32例45个肌瘤;后位子宫24例37个肌瘤.治疗前及治疗后第2天行增强MRI检查;分析治疗中、治疗后患者所有副反应.结果 术后增强MRI显示前位、后位子宫组肌瘤平均消融率分别为(88.7±7.0)%和(84.8±13.8)%.后位子宫组骶尾部疼痛发生率明显高于前位子宫组(95.8% vs 50.0%).结论 超声引导的高强度聚焦超声能安全、有效地治疗后位子宫肌瘤.

  19. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation.

    Science.gov (United States)

    Zhao, Wen-Peng; Chen, Jin-Yun; Chen, Wen-Zhi

    2015-02-01

    The aims of this study were to assess the effects of the biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging (MRI), on ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation. Thirty-five patients with 39 symptomatic uterine fibroids who underwent myomectomy or hysterectomy were enrolled. Before surgery, the uterine fibroids were subdivided into hypo-intense, iso-intense, heterogeneous hyper-intense and homogeneous hyper-intense categories based on signal intensity on T2-weighted MRI. Tissue density and moisture content were determined in post-operative samples and normal uterine tissue, the isolated uterine fibroids were subjected to USgHIFU, and the extent of ablation was measured using triphenyltetrazolium chloride. Hematoxylin and eosin staining and sirius red staining were undertaken to investigate the organizational structure of the uterine fibroids. Estrogen and progesterone receptor expression was assayed via immunohistochemical staining. The mean diameter of uterine fibroids was 6.9 ± 2.8 cm. For all uterine fibroids, the average density and moisture content were 10.7 ± 0.7 mg/mL and 75.7 ± 2.4%, respectively; and for the homogeneous hyper-intense fibroids, 10.3 ± 0.5 mg/mL and 76.6 ± 2.3%. The latter subgroup had lower density and higher moisture content compared with the other subgroups. After USgHIFU treatment, the extent of ablation of the hyper-intense fibroids was 102.7 ± 42.1 mm(2), which was significantly less than those of the hypo-intense and heterogeneous hyper-intense fibroids. Hematoxylin and eosin staining and sirius red staining revealed that the homogeneous hyper-intense fibroids had sparse collagen fibers and abundant cells. Immunohistochemistry results revealed that estrogen and progesterone receptors were highly expressed in the homogeneous hyper-intense fibroids. This study revealed that lower density, higher moisture content, sparse collagen

  20. High intensity focused ultrasound treatment guided with MR gradient dual-echo pulse sequence%磁共振梯度双回波序列监控高强度聚焦超声治疗

    Institute of Scientific and Technical Information of China (English)

    周晓东; 贺强; 倪成

    2011-01-01

    Objective To acquire temperature maps and anatomic images during MRI-guided high-intensity focused ultrasound (MRgHIFU) treatment, so as to ensure the accuracy and safety of the treatment.Methods Independent phase encoding gradients were applied for the first echo and the second echo.One echo was encoded for acquiring high spatial resolution anatomic images, while the other was encoded for acquiring fast temperature maps.The temperature maps were overlayed on the anatomic images for monitoring the treatment.Ex-vivo experiments with ox liver as well as water phantom experiments were done for demonstrating the method.Results Ox liver heating experiments demonstrated that the displaying of temperature maps was better than the conventional method with the maximum updating speed of 1 frame/s.The sensitivity to motion was good, which was proved by phantom experiments.Conclusion The proposed MR duel-echo gradient sequence can achieve good results in terms of temperature monitoring and motion detecting during MRgHIFU experiments.%目的 利用MR梯度双回波脉冲序列监控高强度聚焦超声(MRgHIFU)治疗,同时获取温度图和解剖图,提高治疗的准确性和安全性.方法 在第一、第二个回波上分别施加独立的相位编码梯度,一个回波获取高分辨率的解剖图,另一个回波获取快速的温度图.将温度图叠加在解剖图上治疗监控.通过牛肝离体加热和水膜移动实验加以验证.结果 牛肝离体实验表明,在最快1幅/秒温度图时仍然可以很好地测量和显示温度,优于传统的温度图显示方法.水模实验证明此法对检测运动的敏感度较好,有利于监控治疗的准确性和安全性.结论利用MR梯度双回波脉冲序列可以在HIFU实验中更好地监控温度和检测运动.

  1. 经直肠高强度聚焦超声治疗局限性前列腺癌的疗效分析%Transrectal High-Intensity Focused Ultrasound in the Treatment of Localized Prostate Cancer

    Institute of Scientific and Technical Information of China (English)

    童亮; 吕军; 沈文; 王尉; 淡明江; 吴浩明; 胡卫列; 徐文峰

    2012-01-01

    Objective To evaluate the efficacy of transrectal high -intensity focused ultrasound (HIFU) therapy in the treatment of patients with localized prostate cancer. Methods 85 localized prostate cancer patients admitted to our hospital from December 2002 to October 2009 were divided into lower risk group , intermediate risk group and high risk group. Sonablate 500 was used to perform transrectal HIFU local treatment. Prostate special antigen (PSA) and prostate biopsy negative rate were dynamically observed after operation. Results The levels of PSA were significantly decreased three months , six months and twelve months after operation compared with before operation (P <0. 01 ).66 patients (77. 6% ) had PSA nadir≤0. 5 μg/L, and two -year biochemical free survival rate (BFSR) was 57. 8% (48/83). The prostate biopsy negative rate was 72. 9% (62/ 85) and 51. 8% (43/83) respectively six months and twelve months after operation. Conclusion This study shows that HIFU can achieve good efficacy for low risk and intermediate risk localized prostate cancer , especially for low risk group. But for high risk prostate cancer, HIFU monotherapy cannot achieve satisfactory result.%目的 观察经直肠高强度聚焦超声(HIFU)治疗局限性前列腺癌的临床疗效.方法 将我院2002年12月-2009年10月临床诊断为局限性前列腺癌的85例患者分为低危、中危、高危组,使用Sonablate 500型经直肠HIFU系统行HIFU局部治疗,术后动态观察各组血清前列腺特异性抗原(PSA)变化及前列腺穿刺活检阴性率.结果 术后第3个月、第6个月、第12个月的PSA水平较治疗前明显下降(P<0.01).术后有66例(77.6%)患者PSA最低值≤0.5 μg/L,而2年生化无病生存率达到57.8%(48/83).术后第6个月和第12个月前列腺穿刺阴性率分别为72.9%(62/85)和51.8%(43/83).结论 对于低危和中危局限性前列腺癌,经直肠HIFU治疗可获得良好的肿瘤控制效果,特别对于低危组;而对于高危组局

  2. 音乐治疗在高强度聚焦超声消融子宫腺肌症中的应用%Application of music therapy in ablation of uterine adenomyosis with high intensity focused ultrasound

    Institute of Scientific and Technical Information of China (English)

    吴莺; 高悦; 王燕; 金志春; 陈锦云

    2013-01-01

    Objective:To investigate the effects of music therapy on uterine adenomyosis patients accepting high intensity focused ultrasound (HIFU) ablation. Methods:A total of 90 adenomyosis patients accepting HIFU ablation were randomly divided into the music therapy group and the control group. Music therapy group continued to listen to music from 1 hour before the ablation to the the end of the ablation. The control group was according to the conventional methods for HIFU ablation. Two groups were compared by patients’ preoperative anxiety levels, intra-operative blood pressure and heart rate, post-operative pain and analgesic doses. Results:The preoperative anxiety degree, the intra-operative blood pressure and heart rate, the post-operative pain scores and analgesic doses in the music therapy group were significantly better than those in the control group. Conclusion:Music therapy in HIFU ablation can improve stress state of patients. It can stabilize intra-operative physiological indexes of patients, reduce their anxiety degree, reduce post-operative pain and analgesic drug doses as well, and it’s good for the smooth progress of HIFU ablation.%目的:研究音乐治疗在高强度聚焦超声消融子宫腺肌症中的应用效果。方法:将90例高强度聚焦超声(HIFU)消融治疗的子宫腺肌症患者随机分成实验治疗组和对照组进行研究分析。实验治疗组在常规消融治疗前1h至结束时持续听音乐;对照组则按常规方式进行超声消融治疗。观察二组患者治疗前的焦虑程度,治疗中的血压、心率,治疗后的疼痛及镇痛药物使用剂量情况。结果:实验治疗组治疗前的焦虑程度、治疗中的血压、心率、治疗后的疼痛评分、镇痛药物使用剂量均明显优于对照组。结论:应用音乐治疗可明显改善子宫腺肌症患者HIFU治疗过程中的应激状态,稳定治疗中生理指标,减轻焦虑状态及治疗后疼痛和镇痛药物使用剂

  3. Clinical observation of curative effect of high intensity focused ultrasound treatment in liver metastasis of colorectal cancer%高强度聚焦超声治疗结肠癌术后肝转移

    Institute of Scientific and Technical Information of China (English)

    李洪波; 郑东庆; 胡元清; 丁大明; 张桂媛; 党建波

    2010-01-01

    目的 探讨高强度聚焦超声(HIFU)治疗结直肠癌术后肝转移的临床疗效及其安全性.方法 16例大肠癌术后肝转移患者28个病灶行HIFU治疗,观察患者生命体征、主要脏器功能、影像学检查(CT或MRI等)、并发症和肿瘤转归的情况.结果 所有患者治疗后生命体征平稳,肝、肾功能正常,6个月随访发现6个病灶体积缩小超过80%、18个病灶体积缩小30%~50%,4个病灶体积变化不明显;16例患者中1例失访.15例随访6~24个月,其中5例患者因病灶转移播散于术后6月内死亡,中位生存时间为13个月;1例患者皮肤出现条索状灼痕,经治疗1周后愈合.1例患者治疗区的胸腹部皮肤、皮下出现轻度水肿.结论 HIFU治疗结肠癌术后肝转移病灶是一种非侵入性、安全、有效的治疗手段.%Objective To investigate the clinical efficacy and safety of the high-intensity focused ultrasound therapy in patients with colorectal liver metastases. Methods 28colorectal lesions in 16 patients with liver metastases after HIFU treatment lines observed patient vital signs,the main organ,imaging studies (CT or MRI,etc. ) ,complications and prognosis of cancer cases. Results All patients with stable vital signs after treatment, liver, kidney function was normal,6-month follow up, six more than 80% reduced lesion size,lesion size decreased in 18 of 30% to 50% ,4tumor volume did not change significantly; 16 patients, 1 patient was lost. 15 cases were followed uPfor 6 to 24 months,5 patients were transferred because of lesions disseminated in death within 6 months after surgery, calculated with the Kaplan-Meier median survival time was 13 months; 1 patient skin burning streak marks, healed after 1 week after treatment. 1 patient treatment areas of the chest skin, mild subcutaneous edema. Conclusion The treatment of patients with liver metastasis of colon cancer lesions was a non-invasive, safe and effective treatment.

  4. Clinical dosimetry research on high-intensity focused ultrasound ablating adenomyosis%高强度聚焦超声消融子宫腺肌症的临床剂量学研究

    Institute of Scientific and Technical Information of China (English)

    陈敏; 李铁军; 陈强; 彭松

    2013-01-01

    目的 根据MRI评价的高强度聚焦超声(HIFU)消融结果,探索HIFU消融子宫腺肌症的剂量学特征,建立以能效因子(EEF)为基础的剂量学模型,指导临床剂量的投放.方法 对45例临床诊断为子宫腺肌症的患者(45个腺肌病灶)行HIFU治疗,治疗前、后均行平扫和动态增强MRI检查,评价子宫和病灶情况,记录HIFU治疗时间、辐照时间及辐照能量.以EEF为因变量,相关影响因素为自变量进行多重线性回归分析,建立以EEF为基础的剂量学模型.结果 45例患者均顺利完成一次性超声消融治疗;多重线性回归分析提示腺肌病灶腹侧面到皮肤距离、病灶最大径、年龄及MRI上病灶强化程度与EEF存在线性相关关系.结论 以EEF作为消融子宫腺肌症的剂量学指标,病灶腹侧面到皮肤的距离、病灶最大径、年龄及MRI上病灶强化程度可作为预测消融剂量投放的因素.%Objective Based on the Results of High-intensity focused ultrasound (HIFU) ablation evaluated by MRI,to investigate dosimetry model of HIFU ablating adenomyosis and establish dosimetry model based on energy efficiency factor (EEF),in order to guide clinical treatment.Methods 45 patients (45 lesions) with symptomatic adenomyosis were treated by HIFU.The plane scan and dynamic contrast enhanced MRI were performed to evaluate the status of uterus and lesion before and after treatment in all patients.The treatment time,sonication time and sonication energy were recorded.Logistic regression analysis was carried out taking EEF as dependent variable and related factor as independent variable,in order to establish dosimetry model.Results All patients completed single HIFU ablation procedure safely.Logistic regression analysis demonstrated that the distance between abdomen side of adenomyosis and skin,maximum diameter of adenomyosis,age and enhanced degree of adenomyosis on MRI were obviously related to EEF.Conclusion Based on EEF,the distance between

  5. 缩宫素对超声消融治疗子宫腺肌症的量效关系研究%Dose-effect research on the effect of Oxytocin on high intensity focused ultrasound ablation of adenomysis

    Institute of Scientific and Technical Information of China (English)

    张昕; 何佳; 毛世华; 王健; 何敏; 吴庆蓉; 张瑞涛; 张炼

    2013-01-01

    提目的:评价不同缩宫素剂量对超声消融子宫腺肌症的影响以及缩宫素在超声消融治疗过程中使用的安全性。方法:129例确诊的子宫腺肌症患者随机分为对照组、缩宫素0.32U /min组、缩宫素0.48U /min组进行超声消融治疗,比较各组间的消融效果及相关不良反应。结果缩宫素0.32U /min组和0.48U /min组分别与对照组相比,病灶体积消融率均明显高于对照组,消融单位体积所需时间和能效因子均明显小于对照组,差异有统计学意义。缩宫素0.32U /min组和0.48U /min组相比较,病灶体积消融率、消融单位体积所需时间和能效因子无显著性差异。三组均无严重不良反应。结论缩宫素能安全有效地降低超声消融子宫腺肌症所需的能量,提高治疗效率,但是增大剂量并不能提高超声消融的效益。%Objective :To explore the effects and safety of different dose of oxytocin on high intensity focused ultrasound (HIFU ) ablation of adenomysis . Methods 129 patients with adenomyosis from three hospitals were treated with ultrasound -guided HIFU .The patients were randomly assigned in 0 .32U /min oxytocin group ,0 .48U /min oxytocin group ,or control group .To compare energy ,sonication time required to ablate 1cm3 of adenomyosis ,side-effects between three groups .Results The non -perfused volume (NPV) ratio of the two groups with using oxytocin are significantly higher than without one .The sonication time required to ablate 1cm3 and EEF are below .There are no significantly difference in NPV ratio ,EEF ,sonication time required to ablate1cm3 between the two groups with oxytocin .Conclusion Oxytocin could significantly decrease the energy for ablating adenomysis with HIFU ,enhance the treatment efficiency .It can not increase benefit to increase the doses of Oxytocin .

  6. Study on high intensity focus ultrasound combined with percutaneous ethanol injection in treatment of hysteromyoma%高强度聚焦超声联合无水乙醇消融子宫肌瘤的研究

    Institute of Scientific and Technical Information of China (English)

    陈圣; 唐力; 吴松松; 李建卫; 林宁; 朱琳; 吴道明

    2014-01-01

    目的:探讨高强度聚焦超声(HIFU)联合无水乙醇注射(PEI)治疗子宫肌瘤的应用价值。方法178例的子宫肌瘤患者根据 MRI T2 WI信号分为 A类(低信号)82例、B类(等信号)61例及C类(高信号)35例,其中84例采用 HIFU联合 PEI介入治疗(HIFU+PE治疗组),94例单纯采用 HIFU治疗(HIFU治疗组),分别记录相关治疗参数。结果 A类与 B类子宫肌瘤中,HIFU+PEI治疗组子宫肌瘤在治疗时间、治疗能量上明显少于单纯 HIFU治疗组(P<0.05);C类子宫肌瘤中,HIFU+PEI治疗组对子宫肌瘤的消融率明显高于单纯 HIFU治疗组(P<0.05)。结论 HIFU术前行子宫肌瘤的 PEI治疗,可以明显提高HIFU治疗子宫肌瘤的效果。%Objective To discuss the applicative value of high intensity focus ultrasound(HIFU)combined with ultrasound-guided percutaneous ethanol injection(PEI)in treatment of hysteromyoma.Methods 178 patients with hysteromyoma were divided into three types:type A(low signal)82 cases,type B(signal)61 cases and type C(high signal)35 cases according to the MRI T2 WI signal,and 84 cases were treated with HIFU combined with interventional therapy of PEI(HIFU+PEI group),94 cases were trea-ted only with HIFU(HIFU group),treatment parameters were recorded respectively.Results Treatment time and therapy energy of HIFU combined with PEI in the treatment of hysteromyoma was less than that of the simple HIFU treatment group in uterine fi-broids of type A and type B(P<0.05).The uterine leiomyoma ablation rate of HIFU combined with PEI in the treatment of hyste-romyoma was higher than that of the simple HIFU treatment group in uterine fibroids of type C(P<0.05).Conclusion That PEI therapy is adopted to the treatment of hysteromyoma before HIFU opetation could obviously improve the treatment effect.

  7. 缩宫素在超声消融治疗子宫腺肌症时的作用评价%Effects of oxytocin on high intensity focused ultrasound ablation of adenomysis

    Institute of Scientific and Technical Information of China (English)

    张昕; 何佳; 毛世华; 王健; 何敏; 吴庆蓉; 张瑞涛; 张炼

    2012-01-01

    Objective To explore the effects of oxytocin on the dosage of high intensity focused ultrasound (HIFU) ablation of adenomysis and safety during the treatment. Methods 86 patients with adenomyosis from three hospitals were treated with ultra sound guided HIFU. The patients were randomly assigned in oxytocin group or control group. Then compare the ablation effect and related adverse reactions between two groups. Results In the oxytocin group, the non perfused volume (NPV) ratio was (80. 7 + 11. 6)%;the EEF was (8. 1 + 9. 8)J/mms ,sonication time required to ablate 1 cm8 was (30. 0+36. 0)s/cms. In the control group,the non perfused volume ratio was (70. 8 + 16. 6) % ,EEF was (15. 7 + 19. 5) J/mm! ,sonication time required to ablate 1 cm8 was (58. 1 + 72. 7)s/cms. Significant difference in NPV ratio,EEF,sonication time required to ablate 1 cm8 between the two groups were observed(P<0. 05). No severe adverse reactions were found in both groups. Conclusion Oxytocin could significantly decrease the energy for ablating adenomyosis with HIFU and enhance the treatment efficiency. It has a good clinical application value.%目的 评价缩宫素对超声消融子宫腺肌症治疗剂量的影响及在超声消融治疗过程中使用的安全性.方法 86例确诊的子宫腺肌症患者随机分为缩宫素组和对照组进行超声消融治疗,比较两组间的消融效果及相关不良反应.结果 缩宫素组病灶体积消融率为 (80.7±11.6)%,能效因子(EEF)为(8.1±9.8)J/mm3,消融单位体积所需时间为(30.0±36.0)s/cm3;对照组病灶体积消融率为(70.8±16.6)%,EEF为 (15.7±19.5)J/mm3,消融单位体积所需时间为(58.1±72.7)s/cm3.两组以上指标比较,差异有统计学意义(P<0.05).两组均无严重不良反应.结论 缩宫素能降低超声消融子宫腺肌症所需的能量,提高治疗效率,具有很好的临床应用价值.

  8. The utilization of high-intensity lasers

    International Nuclear Information System (INIS)

    The 1988 progress report of the laboratory for the Utilization of High-Intensity Lasers (Polytechnic School, France), is presented. The research program is focused on the laser-plasma physics, on the generation of high pressures by means of laser shock heating, on the laser spectroscopy and on the laser implosions. Numerical simulation codes are developed. Concerning the atomic physics, the investigations on dense plasmas and the x-laser research developments are carried out. The research activities of the laboratory teams, the published papers, the national and international cooperations, are given

  9. Preliminary Investigation of Patient Suitability for Ultrasound Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids%网络来源子宫肌瘤患者超声消融治疗适合程度分析

    Institute of Scientific and Technical Information of China (English)

    陈骊; 邓勇斌; 邹敏; 吴灿; 岳莹; 熊郁

    2012-01-01

    目的 评价子宫肌瘤患者适合超声监控超声消融治疗的程度.方法 回顾性分析从2011年4月至2012年2月通过网络了解超声消融治疗技术并于重庆海扶医院妇科就诊的172例患者.按照中国食品及药物管理局通过的标准进行初步筛选后,再进行机载超声模拟定位、盆腔核磁共振成像(MRI)检查及临床检查以进一步排除不适合超声消融治疗的患者.结果 172例患者中,149例选择超声消融治疗,21例选择手术治疗,2例选择不治疗.149例选择超声消融治疗的患者经机载超声定位及MRI检查后,141 (94.6%)例最终接受了超声消融治疗,共治疗221个肌瘤;其中前位子宫120例,188个肌瘤;后位子宫21例,33个肌瘤.术后1~3 d行MRI检查,显示平均消融率为(78.7±25.8)%.8(5.4%)例患者不适合超声消融治疗,其原因包括:T2高信号1(0.7%)例;肌瘤自发性坏死1(0.7%)例;肠道推挤困难1(0.7%)例;合并卵巢肿瘤需手术1(0.7%)例;肌瘤过小4(2.7%)例.结论 网络来源子宫肌瘤患者接受超声消融治疗的比例较高;在自愿选择超声消融治疗的患者中,绝大多数患者适合超声消融治疗.%Objective To investigate patient suitability for ultrasound guided high intensity focused ultrasound (HIFU) treatment of symptomatic uterine fibroids. Methods A retrospective analysis of 172 patients seeking for minimally invasive treatment of uterine fibroids from internet was performed. The patients were first evaluated following the eligibility criteria from the State Food and Drug Administration of China. Then, the eligible patients underwent simulation, pelvic MRI and clinical examination to determine suitability for the procedure. Results 149 of 172 patients (86. 7%) had ultrasound guided HIFU (USgHIFU) treatment after consulting with gynecologists. Following further ultrasound simulation and MRI examination, 141 (94. 6%) patients were deemed suitable for USg

  10. 高强度聚焦超声治疗变应性鼻炎远期疗效的临床研究%Clinical research of long-term efficacy of high intensity focused ultrasound in treating allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    易兴梅; 罗小娟

    2014-01-01

    Objective To observe the long-term efficacy of nasal endoscopy-guided high intensity focused ultrasound (HIFU ) in the treatment of allergic rhinitis .Methods 300 patients with allergic rhinitis who failed in medication were randomly divided into the treatment group(n=162) and the control group(n=138) .The patients in the treatment group were accepted the nasal endosco-py-guided HIFU therapy ,while the patients in the control group were subjected to the hypothermy plasma ablation .The two groups were followed up after operation ,and the visual analogue scale(VAS) was employed to evaluate the therapeutic efficacy at postoper-ative 3 ,6 ,12 ,24 months .The saccharin tests were performed at the beginning and ending of treatment to assess the nasal mucocili-ary function in the patients of the two groups who voluntarily accepted the functional test of nasal cilia .Results After 2-week treat-ment ,nasal congestion ,sneezing ,runny nose ,nasal itching and other symptoms in the two groups were significantly relieved with no obvious complication .2-year follow-up demonstrated that the total effective rate in the treatment group was 61 .4% ,which was markedly higher than 50 .7% in the control group(P=0 .017) .The average saccharin clearance time of the treatment group (n=49) and the control group(n=39) were(464 ± 152)s and(738 ± 149)s ,respectively ,and their difference was statistical significant (P=0 .026) .Conclusion The long-term efficacy of HIFU treatment in allergic rhinitis is superior to that of hypothermy plasma abla-tion ,possesses less impacts on the nasal mucociliary function ,and is worthy of clinical promotion .%目的:观察鼻内窥镜下高强度聚焦超声(HIFU)治疗变应性鼻炎的远期疗效。方法将300例药物治疗无效的变应性鼻炎患者分为治疗组(n=162)及对照组(n=138)。治疗组患者在鼻内窥镜下进行HIFU治疗,对照组患者进行低温等离子消融治疗。两组患者术后随访,采用视

  11. 聚焦超声治疗婴幼儿血管瘤的初步临床应用%PRIMARY CLINICAL APPLICATION OF HIGH-INTENSITY FOCUSED ULTRASOUND ON INFANT HEMANGIOMAS

    Institute of Scientific and Technical Information of China (English)

    付时章; 王斌; 黄和平; 黄琳玲

    2011-01-01

    Objective To explore the effectiveness and appropriate energy parameters of high-intensity focused ultrasound (HIFU) in treating infant hemangiomas. Methods Between January 2009 and September 2010, 60 infants with hemangioma were treated. There were 23 boys and 37 girls, aged from 3 to 30 months with an average of 10 months. These hemangiomas were located at head and face (24 cases), trunk (15 cases), limb (16 cases), buttocks (2 cases), perineum (1 case), and multiple lesions (cervix, abdomen, and upper limbs, 2 cases). The size of hemangiomas ranged from 0.8 cm x 0.6 cm to 6.0 cm x 5.0 cm. The 60 infants were randomly divided into 3 groups: groups A, B, and C (?=20) based on different ultrasound energies used in treatment. The lesion surface was irradiated with 3-5 mm/second for 5 continuously by ultrasonic therapeutic apparatus at a frequency of 9 MHz, impulse of 1 000, and 10% of scanning overlap; the powers of 3.5, 4.0, and 4.5 W were used in groups A, B, and C, respectively, 3 times as a course of treatment with 1 month interval. The effect and ulcer and scar risk in irradiation region were observed after 6 months of treatment. Results All cases were treated for one course. After 6 months of treatment, no significant difference in the effect was found among 3 groups based on hemangioma treatment judging criterion (P > 0.05). Neither ulcer nor scar occurred in group A; ulcer occurred in 4 cases (20%) of group B with superficial scars, and in 7 cases (35%) of group C with obvious scars. The rates of ulcer and scar in groups B and C were significantly higher than that in group A (P < 0.05). Conclusion HIFU irradiating is one of effective methods for treating infant hemangioma, but the appropriate energy was below 3.5 W.%目的 探讨聚焦超声治疗婴幼儿血管瘤临床效果及适宜能量参数. 方法 2009年1月-2010年9月,收治60例血管瘤患儿.男23例,女37例;年龄3~30个月,平均10个月.病变部位:头面部24例,躯干15例,四肢16

  12. 面对高强度聚焦超声的应用我们还要做些什么?%Face applications of high intensity focused ultrasound what has yet to be done?

    Institute of Scientific and Technical Information of China (English)

    钱祖文

    2009-01-01

    @@ 高强度聚焦超声(high intensity focuscd ultrasound,HIFU),是通过聚焦方法将大面积辐射元件(换能器)所发出的声能会聚于某个小区域,使局部声压达到很高的值(例如几十MPa以上),这个小区域被称为焦域.由于生物组织器官等对声波有较大的吸收,通过不可逆热力学过程使声能部分转化为热能,使该区域及其邻近区域的温度升高.

  13. Advanced modeling of high intensity accelerators

    Energy Technology Data Exchange (ETDEWEB)

    Ryne, R.D.; Habib, S.; Wangler, T.P.

    1998-11-01

    This is the final report of a three-year, Laboratory Directed Research and Development (LDRD) project at the Los Alamos National Laboratory (LANL). The goals of this project were three-fold: (1) to develop a new capability, based on high performance (parallel) computers, to perform large scale simulations of high intensity accelerators; (2) to apply this capability to modeling high intensity accelerators under design at LANL; and (3) to use this new capability to improve the understanding of the physics of intense charge particle beams, especially in regard to the issue of beam halo formation. All of these goals were met. In particular, the authors introduced split-operator methods as a powerful and efficient means to simulate intense beams in the presence of rapidly varying accelerating and focusing fields. They then applied these methods to develop scaleable, parallel beam dynamics codes for modeling intense beams in linacs, and in the process they implemented a new three-dimensional space charge algorithm. They also used the codes to study a number of beam dynamics issues related to the Accelerator Production of Tritium (APT) project, and in the process performed the largest simulations to date for any accelerator design project. Finally, they used the new modeling capability to provide direction and validation to beam physics studies, helping to identify beam mismatch as a major source of halo formation in high intensity accelerators. This LDRD project ultimately benefited not only LANL but also the US accelerator community since, by promoting expertise in high performance computing and advancing the state-of-the-art in accelerator simulation, its accomplishments helped lead to approval of a new DOE Grand Challenge in Computational Accelerator Physics.

  14. High intensity portable fluorescent light

    Science.gov (United States)

    Kendall, F. B.

    1972-01-01

    Eight high intensity portable fluorescent lights were produced. Three prototype lights were also produced, two of which were subsequently updated to the physical and operational configuration of the qualification and flight units. Positioning of lamp apertures and reflectors in these lights is such that the light is concentrated and intensified in a specific pattern rather than widely diffused. Indium amalgam control of mercury vapor pressure in the lamp gives high output at lamp ambient temperatures up to 105 C. A small amount of amalgam applied to each electrode stem helps to obtain fast warm-up. Shrinking a Teflon sleeve on the tube and potting metal caps on each end of the lamp minimizes dispersion of mercury vapor and glass particles in the event of accidental lamp breakage. Operation at 20 kHz allows the lamps to consume more power than at low frequency, thus increasing their light output and raising their efficiency. When used to expose color photographic film, light from the lamps produces results approximately equal to sunlight.

  15. Chopping high intensity proton beams

    Energy Technology Data Exchange (ETDEWEB)

    Wiesner, Christoph; Dinter, Hannes; Droba, Martin; Meusel, Oliver; Mueller, Ilja; Noll, Daniel; Payir, Onur; Ratzinger, Ulrich; Schneider, Philipp [IAP, Goethe-Universitaet Frankfurt, Max-von-Laue-Str. 1, 60438 Frankfurt am Main (Germany)

    2013-07-01

    A novel E x B chopper system for high intensity proton beams is being developed to deliver 100 ns beam pulses in the low energy transport line of the accelerator driven neutron source FRANZ. It combines a static magnetic deflection field with a pulsed electric compensation field in a Wien filter-type E x B configuration. Behind the deflection unit a massless septum system is used for beam separation. The setup minimizes the risk of voltage breakdowns and provides secure beam dumping outside the transport line. The electric deflection field is driven by a HV pulse generator providing ±6 kV at a repetition rate of 250 kHz. Accurate layout of the deflection plates is required to tackle the issues of field quality, cooling and spark prevention. Careful matching of electric and magnetic deflection forces is required to prevent aberrations and emittance growth. Numerical studies for the field design and their effects on beam transport are presented and an overview of the hardware development is given.

  16. LHC Report: reaching high intensity

    CERN Multimedia

    Jan Uythoven

    2015-01-01

    After both beams having been ramped to their full energy of 6.5 TeV, the last two weeks saw the beam commissioning process advancing on many fronts. An important milestone was achieved when operators succeeded in circulating a nominal-intensity bunch. During the operation, some sudden beam losses resulted in beam dumps at top energy, a problem that needed to be understood and resolved.   In 2015 the LHC will be circulating around 2800 bunches in each beam and each bunch will contain just over 1 x 1011 protons. Until a few days ago commissioning was taking place with single bunches of 5 x 109 protons. The first nominal bunch with an intensity of 1 x 1011 protons was injected on Tuesday, 21 April. In order to circulate such a high-intensity bunch safely, the whole protection system must be working correctly: collimators, which protect the aperture, are set at preliminary values known as coarse settings; all kicker magnets for injecting and extracting the beams are commissioned with beam an...

  17. High-Intensity Proton Accelerator

    Energy Technology Data Exchange (ETDEWEB)

    Jay L. Hirshfield

    2011-12-27

    Analysis is presented for an eight-cavity proton cyclotron accelerator that could have advantages as compared with other accelerators because of its potentially high acceleration gradient. The high gradient is possible since protons orbit in a sequence of TE111 rotating mode cavities of equally diminishing frequencies with path lengths during acceleration that greatly exceed the cavity lengths. As the cavities operate at sequential harmonics of a basic repetition frequency, phase synchronism can be maintained over a relatively wide injection phase window without undue beam emittance growth. It is shown that use of radial vanes can allow cavity designs with significantly smaller radii, as compared with simple cylindrical cavities. Preliminary beam transport studies show that acceptable extraction and focusing of a proton beam after cyclic motion in this accelerator should be possible. Progress is also reported on design and tests of a four-cavity electron counterpart accelerator for experiments to study effects on beam quality arising from variations injection phase window width. This device is powered by four 500-MW pulsed amplifiers at 1500, 1800, 2100, and 2400 MHz that provide phase synchronous outputs, since they are driven from a with harmonics derived from a phase-locked 300 MHz source.

  18. Transverse quadrupole wake field effects in high intensity linacs

    International Nuclear Information System (INIS)

    Transverse quadrupole wake fields exist whenever the beam is not round, and therefore in an alternating-gradient focusing system these fields cannot be eliminated. As a result, these fields represent a potential limitation on high-intensity linac performance. In this note we calculate the magnitude of quadrupole wake field effects for the SLAC linac. (author)

  19. Diagnostics of High-Intensity-Discharges

    Science.gov (United States)

    Adler, Helmar G.

    1996-05-01

    High intensity light sources have come a long way since the introduction of high pressure discharges in mercury and later in sodium. The introduction of other species (e.g. metal halides) into the discharge chemistry led to marked improvements in light intensity (lumens per watt or LPW) and the appearance of the light output (color rendering index or CRI). Many of these improvements have been achieved through qualitative understanding of the discharge and good engineering. The accurate predictions of discharge behavior and spectral power distribution through HID-models remains a difficult and challenging goal for lighting scientists. Modelling of a real lamp is complicated due to the high pressures in the discharge, the geometric influences of the discharge vessel, and the interactions between fills, wall materials and electrodes. The simultaneous use of solid-, liquid-, gaseous- and plasma-state descriptions, including for example effects of radiation transport, becomes necessary. Spectroscopic measurements have been and are still of highest value, not only to determine practical parameters like LPW and CRI, but also to determine species distributions and temperatures, eventually as a function of location in the discharge and time. These measurements are necessary not only for the quantitative understanding of the discharge mechanisms, but also to serve as a testbed for all simulation efforts. This paper will focus on diagnostic possibilities and opportunities using imaging data acquisition systems.

  20. High Intensity heavy ion Accelerator Facility (HIAF) in China

    International Nuclear Information System (INIS)

    HIAF (High Intensity heavy ion Accelerator Facility), a new facility planned in China for heavy ion related researches, consists of two ion sources, a high intensity Heavy Ion Superconducting Linac (HISCL), a 45 Tm Accumulation and Booster Ring (ABR-45) and a multifunction storage ring system. The key features of HIAF are unprecedented high pulse beam intensity and versatile operation mode. The HIAF project aims to expand nuclear and related researches into presently unreachable region and give scientists possibilities to conduct cutting-edge researches in these fields. The general description of the facility is given in this article with a focus on the accelerator design

  1. Immunogenicities of Env glycoproteins from circulating HIV-1 isolates in China focusing on the strategy of "DNA prime plus protein boost"

    Institute of Scientific and Technical Information of China (English)

    WANG Zheng; WANG Shi-xia; LIU Si-yang; BAO Zuo-yi; ZHUANG Dao-min; LI Lin; ZHANG Chun-hua; ZHANG Lu; LI Jing-yun; LU Shan

    2009-01-01

    Background The adenovirus-based HIV-1 vaccine developed by Merck Company suffered from an unexpected failure in September 2007. This generated a big shift in the strategy of HIV vaccine development with renewed focus on the induction of neutralizing antibodies. A major challenge in developing an HIV-1 vaccine is to identify immunogens and adopt delivery methods that can elicit broadly neutralizing antibodies against primary isolates of different genetic subtypes.Methods Most circulating HIV-1 isolates in China are composed of clades Thai-B, CRF_BC and CRF01_AE. In order to construct DNA vaccines against these 3 HIV-1 subtypes, DNA vaccines carrying the gp120 regions from HIV-1 isolates of GX48(AE), GX79(AE), NX22(BC), GS22(BC), HN24(Thai-B) were constructed. Expression of gp120 from these DNA vaccines was detected by Western blotting in transiently transfected 293T cells. Pilot immunizations of New Zealand white rabbits were performed using the strategy of "DNA prime plus protein boost" and the neutralizing antibody response was detected in a Tzm-bl cell based assay against different HIV-1 strains.Results Response of gp120-specific antibody was relatively low after DNA primes (mean titer=10~(4.72)); however, the titer of gp120-specific antibody went up with 2 protein boosts (mean titer=10~(6.81)). Above all, neutralizing antibody (Nab) titers induced by this combined approach were much better than those elicited by DNA or protein used alone (P <0.01). Neutralizing activities of immunized rabbit sera against several pseudoviruses and laboratorial strains were evaluated, most rabbit sera primed with monovalent vaccine were capable of neutralizing only 1 of 5 viruses, however, sera primed with the polyvalent DNA vaccines were able to neutralize at least 2 of 5 viruses.Conclusion Polyvalent DNA prime plus protein boost is an effective immunization strategy to broaden the neutralization breadth and further research should be performed on the basis of this pilot study.

  2. High-Intensity Plasma Glass Melter

    Energy Technology Data Exchange (ETDEWEB)

    None

    2004-01-01

    Modular high-intensity plasma melter promises improved performance, reduced energy use, and lower emissions. The glass industry has used the same basic equipment for melting glass for the past 100 years.

  3. High Intensity Exercise in Multiple Sclerosis

    DEFF Research Database (Denmark)

    Wens, Inez; Dalgas, Ulrik; Vandenabeele, Frank;

    2015-01-01

    exercise groups that performed 12 weeks of a high intensity interval (HITR, n = 12) or high intensity continuous cardiovascular training (HCTR, n = 11), both in combination with resistance training. M.vastus lateralis fiber cross sectional area (CSA) and proportion, knee-flexor/extensor strength, body...... composition, maximal endurance capacity and self-reported physical activity levels were assessed before and after 12 weeks. Results Compared to SED, 12 weeks of high intensity exercise increased mean fiber CSA (HITR: +21±7%, HCTR: +23±5%). Furthermore, fiber type I CSA increased in HCTR (+29±6%), whereas type...... lean tissue mass (+1.4±0.5%) only increased in HITR. Finally self-reported physical activity levels increased 73±19% and 86±27% in HCTR and HITR, respectively. Conclusion High intensity cardiovascular exercise combined with resistance training was safe, well tolerated and improved muscle contractile...

  4. Cyclotrons for high-intensity beams

    CERN Document Server

    Seidel, Mike

    2013-01-01

    This paper reviews the important physical and technological aspects of cyclotrons for the acceleration of high-intensity beams. Special emphasis is given to the discussion of beam loss mechanisms and extraction schemes.

  5. Diversity-Based Boosting Algorithm

    Directory of Open Access Journals (Sweden)

    Jafar A. Alzubi

    2016-05-01

    Full Text Available Boosting is a well known and efficient technique for constructing a classifier ensemble. An ensemble is built incrementally by altering the distribution of training data set and forcing learners to focus on misclassification errors. In this paper, an improvement to Boosting algorithm called DivBoosting algorithm is proposed and studied. Experiments on several data sets are conducted on both Boosting and DivBoosting. The experimental results show that DivBoosting is a promising method for ensemble pruning. We believe that it has many advantages over traditional boosting method because its mechanism is not solely based on selecting the most accurate base classifiers but also based on selecting the most diverse set of classifiers.

  6. Effects of fat and muscle tissue on MR-guided high-intensity focused ultrasound ablation energy deposition and focus shape%脂肪及肌肉组织对高强度聚焦超声消融能量沉积及焦域形态的影响

    Institute of Scientific and Technical Information of China (English)

    高晓倩; 何敏; 税莲; 刘映江; 张炼

    2014-01-01

    目的:比较高强度聚焦超声(HIFU)通过不同厚度脂肪及肌肉组织消融猪肉靶点时的能量衰减情况。方法在MRI监控下分别选择脂肪厚度为0 mm、20 mm、28 mm的猪肉靶点,以输出功率200 W、辐照时间10 s进行单点消融,比较相同辐照条件下所产生的凝固性坏死体积。进一步选择脂肪厚度25 mm带皮猪肉及无皮和脂肪猪肉,分别将焦点置于距肌肉表面深度20 mm、30 mm的靶点进行单点辐照。结果随着脂肪厚度的增加,相同辐照条件下产生凝固性坏死区体积逐渐缩小,长轴逐渐增加,短轴逐渐缩小。当辐照无脂肪的猪肉组织时,随肌肉厚度的增加,损伤体积缩小;但相同厚度的脂肪组织对超声能量的衰减大于肌肉组织。结论 HIFU通过离体脂肪组织、肌肉组织时均有能量衰减;脂肪组织对超声能量的衰减程度高于肌肉组织。%Objective To compare the acoustic attenuation of high-intensity focused ultrasound(HIFU) energy within the pork when through different thickness of fat and muscle tissue. Methods All the processes were monitored under MRI. The pork with different thickness of fat(0 mm,20 mm,28 mm) were selected. The focus of HIFU was placed at the same distance from the superficial and sonicated with the same power of 200 W for 10 s. The necrosis regions were compared. Then the pork with 25 mm thickness of fat was selected,and the focus was placed at 20 mm,30 mm away from the muscle surface and sonicated with 200 W of power for 10 s. After that,skin and fat-free pork was selected. Focus was placed at 20 mm,30 mm away from the muscle surface and sonicated with the same power for 10 s. Results With the increase of fat thickness under the same sonication condition,the volume of coagulation necrosis region gradually reduced,the long axis of coagulation necrosis area gradually increased,and the minor axis gradually narrowed. When treat fat free pork under the same

  7. Quality assurance for clinical high intensity focused ultrasound fields.

    Science.gov (United States)

    Civale, John; Rivens, Ian; ter Haar, Gail

    2015-03-01

    As the use of HIFU in the clinic becomes more widespread there is an ever increasing need to standardise quality assurance protocols, an important step in facilitating the wider acceptance of HIFU as a therapeutic modality. This article reviews pertinent aspects of HIFU treatment delivery, encompassing the closely related aspects of quality assurance and calibration. Particular attention is given to the description and characterisation of relevant acoustic field parameters and the measurement of acoustic power. Where appropriate, recommendations are made. PMID:25677839

  8. Cardiac ablation by transesophageal high intensity focused ultrasound

    Institute of Scientific and Technical Information of China (English)

    JIANG Chen-xi; YU Rong-hui; MA Chang-sheng

    2010-01-01

    @@ Cardiac ablation is an important modality of invasive therapy in modern cardiology, especially in the treatment of arrhythmias, as well as other diseases such as hypertrophic obstructive cardiomyopathy (HOCM). Since Huang et al1 used radiofrequency (RF) to ablate canine atrial ventricular junction, RF has developed into the leading energy source in catheter ablation of arrhythmias.

  9. 对采用高强度聚焦超声刀治疗肿瘤患者行音乐疗法的效果评价%Effect of music therapy on cancer patients treated by high intensity focused ultrasound

    Institute of Scientific and Technical Information of China (English)

    黄云娜

    2012-01-01

    Objective To study the effect of music therapy on psychological state of cancer patients during treatment by high intensity focused ultrasound,as well as its influence on vital signs.Methods 157cases treated by high intensity focused ultrasound were randomly divided into the observation group(78cases)and the control group(79 cases).The control group received routine care,the observation group received the intervention of individual music therapy on the basis of routine care.The treatment effect was compared between the two groups.Results After the music intervention the observation group's breathing,heart rate,systolic and diastolic blood pressure were significantly different compared with those of the control group,After the music intervention the observation group's SAS,SDS scores were lower than those of the control group.Conclusions Music therapy can ease the anxiety and depression of cancer patients treated by high intensity focused ultrasound,the treatment can effectively improve the psychological and physiological regulation,make patients more comfortable and improve the quality of life of patients too.%目的 探讨在肿瘤患者接受高强度聚焦超声刀治疗时采用音乐疗法的情绪及其对生命体征的影响.方法 将157例行高强度聚焦超声刀治疗的肿瘤患者按完全随机分组方法分为观察组78例和对照组79例,在对照组实行常规护理,观察组在常规护理的基础上实行个体音乐疗法干预.比较2组治疗效果.结果 观察组音乐干预后呼吸、心率、收缩压、舒张压与对照组比较差异显著,观察组音乐干预后SAS、SDS评分均显著低于同期对照组.结论 实施音乐疗法能缓解肿瘤患者在高强度聚焦超声刀治疗时的焦虑、抑郁情绪,有效促进心理生理调节,提高患者舒适度,改善患者的生存质量.

  10. High Intensity Secondary Beams Driven by Protons

    CERN Document Server

    Galambos, John; Nagaitsev, Sergei

    2013-01-01

    As part of the Intensity Frontier effort within the 2013 Community Summer Study, a workshop on the proton machine capabilities was held (High Intensity Secondary Beams Driven by Proton Beams) April 17-20, 2013 at Brookhaven National Laboratory in Upton, NY. Primary aims of the workshop were to understand: 1) the beam requirements for proposed high intensity proton beam based measurements; 2) the capabilities of existing world-wide high power proton machines; 3) proton facility upgrade plans and proposals for new facilities; 4) and to document the R&D needs for proton accelerators and target systems needed to support proposed intensity frontier measurements. These questions are addressed in this summary.

  11. High Intensity Interval Training: New Insights

    Institute of Scientific and Technical Information of China (English)

    Martin J.Gibala

    2008-01-01

    @@ KEY POINTS ·High-intensity interval training(HIT)is characterized by repeated sessions of relatively brief,intermittent exercise.often performed with an“a11 out”effort or at an intensity close to that which elicits peak oxygen uptake(i.e.,≥90%of VO2 peak).

  12. Gradient boosting machines, a tutorial.

    Science.gov (United States)

    Natekin, Alexey; Knoll, Alois

    2013-01-01

    Gradient boosting machines are a family of powerful machine-learning techniques that have shown considerable success in a wide range of practical applications. They are highly customizable to the particular needs of the application, like being learned with respect to different loss functions. This article gives a tutorial introduction into the methodology of gradient boosting methods with a strong focus on machine learning aspects of modeling. A theoretical information is complemented with descriptive examples and illustrations which cover all the stages of the gradient boosting model design. Considerations on handling the model complexity are discussed. Three practical examples of gradient boosting applications are presented and comprehensively analyzed. PMID:24409142

  13. In vivo hyperthermia effect induced by high-intensity pulsed ultrasound

    International Nuclear Information System (INIS)

    Hyperthermia effects (39–44 °C) induced by pulsed high-intensity focused ultrasound (HIFU) have been regarded as a promising therapeutic tool for boosting immune responses or enhancing drug delivery into a solid tumor. However, previous studies also reported that the cell death occurs when cells are maintained at 43 °C for more than 20 minutes. The aim of this study is to investigate thermal responses inside in vivo rabbit auricular veins exposed to pulsed HIFU (1.17 MHz, 5300 W/cm2, with relatively low-duty ratios (0.2%–4.3%). The results show that: (1) with constant pulse repetition frequency (PRF) (e.g., 1 Hz), the thermal responses inside the vessel will increase with the increasing duty ratio; (2) a temperature elevation to 43 °C can be identified at the duty ratio of 4.3%; (3) with constant duty ratios, the change of PRF will not significantly affect the temperature measurement in the vessel; (4) as the duty ratios lower than 4.3%, the presence of microbubbles will not significantly enhance the thermal responses in the vessel, but will facilitate HIFU-induced inertial cavitation events. (electromagnetism, optics, acoustics, heat transfer, classical mechanics, and fluid dynamics)

  14. High-Intensity Sweeteners and Energy Balance

    OpenAIRE

    Swithers, Susan E.; Martin, Ashley A.; Davidson, Terry L.

    2010-01-01

    Recent epidemiological evidence points to a link between a variety of negative health outcomes (e.g. metabolic syndrome, diabetes and cardiovascular disease) and the consumption of both calorically sweetened beverages and beverages sweetened with high-intensity, non-caloric sweeteners. Research on the possibility that non-nutritive sweeteners promote food intake, body weight gain, and metabolic disorders has been hindered by the lack of a physiologically-relevant model that describes the mech...

  15. CW high intensity non-scaling FFAG proton drivers

    CERN Document Server

    Johnstone, C; Makino, K; Snopok, P

    2012-01-01

    Accelerators are playing increasingly important roles in basic science, technology, and medicine including nuclear power, industrial irradiation, material science, and neutrino production. Proton and light-ion accelerators in particular have many research, energy and medical applications, providing one of the most effective treatments for many types of cancer. Ultra high-intensity and high-energy (GeV) proton drivers are a critical technology for accelerator-driven sub-critical reactors (ADS) and many HEP programs (Muon Collider). These high-intensity GeV-range proton drivers are particularly challenging, encountering duty cycle and space-charge limits in the synchrotron and machine size concerns in the weaker-focusing cyclotrons; a 10-20 MW proton driver is not presently considered technically achievable with conventional re-circulating accelerators. One, as-yet, unexplored re-circulating accelerator, the Fixed-field Alternating Gradient, or FFAG, is an attractive alternative to the cyclotron. Its strong foc...

  16. 三维适形放疗联合高强度聚焦超声治疗老年性前列腺癌临床疗效观察%Clinical observation of aged-related prostate cancer treatment with the combined 3D conformal radiation therapy and high-intensity focused ultrasound

    Institute of Scientific and Technical Information of China (English)

    姚晖; 李莉; 王芸; 王梦绮; 余建军

    2011-01-01

    Background and purpose: Prostate cancer tends to develop in men over the age of SO. It is one of the most prevalent types of cancer in men. This article introduced a new prostate cancer treatment method with the combination of three dimensional radiation therapy (3D-CRT) and high-intensity focused ultrasound, its efficacy is evaluated. Methods: From Jan. 2004 to Dec. 2009, 95 patients were diagnosed with prostate cancer, among them, 48 patients were received combined therapy with total irradiation of TD 60 Gy/30 Fx and 5 fractions of high-intensity focused ultrasound treatment, while 47 patients were received with pure 3D-CRT with total irradiation of TD (66-72) Gy/(33-36) Fx. Various indicators were evaluated, such as the local control rate and distant metastasis rate, the changes in blood PSA and fPSA, changes in T-lymphocyte subsets and NK cells, as well as acute adverse reaction of normal tissue. Results: The local response rate difference between the 2 groups had statistical significance (P0.05); the combined group had lower blood cells reduction and level II acute adverse reaction of rectum, bladder and caput humeri than the pure group, but the level II acute adverse reaction of urogenital canal in the combined group was higher(P0.05);3D-CRT十HIFU组血细胞减少、反射性直肠炎和膀胱炎等II级以上急性不良反应较3D-CRT组减少,差异有显著统计学意义(P<0.01),但泌尿生殖道II级以上急性不良反应较3D-CRT组增加,差异有统计学意义(P<0.05).结论:3D-CRT联合H工FU治疗老年性前列腺癌,能提高肿瘤局部控制率,升高患者机体免疫细胞,并显著减少急性不良反应,是治疗失去手术指征的老年性前列腺癌的有效方法.

  17. Cryogenic semiconductor high-intensity radiation monitors

    Energy Technology Data Exchange (ETDEWEB)

    Palmieri, V.G. E-mail: vittorio.palmieri@cern.ch; Bell, W.H.; Borer, K.; Casagrande, L.; Da Via, C.; Devine, S.R.H.; Dezillie, B.; Esposito, A.; Granata, V.; Hauler, F.; Jungermann, L.; Li, Z.; Lourenco, C.; Niinikoski, T.O.; Shea, V. O' ; Ruggiero, G.; Sonderegger, P

    2003-09-01

    This paper describes a novel technique to monitor high-intensity particle beams by means of a semiconductor detector. It consists of cooling a semiconductor detector down to cryogenic temperature to suppress the thermally generated leakage current and to precisely measure the integrated ionization signal. It will be shown that such a device provides very good linearity and a dynamic range wider than is possible with existing techniques. Moreover, thanks to the Lazarus effect, extreme radiation hardness can be achieved providing in turn absolute intensity measurements against precise calibration of the device at low beam flux.

  18. Cryogenic semiconductor high-intensity radiation monitors

    CERN Document Server

    Palmieri, V G; Borer, K; Casagrande, L; Da Vià, C; Devine, S R H; Dezillie, B; Esposito, A; Granata, V; Hauler, F; Jungermann, L; Li, Z; Lourenço, C; Niinikoski, T O; O'Shea, V

    2003-01-01

    This paper describes a novel technique to monitor high-intensity particle beams by means of a semiconductor detector. It consists of cooling a semiconductor detector down to cryogenic temperature to suppress the thermally generated leakage current and to precisely measure the integrated ionization signal. It will be shown that such a device provides very good linearity and a dynamic range wider than is possible with existing techniques. Moreover, thanks to the Lazarus effect, extreme radiation hardness can be achieved providing in turn absolute intensity measurements against precise calibration of the device at low beam flux.

  19. Low impedance kicker for high intensity accelerator

    International Nuclear Information System (INIS)

    A kicker magnet is one of the most important components in a synchrotron. To kick the beam from injection line to synchrotron orbit or opposite direction, a ferrite material is used to achieve a fast rise time. In case of a high intensity accelerator, the material is heated by beam current. Sometimes, it is reported that characteristic of material is changed when the material reaches Curie temperature. In this paper, we propose a low impedance kicker which consists of thin magnetic alloy ribbon. The structure of the new kicker is suitable to avoid to receive the beam effects. (author)

  20. Progress in prevention and treatment of skin lesions caused by the treatment of liver cancer by high intensity focused ultrasound%高强度聚焦超声治疗肝癌中皮肤损伤防治进展

    Institute of Scientific and Technical Information of China (English)

    白愿; 陈锦云

    2016-01-01

    Liver cancer is one of the most common malignant tumour,High intensity focused ultrasound (HIFU) as a new type of treatment,is capable of ablating the tumor tissue safely,precisely,and efficiently without damaging the peripheral normal tissue,thus it’s more and more widely used in the treatment of malignant tumor.However, in clinical practice, medical workers found that there are some complications and adverse reactions in the treatment of liver cancer with HIFU, among which the skin lesions are more common.This paper reviews the progress in prevention and treatment of skin lesions caused by the treatment of liver cancer by HIFU.%肝癌是常见的恶性肿瘤,高强度聚焦超声(HIFU)作为一种新型治疗手段。因其具有无创性、安全性、有效性、无放射性等优点,使其在恶性肿瘤的临床治疗中日趋常见。然而在临床实践中,HIFU治疗肝癌也出现一些并发症及不良反应,其中以皮肤损伤较为多见,本文就HIFU治疗肝癌皮肤损伤的发生机理、临床表现及预防治疗做一综述。

  1. Nuclear diagnostics of high intensity laser plasma interactions

    International Nuclear Information System (INIS)

    Nuclear activation has been observed in materials exposed to energetic protons and heavy ions generated from high intensity laser-solid interactions (at focused intensities up to 5x1019 W/cm2). The energy spectrum of the protons is determined through the use of these nuclear activation techniques and is found to be consistent with other ion diagnostics. Heavy ion fusion reactions and large neutron fluxes from the (p, n) reactions were also observed. The reduction of proton emission and increase in heavy ion energy using heated targets was also observed

  2. Ultra-High Intensity Proton Accelerators and their Applications

    International Nuclear Information System (INIS)

    The science and technology of proton accelerators have progressed considerably in the past three decades. Three to four orders of magnitude increase in both peak intensity and average flux have made it possible to construct high intensity proton accelerators for modern applications, such as: spallation neutron sources, kaon factory, accelerator production of tritium, energy amplifier and muon collider drivers. The accelerator design focus switched over from intensity for synchrotrons, to brightness for colliders to halos for spallation sources. An overview of this tremendous progress in both accelerator science and technology is presented, with special emphasis on the new challenges of accelerator physics issues such as: H(-) injection, halo formation and reduction of losses

  3. Gradient boosting machines, a tutorial

    OpenAIRE

    Natekin, Alexey; Knoll, Alois

    2013-01-01

    Gradient boosting machines are a family of powerful machine-learning techniques that have shown considerable success in a wide range of practical applications. They are highly customizable to the particular needs of the application, like being learned with respect to different loss functions. This article gives a tutorial introduction into the methodology of gradient boosting methods with a strong focus on machine learning aspects of modeling. A theoretical information is complemented with de...

  4. 高强度聚焦超声对前列腺癌小鼠的疗效及T细胞亚群的影响%Therapeutic Effects of High Intensity Focused Ultrasound on Mice with Prostate Cancer and Its Influence on Systemic T Cell Subsets in Mice

    Institute of Scientific and Technical Information of China (English)

    武睿毅; 王国民; 徐叶青

    2012-01-01

    目的 探讨高强度聚焦超声(high intensity focused ultrasound,HIFU)对前列腺癌荷瘤小鼠的疗效及T细胞亚群的影响.方法 RM-1细胞接种于C57BL6小鼠建立小鼠前列腺癌皮下移植瘤模型,随机分为肿瘤对照组、HIFU组、放疗组和HIFU联合放疗组.观察治疗后各组的肿瘤生长曲线,计算肿瘤体积倍增时间(DT).2周后,通过流式细胞仪检测正常小鼠和荷瘤小鼠外周血CD3+、CD3+CD4+、CD3+ CD8+细胞占白细胞总数的百分比.结果 与肿瘤对照组相比,HIFU组、放疗组肿瘤生长延缓,DT显著延长.HIFU组小鼠的CD3+(%)、CD4+(%)显著高于肿瘤对照组,而放疗组与肿瘤对照组差异无统计学意义.HIFU联合放疗组的DT较HIFU组显著延长,小鼠的CD3+(%)、CD4+(%)显著高于HIFU组,且CD4+(%)显著高于正常小鼠.结论 HIFU治疗前列腺癌不仅能局部抑制肿瘤生长,而且能通过对T细胞亚群的影响提高机体的细胞免疫水平.HIFU联合放疗能进一步提高疗效.%Objective To explore therapeutic effects of high intensity focused ultrasound( HIFU) on prostate cancer and influence on systemic T cell subsets in mice. Methods Subcutaneous prostate carcinoma model was established by vaccinating RM-1 cells to C57BL6 mice. Model mice were randomly divided into control group, radiotherapy group, HIFU group,and HIFU combined with radiotherapy group. We calculated the growing curve of tumor and the tumor doubling time(DT). Two weeks later,CD3 + , CD3 + CD4+ and CD3+ /CD8+ ratio within the total white blood cell were observed by flow cytometric analysis in diffferent groups. Results Comparing with control group, both HIFU and radiotherapy groups had slower tumor's growth and significantly longer the DT. CD3+ (%) and CD4+ (%) in HIFU group were higher than those in control group, and there was no significant difference between radiotherapy group and control group. The DT of HIFU combined with radiotherapy group was significantly

  5. 三维适形放疗联合高强度聚焦超声治疗前列腺癌临床疗效观察%Application of three dimensional conformal radiation therapy combined with high-intensity focused ultrasound for prostate cancer

    Institute of Scientific and Technical Information of China (English)

    Hui Yao; Jinlan Gong; Li Li; Xiaofeng Wu; Jianjun Yu

    2012-01-01

    Objective: Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system.Prostate cancer tends to develop in men over the age of fifty; it is one of the most prevalent types of cancer in men.This article introduced a new method of prostate cancer treatment with the combination of three dimensional conformal radiation therapy (3D-CRT) and high-intensity focused ultrasound (HIFU), its efficacy was evaluated.Methods: From January 2004 to December 2009, 95 patients were diagnosed with prostate cancer, among them, 48 patients were received combined therapy with total irradiation of TD 60 Gy/30 Fx and 5 fractions of HIFU treatment, while 47 patients were received with pure 3D-CRT with total irradiation of TD (66-72) Gy/(33-36) Fx.Various indicators were evaluated, such as the local control rate and distant metastasis rate, the changes in blood PSA and fPSA, changes in T-lymphocyte subsets and NK cells, as well as acute adverse reaction of normal tissue.Results: The local response rate difference between the two groups had statistical significance (P 0.05); the combined group had lower blood cells reduction and II-level acute adverse reaction of rectum, bladder and caput humeri than the pure group, but the II-level acute adverse reaction of urogenital canal in the combined group was higher (P < 0.05).Conclusion: The combined therapy with 3D-CRT and HIFU is a good way for the treatment of aged-related prostate cancer.It can ease the symptoms, control the disease and lengthen the survival time.

  6. Clinical Observation of High Intensity Focused Ultrasound Combined with Radiotherapy、Testicular Castration for Prostate Cancer%高强度聚焦超声联合放疗、睾丸去势治疗前列腺癌的疗效观察

    Institute of Scientific and Technical Information of China (English)

    唐勇军; 余建军; 冯慧萍

    2014-01-01

    目的:探讨高强度聚焦超声( HIFU)联合放疗、睾丸去势治疗前列腺癌的疗效。方法对38例已行放疗、睾丸去势治疗的前列腺癌进行HIFU治疗。结果15例(39%)前列腺特异性抗原(PSA)水平降至正常,20例(52%) PSA下降,2例(10%)仅症状缓解,有效率达92%。前列腺体积也明显缩小。结论 HIFU联合放疗、睾丸去势治疗前列腺癌,能有效控制肿瘤进展,为前列腺癌提供了1种新的有效治疗手段。%Objective To study the efficacy of high intensity focused ultrasound ( HIFU) combined with radiotherapy , testicular castration for prostate cancer .Methods 38 patients with prostate cancer who underwent radiotherapy and testicular castration were treated with HIFU.Results 15 cases (39%),prostate specific antigen (PSA) have fallen to normal,20 cases (52%) of the PSA declined,2 cases (10%) of symptoms relieved,effective rate was 92%.Prostate volume also narrowed con-siderably.Conclusion HIFU combined with radiotherapy and testicular castration can effectively control the progression of the tumor,it is a new effective treatment for prostate cancer .

  7. Applications of High Intensity Proton Accelerators

    Science.gov (United States)

    Raja, Rajendran; Mishra, Shekhar

    2010-06-01

    Superconducting radiofrequency linac development at Fermilab / S. D. Holmes -- Rare muon decay experiments / Y. Kuno -- Rare kaon decays / D. Bryman -- Muon collider / R. B. Palmer -- Neutrino factories / S. Geer -- ADS and its potential / J.-P. Revol -- ADS history in the USA / R. L. Sheffield and E. J. Pitcher -- Accelerator driven transmutation of waste: high power accelerator for the European ADS demonstrator / J. L. Biarrotte and T. Junquera -- Myrrha, technology development for the realisation of ADS in EU: current status & prospects for realisation / R. Fernandez ... [et al.] -- High intensity proton beam production with cyclotrons / J. Grillenberger and M. Seidel -- FFAG for high intensity proton accelerator / Y. Mori -- Kaon yields for 2 to 8 GeV proton beams / K. K. Gudima, N. V. Mokhov and S. I. Striganov -- Pion yield studies for proton driver beams of 2-8 GeV kinetic energy for stopped muon and low-energy muon decay experiments / S. I. Striganov -- J-Parc accelerator status and future plans / H. Kobayashi -- Simulation and verification of DPA in materials / N. V. Mokhov, I. L. Rakhno and S. I. Striganov -- Performance and operational experience of the CNGS facility / E. Gschwendtner -- Particle physics enabled with super-conducting RF technology - summary of working group 1 / D. Jaffe and R. Tschirhart -- Proton beam requirements for a neutrino factory and muon collider / M. S. Zisman -- Proton bunching options / R. B. Palmer -- CW SRF H linac as a proton driver for muon colliders and neutrino factories / M. Popovic, C. M. Ankenbrandt and R. P. Johnson -- Rapid cycling synchrotron option for Project X / W. Chou -- Linac-based proton driver for a neutrino factory / R. Garoby ... [et al.] -- Pion production for neutrino factories and muon colliders / N. V. Mokhov ... [et al.] -- Proton bunch compression strategies / V. Lebedev -- Accelerator test facility for muon collider and neutrino factory R&D / V. Shiltsev -- The superconducting RF linac for muon

  8. Beam halo in high-intensity hadron linacs

    International Nuclear Information System (INIS)

    This document aims to cover the most relevant mechanisms for the development of beam halo in high-intensity hadron linacs. The introduction outlines the various applications of high-intensity linacs and it will explain why, in the case of the CERN Superconducting Proton Linac (SPL) study a linac was chosen to provide a high-power beam, rather than a different kind of accelerator. The basic equations, needed for the understanding of halo development are derived and employed to study the effects of initial and distributed mismatch on high-current beams. The basic concepts of the particle-core model, envelope modes, parametric resonances, the free-energy approach, and the idea of core-core resonances are introduced and extended to study beams in realistic linac lattices. The approach taken is to study the behavior of beams not only in simplified theoretical focusing structures but to highlight the beam dynamics in realistic accelerators. All effects which are described and derived with simplified analytic models, are tested in realistic lattices and are thus related to observable effects in linear accelerators. This approach involves the use of high-performance particle tracking codes, which are needed to simulate the behavior of the outermost particles in distributions of up to 100 million macro particles. In the end a set of design rules are established and their impact on the design of a typical high-intensity machine, the CERN SPL, is shown. The examples given in this document refer to two different design evolutions of the SPL study: the first conceptual design report (SPL I) and the second conceptual design report (SPL II). (orig.)

  9. Beam halo in high-intensity hadron linacs

    Energy Technology Data Exchange (ETDEWEB)

    Gerigk, F.

    2006-12-21

    This document aims to cover the most relevant mechanisms for the development of beam halo in high-intensity hadron linacs. The introduction outlines the various applications of high-intensity linacs and it will explain why, in the case of the CERN Superconducting Proton Linac (SPL) study a linac was chosen to provide a high-power beam, rather than a different kind of accelerator. The basic equations, needed for the understanding of halo development are derived and employed to study the effects of initial and distributed mismatch on high-current beams. The basic concepts of the particle-core model, envelope modes, parametric resonances, the free-energy approach, and the idea of core-core resonances are introduced and extended to study beams in realistic linac lattices. The approach taken is to study the behavior of beams not only in simplified theoretical focusing structures but to highlight the beam dynamics in realistic accelerators. All effects which are described and derived with simplified analytic models, are tested in realistic lattices and are thus related to observable effects in linear accelerators. This approach involves the use of high-performance particle tracking codes, which are needed to simulate the behavior of the outermost particles in distributions of up to 100 million macro particles. In the end a set of design rules are established and their impact on the design of a typical high-intensity machine, the CERN SPL, is shown. The examples given in this document refer to two different design evolutions of the SPL study: the first conceptual design report (SPL I) and the second conceptual design report (SPL II). (orig.)

  10. TRIUMF high intensity cyclotron development for ISAC

    International Nuclear Information System (INIS)

    Over the last 15 years the 500 MeV H- cyclotron has been extracting routinely a total current of up to 220 μA protons through three lines at different energies. For ISAC a new 500 MeV beamline which was recently commissioned to 100 μA is now being operated up to 70 μA. Work to increase the total cyclotron extracted current to 300 μA was approved within the 2000-2005 plan. 300 μA peak was successfully obtained at 95% duty cycle, limited only by the maximum beam current presently accepted by the beamlines. Measurements also confirmed the feasibility of 400 μA total cw extracted beam, provided total beam dump capacity be increased. Total 400 μA peak at 25% duty cycle was achieved with good transmission and reasonable percentage losses. Because of these results a new high intensity beam line with a 200 μA beam dump and an additional RIB target ion-source was included in the next 2005-2010 plan submission. The new station will allow studies of target efficiency. Delivery of a second simultaneous RIB beam for experiments is also being considered. The paper will review recent results, and cyclotron refurbishing and primary beamline upgrade plans. (author)

  11. High intensity neutrino oscillation facilities in Europe

    CERN Document Server

    Edgecock, T R; Davenne, T; Densham, C; Fitton, M; Kelliher, D; Loveridge, P; Machida, S; Prior, C; Rogers, C; Rooney, M; Thomason, J; Wilcox, D; Wildner, E; Efthymiopoulos, I; Garoby, R; Gilardoni, S; Hansen, C; Benedetto, E; Jensen, E; Kosmicki, A; Martini, M; Osborne, J; Prior, G; Stora, T; Melo-Mendonca, T; Vlachoudis, V; Waaijer, C; Cupial, P; Chancé, A; Longhin, A; Payet, J; Zito, M; Baussan, E; Bobeth, C; Bouquerel, E; Dracos, M; Gaudiot, G; Lepers, B; Osswald, F; Poussot, P; Vassilopoulos, N; Wurtz, J; Zeter, V; Bielski, J; Kozien, M; Lacny, L; Skoczen, B; Szybinski, B; Ustrycka, A; Wroblewski, A; Marie-Jeanne, M; Balint, P; Fourel, C; Giraud, J; Jacob, J; Lamy, T; Latrasse, L; Sortais, P; Thuillier, T; Mitrofanov, S; Loiselet, M; Keutgen, Th; Delbar, Th; Debray, F; Trophine, C; Veys, S; Daversin, C; Zorin, V; Izotov, I; Skalyga, V; Burt, G; Dexter, A C; Kravchuk, V L; Marchi, T; Cinausero, M; Gramegna, F; De Angelis, G; Prete, G; Collazuol, G; Laveder, M; Mazzocco, M; Mezzetto, M; Signorini, C; Vardaci, E; Di Nitto, A; Brondi, A; La Rana, G; Migliozzi, P; Moro, R; Palladino, V; Gelli, N; Berkovits, D; Hass, M; Hirsh, T Y; Schaumann, M; Stahl, A; Wehner, J; Bross, A; Kopp, J; Neuffer, D; Wands, R; Bayes, R; Laing, A; Soler, P; Agarwalla, S K; Villanueva, A Cervera; Donini, A; Ghosh, T; Cadenas, J J Gómez; Hernández, P; Martín-Albo, J; Mena, O; Burguet-Castell, J; Agostino, L; Buizza-Avanzini, M; Marafini, M; Patzak, T; Tonazzo, A; Duchesneau, D; Mosca, L; Bogomilov, M; Karadzhov, Y; Matev, R; Tsenov, R; Akhmedov, E; Blennow, M; Lindner, M; Schwetz, T; Martinez, E Fernández; Maltoni, M; Menéndez, J; Giunti, C; García, M C González; Salvado, J; Coloma, P; Huber, P; Li, T; López-Pavón, J; Orme, C; Pascoli, S; Meloni, D; Tang, J; Winter, W; Ohlsson, T; Zhang, H; Scotto-Lavina, L; Terranova, F; Bonesini, M; Tortora, L; Alekou, A; Aslaninejad, M; Bontoiu, C; Kurup, A; Jenner, L J; Long, K; Pasternak, J; Pozimski, J; Back, J J; Harrison, P; Beard, K; Bogacz, A; Berg, J S; Stratakis, D; Witte, H; Snopok, P; Bliss, N; Cordwell, M; Moss, A; Pattalwar, S; Apollonio, M

    2013-01-01

    The EUROnu project has studied three possible options for future, high intensity neutrino oscillation facilities in Europe. The first is a Super Beam, in which the neutrinos come from the decay of pions created by bombarding targets with a 4 MW proton beam from the CERN High Power Superconducting Proton Linac. The far detector for this facility is the 500 kt MEMPHYS water Cherenkov, located in the Fr\\'ejus tunnel. The second facility is the Neutrino Factory, in which the neutrinos come from the decay of {\\mu}+ and {\\mu}- beams in a storage ring. The far detector in this case is a 100 kt Magnetised Iron Neutrino Detector at a baseline of 2000 km. The third option is a Beta Beam, in which the neutrinos come from the decay of beta emitting isotopes, in particular 6He and 18Ne, also stored in a ring. The far detector is also the MEMPHYS detector in the Fr\\'ejus tunnel. EUROnu has undertaken conceptual designs of these facilities and studied the performance of the detectors. Based on this, it has determined the ph...

  12. AGS Resonant Extraction with High Intensity Beams

    International Nuclear Information System (INIS)

    The Brookhaven AGS third integer resonant extraction system allows the AGS to provide high quality, high intensity 25.5 GeV/c proton beams simultaneously to four target stations and as many as 8 experiments. With the increasing intensities (over 7 x 1013 protons/pulse) and associated longer spill periods (2.4 to 3 seconds long), they continue to run with low losses and high quality low modulation continuous current beams. Learning to extract and transport these higher intensity beams has required a process of careful modeling and experimentation. They have had to learn how to correct for various instabilities and how to better match extraction and the transport lines to the higher emittance beams being accelerated in the AGS. Techniques employed include ''RF'' methods to smooth out momentum distributions and fine structure. They will present results of detailed multi-particle tracking modeling studies which enabled them to develop a clear understanding of beam loss mechanisms in the transport and extraction process. They report on their status, experiences, and the present understanding of the intensity limitations imposed by resonant extraction and transport to fixed target stations

  13. AGS RESONANT EXTRACTION WITH HIGH INTENSITY BEAMS.

    Energy Technology Data Exchange (ETDEWEB)

    AHRENS,L.; BROWN,K.; GLENN,J.W.; ROSER,T.; TSOUPAS,N.; VANASSELT,W.

    1999-03-29

    The Brookhaven AGS third integer resonant extraction system allows the AGS to provide high quality, high intensity 25.5 GeV/c proton beams simultaneously to four target stations and as many as 8 experiments. With the increasing intensities (over 7 x 10{sup 13} protons/pulse) and associated longer spill periods (2.4 to 3 seconds long), we continue to run with low losses and high quality low modulation continuous current beams.[1] Learning to extract and transport these higher intensity beams has required a process of careful modeling and experimentation. We have had to learn how to correct for various instabilities and how to better match extraction and the transport lines to the higher emittance beams being accelerated in the AGS. Techniques employed include ''RF'' methods to smooth out momentum distributions and fine structure. We will present results of detailed multi-particle tracking modeling studies which enabled us to develop a clear understanding of beam loss mechanisms in the transport and extraction process. We will report on our status, experiences, and the present understanding of the intensity limitations imposed by resonant extraction and transport to fixed target stations.

  14. ''High intensity per bunch'' working group

    International Nuclear Information System (INIS)

    Third Generation Light Sources are supposed to store high intensity beams not only in many tightly spaced bunches (multibunch operation), but also in few bunch or even single lunch modes of operation, required for example for time structure experiments. Single bunch instabilities, driven by short-range wake fields, however spoil the beam quality, both longitudinally and transversely. Straightforward ways of handling them, by pushing up the chromaticity (ζ = ΔQ/(Δp/p)) for example, enabled to raise the charge per bunch, but to the detriment of beam lifetime. In addition, since the impedance of the vacuum chamber deteriorates with the installation of new insertion devices, the current thresholds tend to dope down continuously. The goal of this Working Group was then to review these limitations in the existing storage rings, where a large number of beam measurements have been performed to characterise them, and to discuss different strategies which are used against them. About 15 different laboratories reported on the present performance of storage rings, experiences gained in high charge per bunch, and on simulation results and theoretical studies. More than 25 presentations addressed the critical issues and stimulated the discussion. Four main topics came out: - Observation and experimental data; - Impedance studies and tracking codes; - Theoretical investigations; - Cures and feedback. (author)

  15. High-Intensity Sweeteners and Energy Balance

    Science.gov (United States)

    Swithers, Susan E.; Martin, Ashley A.; Davidson, Terry L.

    2010-01-01

    Recent epidemiological evidence points to a link between a variety of negative health outcomes (e.g. metabolic syndrome, diabetes and cardiovascular disease) and the consumption of both calorically sweetened beverages and beverages sweetened with high-intensity, non-caloric sweeteners. Research on the possibility that non-nutritive sweeteners promote food intake, body weight gain, and metabolic disorders has been hindered by the lack of a physiologically-relevant model that describes the mechanistic basis for these outcomes. We have suggested that based on Pavlovian conditioning principles, consumption of non-nutritive sweeteners could result in sweet tastes no longer serving as consistent predictors of nutritive postingestive consequences. This dissociation between the sweet taste cues and the caloric consequences could lead to a decrease in the ability of sweet tastes to evoke physiological responses that serve to regulate energy balance. Using a rodent model, we have found that intake of foods or fluids containing non-nutritive sweeteners was accompanied by increased food intake, body weight gain, accumulation of body fat, and weaker caloric compensation, compared to consumption of foods and fluids containing glucose. Our research also provided evidence consistent with the hypothesis that these effects of consuming saccharin may be associated with a decrement in the ability of sweet taste to evoke thermic responses, and perhaps other physiological, cephalic phase, reflexes that are thought to help maintain energy balance. PMID:20060008

  16. US-guided high-intensity focused ultrasound (HIFU) surgery for uterine fibroids:relationship between the therapeutic effects and signal intensity of preexisting T2-weighted MR images%MRI T2WI信号强度与高强度聚焦超声消融子宫肌瘤疗效关系的研究

    Institute of Scientific and Technical Information of China (English)

    侯静; 刘晟; 王维; 梁琪; 廖云杰

    2014-01-01

    目的:通过研究消融前M RI T2 WI信号强度特点与高强度聚焦超声消融术(high intensity focused ultrasound ablation ,HIFU )治疗子宫肌瘤消融疗效之间的关系,从信号方面探讨影响 HIFU 治疗子宫肌瘤疗效的因素。方法选择2011年10月~2013年7月经MRI诊断的子宫肌瘤患者50例,行超声引导下的 HIFU 治疗,共有子宫肌瘤56个,消融前根据M RI T2 WI信号强度将其分为四种类型:①高信号;②等信号;③低信号;④混杂信号,消融后次日及术后6个月行增强M RI扫描评估肌瘤体积的消融范围,计算消融率及术后6个月肌瘤体积的缩小率,分别作为早期和中期 HIFU疗效的指标,同时记录术中与消融有关的不良反应。结果所有患者顺利完成治疗,未出现显著并发症。消融前肌瘤的体积0.43~502.12cm3,平均(125.13±111.40)cm3,消融后次日增强M RI中无增强剂灌注区域体积0.38~316.63cm3,平均(87.09±78.05)cm3,消融率25.16%~97.92%,平均(70.61±15.62)%,且MRI T2WI不同信号强度之间疗效差异有统计学意义(P <0.05),低信号强度的肌瘤消融率最高,6个月后此类肌瘤体积进一步缩小,且此缩小率与术后次日消融率呈正相关( r =0.67,P <0.05)。结论 M RI T2 WI低信号子宫肌瘤更易达到理想的消融疗效,且术后肌瘤体积缩小程度较大,可为选择患者提供依据。%Objective To investigate the relationship between the signal intensity of T 2-weighted magnetic resonance im-ages and the therapeutic effect of US-guided high-intensity focused ultrasound (HIFU ) ablation in the treatment of uterine fibroids .Methods Fifty patients with 56 uterine fibrcids were enrolled in the study from October 2011 to July 2013 .They underwent US-guided HIFU ablation ,which were classified into 4 types based on the signal intensity of T2-weighted mag

  17. A transparent vacuum window for high-intensity pulsed beams

    CERN Document Server

    Monteil, M; Veness, R

    2011-01-01

    The HiRadMat (High-Radiation to Materials) facility Ill will allow testing of accelerator components, in particular those of the Large Hadron Collider (LHC) at CERN, under the impact of high-intensity pulsed beams. To reach this intensity range, the beam will be focused on a focal point where the target to be tested is located. A 60 mm aperture vacuum window will separate the vacuum of the beam line which is kept under high vacuum 10(-8) mbar, from the test area which is at atmospheric pressure. This window has to resist collapse due to beam passage. The high-intensity of the beam means that typical materials used for standard vacuum windows (such as stainless steel, aluminium and titanium alloy) cannot endure the energy deposition induced by the beam passage. Therefore, a vacuum window has been designed to maintain the differential pressure whilst resisting collapse due to the beam impact on the window. In this paper, we will present calculations of the energy transfer from beam to window, the design of the ...

  18. 超声造影在高强度聚焦超声治疗中晚期前列腺癌应用%Application of ultrasound contrast agents in high-intensive focused ultrasound for clinical treatment of middle-late stage prostate cancer

    Institute of Scientific and Technical Information of China (English)

    金玉明; 吕军; 姜新; 姜应波; 王敏捷; 李蓉

    2013-01-01

    目的 探讨超声造影在高强度聚焦超声(high intensity focused ultrasound,HIFU)治疗中晚期前列腺癌的临床应用价值.方法 将10例中晚期前列腺癌病例别行高强度聚焦超声治疗.治疗过程中行超声造影检查,通过病灶血流信号变化判断消融效果.所有病例随访1年,在术前、治疗后1、2、6和12个月,经直肠超声观察前列腺和前列腺部尿道的影像学变化,通过尿液分析、国际前列腺症状(IPSS)评分、生活质量(QOL)评分、最大尿流率(Qmax)和残余尿量(PVR)进行疗效评估.结果 随访12个月,治疗前、治疗后1、2、6和12个月患者IPSS评分、QOL评分逐渐降低,Qmax逐渐升高,PVR逐渐降低,前列腺体积逐渐降低,动脉收缩期峰值速度(Vs)、舒张末期速度(Vd)、阻力指数(RI)、加速指数(AI)、血管内径(D)均逐渐降低,差异有显著性(P<0.05).结论HIFU是治疗前列腺癌安全有效的方法,超声造影能准确显示HIFU治疗前列腺癌的消融范围及程度,且超声造影剂可以起到增效剂的作用经直肠彩色多普勒超声为其疗效评估提供了一种直观,准确的方法.

  19. High-intensity focused ultrasound in treatment of localized prostate cancer(a clinical report of 36 cases)%经直肠高强度聚焦超声治疗局限性前列腺癌(附36例报告)

    Institute of Scientific and Technical Information of China (English)

    邱晓拂; 胡卫列; 王尉; 吕军; 赵永斌; 郭飞

    2009-01-01

    目的 总结经直肠高强度聚焦超声(high-intensity focused ultrasound,HIFU)治疗局限性前列腺癌的临床经验并评估其有效性及安全性. 方法 使用Sonablate-500聚焦超声系统对36例局限性前列腺癌患者进行治疗,观察患者治疗时耐受情况,监测治疗后3、6、12个月时的血清前列腺特异性抗原(PSA)、直肠指诊(DRE)、最大尿流率(Qmax)及经直肠前列腺B超情况,治疗后6~12个月行经直肠前列腺穿刺活检. 结果 平均手术操作时间41 min(25~76 min),平均术后住院时间3.4 d (2~9 d).治疗后3、6、12个月时PSA与治疗前相比均明显降低(P<0.05),Qmax较治疗前均增加(P<0.05),前列腺体积较治疗前均缩小(P<0.05),DRE发现结节消失或减小的占77.8%(28/36),B超提示低回声结节消失或缩小的占83.3%(30/36).治疗后3、6、12个月各项检查结果差异无统计学意义(P>0.05). 结论 HIFU治疗前列腺癌具有微创、安全、痛苦少、效果好、恢复快和并发症少等优点,对于无法耐受根治性前列腺切除术的局限性前列腺癌患者可考虑行HIFU治疗.

  20. Analyse the efficacy in the near future and the measures of improvement for high intensity focused ultrasound in the treatment of Httle uterine leiomyomas%高强度聚焦超声治疗子宫小肌瘤疗效分析

    Institute of Scientific and Technical Information of China (English)

    段廷旺; 蒲怀智; 雷小林

    2012-01-01

    Objective To probe the efficacy in the near future and measures of amelioration for high intensity focused ultrasound (HIFU) in the treatment of little uterine leiomyomas. Methods To guide the location of the focal field and monitor the ablating procedure by color Doppler ultrasound, 68 cases of sufferers with little uterine leiomyomas ( 10mm x 10mm ~ 40mm x 40mm) were admitted for the therapy with HIFU. After treatment,the amelioration of linical symptoms and ultrasonographic changes were observed and evaluated periodically. Results Among 68 cases, 48 cases achieved sigificant curative effect, 20 cases achieved moderate or mild curative effect; Little uterine leiomyomas disappeared for 16 cases of sufferers, and recurred for 3 cases Conclusion treatment of little uterine leiomyomas by HIFU is safe N effective and mild side-effect. But it needs to improve the meas ures of the therapy with HIFU for the aim of no- recrudescence at a specified future date.%目的 分析高强度聚焦超声(HIFU)治疗子宫小肌瘤近期疗效及改进方法.方法 在彩色多普勒超声定位下,应用FEP-BY02型高强度聚焦超声治疗系统对68例子宫肌瘤(10mm X10mm~40mm x40mm)患者进行治疗,治疗后定期彩超随访观察瘤体影像学变化及临床症状改善情况.结果 效果显著48例,其中16例肌瘤消失;有效或部分有效20例,其中复发3例.结论 HIFU治疗子宫小肌瘤近期疗效好,安全、不良反应小,但需要改进方法,以达到远期无复发.

  1. Comparison of low-versus high-intensity focused ultrasound in treating pain due to chronic soft tissue injury%低强度和高强度聚焦超声治疗慢性软组织损伤性疼痛效果的比较

    Institute of Scientific and Technical Information of China (English)

    徐城; 刘丹彦

    2015-01-01

    目的 比较低强度和高强度聚焦超声治疗慢性软组织损伤性疼痛的效果.方法 慢性软组织损伤性疼痛病人93例,性别不限,年龄18~ 80岁,BMI 18~31 kg/m2,病程3个月~ 10年,数字评估量表评分4~8分,采用随机数字表法,将病人分为2组:低强度组(LI组,n=49)和高强度组(HI组,n=44).LI组以能感受到(酸、麻、胀、痛)的最小聚焦超声强度持续治疗10 min;HI组以不能耐受的聚焦超声强度治疗1 min,停止1 min,共治疗10 min;1次/d,2组疗程均为5d.治疗期间当数字评估量表评分仍>4分时肌肉注射帕瑞昔布钠40 mg;根据疗效指数和活动功能改善情况评估疗效,并进行生活质量评分和抑郁评分,记录治疗有关不良事件的发生情况.结果 LI组和HI组治疗总有效率分别为98%和84%;与HI组比较,LI组治疗总有效率升高,生活质量评分升高(P<0.05),抑郁评分差异无统计学意义(P>0.05).LI组无一例病人使用帕瑞昔布钠,未见治疗有关不良事件发生,HI组有1例病人(2%)使用帕瑞昔布钠,皮肤灼伤、神经损伤和异常疼痛的发生率分别为4%、2%和2%,未见组织肿胀发生.结论 与高强度聚焦超声比较,低强度聚焦超声治疗慢性软组织损伤性疼痛的疗效高,且安全性良好.%Objective To compare the low-intensity focused ultrasound (LIFU) and high-intensity focused ultrasound (HIFU) in treating pain due to chronic soft tissue injury.Methods Ninety-three patients with pain due to chronic soft tissue injury, aged 18-80 yr, with body mass index of 18-31 kg/m2,course of the disease 3 months-10 yr, and pain intensity of 4-8 in a numeric rating scale, were randomly divided into 2 groups using a random number table: low intensity group (group LI, n =49) and high intensity group (group HI, n =44).In group LI, the patients received LIFU with the minimum ultrasonic intensity causing senses (acid, hemp, swelling, pain) , and the treatment was continued

  2. Electrostatic LEBTs for High-Intensity Linac-Injectors

    International Nuclear Information System (INIS)

    This paper discusses options for Low-Energy Beam Transport (LEBT) systems as part of injectors for high-intensity linear accelerators such as proton drivers and similar machines. Building on the demonstrated success of the Spallation Neutron Source (SNS) front end, the presented LEBT designs are based on the electrostatic focusing principle, but the arrangement of lenses and steerer elements is modified for ease of operation and to reduce optical aberrations that somewhat affected the performance of the SNS LEBT. After treating two examples of such LEBTs to be applied to proton and deuteron beams, an extraction system for H-beams is presented that provides for electron removal at intermediate energy and can easily be integrated into an electrostatic LEBT of the type discussed before. Beam simulation results with output emittances for the three systems are included in the paper

  3. Short-term Efficacy and Quality of Life Evaluation for Adenomyosis after High Intensity Focused Ultrasound Treatment%高强度聚焦超声治疗子宫腺肌病的近期疗效及生活质量评价

    Institute of Scientific and Technical Information of China (English)

    卢白玉; 胡奎; 鄢利梅; 何敏; 黄国华; 黎克全; 何佳

    2013-01-01

      目的:评价高强度聚焦超声(HIFU)治疗子宫腺肌病的近期疗效及对生活质量的影响。方法:采用HIFU治疗35例子宫腺肌病患者,通过增强磁共振成像(MRI)评价消融的情况,采用彩色多普勒超声监测病灶变化情况;使用标准子宫肌瘤症状及健康相关生活质量(UFS-QOL)量表评价患者临床症状及生活质量改善情况,并随访分析患者不良反应发生及转归。结果:治疗后第2天增强MRI显示子宫腺肌病病灶消融率为(68.9±18.9)%。治疗后所有不良反应均未超过国际介入放射治疗协会(SIR)标准不良反应分级B级。HIFU治疗前病灶体积中位数为36.9 cm3(P25,P75为20.5,44.8 cm3),治疗后1个月病灶体积中位数为19.1 cm3(P25,P75为12.1,31.1 cm3),两者差异有统计学意义(Z=2.801,P=0.005)。HIFU治疗前UFS评分中位数为22.5分(P25,P75为17.5,32.5分),治疗后1个月UFS评分中位数为15.0分(P25,P75为7.5,25.0分),差异有统计学意义(Z=3.695,P=0.000)。治疗前QOL评分为(77.9±10.5)分,治疗后1个月QOL评分为(81.4±13.3)分,差异无统计学意义(t=1.230,P=0.223)。术后痛经症状明显改善(Zc=7.280,P=0.000)。结论:HIFU治疗能有效消融子宫腺肌病病灶,相关临床症状可迅速缓解,病灶明显缩小,但生活质量改善可能需要更长时间。%Objective: To evaluate the efficacy of the ultrasound ablation with real-time ultrasonic monitoring in adenomyosis treatment and the effect on life quality. Methods:35 patients with adenomyosis were treated with the high intensity focused ultrasound(HIFU). The effecacy of ablation was evaluate by the enhanced MRI. The lesions were monitored by the color Doppler ultrasound. Clinical symptoms,life quality,the side effects after treatment,as well as prognosis,were recorded by the standard UFS-QOL measuring scale. Results:The ablation

  4. To boost or not boost in radiotherapy

    International Nuclear Information System (INIS)

    The aim of this paper it to analyse and discuss standard definition of the 'boost' procedure in relation to clinical results and new forms of the boost designed on physical and radiobiological bases. Seventeen sets of clinical data including over 5000 cases cancer with different tumour stages and locations and treated with various forms of 'boost' method have been subtracted from literature. Effectiveness of boost is analyzed regarding its place in combined treatment, timing and subvolume involved. Radiobiological parameter of D10 and normalization method for biologically equivalent doses and dose intensity are used to simulated cold and not subvolumes (hills and dales) and its influence of effectiveness on the boost delivery. Sequential and concomitant boost using external irradiation, although commonly used, offers LTC benefit lower than expected. Brachytherapy, intraoperative irradiation and concurrent chemotherapy boost methods appear more effective. Conformal radiotherapy, with or without dose-intensity modulation, allows heterogeneous increase in dose intensity within the target volume and can be used to integrate the 'boost dose' into baseline treatment (Simultaneous Integrated Boost and SIB). Analysis of interrelationships between boost-dose; boost volume and its timing shows that a TCP benefit from boosting can be expected when a relatively large part of the target volume is involved. Increase in boost dose above 1.2-1.3 of baseline dose using 'standard' methods does not substantially further increase the achieved TCP benefit unless hypoxic cells are a problem. Any small uncertainties in treatment planning can ruin all potential beneficial effect of the boost. For example, a 50% dose deficit in a very small (e.g. 1%) volume of target can decrease TCP to zero. Therefore boost benefits should be carefully weighed against any risk of cold spots in the target volume. Pros and cons in discussion of the role of boost in radiotherapy lead to the important

  5. 邻近山羊门静脉行高强度聚焦超声消融的病理观察%Pathological Observation after MRI Guided High Intensity Focused Ultrasound Therapy for Ablating the Liver Tissues Adjacent to Goat Portal Vein

    Institute of Scientific and Technical Information of China (English)

    江车; 何敏; 刘映江; 黄秀; 张炼; 白晋; 王智彪

    2011-01-01

    The present study was aimed to investigate the pathological changes after magnetic resonance imaging (MRI) guided high intensity focused ultrasound (MRgHIFU) therapy for ablating the liver tissue adjacent to goat portal vein. Fifty goats were involved in this study. Normal liver tissues at 0, 5, and 10 mm distance from portal vein, respectively, were ablated with MRgHIFU. Among the 50 tested subjects, 40 goats were sacrificed immediately after the operations, and the other 10 were sacrificed 7 days after the procedure for pathological examination of the targeted areas and the contiguous portal veins. Coagulation necrosis was observed in all the treated liver tissues. Collagen swelling(CS) and vessel wall fracture (VWF) emerged more frequently in the 0mm group than that in the 5mm groups CS [0mm group VS 5mm group= 27/40(67. 5%) VS 7/40(17. 5%) ,P<0. 05], VWF [0mm group VS 5mm group=8/40(20%)VS 0/40(0%), P<0. 05]. Seven days after ablation, no portal vein damages (CS and VWF) were observed under light microscope. The results indicated that MRgHIFU could be used to ablate the liver tissue adjacent to goat portal vein effectively, which may cause blood vessel damage when the focus is on the wall of blood vessels (0 mm). However, the pathological results indicated that these damages are reversible.%观察使用磁共振(MRI)导航的高强度聚焦超声(MRgHIFU)消融靠近山羊门静脉的肝组织的病理变化;在MRI监控下,对50只山羊靠近门静脉0、5和10 mm处的肝组织进行热消融.其中40只山羊术后立即处死,另外10只在消融7d后处死.病理观察显示靶区肝组织完全坏死,治疗后即刻0 mm组门静脉出现胶原纤维肿胀(CS)27/40(67.5%)例,血管壁断裂(VWF)为7/40(17.5%)例;5 mm组门静脉CS为8/40(20%)例,VWF(0/40,0%),两组间CS和VWF发生率差异有显著性(P<0.05);10 mm组未见CS (0/40,0%)和VWF(0/40,0%).消融后7d,各组门静脉标本在光镜下均未见CS和VWF.以上结果

  6. A boost for the ISOLDE beams

    CERN Multimedia

    Corinne Pralavorio

    2015-01-01

    The first HIE-ISOLDE cryomodule was commissioned at the end of October. The radioactive ion beams can now be accelerated to 4.3 MeV per nucleon.   The ISOLDE beamline that supplies the Miniball array. The first HIE-ISOLDE cryomodule can be seen in the background, in its light-grey cryostat. ISOLDE is getting an energy boost. The first cryomodule of the new superconducting linear accelerator HIE-ISOLDE (High Intensity and Energy ISOLDE), located downstream of the REX-ISOLDE accelerator, increases the energy of the radioactive ion beams from 3 to 4.3 MeV per nucleon. It supplies the Miniball array, where an experiment using radioactive zinc ions (see box) began at the end of October. This is the first stage in the commissioning of HIE-ISOLDE. The facility will ultimately be equipped with four cryomodules that will accelerate the beams to 10 MeV per nucleon. Each cryomodule has five accelerating cavities and a solenoid, which focuses the beam. All of these components are superconducting. This first ...

  7. Pharmacotherapy of HIV: A Focus on Atazanavir/Ritonavir a Potent and Convenient Once Daily Ritonavir Boosted Protease-Inhibitor for HIV-1 Infected Adults

    Directory of Open Access Journals (Sweden)

    Clotilde Allavena

    2009-01-01

    Full Text Available Atazanavir is the first azapeptide protease inhibitor. As a consequence of metabolism by the Cytochrome P450 system and excretion by drug-transporters such as P-Glycoprotein, drug interactions are considerable. They can be used to improve efficacy (ritonavir boosting but may also cause adverse effects. Efficacy of ATV/RTV has been shown to be comparable to lopinavir/ritonavir in antiretroviral naïve patients, providing even better results in patients with high viral load. Efficacy has also been demonstrated in maintenance therapy in antiretroviral-experienced patients, and in patients with previous virologic failure, providing the best virologic response when the virus harbors less than four resistance PI mutations. The gastrointestinal tolerability and the lipid profile are better than with other PIs. The major side effect is a jaundice caused by unconjugated hyperbilirubinemia that rarely leads to discontinuation. ATV/RTV simple administration as well as tolerability may be linked with better treatment adherence. ATV/RTV is simple, potent and well tolerated. Thus it takes an important place in the treatment of HIV-infected patients, preferentially in antiretroviral-naïve or moderately pretreated populations.

  8. Neutralized transport of high intensity beams

    International Nuclear Information System (INIS)

    The NTX experiment at the Heavy Ion Fusion Virtual National Laboratory is exploring the performance of neutralized final focus systems for high perveance heavy ion beams. A converging ion beam at the exit of the final focus magnetic system is injected into a neutralized drift section. The neutralization is provided by a metal arc source and an RF plasma source. Effects of a ''plasma plug'', where electrons are extracted from a localized plasma in the upstream end of the drift section, and are then dragged along by the ion potential, as well as the ''volumetric plasma'', where neutralization is provided by the plasma laid down along the ion path, are both studied and their relative effects on the beam spot size are compared. Comparisons with 3-D PIC code predictions will also be presented

  9. 六氟化硫微泡造影在高强度聚焦超声治疗子宫后壁肌瘤中的作用评价%Evaluation of the role of contrast enhanced ultrasound in treatment of ultrasound guided high intensity focused ultrasound ablation for uterine fibroids

    Institute of Scientific and Technical Information of China (English)

    林丽; 刘晓芳; 何佳

    2014-01-01

    目的:评价六氟化硫微泡造影在高强度聚焦超声(HIFU)治疗子宫后壁肌瘤的过程中即刻判断消融效果的价值。方法将2012年1~12月在该院就诊的48例子宫后壁肌瘤患者(共77个肌瘤),分为超声造影组(25例,共42个肌瘤)和非造影组(23例,共35个肌瘤)。比较两组HIFU治疗后即刻和治疗后2d的肌瘤体积变化、消融率、血流灌注情况及不良反应。结果造影组和非造影组肌瘤在HIFU治疗后即刻经六氟化硫微泡造影显示非灌注区体积分别为19.5(18.2)cm3和22.5(14.5)cm3,平均消融体积分别为20.6(19.0)cm3和23.5(15.0)cm3,消融率分别为(78±18)%和(87±13)%,术后2d非灌注区体积分别为18.6(18.2)cm3和19.5(18.7)cm3,平均消融体积分别为19.7(16.2)cm3和20.8(17.3)cm3,消融率分别为(85.7±15.2)%和(87.6±8.0)%,两组术后即刻和术后2d非灌注区体积、瘤体体积及消融率差异无统计学意义(P>0.05),非造影组骶尾部疼痛发生率明显高于造影组(72.00%vs.30.43%),差异有统计学意义(P<0.05)。结论六氟化硫微泡超声造影是一种准确评价HIFU消融效果的方法,可安全用于HIFU术中即刻评价子宫后壁肌瘤消融效果,缩短HIFU治疗时间,且不良反应更小。%Objective To evaluate the role of contrast enhanced ultrasound in treatment of ultrasound guided high intensity fo‐cused ultrasound ablation for uterine fibroids .Methods Forty eight women with uterine fibroids were allocated into contrast en‐hanced group(25cases ,42fibroids) and non contrast enhanced group(23 cases ,35 fibroids) .The average volume of fibroids and the non perfused volume and the fractional ablation and adverse effects between the tow groups were compared .Results Non perfused volume was observed in all fibroids of the two groups after high

  10. 高强度聚焦超声对手术去势后前列腺癌患者抗肿瘤免疫功能的影响%How high intensity focused ultrasound affect the body anti-tumor immunity of prostate cancer patients after surgical castration

    Institute of Scientific and Technical Information of China (English)

    徐磊; 王国民; 武睿毅; 张博恒

    2009-01-01

    目的 探讨高强度聚焦超声(high intensity focused ultrasound,HIFU)对中晚期前列腺癌患者手术去势治疗后机体抗肿瘤免疫功能的影响.方法 2007年9月至2008年1月在复旦大学附属中山医院行手术去势治疗的中晚期前列腺癌患者23例随机分为2组,HIFU组为去势手术后行HIFU治疗12例,对照组为单纯去势手术11例.HIFU组平均年龄为(70.92±2.04)岁,初始PSA为(117.75±40.93)ng/mL;对照组平均年龄为(73.27±1.31)岁,初始PSA为(119.44±44.68)ng/mL.所有患者分别于治疗前和治疗后抽取静脉血5 mL,两次抽血时间间隔约6周.检测项目包括CD19+、CD4+CD25+Foxp3+调节性T细胞、VEGF、TGF-β1、IFN-γ和IL-2.HIFU组与对照组治疗前后对照采用Wilcoxon秩和检验(Wilcoxon rank sum test),两组差值对照取对数采用t检验,取P<0.05有统计学差异.结果 HIFU组患者HIFU治疗后TGF-β1(P=0.046)显著降低,CD19+治疗前后无变化,IFN-γ和IL-2较治疗前上升,VEGF较治疗前下降,但均无显著差异.对照组患者去势术后CD4+CD25+Foxp3+调节性T细胞显著上升(P=0.020),CD19+、IFN-γ和IL-2较前下降,VEGF和TGF-β1比治疗前上升,但均无显著差异.HIFU组治疗前后差值与对照组治疗前后差值比较,IL-2(P=0.0151)呈显著上升,CD4+CD25+Foxp3+调节性T细胞(P=0.023 0)、VEGF (P=0.001 7)和TGF-β1(P=0.000 6)呈显著降低.结论 HIFU治疗可在一定程度上提高去势术后前列腺癌患者的机体抗肿瘤功能,其机制可能通过降低机体免疫抑制和分泌免疫促进因子等实现.

  11. High intensity focused ultrasound affect the body anti-tumor immune indexes of intermediate and advanced prostate cancer patients after castration%高强度聚焦超声对中晚期前列腺癌患者去势治疗后机体免疫指标的影响

    Institute of Scientific and Technical Information of China (English)

    吴同胜; 谭卫林; 肖平; 付俊; 吴云

    2014-01-01

    背景与目的:高强度聚焦超声(high intensity focused ultrasound,HIFU)可以有效治疗前列腺癌,但肿瘤是一种全身性的疾病,理想的肿瘤治疗方法是能够在不损伤正常组织的同时进行局部肿瘤切除,还能够激活全身的抗肿瘤免疫反应.本研究旨在探讨HIFU治疗对去势治疗后中晚期前列腺癌患者机体免疫指标的影响.方法:行去势治疗的中晚期前列腺癌患者40例,随机分为2组,HIFU组为去势治疗后2周行HIFU治疗(n=20),对照组为单纯去势治疗(n=20),全部经直肠前列腺穿刺病理检查确诊,均为晚期前列腺癌患者,即前列腺特异性抗原(prostate specific antigen,PSA) >20 ng/mL.患者自愿接受HIFU治疗并签署知情同意书.HIFU组与对照组患者平均年龄(72.56±12.38)岁、(75.23±9.35)岁(P=0.446 3);初始PSA为(105.22±20.55) ng/mL、(100.53±18.38) ng/mL (P=0.451 5).分别取治疗前和治疗后2周前列腺癌患者外周血6d,检测T淋巴细胞亚群(CD4+、CD8+、CD4+/CD8+)和外周血Th细胞因子(IFN-γ、IL-2、IL-4、IL-10).结果:HIFU组患者治疗后CD4+百分比及CD4+/CD8+比值明显升高;细胞因子IFN-γ、IL-2水平明显增高,而IL-4、IL-10水平明显降低,与治疗前相比差异有统计学意义(P<0.05),Th1/Th2平衡向Th1漂移.而对照组患者治疗前、后各项免疫指标差异无统计学意义(P>0.05).HIFU组与对照组前、后各项免疫指标差值比较差异有统计学意义(P<0.05).结论:HIFU治疗可在近期内改善去势治疗后中晚期前列腺癌患者机体免疫功能.

  12. Analysis on mechanism of outcome of residual uterine fibroid tissue after high intensity focused ultrasound ablation%探讨高强度聚焦超声消融后残余子宫肌瘤组织转归的机制

    Institute of Scientific and Technical Information of China (English)

    秦娟; 陈锦云; 王琦; 彭松; 胡亮; 刘政; 王智彪

    2012-01-01

    Objective To analyze the mechanism of outcome of residual uterine fibroid tissue after high intensity focused ultrasound (HIFU) ablation by detecting the expression of estrogen receptor (ER) and progesterone receptor (PR) as well as P450 aromatase on different sites of uterine fibroid tissue outside the ablated areas. Methods MR-guided HIFU ablation was performed on 8 uterine fibroid samples under the acoustic power of 400 W for 60 s. During ablation, temperature elevation was monitored by MR system. The experimental fibroid tissue was taken at 0. 5 (A) , 1. 0 (B) , 1. 5 cm (C) outside necrotic tissue after ablation respectively, and the controls were selected from the uterine fibroids before ablation. Immuno-histochemistry was applied to detect the expression of ER, PR and P450 aromatase, and Western-blot was applied for semi-quantitative detection of P450 aromatase protein. Results Different degrees of temperature elevation outside ablated area were shown on temperature maps. The expression of ER and PR at point A, B and C were similar to the control group. The level of P450 aromatase protein at point A, B was significantly lower than that of control group (P<0. 05) proved by immunohistochemical detection and Western-blot. Conclusion The mechanism on inhibition of residual uterine fibroids within certain range after ultrasound ablation may be related to the expression of P450 aromatase protein affected by temperature.%目的 分析超声消融对靶区外不同位点子宫肌瘤组织雌、孕激素受体以及芳香化酶的表达情况,探讨残余子宫肌瘤的转归的可能机制.方法 采用MR引导下高强度聚焦超声(HIFU)肿瘤治疗系统消融8个子宫肌瘤,声功率400 W,辐照时间60 s,以MR检测靶区外子宫肌瘤组织的升温情况.治疗前取1 cm×1 cm子宫肌瘤组织为对照组.辐照完毕后取靶区外0.5 cm、1.0 cm、1.5 cm处子宫肌瘤组织.以免疫组化法检测超声消融靶区边缘雌、孕

  13. 超声造影在高强度聚焦超声治疗子宫肌瘤中的作用评价%Contrast-enhanced Ultrasound in Treatment of Ultrasound-guided High Intensity Focused Ultrasound Ablation for Uterine Fibroids

    Institute of Scientific and Technical Information of China (English)

    谢斌; 王亚琴; 左鹏; 张昕; 何敏; 何佳

    2013-01-01

    Objective To evaluate the role of contrast-enhanced ultrasound (CEUS) in the treatment of ultrasound-guided high intensity focused ultrasound (HIFU) for uterine fibroids.Methods A total of 72 patients with 92 uterine fibroids were both evaluated with CEUS and MRI during and after HIFU treatment.Results The size of fibroids,the volume,the non-perfused volume,and non-perfused volume ratio detected on CEUS vs.MRI were (4.87±2.12) cm vs.(4.85±2.11) cm,(71.1±89.1) cm3 vs.(74.1±91.7) cm3,(59.1±83.4) cm3 vs.(59.2±89.6) cm3,(83.8±26.5) % vs.(83.1±21.6) %,respectively.No statistically difference was observed between them (P>0.05).The correlation analysis showed that there was close relationship between the results from CEUS and MRI.The adverse effects occurred in the treatment were not related to CEUS.Conclusions CEUS is an accurate method in assessing the treatment effect of HIFU and could be safely used during HIFU treatment for uterine fibroids.%目的 通过与磁共振成像(MRI)结果比较,评价超声造影(CEUS)在高强度聚焦超声(HIFU)治疗子宫肌瘤过程中实时判断消融效果的价值.方法 对72例子宫肌瘤患者92个肌瘤行HIFU治疗的同时行CEUS和MRI检查.结果 CEUS与MRI检查结果比较,治疗前肌瘤最大径,肌瘤体积,非灌注区体积,肌瘤消融率分别为(4.87±2.12) cm比(4.85±2.11) cm,(71.1±89.1) cm3比(74.1±91.7) cm3,(59.1±83.4) cm3比(59.2±89.6) cm3,(83.8±26.5)%比(83.1±21.6)%;2种检查方法所测定各指标间无统计学差异(P>0.05).CEUS与术后MRI检查的各指标分别具有高度相关性.术中出现的所有副反应与CEUS无关.结论 CEUS是一种准确评价HIFU消融效果的方法,可安全用于HIFU术中实时评价子宫肌瘤消融效果.

  14. Safety and effectiveness of high-intensity focused ultrasound ablation for liver tumor adjacent to rabbit abdominal aorta%高强度聚焦超声消融兔腹主动脉旁肝肿瘤的安全性和有效性

    Institute of Scientific and Technical Information of China (English)

    税莲; 何敏; 刘映江; 龚春梅; 张炼

    2014-01-01

    目的:观察高强度聚焦超声消融兔腹主动脉旁肝肿瘤后肝肿瘤剂量学、磁共振图像、病理学及生存期影响,评价HIFU消融兔腹主动脉旁肝肿瘤安全性和有效性。方法:分别于HIFU组(32只)和对照组(20只)实验兔建立腹主动脉旁的VX2肝肿瘤模型,HIFU组瘤兔于MR引导的高强度聚焦超声消融肿瘤,分析腹主动脉旁肿瘤消融剂量学,MR观察消融前后肿瘤影像学变化,病理学观察肿瘤消融后坏死情况,对比观察HIFU组与对照组瘤兔生存期。结果:MRI和病理学均表明MR引导下HIFU能完全消融兔腹主动脉旁VX2肝肿瘤,EEF为25.72±11.40 J/mm3 HIFU组的生存期明显高于对照组,差异具有统计学意义(P<0.05)。结论:HIFU能安全有效消融兔腹主动脉旁VX2肝肿瘤并且能明显提高存活期。%Objective:To evaluate the safety and efficacy of high-intensity focused ultrasound (HIFU) ablation for the VX2 liver tumor near the hepatic main blood vessels of rabbits by using dosimetry and magnetic resonance imaging (MRI) and by analyzing path-ological changes and survival. Methods:Rabbits with VX2 liver tumor adjacent to the abdominal aorta were divided into the HIFU (n=32) and control groups (n=20). MRI-guided HIFU was employed for the ablation of the liver tumor in the HIFU group. The ablation vol-ume and the energy efficiency factor (EEF) of the 32 ablated rabbits were further analyzed. MRI and pathology were used to compare the changes in the tumor before and after HIFU. The survival of the animals in the HIFU and control groups was also determined. Re-sults: Both pathology and imaging showed that the rabbit liver VX2 tumor adjacent to the abdominal aorta was completely ablated, with an EEF of (25.72±11.40) J/mm3. The survival rate was significantly higher in the HIFU group than in the control group (P<0.05). Conclusion: HIFU ablation is safe and effective in rabbit VX2 liver tumor near the abdominal

  15. 常规MRI在子宫肌瘤超声消融疗效评价及随访中的价值%High-intensity focused ultrasound ablation for hysteromyoma:Role of routine MR techniques in evaluation the therapeutic effect and follow up

    Institute of Scientific and Technical Information of China (English)

    刘映江; 王智彪; 刘仙明; 彭松; 吕发金; 何敏; 黄秀; 张炼; 陈文直; 白晋

    2011-01-01

    目的 探讨常规MRI在评价超声消融治疗子宫肌瘤疗效及随访中的价值.方法 回顾性分析158例经超声消融治疗后6个月内接受MR检查的子宫肌瘤患者.所有患者均接受FS TSE T2W序列及增强前后T1W VIBE FS序列成像.分析超声消融后肌瘤的MR平扫图像信号改变,并与增强图像进行比较,观察信号变化规律,计算信号变化区域的体积及其相关性.结果 超声消融治疗后,VIBE FS T1WI上子宫肌瘤高信号区域与增强后所测坏死区域一致,二者间体积差异无统计学意义.单变量分析发现平扫VIBE FS T1WI上高信号区域的体积与增强图像上坏死区域的体积呈高度相关(r=0.99,P<0.001).FS TSE T2WI可以确定子宫肌瘤的边界、大小.结论 常规MR平扫可准确评价超声消融治疗子宫肌瘤的疗效,T2WI可确定子宫肌瘤的边界、大小,T1WI可准确测最肌瘤坏死区域的体积.%Objective To observe the value of curative evaluation and follow up of ultrasound imaging-guided high-intensity focused ultrasound (HIFU) ablation for hysteromyoma. Methods MR images of 158 patients with uterine fibroids who underwent HIFU ablation were reviewed retrospectively within 6 months after operation. Images of FS TSE T2Wt plain and contrast-enhanced T1W VIBE FS were obtained in all patients. The signal changes of hysteromyoma in plain MR images after treatment were analyzed, and compared with enhanced MR images. The volumes of signal change areas were calculated. Results After HIFU ablation, hyperintense areas in plain MR images were consistent with the areas of necrosis in enhanced MR images (VIBE sequence). High correlation was observed in volume between hyperintense areas in plain MR images and the areas of necrosis in enhanced MR images with univariate analysis (r=0. 99, P<0. 001). The border and size of hysteromyoma were observed in FS TSE T2WI. Conclusion Conventional plain MRI is useful in evaluating the response of uterine fibroids

  16. Implementation of Fuzzy Logic controller in Photovoltaic Power generation using Boost Converter and Boost Inverter

    Directory of Open Access Journals (Sweden)

    Abubakkar Siddik A

    2012-06-01

    Full Text Available Increasing in power demand and shortage of conventional energy sources, researchers are focused on renewable energy. The proposed solar power generation circuit consists of solar array, boost converter and boost inverter. Low voltage, of photovoltaic array, is boosted using dc-dc boost converter to charge the battery and boost inverter convert this battery voltage to high quality sinusoidal ac voltage. The output of solar power fed from boost inverter feed to autonomous load without any intermediate conversion stage and a filter. For boost converter operation duty cycle is varied through fuzzy logic controller and PWM block to regulate the converter output voltage. The ac voltage total harmonic distortion (THD obtained using this configuration is quite acceptable. The proposed power generation system has several desirable features such as low cost and compact size as number of switches used, are limited to four as against six switches used in classical two-stage inverters.

  17. 磁共振引导高强度聚焦超声消融犬肾上腺的可行性研究%Experimental study on MRI-guided high-intensity focused ultrasound ablation of adrenal glands in dogs

    Institute of Scientific and Technical Information of China (English)

    唐颖; 朱悫; 刘映江; 周莹莹; 邓昌明; 刘地川; 江永红; 黄晶

    2012-01-01

    目的 探讨磁共振(magnetic resonance imaging,MRI)引导高强度聚焦超声(high intensity focused ultrasound,HIFU)体外消融肾上腺的可行性.方法 16只体质量9~13 kg的健康杂种犬,随机分为对照组(n=4)、相对低能量HIFU消融组(声功率200 W组,n=6)、相对高能量HIFU消融组(声功率400 W组,n=6),在MRI引导下消融左侧肾上腺.术后利用MRI增强造影,观察肾上腺消融情况以及周围脏器损伤情况.术后每天动态监测各组血液中皮质醇、醛固酮激素的含量.5d后处死实验犬,对左侧肾上腺进行大体及病理学观察,评估200、400W声功率下肾上腺消融面积以及消融比的差异.结果 HIFU消融术后犬生命体征平稳,MRI增强造影可见消融区域肾上腺信号明显减低,周围脏器组织未见明显信号异常.大体观察可见左侧肾上腺头部和尾部出血、肿胀及部分液化,消融区域皮肤及肾上腺周围脏器均未见明显损伤.病理检查可见消融区域肾上腺出现凝固性坏死灶,与周围组织分界清楚.400W组消融灶数量要明显多于200 W组的消融灶.200 W组消融灶面积为(1.8±0.3)cm2,消融比率为(40.3±18.1)%;400 W组消融灶面积为(2.7 ± 0.6)cm2,消融比率为(60.3±23.3)%,2组间消融面积和消融比率差异有统计学意义(P<0.05).术后第1天与对照组相比,血液中皮质醇及醛固酮出现一过性升高,第2天开始出现下降趋势,第4~5天趋于稳定.2声功率组激素含量从第3天开始均与对照组存在统计学差异(P<0.05).结论 MRI引导HIFU技术可以实现活体动物肾上腺消融,消融范围可控,在肾上腺疾病外科无创治疗方面可能有应用前景.%Objective To evaluate the feasibility of extracorporeal ablation of adrenal glands by magnetic resonance imaging (MRI)-guided high-intensity focused ultrasound (HIFU). Methods Sixteen healthy mongrel dogs weighing 9 - 13 kg were randomly divided into a control group, a low

  18. Beam halo in high-intensity beams

    International Nuclear Information System (INIS)

    In space-charge dominated beams the nonlinear space-charge forces produce a filamentation pattern, which in projection to the 2-D phase spaces results in a 2-component beam consisting of an inner core and a diffuse outer halo. The beam-halo is of concern for a next generation of cw, high-power proton linacs that could be applied to intense neutron generators for nuclear materials processing. The author describes what has been learned about beam halo and the evolution of space-charge dominated beams using numerical simulations of initial laminar beams in uniform linear focusing channels. Initial results are presented from a study of beam entropy for an intense space-charge dominated beam

  19. Boosting foundations and algorithms

    CERN Document Server

    Schapire, Robert E

    2012-01-01

    Boosting is an approach to machine learning based on the idea of creating a highly accurate predictor by combining many weak and inaccurate "rules of thumb." A remarkably rich theory has evolved around boosting, with connections to a range of topics, including statistics, game theory, convex optimization, and information geometry. Boosting algorithms have also enjoyed practical success in such fields as biology, vision, and speech processing. At various times in its history, boosting has been perceived as mysterious, controversial, even paradoxical.

  20. Device to color modulate a stationary light beam gives high intensity

    Science.gov (United States)

    Gantz, W. A.

    1966-01-01

    Signal controlled system color modulates a beam of light while also providing high intensity and a stationary beam, either collimated or focused. The color modulation acquired by the presented system can be compatible with any color film by employing color filters formed to provide a color wedge having a color distribution compatible with the films color sensitivity.

  1. 去势联合高强度聚焦超声治疗晚期前列腺癌对患者生存及免疫状态的影响%The influence of castration in combination with high intensity focused ultrasound treatment on survival and immune state of patients with advanced prostate cancer

    Institute of Scientific and Technical Information of China (English)

    武睿毅; 王国民; 徐磊; 徐叶青

    2012-01-01

    Objective: To explore the influence of castration in combination with high intensity focused ultra-sound(HIFU) treatment on survival and immune state of patients as local therapy for advanced prostate cancer. Method:Between March 2000 and December 2010, we performed a prospective,controlled,and nonrandomized stud-y on 64 patients with advanced PCa after hormonal therapy. 30 cases in control group received hormonal therapy a-lone.and 34 cases in H1FU group received HIFU treatment following castration. To make survival analyses by the method of Kaplan-Meier survival curves and calculating survival rates. Some patients(control group 11 cases, HIFU group 12 cases)were detected the immunity index of peripheral blood before and after treatments, including IL-2, IFN-γ. VEGF,TGF-β1 and CD4 + CD25+ Foxp3+ cell. Result:The 3-year and 5-year survival rates of control group were 45. 19% and 25. 83%.and those of HIFU group were 76. 92% and 51. 26%. There was significant difference between two groups in survival curve( P =0. 0404). Compared with control group,IL-2( P =0. 042)and IFN-γ( P = 0. 019)level of peripheral blood in HIFU group significantly rose,and VEGF( P =0. 032) ,TGF-β1( P =0. 042) level and CD4+ CD25+ Foxp3+ ( % ) ( P =0. 001) significantly decreased. Conclusion: After castration treatment for advanced prostate cancer,combination with HIFU to strengthen local control of primary lesions could enhanced the therapeutic response of patients to hormone therapy, also improved systemic immune state, significantly prolonged the survival time of patients.%目的:探索晚期前列腺癌(prostate cancer,PCa)去势后,联合高强度聚焦超声(HIFU)局部治疗原发灶对患者生存和免疫状态的影响.方法:我院于2000年3月~2010年12月对64例晚期PCa去势手术后的患者进行前瞻性对照非随机研究,对照组30例接受单纯内分泌治疗,HIFU组34例去势后联合HIFU治疗.绘制两组患者的Kaplan-Meier生存曲线和并计算生存

  2. 超声引导高强度聚焦超声治疗肌壁间子宫肌瘤的效果%Efficacy of US-guided high-intensity focused ultrasound ablation for the treatment of intramural leiomyoma

    Institute of Scientific and Technical Information of China (English)

    侯静; 刘晟; 梁琪; 廖云杰

    2013-01-01

    Objective To explore the efficacy of US-guided high-intensity focused ultrasound (HIFU) ablation for the treatment of intramural leiomyoma, and to observe the difference of ablation rate between anterior and posterior intramural leiomyoma. Methods Fifty-four patients with intramural leiomyoma diagnosed by MRI were enrolled, who underwent US-guided HIFU ablation. The day or the next day and 3 months after ablation, the volume of the non-perfused fibroids was observed on contrast-enhanced MRI to calculate the ablation rate. The treatment outcome was divided into three categories: Excellent (ablation rate≥50%), effective (0

  3. Evaluation of contrast-enhanced ultrasound in treatment of ultrasound-guided high intensity focused ultrasound ablation for uterine adenomyosis%超声造影评价高强度聚焦超声治疗子宫腺肌病效果

    Institute of Scientific and Technical Information of China (English)

    秦瑞英; 王艳敏; 华彩虹; 王世进; 侯瑞杰; 郭会敏

    2014-01-01

    目的:评价超声造影(CEUS)在高强度聚焦超声(HIFU )消融治疗子宫腺肌病过程中实时判断效果的应用及价值。方法2013年1~9月,将临床确诊的67例子宫腺肌病患者纳入本研究,其中弥散型腺肌病患者49例,局限型18例。在超声治疗前、治疗中及治疗后即刻行CEUS ,明确病灶情况及行消融效果评价。结果67例患者术前CEUS ,病灶及子宫明显灌注率100%;15例(22.4%)患者第一次结束治疗后行CEUS ,消融欠满意,继续治疗;所有患者在最终治疗结束后CEUS显示全部患者出现凝固性坏死。术中42例(62.7%)出现整体灰度变化,25例(37.3%)出现团块状灰度变化。HIFU术中CEUS能清楚显示腺肌病灶及治疗后的非灌注区。CEUS检查示治疗前病灶最大径、病灶体积、非灌注区体积、腺肌病灶消融率分别为(4.8±1.5)cm、(63.1±57.2)cm3、(59.1±53.4)cm3、(76.4±27.0)%。术中出现的所有不良反应与CEUS无关。结论 CEUS是一种准确评价HIFU消融效果的方法,可安全用于HIFU术中实时评价子宫腺肌病消融效果。%Objective To evaluate the effect of contrast-enhanced ultrasound(CEUS) in the real-time monitoring treatment of ultrasound-guided high intensity focused ultrasound (HIFU ) for uterine adenomyosis .Methods From January 2013 to September 2013 ,a total of 67 patients who were clinically diagnosticated as uterine adenomyosis were enrolled in this study .49 patients were diffuse type and 18 patients were localized .CEUS was used before ,in ,after ultrasonic treatment to make sure lesions and evaluate the ablation effect .Results 67 patients were 100% perfused before HIFU treatment by CEUS ,the non-perfused volume ratio of 15 patients(22 .4% ) were not enough during treatment ,and more energy were given .During HIFU treatment ,uniform grey scale change was observed in 42 of 67(62 .7% ) patients and

  4. Bunching high intensity proton beams with a CH-DTL

    Energy Technology Data Exchange (ETDEWEB)

    Schwarz, Malte; Claessens, Christine; Heilmann, Manuel; Hinrichs, Ole; Koser, Daniel; Meusel, Oliver; Noll, Daniel; Podlech, Holger; Ratzinger, Ulrich; Seibel, Anja [Institut fuer Angewandte Physik, Goethe-Universitaet Frankfurt am Main (Germany)

    2014-07-01

    The Frankfurt Neutron Source at the Stern-Gerlach-Zentrum (FRANZ) will provide ultra short neutron pulses at high intensities and repetition rates. The facility is under construction with an expected first beam by the end of 2014. A 5-Gap CH rebuncher is installed behind a coupled RFQ/IH-DTL combination at the end of the LINAC section between two magnetic quadrupole triplets. It will be used for varying the final energy between 1.8 and 2.2 MeV, as well as for focusing the proton beam bunch longitudinally, to compensate RF defocusing effects and huge space charge forces at currents up to 200 mA at the final stage of extension. Therefore high current beam dynamic simulations are in progress. They include benchmarking of different beam dynamic codes like LORASR, TraceWin and Bender (a new PIC tracking code developed at IAP), as well as validating the results by measurements. Detailed error tolerance studies, thermal simulations and examination of multipole field impact, due to the cavity geometry, are also done. Furthermore, this CH rebuncher serves as prototype for CH cavity operation at MYRRHA (Belgium), an Accelerator Driven System (ADS) for transmutation of high level nuclear waste. After copper-plating the cavity, RF conditioning will start in spring 2014.

  5. Bunching high intensity proton beams with a CH-DTL

    International Nuclear Information System (INIS)

    The Frankfurt Neutron Source at the Stern-Gerlach-Zentrum (FRANZ) will provide ultra short neutron pulses at high intensities and repetition rates. The facility is under construction with an expected first beam by the end of 2014. A 5-Gap CH rebuncher is installed behind a coupled RFQ/IH-DTL combination at the end of the LINAC section between two magnetic quadrupole triplets. It will be used for varying the final energy between 1.8 and 2.2 MeV, as well as for focusing the proton beam bunch longitudinally, to compensate RF defocusing effects and huge space charge forces at currents up to 200 mA at the final stage of extension. Therefore high current beam dynamic simulations are in progress. They include benchmarking of different beam dynamic codes like LORASR, TraceWin and Bender (a new PIC tracking code developed at IAP), as well as validating the results by measurements. Detailed error tolerance studies, thermal simulations and examination of multipole field impact, due to the cavity geometry, are also done. Furthermore, this CH rebuncher serves as prototype for CH cavity operation at MYRRHA (Belgium), an Accelerator Driven System (ADS) for transmutation of high level nuclear waste. After copper-plating the cavity, RF conditioning will start in spring 2014.

  6. ELECTRON CLOUD EFFECTS IN HIGH INTENSITY PROTON ACCELERATORS.

    Energy Technology Data Exchange (ETDEWEB)

    WEI,J.; MACEK,R.J.

    2002-04-14

    One of the primary concerns in the design and operation of high-intensity proton synchrotrons and accumulators is the electron cloud and associated beam loss and instabilities. Electron-cloud effects are observed at high-intensity proton machines like the Los Alamos National Laboratory's PSR and CERN's SPS, and investigated experimentally and theoretically. In the design of next-generation high-intensity proton accelerators like the Spallation Neutron Source ring, emphasis is made in minimizing electron production and in enhancing Landau damping. This paper reviews the present understanding of the electron-cloud effects and presents mitigation measures.

  7. High intensity electron cyclotron resonance proton source for low energy high intensity proton accelerator

    Energy Technology Data Exchange (ETDEWEB)

    Roychowdhury, P.; Chakravarthy, D. P. [Accelerator and Pulse Power Division, Bhabha Atomic Research Centre, Mumbai 400085 (India)

    2009-12-15

    Electron cyclotron resonance (ECR) proton source at 50 keV, 50 mA has been designed, developed, and commissioned for the low energy high intensity proton accelerator (LEHIPA). Plasma characterization of this source has been performed. ECR plasma was generated with 400-1100 W of microwave power at 2.45 GHz, with hydrogen as working gas. Microwave was fed in the plasma chamber through quartz window. Plasma density and temperature was studied under various operating conditions, such as microwave power and gas pressure. Langmuir probe was used for plasma characterization using current voltage variation. The typical hydrogen plasma density and electron temperature measured were 7x10{sup 11} cm{sup -3} and 6 eV, respectively. The total ion beam current of 42 mA was extracted, with three-electrode extraction geometry, at 40 keV of beam energy. The extracted ion current was studied as a function of microwave power and gas pressure. Depending on source pressure and discharge power, more than 30% total gas efficiency was achieved. The optimization of the source is under progress to meet the requirement of long time operation. The source will be used as an injector for continuous wave radio frequency quadrupole, a part of 20 MeV LEHIPA. The required rms normalized emittance of this source is less than 0.2 {pi} mm mrad. The simulated value of normalized emittance is well within this limit and will be measured shortly. This paper presents the study of plasma parameters, first beam results, and the status of ECR proton source.

  8. A comparative study of complete ablation rate of ifbroid with different grade of blood supply using radio frequency and high-intensity focused ultrasound%高强度聚焦超声和射频消融治疗不同等级血供子宫肌瘤的疗效比较

    Institute of Scientific and Technical Information of China (English)

    孟欣; 李剑平; 郑敏娟; 何光彬; 方玲; 刘丹; 周晓东

    2013-01-01

    Objective To compare the complete ablation rate of radiofrequency (RF) ablation and high-intensity focused ultrasound (HIFU) in the treatment of uterine ifbroids with different blood supply. Methods One hundred and ten patients with 146 uterine ifbroids in Xijing Hospital of the Fourth Military Medical University from January 2009 to December were randomly divided into two groups and treated with HIFU or RF respectively. Each group had 55 patients. All patients were examined by color Doppler lfow imaging before the treatment. The blood supply of ifbroids were semi-quantitatively classiifed into three grades including G1, G2 and G3. The HIFU group had 15 patients with 20 ifbroids in which blood supply was G1, had 32 patients with 38 ifbroids in which blood supply was G2, and had 8 patients with 10 ifbroids in which blood supply was G3. The RF group had 14 patients with 18 ifbroids in which blood supply was G1, had 31 patients with 42 ifbroids in which blood supply was G2, and had 10 patients with 18 ifbroids in which blood supply was G3. The complete ablation rates of the two treatments were evaluated by contrast-enhanced ultrasound one week before and after treatments. Fibroids which had no contrast agent perfusion and smooth boundary were completely ablated. Statistical analyses were used to compare the complete ablation rates and postoperative complications rates of these two methods. Results When ifbroid′s blood supply was G1, the complete ablation rate was 80.0%(16/20) and 88.9%(16/18) in HIFU and RF group, respectively. The difference was not statistically signiifcant (χ2=0.563, P>0.05). When ifbroid′s blood supply was G2 and G3, the complete ablation rate in HIFU and RF group was 90.5%(38/42) vs 55.3%(21/38) and 72.2% (13/18) vs 20.0% (2/10), respectively. There was statistically difference between these two groups (χ2 =12.778, P < 0.05;χ2=7.049, P < 0.05, respectively). Postoperative complications included fever, abdominal pain, pelvic effusion and

  9. Acute psychological effects of one high intensity exercise

    OpenAIRE

    Kleppe, Kim Daniel

    2011-01-01

    The aim of this study was to examine if there are positive acute mood effects of one high intensity exercise. Method: self-completion questionnaires were used to measure the state mood of the participants. 20 persons with a diagnosis of a psychotic disorder (group one), 22 persons with a psychiatric diagnosis of a non-psychotic disorder (group two) and 20 persons with no psychiatric disorder (group three) performed one high intensity exercise while completing the same questionnaire before and...

  10. Concept for a new high resolution high intensity diffractometer

    Energy Technology Data Exchange (ETDEWEB)

    Stuhr, U. [Paul Scherrer Inst. (PSI), Villigen (Switzerland)

    1997-09-01

    A concept of a new time-of-flight powder-diffractometer for a thermal neutral beam tube at SINQ is presented. The design of the instrument optimises the contradictory conditions of high intensity and high resolution. The high intensity is achieved by using many neutron pulses simultaneously. By analysing the time-angle-pattern of the detected neutrons an assignment of the neutrons to a single pulse is possible. (author) 3 figs., tab., refs.

  11. Analgesic Effect of High Intensity Laser Therapy in Knee Osteoarthritis

    OpenAIRE

    Štiglić-Rogoznica, Nives; Stamenković, Doris; Frlan-Vrgoč, Ljubinka; Avancini-Dobrović, Viviana; Schnurrer-Luke Vrbanić, Tea

    2011-01-01

    Knee osteoarthritis (KOA), the most common type of osteoarthritis (OA), is associated with pain and inflammation of the joint capsule, impaired muscular stabilization, reduced range of motion and functional disability. High-intensity laser therapy (HILT) involves higher-intensity laser radiation and causes minor and slow light absorption by chromophores. Light stimulation of the deep structures, due to high intensity laser therapy, activates cell metabolism through photochemical e...

  12. Effect of high intensity ultrasound on the allergenicity of shrimp

    Institute of Scientific and Technical Information of China (English)

    2006-01-01

    The tropomyosin fraction of shrimp proteins is potentially responsible for allergic reaction in individuals with genetic predisposition to allergy. However, there are no efficient and safe methods to reduce its allergenicity. High intensity ultrasound is known to change the structure of proteins. This study is aimed at assessing high intensity ultrasound's effect on the allergenicity of shrimp allergen. Shrimp and purified shrimp allergen were treated with high intensity ultrasound for 30~180 min. Extracts of treated samples were analyzed by enzyme-linked immunosorbent assay (ELISA) with pool serum of shrimp allergy patients and polyclonal anti-allergen antibodies and by immunoblotting after polyacrylamide gel electrophoresis. Shrimp treated with high intensity ultrasound showed a decrease in allergenicity measured with ELISA. A linear relationship between the immune response induced by treated shrimp allergen and the applied treatment time was observed. The decrease in allergenicity was confirmed by immunoblot assays with shrimp allergic patients serum. Allergenicity of shrimp allergen extracted from treated shrimp was higher than that of purified shrimp allergen with the same treatment time. Gel-filtration HPLC was applied for analysis of shrimp allergen after treatment with high intensity ultrasound. Some fractions were appeared with increasing treatment time. The results suggested that high intensity ultrasound could be used to reduce the allergenicity of shrimp.

  13. Repeated high-intensity exercise in professional rugby union.

    Science.gov (United States)

    Austin, Damien; Gabbett, Tim; Jenkins, David

    2011-07-01

    The aim of the present study was to describe the frequency, duration, and nature of repeated high-intensity exercise in Super 14 rugby union. Time-motion analysis was used during seven competition matches over the 2008 and 2009 Super 14 seasons; five players from each of four positional groups (front row forwards, back row forwards, inside backs, and outside backs) were assessed (20 players in total). A repeated high-intensity exercise bout was considered to involve three or more sprints, and/or tackles and/or scrum/ruck/maul activities within 21 s during the same passage of play. The range of repeated high-intensity exercise bouts for each group in a match was as follows: 11-18 for front row forwards, 11-21 for back row forwards, 13-18 for inside backs, and 2-11 for outside backs. The durations of the most intense repeated high-intensity exercise bouts for each position ranged from 53 s to 165 s and the minimum recovery periods between repeated high-intensity exercise bouts ranged from 25 s for the back row forwards to 64 s for the front row forwards. The present results show that repeated high-intensity exercise bouts vary in duration and activities relative to position but all players in a game will average at least 10 changes in activity in the most demanding bouts and complete at least one tackle and two sprints. The most intense periods of activity are likely to last as long as 120 s and as little as 25 s recovery may separate consecutive repeated high-intensity exercise bouts. The present findings can be used by coaches to prepare their players for the most demanding passages of play likely to be experienced in elite rugby union. PMID:21756130

  14. HiRadMat High Intensity Beam Commissioning

    CERN Document Server

    Blanco Sancho, J; Cornelis, K; Goddard, B; Hessler, C; Jensen, L; Kain, V; Meddahi, M; Theis, C; Vincke, H; Vojtyla, P; Wenninger, J

    2011-01-01

    On Wednesday 14 September and Monday 19 September 2011, high intensity proton beam was sent for the first time down the HiRadMat primary beam line (thereafter TT66), onto the beam dump located in the HiRadMat experimental cavern. This high intensity beam commissioning followed a first period of low intensity beam commissioning which took place in June 2011. During the low intensity beam commissioning, it was checked that all beam line equipment operated as specified. Energy matching and beam steering were performed; optics checks did not reveal any optical errors. Aperture measurements confirmed that there were no bottlenecks. Radiation protection monitoring worked as expected and the measurements were within expectation [1]. With the completion of the HiRadMat ventilation system, the high intensity beam commissioning could successfully continue in September 2011. The main outcome is reported in this note.

  15. Beam diagnostics at high-intensity storage rings

    International Nuclear Information System (INIS)

    Beam diagnostics at high-intensity facilities feature their own special set of problems and characteristics. Issues peculiar to high-intensity storage rings include beam loss, beam halos, extraction efficiency, beam in the gap, clearing electrodes, and beam-profile measurement. The Los Alamos Proton Storage Ring (PSR) is a nice example of a high-intensity storage ring. The author discusses in some detail three diagnostic systems currently in use at the PSR: the beam-loss-monitor system, the electron-clearing system, and the beam-in-the-gap monitor. Much of the discussion is inspired by the problems that were encountered and the useful things learned while commissioning and developing the PSR. Another inspiration is the work on the next-generation neutron-spallation source, also known as the National Center for Neutron Research (NCNR)

  16. High intensity, argon ion laser-jet photochemistry

    Science.gov (United States)

    Wilson, R. Marshall; Schnapp, Karlyn A.; Hannemann, Klaus; Ho, Douglas M.; Memarian, Hamid R.; Azadnia, Ardeshir; Pinhas, Allan R.; Figley, Timothy M.

    A new technique for the study of high intensity solution photochemistry has been developed. With this laser-jet technique, a high velocity microjet is irradiated with the focussed output of an argon ion laser. Under these extremely high intensity conditions, photochemically generated transient species with suitable absorption properties are excited further and produce relatively large amounts of photoproducts which are not observed under low intensity conditions. The application of this laser-jet technique in the study of the photochemistry of radicals, biradicals, photoenols and the higher excited states of carbonyl and polycyclic aromatic compounds is described.

  17. Learning Boost C++ libraries

    CERN Document Server

    Mukherjee, Arindam

    2015-01-01

    If you are a C++ programmer who has never used Boost libraries before, this book will get you up-to-speed with using them. Whether you are developing new C++ software or maintaining existing code written using Boost libraries, this hands-on introduction will help you decide on the right library and techniques to solve your practical programming problems.

  18. A more robust boosting algorithm

    OpenAIRE

    Freund, Yoav

    2009-01-01

    We present a new boosting algorithm, motivated by the large margins theory for boosting. We give experimental evidence that the new algorithm is significantly more robust against label noise than existing boosting algorithm.

  19. Annotated bibliography on high-intensity linear accelerators

    International Nuclear Information System (INIS)

    A technical bibliography covering subjects important to the design of high-intensity beam transport systems and linear accelerators is presented. Space charge and emittance growth are stressed. Subject and author concordances provide cross-reference to detailed citations, which include an abstract and notes on the material. The bibliography resides in a computer database that can be searched for key words and phrases

  20. Pedalling rate affects endurance performance during high-intensity cycling

    DEFF Research Database (Denmark)

    Nielsen, Jens Steen; Hansen, Ernst Albin; Sjøgaard, Gisela

    2004-01-01

    The purpose of this study into high-intensity cycling was to: (1) test the hypothesis that endurance time is longest at a freely chosen pedalling rate (FCPR), compared to pedalling rates 25% lower (FCPR-25) and higher (FCPR+25) than FCPR, and (2) investigate how physiological variables, such as...

  1. High-Intensity Interval Training for Improving Postprandial Hyperglycemia

    Science.gov (United States)

    Little, Jonathan P.; Francois, Monique E.

    2014-01-01

    High-intensity interval training (HIIT) has garnered attention in recent years as a time-efficient exercise option for improving cardiovascular and metabolic health. New research demonstrates that HIIT may be particularly effective for improving postprandial hyperglycemia in individuals with, or at risk for, type 2 diabetes (T2D). These findings…

  2. Simulation study of the high intensity S-Band photoinjector

    Energy Technology Data Exchange (ETDEWEB)

    Zhu, Xiongwei; Nakajima, Kazuhisa [High Energy Accelerator Research Organization, Tsukuba, Ibaraki (Japan)

    2001-10-01

    In this paper, we report the results of simulation study of the high intensity S-Band photoinjector. The aim of the simulation study is to transport high bunch charge with low emittance evolution. The simulation result shows that 7nC bunch with rms emittance 22.3 {pi} mm mrad can be outputted at the exit of photoinjector. (author)

  3. Annotated bibliography on high-intensity linear accelerators. [240 citations

    Energy Technology Data Exchange (ETDEWEB)

    Jameson, R.A.; Roybal, E.U.

    1978-01-01

    A technical bibliography covering subjects important to the design of high-intensity beam transport systems and linear accelerators is presented. Space charge and emittance growth are stressed. Subject and author concordances provide cross-reference to detailed citations, which include an abstract and notes on the material. The bibliography resides in a computer database that can be searched for key words and phrases.

  4. Nonlinear Behavior in High-Intensity Discharge Lamps

    CERN Document Server

    Baumann, Bernd; Wolff, Marcus; Manders, Freddy; Suijker, Jos

    2015-01-01

    The light flicker problem of high intensity discharge lamps is studied numerically and experimentally. It is shown that in some respects the systems behaves very similar to the forced Duffing oscillator with a softening spring. In particular, the jump phenomenon and hysteresis are observed in the simulations and in the experiments.

  5. Nonlinear behavior in high-intensity discharge lamps

    Science.gov (United States)

    Baumann, Bernd; Schwieger, Joerg; Wolff, Marcus; Manders, Freddy; Suijker, Jos

    2016-06-01

    The light flicker problem of high intensity discharge lamps is studied numerically and experimentally. It is shown that in some respects the systems behave very similar to the forced Duffing oscillator with a softening spring. In particular, the jump phenomenon and hysteresis are observed in the simulations and in the experiments.

  6. Direct diagnostic technique of high-intensity laser profile based on laser-compton scattering

    International Nuclear Information System (INIS)

    A high-intensity laser is essential for plasma generation for EUV (Extreme Ultraviolet) lithography, which is studied as the next generation of ultra-fine semiconductor lithography. Nevertheless, there is no way to directly measure profile of high-intensity laser at the present day. Therefore, we have been developing a method for measuring high-intensity laser profile based on the laser-Compton scattering using Cs-Te photo cathode RF-Gun at Waseda University. Specifically, laser profile is obtained by scanning the electron beam which is focused to about 10μm by solenoid lens. We have simulated beam size focused by solenoid lens using tracking code GPT (General Particle Tracer) and optimized the beam parameter to obtain beam size of 10μm. Then, we have installed solenoid lens and generated focused beam. We measured beam size using radiochromic film called GAFCHROMIC dosimetry film type HD-810. In this conference, we will report the result of GPT simulations, beam size measurements, the present progress and future prospects. (author)

  7. Frequency conversion of high-intensity, femtosecond laser pulses

    Energy Technology Data Exchange (ETDEWEB)

    Banks, P S

    1997-06-01

    Almost since the invention of the laser, frequency conversion of optical pulses via non- linear processes has been an area of active interest. However, third harmonic generation using ~(~1 (THG) in solids is an area that has not received much attention because of ma- terial damage limits. Recently, the short, high-intensity pulses possible with chirped-pulse amplification (CPA) laser systems allow the use of intensities on the order of 1 TW/cm2 in thin solids without damage. As a light source to examine single-crystal THG in solids and other high field inter- actions, the design and construction of a Ti:sapphire-based CPA laser system capable of ultimately producing peak powers of 100 TW is presented. Of special interest is a novel, all-reflective pulse stretcher design which can stretch a pulse temporally by a factor of 20,000. The stretcher design can also compensate for the added material dispersion due to propagation through the amplifier chain and produce transform-limited 45 fs pulses upon compression. A series of laser-pumped amplifiers brings the peak power up to the terawatt level at 10 Hz, and the design calls for additional amplifiers to bring the power level to the 100 TW level for single shot operation. The theory for frequency conversion of these short pulses is presented, focusing on conversion to the third harmonic in single crystals of BBO, KD*P, and d-LAP (deuterated I-arginine phosphate). Conversion efficiencies of up to 6% are obtained with 500 fs pulses at 1053 nm in a 3 mm thick BBO crystal at 200 GW/cm 2. Contributions to this process by unphasematched, cascaded second harmonic generation and sum frequency generation are shown to be very significant. The angular relationship between the two orders is used to measure the tensor elements of C = xt3)/4 with Crs = -1.8 x 1O-23 m2/V2 and .15Cri + .54Crs = 4.0 x 1O-23 m2/V2. Conversion efficiency in d-LAP is about 20% that in BBO and conversion efficiency in KD*P is 1% that of BBO. It is calculated

  8. Review of High-intensity Interval Training in Cardiac Rehabilitation.

    Science.gov (United States)

    Ito, Shigenori; Mizoguchi, Tatsuya; Saeki, Tomoaki

    2016-01-01

    For the secondary prevention of cardiovascular disease, comprehensive cardiac rehabilitation is required. This involves optimal medical therapy, education on nutrition and exercise therapy, and smoking cessation. Of these, efficient exercise therapy is a key factor. A highly effective training protocol is therefore warranted, which requires a high rate of compliance. Although moderate-intensity continuous training has been the main training regimen recommended in cardiac rehabilitation guidelines, high-intensity interval training has been reported to be more effective in the clinical and experimental setting from the standpoint of peak oxygen uptake and central and peripheral adaptations. In this review, we illustrate the scientific evidence for high-intensity interval training. We then verify this evidence and discuss its significance and the remaining issues. PMID:27580530

  9. Response of graphene to femtosecond high-intensity laser irradiation

    International Nuclear Information System (INIS)

    We study the response of graphene to high-intensity, 50-femtosecond laser pulse excitation. We establish that graphene has a high (∼3 x 1012 Wcm-2) single-shot damage threshold. Above this threshold, a single laser pulse cleanly ablates graphene, leaving microscopically defined edges. Below this threshold, we observe laser-induced defect formation leading to degradation of the lattice over multiple exposures. We identify the lattice modification processes through in-situ Raman microscopy. The effective lifetime of chemical vapor deposition grown graphene under femtosecond near-infrared irradiation and its dependence on laser intensity is determined. These results also define the limits of non-linear applications of graphene in femtosecond high-intensity regime.

  10. An improved high intensity recycling helium-3 beam source

    International Nuclear Information System (INIS)

    We describe an improved high intensity, recycling, supersonic atomic beam source. Changes address several issues previously limiting performance and reliability of the apparatus, including the use of newly available vacuum pumps and modifications to the recycling system. We achieve a source intensity of 2.5x1019 atoms/s/sr, almost twice that previously achievable during recycling. Current limits on intensity are discussed.

  11. Wet High Intensity Magnetic Separation of Iron Minerals

    OpenAIRE

    Shao, Y.; Veasey, T. J.; Rowson, N. A.

    1996-01-01

    Four different iron minerals were selected for study, and five size fractions of each mineral were prepared. The magnetic properties of these minerals were measured. The effect of particle size and magnetic susceptibility on wet high intensity magnetic separation was studied simultaneously. It was found that hematite—1 was a strongly paramagnetic mineral, and the effect of particle size in WHIMS was not significant. Goethite and limonite were weakly paramagnetic minerals, and could not be eff...

  12. Spallation neutron source and other high intensity froton sources

    Energy Technology Data Exchange (ETDEWEB)

    Weiren Chou

    2003-02-06

    This lecture is an introduction to the design of a spallation neutron source and other high intensity proton sources. It discusses two different approaches: linac-based and synchrotron-based. The requirements and design concepts of each approach are presented. The advantages and disadvantages are compared. A brief review of existing machines and those under construction and proposed is also given. An R&D program is included in an appendix.

  13. High intensity sweeteners chemicals structure, properties and applications

    OpenAIRE

    Ibrahim, Osama O

    2015-01-01

    High Intense-sweeteners (HIS) are commonly used as a sugar substitutes or sugar alternatives and provide sweet without calories. HIS are in high demands due to its multiple advantages including assisting people in losing weight or avoiding obesity and assisting diabetics to control their blood sugar level. The first known intense-sweetener is Saccharine that was discovered in the year 1878. Since then scientists discovered several other intensive sweeteners that are sweater than sucrose with ...

  14. A NEW HIGH-INTENSITY ULTRASONIC TECHNOLOGY FOR FOOD DEHYDRATION

    OpenAIRE

    Gallego Juárez, Juan Antonio; Rodríguez Corral, Germán; Gálvez, J. C.; Yang, T S

    1999-01-01

    At present, there is a growing interest in the field of dehydration for preserving food. Ultrasonic energy represents a means to obtain dehydration without affecting the food. This paper deals with an experimental study about the use of high-intensity ultrasound for vegetable dehydration by using a new power ultrasound generator and a procedure in which ultrasonic vibrations are applied in direct contact with the product and under a certain static pressure. The drying effect of this new proce...

  15. An improved high intensity recycling helium-3 beam source.

    Science.gov (United States)

    Hedgeland, H; Kole, P R; Allison, W; Ellis, J; Jardine, A P

    2009-07-01

    We describe an improved high intensity, recycling, supersonic atomic beam source. Changes address several issues previously limiting performance and reliability of the apparatus, including the use of newly available vacuum pumps and modifications to the recycling system. We achieve a source intensity of 2.5 x 10(19) atoms/s/sr, almost twice that previously achievable during recycling. Current limits on intensity are discussed. PMID:19655995

  16. Feasibility of high-intensity interval training in cardiac rehabilitation

    OpenAIRE

    Aamot, Inger-Lise

    2013-01-01

    High-intensity interval training (at 85-95% of maximal heart rate) has been found to be a feasible, well-tolerated and time-efficient exercise mode to improve peak oxygen uptake in patients with coronary artery disease, in short term. Most exercise studies, however, are performed during laboratory conditions with strict supervision and monitoring of exercise intensity. In the clinic, the exercise is supervised but with less ability to monitor exercise intensity due to the number of participan...

  17. Energy Stability in a High Intensity Pulsed SC Proton Linac

    OpenAIRE

    Mosnier, Alban

    2000-01-01

    Spallation source dedicated for neutron scattering experiments, as well as multi-purpose facilities serving several applications call for pulsed mode operation of a high intensity proton linac. There is general agreement on the superconducting technology for the high-energy part, which offers some advantages, like higher gradient capabilities or operational costs reduction, as compared to room-temperatures accelerating structures. This mode of operation however could spoil the energy stabilit...

  18. High intensity ion beam injection into the 88-inch cyclotron

    OpenAIRE

    Wutte, Daniela; Clark, Dave J.; Laune, Bernard; Leitner, Matthaeus A.; Lyneis, Claude M.

    2000-01-01

    Low cross section experiments to produce super-heavy elements have increased the demand for high intensity heavy ion beams at energies of about 5 MeV/nucleon at the 88-Inch Cyclotron at the Lawrence Berkeley National Laboratory. Therefore, efforts are underway to increase the overall ion beam transmission through the axial injection line and the cyclotron. The ion beam emittance has been measured for various ion masses and charge states. Beam transport simulations including space charge ...

  19. Beta-alanine supplementation in high-intensity exercise.

    Science.gov (United States)

    Harris, Roger C; Sale, Craig

    2012-01-01

    Glycolysis involves the oxidation of two neutral hydroxyl groups on each glycosyl (or glucosyl) unit metabolised, yielding two carboxylic acid groups. During low-intensity exercise these, along with the remainder of the carbon skeleton, are further oxidised to CO(2) and water. But during high-intensity exercise a major portion (and where blood flow is impaired, then most) is accumulated as lactate anions and H(+). The accumulation of H(+) has deleterious effects on muscle function, ultimately impairing force production and contributing to fatigue. Regulation of intracellular pH is achieved over time by export of H(+) out of the muscle, although physicochemical buffers in the muscle provide the first line of defence against H(+) accumulation. In order to be effective during high-intensity exercise, buffers need to be present in high concentrations in muscle and have pK(a)s within the intracellular exercise pH transit range. Carnosine (β-alanyl-L-histidine) is ideal for this role given that it occurs in millimolar concentrations within the skeletal muscle and has a pK(a) of 6.83. Carnosine is a cytoplasmic dipeptide formed by bonding histidine and β-alanine in a reaction catalysed by carnosine synthase, although it is the availability of β-alanine, obtained in small amounts from hepatic synthesis and potentially in greater amounts from the diet that is limiting to synthesis. Increasing muscle carnosine through increased dietary intake of β-alanine will increase the intracellular buffering capacity, which in turn might be expected to increase high-intensity exercise capacity and performance where this is pH limited. In this study we review the role of muscle carnosine as an H(+) buffer, the regulation of muscle carnosine by β-alanine, and the available evidence relating to the effects of β-alanine supplementation on muscle carnosine synthesis and the subsequent effects of this on high-intensity exercise capacity and performance. PMID:23075550

  20. Enhancement of vasorelaxation in hypertension following high-intensity exercise.

    Science.gov (United States)

    Yang, Ai-Lun; Lo, Chia-Wen; Lee, Jen-Ting; Su, Chia-Ting

    2011-04-30

    Exercise can ameliorate vascular dysfunction in hypertension, but its underlying mechanism has not been explored thoroughly. We aimed to investigate whether the high-intensity exercise could enhance vasorelaxation mediated by insulin and insulin-like growth factor-1 (IGF-1) in hypertension. Sixteen-week-old spontaneously hypertensive rats were randomly divided into non-exercise sedentary (SHR) and high-intensity exercise (SHR+Ex) groups conducted by treadmill running at a speed of 30 m/ min until exhaustion. Age-matched Wistar-Kyoto rats (WKY) were used as the normotensive control group. Immediately after exercise, the agonist-induced vasorelaxation of aortas was evaluated in organ baths with or without endothelial denudation. Selective inhibitors were used to examine the roles of nitric oxide synthase (NOS) and phosphatidylinositol-3 kinase (PI3K) in the vasorelaxation. By adding superoxide dismutase (SOD), a superoxide scavenger, the role of superoxide production in the vasorelaxation was also clarified. We found that, the high-intensity exercise significantly (P exercise ameliorated the insulin- and IGF-1-mediated vasorelaxation through the endothelium-dependent pathway, which was associated with the reduced level of superoxide production. PMID:21789889

  1. Online Gradient Boosting

    OpenAIRE

    Beygelzimer, Alina; Hazan, Elad; Kale, Satyen; Luo, Haipeng

    2015-01-01

    We extend the theory of boosting for regression problems to the online learning setting. Generalizing from the batch setting for boosting, the notion of a weak learning algorithm is modeled as an online learning algorithm with linear loss functions that competes with a base class of regression functions, while a strong learning algorithm is an online learning algorithm with convex loss functions that competes with a larger class of regression functions. Our main result is an online gradient b...

  2. The development of a high intensity dance performance fitness test.

    Science.gov (United States)

    Redding, Emma; Weller, Peter; Ehrenberg, Shantel; Irvine, Sarah; Quin, Edel; Rafferty, Sonia; Wyon, Matthew; Cox, Carol

    2009-01-01

    While there is currently a validated dance-specific exercise method of measuring aerobic fitness, no such test has been developed to measure high intensity capabilities in dance. The purpose of this study was to initiate an intermittent high intensity dance-specific fitness test. The test was designed to be able to observe changes in heart rate (HR), thereby allowing for a measurement of physical fitness at high intensities. Sixteen professional dancers (4 males and 12 females) volunteered to take part in this study. The fitness test protocol consists of movements that are representative of contemporary dance, and contains exercise and rest periods that mimic the intermittent nature of dance. The participants performed four trials. The physiological variables measured were HR (b.min(-1)) for each one minute bout of the four minute test for all trials, oxygen uptake (VO(2)) throughout the test, and end blood lactate (BLa mmol.L) for each trial. In addition, five of the participants undertook a maximal oxygen uptake treadmill test, and the scores obtained were compared with those from the dance test. Results show HR consistency across each one minute bout of the test and across each of the four trials of testing for all participants, indicating that the test is reliable. There was good reliability between bouts of each trial (typical error as % of CV = 1.5), intraclass "r" = 0.8, and good reliability between the four trials (typical error as % of CV = 2.1), intraclass "r" = 0.82. There were no significant differences between the maximal VO(2) and BLa scores established in the treadmill and dance tests, demonstrating validity. Thus, the results of this study indicate that the high intensity dance-specific test is a reliable and valid means of assessing and monitoring the cardiovascular fitness of dancers. The test allows dancers to be assessed within an environment that they are accustomed to (the studio), using a mode of exercise that is relevant (dance), and it is

  3. Simplified shielding calculation system for high-intensity proton accelerators

    International Nuclear Information System (INIS)

    A simplified shielding calculation system is developed for applying conceptual shielding design of facilities in the joint project for high-intensity proton accelerators. The system is composed of neutron transmission calculation part for bulk shielding using simplified formulas: Moyer model and Tesch's formula, and neutron skyshine calculation part using an empirical formula: Stapleton's formula. The system is made with the Microsoft Excel software for user's convenience. This report provides a manual for the system as well as calculation conditions used in the calculation such as Moyer model's parameters. In this report preliminary results based on data at December 8, 1999, are also shown as an example. (author)

  4. Survey of proposed high intensity accelerators and their applications

    International Nuclear Information System (INIS)

    Many interesting applications are being considered for high intensity accelerators. Implications of the technology developments that are enhancing these opportunities, or making them possible, will be covered in context of the applications. Applications include those for research (in areas such as material science, biological sciences, nuclear and high energy physics), accelerator-driven transmutation technologies, defense, and medicine. Specific examples will be used to demonstrate the impact that technology development can have and how transfer of this technology to industry can have an impact in the consumer and commercial arenas. Technology Development in rf power, controls, beam optics, rf structures, magnets, injectors, and beam halos will be considered

  5. The joint project for high-intensity proton accelerators

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-02-01

    Japan Atomic Energy Research Institute (JAERI) and the High Energy Accelerator Research Organization (KEK) are promoting the joint project integrating both the Neutron Science Project (NSP) of JAERI and the Japan Hadron Facility Project (JHF) of KEK for comprehensive studies on basic science and technology using high-intensity proton accelerator. This document describes the joint project prepared by the Joint Project Team of JAERI and KEK to construct accelerators and research facilities necessary both for the NSP and the JHF at the site of JAERI Tokai Establishment. It was originally written in English and translated into Japanese with some corrections. (author)

  6. HELIOS: A high intensity chopper spectrometer at LANSCE

    Energy Technology Data Exchange (ETDEWEB)

    Mason, T.E. [Oak Ridge National Lab., TN (United States); Broholm, C. [Johns Hopkins Univ., Baltimore, MD (United States). Dept. of Physics and Astronomy; Fultz, B. [California Inst. of Tech., Pasadena, CA (United States). Dept. of Materials Science] [and others

    1998-12-31

    A proposal to construct a high intensity chopper spectrometer at LANSCE as part of the SPSS upgrade project is discussed. HELIOS will be optimized for science requiring high sensitivity neutron spectroscopy. This includes studies of phonon density of states in small polycrystalline samples, magnetic excitations in quantum magnets and highly correlated electron systems, as well as parametric studies (as a function of pressure, temperature, or magnetic field) of S(Q,{omega}). By employing a compact design together with the use of supermirror guide in the incident flight path the neutron flux at HELIOS will be significantly higher than any other comparable instrument now operating.

  7. The joint project for high-intensity proton accelerators

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-08-01

    Japan Atomic Energy Research Institute (JAERI) and the High Energy Accelerator Research Organization (KEK) agreed to promote the joint project integrating both the Neutron Science Project (NSP) of JAERI and the Japan Hadron Facility Project (JHF) of KEK for comprehensive studies on basic science and technology using high-intensity proton accelerator. This document describes the joint proposal prepared by the Joint Project Team of JAERI and KEK to construct accelerators and research facilities necessary both for the NSP and the JHF at the site of JAERI Tokai Establishment. (author)

  8. High-Intensity, High Charge-State Heavy Ion Sources

    CERN Document Server

    Alessi, J

    2004-01-01

    There are many accelerator applications for high intensity heavy ion sources, with recent needs including dc beams for RIA, and pulsed beams for injection into synchrotrons such as RHIC and LHC. The present status of sources producing high currents of high charge state heavy ions will be reviewed. These sources include ECR, EBIS, and Laser ion sources. The benefits and limitations for these type sources will be described, for both dc and pulsed applications. Possible future improvements in these type sources will also be discussed.

  9. HELIOS: A high intensity chopper spectrometer at LANSCE

    International Nuclear Information System (INIS)

    A proposal to construct a high intensity chopper spectrometer at LANSCE as part of the SPSS upgrade project is discussed. HELIOS will be optimized for science requiring high sensitivity neutron spectroscopy. This includes studies of phonon density of states in small polycrystalline samples, magnetic excitations in quantum magnets and highly correlated electron systems, as well as parametric studies (as a function of pressure, temperature, or magnetic field) of S(Q,ω). By employing a compact design together with the use of supermirror guide in the incident flight path the neutron flux at HELIOS will be significantly higher than any other comparable instrument now operating

  10. Intelligent Controller of Digital High Intensity Discharge Lamp

    Institute of Scientific and Technical Information of China (English)

    2006-01-01

    High-intensity discharge (HID) lamps include these types of electrical lamps: mercury vapor, metal halide (also HQI), high-pressure sodium, low-pressure sodium and less commonly, xenon short-arc lamps. The light-producing element of these lamp types is a well-stabilized arc discharge contained within a refractory envelope (arc tube) with wall loading in excess of 3 W/cm (19.4 W/in.). Compared to fluorescent and incandescent lamps, HID lamps produce a much larger quantity of light in a relatively small package. With tests made by the National Quality Supervision and

  11. The joint project for high-intensity proton accelerators

    International Nuclear Information System (INIS)

    Japan Atomic Energy Research Institute (JAERI) and the High Energy Accelerator Research Organization (KEK) agreed to promote the joint project integrating both the Neutron Science Project (NSP) of JAERI and the Japan Hadron Facility Project (JHF) of KEK for comprehensive studies on basic science and technology using high-intensity proton accelerator. This document describes the joint proposal prepared by the Joint Project Team of JAERI and KEK to construct accelerators and research facilities necessary both for the NSP and the JHF at the site of JAERI Tokai Establishment. (author)

  12. Beam instrumentation for future high intense hadron accelerators at Fermilab

    Energy Technology Data Exchange (ETDEWEB)

    Wendt, M.; Hu, M.; Tassotto, G.; Thurman-Keup, R.; Scarpine, V.; Shin, S.; Zagel, J.; /Fermilab

    2008-08-01

    High intensity hadron beams of up to 2 MW beam power are a key element of new proposed experimental facilities at Fermilab. Project X, which includes a SCRF 8 GeV H{sup -} linac, will be the centerpiece of future HEP activities in the neutrino sector. After a short overview of this, and other proposed projects, we present the current status of the beam instrumentation activities at Fermilab with a few examples. With upgrades and improvements they can meet the requirements of the new beam facilities, however design and development of new instruments is needed, as shown by the prototype and conceptual examples in the last section.

  13. High Intensity Particle Physics at PW-class laser facilities

    Science.gov (United States)

    Bulanov, Stepan; Schroeder, Carl; Esarey, Eric; Esirkepov, Timur; Kando, Masaki; Rosanov, Nikolay; Korn, Georg; Bulanov, Sergey V.; Leemans, Wim P.

    2015-11-01

    The processes typical for high intensity particle physics, i.e., the interactions of charged particles with strong electromagnetic fields, have attracted considerable interest recently. Some of these processes, previously believed to be of theoretical interest only, are now becoming experimentally accessible. High intensity electromagnetic (EM) fields significantly modify the interactions of particles and EM fields, giving rise to the phenomena that are not encountered either in classical or perturbative quantum theory of these interactions. One of such phenomena is the radiation reaction, which radically influences the electron motion in an electromagnetic standing wave formed by two super-intense counter-propagating laser pulses. Depending on the laser intensity and wavelength, either classical or quantum mode of radiation reaction prevail, or both are strong. When radiation reaction dominates, electron motion evolves to limit cycles and strange attractors. This creates a new framework for high energy physics experiments on an interaction of energetic charged particle beams and colliding super-intense laser pulses. Work supported by U.S. DOE under Contract No. DE-AC02-05CH11231.

  14. Development of High Intensity Beam Emittance Measurement Unit

    Institute of Scientific and Technical Information of China (English)

    2011-01-01

    Three sets of High Intensity Beam Emittance Measurement Units (HIBEMUs) are being developed at Peking University. They are HIBEMU-2 (slit-wire type, one direction), HIBEMU-3 (Allison scanner type, one direction) and HIBEMU-4 (slit-wire type, two directions). For HIBEMU-2 and HIBEMU-3, more recent work has been done on software redesign in order to measure beam emittance and to draw phase diagram more efficiently and precisely. Software for control and data processing of them were developed in Labveiw environment, trying to improve calculation rationality and to offer user-friendly interface. Mechanical modification was also done for HIBEMU-3, mainly concentrating on the protection of Faraday cups from being overheated by the high intensity beam and also from interference of secondary electrons. This paper will also cover the mechanical structure as well as the software development of HIBEMU-4, which is a two-direction emittance scanner newly designed and manufactured for the high energy beam transport (HEBT) of Peking University Neutron Imaging FaciliTY (PKUNIFTY). At the end of this paper, comparison and analysis of the three HIBEMUs are given to draw forth better design of the future emittance measurement facility.

  15. Physiological and performance adaptations to high-intensity interval training.

    Science.gov (United States)

    Gibala, Martin J; Jones, Andrew M

    2013-01-01

    High-intensity interval training (HIIT) refers to exercise that is characterized by relatively short bursts of vigorous activity, interspersed by periods of rest or low-intensity exercise for recovery. In untrained and recreationally active individuals, short-term HIIT is a potent stimulus to induce physiological remodeling similar to traditional endurance training despite a markedly lower total exercise volume and training time commitment. As little as six sessions of 'all-out' HIIT over 14 days, totaling ∼15 min of intense cycle exercise within total training time commitment of ∼2.5 h, is sufficient to enhance exercise capacity and improve skeletal muscle oxidative capacity. From an athletic standpoint, HIIT is also an effective strategy to improve performance when supplemented into the already high training volumes of well-trained endurance athletes, although the underlying mechanisms are likely different compared to less trained subjects. Most studies in this regard have examined the effect of replacing a portion (typically ∼15-25%) of base/normal training with HIIT (usually 2-3 sessions per week for 4-8 weeks). It has been proposed that a polarized approach to training, in which ∼75% of total training volume be performed at low intensities, with 10-15% performed at very high intensities may be the optimal training intensity distribution for elite athletes who compete in intense endurance events. PMID:23899754

  16. High energy neutral atoms from high intensity laser plasma interaction

    International Nuclear Information System (INIS)

    Interaction of a high intensity laser with solid targets leads to acceleration of ions from the surface of the target. Ion acceleration is governed by electron dynamics at the target vacuum interface setting up a charge separation. This electron cloud near the target interface can also provide a neutralizing background for ions that have been accelerated. The accelerated ions are thus detected as a high energy neutral atom on a detector. Further, due to the inherent contrast profile of high intensity lasers a pre-plasma is almost always formed and neutral atoms can be detected. The ion and neutral atom energies are measured by a Thomson parabola spectrometer coupled with a 'time of flight' measurement. The neutral atom energies are obtained from the time of flight. The TIFR 20TW laser with an intensity contrast 10-5 was used to carry out the experiment. Defocusing the target led to a 2 fold increase in the neutral atom yield suggesting the role of the pre-plasma. Using a high contrast laser we attempt to tune the recombination dynamics for efficient neutralization of ions by using a controlled pre-plasma. (author)

  17. Formation of intermetallic surface layers with high intensity ion implantation

    International Nuclear Information System (INIS)

    Full text: Ion implantation is an effective method to produce the intermetallic phases and for improving of surface properties of the construction materials. From the variety of the well-known methods, the high intensity ion implantation is the most attractive one, since it allows us to obtain in the target materials the ion ion-alloyed layers with the thickness several orders greater than the ion projected range. The increase of the thickness of ion-alloyed surface layers at high intensity implantation can be achieved by the means of controlled heating of target by the ion beam, as well as by the saturation of the surface layer by high concentrated ion beam, followed by radiation-stimulated diffusion. Now the task of obtaining of high intensity ion beams is successfully solved not only for the gas ions, but also for the metals ions. The new vacuum-arc beam and plasma flow source 'Raduga-5' has the opportunity to carry out the implantation of the conductive material ions in the high intensity mode. The high intensity ion implantation allows us to form in the surface layer the fine dispersed intermetallic phases in order to improve the wear resistance and the heat resistance of the metallic work pieces. In the present work, titanium was used as a target for ion implantation. Ion implantation of aluminum ions into titanium was carried out using the 'Raduga-5' ion source at the accelerating voltage 20 kV. The surface sputtering was compensated by plasma deposition of ions. The variation of the time of the ion implantation allowed us to change the dose of the implanted aluminium ions. The chemical and phase composition, as well as morphologic structure of the ion-alloyed surface layers were analyzed by the Auger spectroscopy and by the transmission electron microscopy. Additionally, the tests of the tribological and mechanical properties of the implanted materials have been carried out. It was found out that increasing of the dose of aluminum ions from 2.2·1017 up to

  18. Analysis of technology and seminar on economic trends about High-intensity LED

    International Nuclear Information System (INIS)

    This is divided into two parts. Contents of this report in the first part are technical trends on high-intensity LED which reports introduction of LED as compound semiconductor, white LED? patent issues, review on technology of High-intensity LED and Reliability of High-intensity LED. The second part deals with economic tends about High-intensity LED. This seminar was held to report analysis and economical trends about High-intensity LED by Korea Industrial Education Institute in 2003.

  19. Nonlinear optics as a path to high-intensity circular machines

    CERN Document Server

    Nagaitsev, Sergei; Danilov, V

    2012-01-01

    What prevents us from building super-high intensity accelerators? The answer is case-specific, but it often points to one of the following phenomena: machine resonances, various tune shifts (and spreads), and instabilities. These three phenomena are interdependent in all present machines. In this paper we propose a path toward alleviating these phenomena by making accelerators nonlinear. This idea is not new: Orlov (1963) and McMillan (1967) have proposed initial ideas on nonlinear focusing systems for accelerators. However, practical implementations of such ideas proved elusive, until recently.

  20. Effects of high-intensity strength interval training program on body composition

    OpenAIRE

    Juránková, Michaela; Bílý, Jiří; Hrazdíra, Eduard

    2015-01-01

    The aim of this work was to examine effects of 10-week high-intensity strength interval training (HIIT) program on body composition. Seven women (31.0 ± 6.0 years old, 65.7 ± 9.8 kg body weight, 23.6 ± 2.8 kg*m−2 BMI, 18.6 ± 5.8 kg body fat, 26.0 ± 3.4 kg muscle mass) completed intervention program. We performed an analyze of body composition before and after training program. We focused especially on body fat and muscle mass. Each session consisted of short term bouts (until 30 s duration) w...

  1. Whole Body Bone Scan Findings after High Intensity Focused Ultrasound (HIFU) Treatment

    Energy Technology Data Exchange (ETDEWEB)

    Seo, Ye Young; O, Joo Hyun; Sohn, Hyung Sun; Choi, Eun Kyoung; Yoo, Ik Dong; Oh, Jin Kyoung; Han, Eun Ji; Jung, Seung Eun; Kim, Sung Hoon [The Catholic Univ. of Korea, Seoul (Korea, Republic of)

    2011-12-15

    This study aims to examine the findings of {sup 99mT}c diphosphonate bone scans in cancer patients with a history of HIFU treatment. Bone scan images of patients with a history of HIFU treatment for primary of metastatic cancer from January 2006 to July 2010 were retrospectively reviewed. Cases of primary bone tumor or HIFU treatment reaching only the superficial soft tissue layer were excluded. Bone scan images of 62 patients (26 female, 36 male; mean age 57{+-}9 years) were studied. HIFU treatment was performed in the liver (n=40), pancreas (n=40), pancreas (n=16), and breast (n=6). Mean interval time between HIFU treatment and bone scan was 106{+-}105 days (range: 1-572 days). Of 62 scans, 43 showed diffusely decreased uptake of bone within the path of HIFU treatment: antero axillary and/or posterior arcs of right 5th to 11th ribs in 34 cases after treatment of hepatic lesions; anterior arcs of 2nd to 5th ribs in 5 cases after treatment for breast tumors; and posterior arcs of left 9th to 11th ribs or thoraco lumbar vertebrae in 4 cases after treatment for pancreas tumor. Of 20 patients who had bone scans more than twice, five showed recovered uptake of the radiotracer in the involved ribs in the follow up bone scan. Of 62 bone scans in patients with a history of HIFU treatment for primary of metastatic cancer, 69% presented diffusely decreased uptake in the bone in the path of HIFU treatment.

  2. Magnetic Resonance-Guided High Intensity Focused Ultrasound Ablation of Breast Cancer.

    Science.gov (United States)

    Knuttel, Floortje M; van den Bosch, Maurice A A J

    2016-01-01

    This chapter describes several aspects of MR-HIFU treatment for breast cancer. The current and future applications, technical developments and clinical results are discussed. MR-HIFU ablation is under investigation for the treatment of breast cancer, but is not yet ready for clinical implementation. Firstly, the efficacy of MR-HIFU ablation should be investigated in large trials. The existing literature shows that results of initial, small studies are moderate, but opportunities for improvement are available. Careful patient selection, taking treatment margins into account and using a dedicated breast system might improve treatment outcomes. MRI-guidance has proven to be beneficial for the accuracy and safety of HIFU treatments because of its usefulness before, during and after treatments. In conclusion, MR-HIFU is promising for the treatment of breast cancer and might lead to a change in breast cancer care in the future. PMID:26486332

  3. Whole Body Bone Scan Findings after High Intensity Focused Ultrasound (HIFU) Treatment

    International Nuclear Information System (INIS)

    This study aims to examine the findings of 99mTc diphosphonate bone scans in cancer patients with a history of HIFU treatment. Bone scan images of patients with a history of HIFU treatment for primary of metastatic cancer from January 2006 to July 2010 were retrospectively reviewed. Cases of primary bone tumor or HIFU treatment reaching only the superficial soft tissue layer were excluded. Bone scan images of 62 patients (26 female, 36 male; mean age 57±9 years) were studied. HIFU treatment was performed in the liver (n=40), pancreas (n=40), pancreas (n=16), and breast (n=6). Mean interval time between HIFU treatment and bone scan was 106±105 days (range: 1-572 days). Of 62 scans, 43 showed diffusely decreased uptake of bone within the path of HIFU treatment: antero axillary and/or posterior arcs of right 5th to 11th ribs in 34 cases after treatment of hepatic lesions; anterior arcs of 2nd to 5th ribs in 5 cases after treatment for breast tumors; and posterior arcs of left 9th to 11th ribs or thoraco lumbar vertebrae in 4 cases after treatment for pancreas tumor. Of 20 patients who had bone scans more than twice, five showed recovered uptake of the radiotracer in the involved ribs in the follow up bone scan. Of 62 bone scans in patients with a history of HIFU treatment for primary of metastatic cancer, 69% presented diffusely decreased uptake in the bone in the path of HIFU treatment.

  4. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer : a multicenter study

    OpenAIRE

    UCHIDA, TOYOAKI; Baba, Shiro; Irie, Akira; Soh, Shigehiro; Masumori, Naoya; Tsukamoto, Taiji; Nakatsu, Hiroomi; Fujimoto, Hiroyuki; Kakizoe, Tadao; Ueda, Takeshi; Ichikawa, Tomohiko; Ohta, Nobutaka; Kitamura, Tadaichi; Sumitomo, Makoto; Hayakawa, Masamichi

    2005-01-01

    限局性前立腺癌に対する高密度焦点式超音波療法の多施設共同研究の成績について報告した.対象は,stageT1-2N0M0の72例の限局性前立腺癌で,症例の年齢中央値は72歳,血清PSA中央値は8.10n/mlであった.その結果,治療効果は全体では1年78%,2年76%が非再発生存であった.浸潤度別に2年目の生化学的非再発生存率を集計したところ,stage T1cが89%,stage T2a 67%,stage T2bは40%(p=0.0817)であった.悪性度別では,Gleason 2~4群は88%,Gleason 5~7群は72%,Gleason 8~10群は80%(p=0.6539)であった.術前の血清PSA値別2年非再発生存率は,PSAが10ng/ml以下群は75%,10~20ng/ml群は78%(p=0.6152)であった.術後6ヵ月目の前立腺生検では68%において癌細胞は認められなかった.前立腺体積は,術前24.2mlから術後6ヵ月目14.0mlと縮小していた(p...

  5. HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER

    OpenAIRE

    L. V. Shaplygin; V. A. Solovov; M. O. Vozdvizhenskiy; Yа. S. Matyash; R. Z. Khametov; D. V. Fesenko

    2014-01-01

    In this study the results of retrospective analysis of treatment of 311 patients in Samara Oncology Center in 2008–2011 with locally advanced prostate cancer are presented. According to the received treatment patients were divided into 3 groups: 103 underwent HIFU, 101 patients had a course of EBRT, 107 patients received only hormone therapy (HT). Overall survival in patients with locally advanced prostate cancer after HIFU therapy was 86.2 %, after EBRT and HT – 66.3% and 18.1 %, respectivel...

  6. Transrectal high-intensity focused ultrasound ablation of prostate cancer: Effective treatment requiring accurate imaging

    Energy Technology Data Exchange (ETDEWEB)

    Rouviere, Olivier [Hospices Civils de Lyon, Department of Urinary and Vascular Radiology, Pavillon P Radio, Hopital Edouard Herriot, F-69437 Lyon cedex 03 (France); Universite de Lyon, Lyon F-69003 (France); Universite de Lyon 1, Faculte de Medecine Lyon Nord, Lyon F-69003 (France); INSERM, Unit 556, 151 cours Albert Thomas, F-69424 Lyon cedex 03 (France)], E-mail: Olivier.rouviere@netcourrier.com; Souchon, Remi [INSERM, Unit 556, 151 cours Albert Thomas, F-69424 Lyon cedex 03 (France)], E-mail: souchon@lyon.inserm.fr; Salomir, Rares [INSERM, Unit 556, 151 cours Albert Thomas, F-69424 Lyon cedex 03 (France)], E-mail: salomir@lyon.inserm.fr; Gelet, Albert [Hospices Civils de Lyon, Department of Urology, Pavillon P Radio, Hopital Edouard Herriot, F-69437 Lyon cedex 03 (France)], E-mail: Albert.gelet@chu-lyon.fr; Chapelon, Jean-Yves [INSERM, Unit 556, 151 cours Albert Thomas, F-69424 Lyon cedex 03 (France)], E-mail: chapelon@lyon.inserm.fr; Lyonnet, Denis [Hospices Civils de Lyon, Department of Urinary and Vascular Radiology, Pavillon P Radio, Hopital Edouard Herriot, F-69437 Lyon cedex 03 (France); Universite de Lyon, Lyon F-69003 (France); Universite de Lyon 1, Faculte de Medecine Lyon Nord, Lyon F-69003 (France); INSERM, Unit 556, 151 cours Albert Thomas, F-69424 Lyon cedex 03 (France)], E-mail: Denis.lyonnet@chu-lyon.fr

    2007-09-15

    Transrectal HIFU ablation has become a reasonable option for the treatment of localized prostate cancer in non-surgical patients, with 5-year disease-free survival similar to that of radiation therapy. It is also a promising salvage therapy of local recurrence after radiation therapy. These favourable results are partly due to recent improvements in prostate cancer imaging. However, further improvements are needed in patient selection, pre-operative localization of the tumor foci, assessment of the volume treated and early detection of recurrence. A better knowledge of the factors influencing the HIFU-induced tissue destruction and a better pre-operative assessment of them by imaging techniques should improve treatment outcome. Whereas prostate HIFU ablation is currently performed under transrectal ultrasound guidance, MR guidance with real-time operative monitoring of temperature will be available in the near future. If this technique will give better targeting and more uniform tissue destruction, its cost-effectiveness will have to be carefully evaluated. Finally, a recently reported synergistic effect between HIFU ablation and chemotherapy opens possibilities for treatment in high-risk or clinically advanced tumors.

  7. HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER

    Directory of Open Access Journals (Sweden)

    L. V. Shaplygin

    2014-01-01

    Full Text Available In this study the results of retrospective analysis of treatment of 311 patients in Samara Oncology Center in 2008–2011 with locally advanced prostate cancer are presented. According to the received treatment patients were divided into 3 groups: 103 underwent HIFU, 101 patients had a course of EBRT, 107 patients received only hormone therapy (HT. Overall survival in patients with locally advanced prostate cancer after HIFU therapy was 86.2 %, after EBRT and HT – 66.3% and 18.1 %, respectively. These data indicate a high clinical efficacy of ultrasound ablation. 

  8. Robotic high-intensity focused ultrasound (rHIFU) for the prostate cancer treatment

    Science.gov (United States)

    Solovov, Vyacheslav; Shaplygin, Leonid; Vozdvizhenskiy, Mikhail

    2012-11-01

    Introduction & Objectives: rHIFU shows a successful treatment for localized prostate cancer (PC). Here we explored the effectiveness of the rHIFU treatment for the prostate cancer, hormone-resistant prostate cancer (HRPC) and failure after external beam radiotherapy (EBRT) and radical prostatectomy (RPE). Materials & Methods: 748 patients were treated in our center between Sep 2007 - February 2012: 137 - hormone-resistance (median time before hormone-resistance 25 months), 286 - received neoadjuvant hormone therapy 6 months, 293 - no treatment before HIFU, 32 - after the EBRT failure. 667 patients underwent TURP+rHIFU, 81 only rHIFU (volume prostate prostate volume - 39 (5,5-108) cc. Results: Median PSA level 12 months after rHIFU treatment were 0,04 (0-2,24) ng/ml - low risk group, for high risk group - 0,5 (0-48,4) ng/ml, with failure after EBRT and RPE- 0,5 (0-3,2) ng/ml; 36 months after rHIFU treatment were 0,5 (0,02-3,6) ng/ml - low risk group, for high risk group - 3,2 (0-21,38) ng/ml, with failure after EBRT and RPE - 1,7 (0-9,8) ng/ml. Patients with low risk had 4,5% of progression, with high risk PC - 25%, with failure after EBRT and RPE - 19,6%. Kaplan-Meir analyses of the total group indicated that the risk of progression after 1 year follow-up was 10%, the risk of progression was 23% after 4 years of follow-up. Complications: incontinence I - 17,5%, incontinence II - 7,7%, stricture - 18,2%, fistula - 0,3 %. Conclusions: Our experience shows that rHIFU ablation is safe, minimally invasive, effective treatment with moderate side effects for the PC, hormone-resistant prostate cancer, rHIFU also may be used as a salvage therapy after EBRF. Further studies are required.

  9. Results of low threshold to biopsy following high-intensity focused ultrasound for localized prostate cancer

    Directory of Open Access Journals (Sweden)

    Richard L Haddad

    2012-01-01

    Conclusions: A low threshold to re-biopsy post-HIFU reveals a high local failure rate of 82%. Oncological efficacy is questioned, and using high threshold to biopsy may therefore be overestimating the effectiveness of HIFU as a primary treatment for localized prostate cancer.

  10. HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER

    Directory of Open Access Journals (Sweden)

    L. V. Shaplygin

    2014-07-01

    Full Text Available In this study the results of retrospective analysis of treatment of 311 patients in Samara Oncology Center in 2008–2011 with locally advanced prostate cancer are presented. According to the received treatment patients were divided into 3 groups: 103 underwent HIFU, 101 patients had a course of EBRT, 107 patients received only hormone therapy (HT. Overall survival in patients with locally advanced prostate cancer after HIFU therapy was 86.2 %, after EBRT and HT – 66.3% and 18.1 %, respectively. These data indicate a high clinical efficacy of ultrasound ablation. 

  11. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series

    OpenAIRE

    Ahmed, H. U.; Zacharakis, E.; Dudderidge, T; Armitage, J N; Scott, R.; Calleary, J.; Illing, R.; Kirkham, A; Freeman, A; Ogden, C.; Allen, C.; Emberton, M

    2009-01-01

    BACKGROUND: The use of minimally invasive ablative therapies in localised prostate cancer offer potential for a middle ground between active surveillance and radical therapy.METHODS: An analysis of men with organ-confined prostate cancer treated with transrectal whole-gland HIFU (Sonablate 500) between 1 February 2005 and 15 May 2007 was carried out in two centres. Outcome data (side-effects using validated patient questionnaires, biochemical, histology) were evaluated.RESULTS: A total of 172...

  12. First Experience Of Application Of High-Intensity Focused Ultrasonic Ablation (Hifu) In Prostate Cancer Treatment

    OpenAIRE

    A.V. Stativko; B.I. Blumberg; A.N. Ponukalin; R.N. Fomkin; P.V. Glybochko

    2009-01-01

    The scientific article points out that 40 sessions of HIFU prostate ablation have been performed for estimation of clinical efficiency. Average frequency of influences presents 628±164 impulses; average volume of tissues subjected to influence during one procedure is 33,8±16,3 smi (132 %) of prostate volume; average operation time constitutes 150 minutes (from 90 to 200 minutes). During the operation no complications have been occurred. In the first days after the session of HIFU there was a ...

  13. SALVAGE THERAPY WITH HIGH INTENSITY FOCUSED ULTRASOUND IN LOCAL RADIO RECURRENT PROSTATE CANCER

    OpenAIRE

    AUTRAN GOMEZ, ANA MARIA

    2013-01-01

    Introduction & Objectives.- To evaluate the predictive factors for local failure with follow-up- biopsy after whole-gland salvage HIFU in local radio-recurrent PCa pts and to analyses the effects adverse following the therapy in terms of morbidity and quality of life on short-term. Materials and Methods.-From April 2006 to Sept 2010. Fifty-five pts with biopsy-proven localized radio-recurrent PCa and no distant metastasis, were subjected to whole- gland salvage HIFU using Sonablate®...

  14. CLINICAL ASPECTS OF THE TREATMENT OF BREAST FIBROADENOMAS WITH HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)

    OpenAIRE

    Seidagaliyeva, Zh; Imankulov, S.; Tuganbekov, T.; Rustemova, K

    2015-01-01

    The main method of treatment of fibroadenomas of the mammary glands to date is surgical. Surgery is often accompanied by complications: hematoma, inflammation, divergence joints, pain in the surgery, etc. Introduction of new technologies of minimally invasive alternative to open surgery are laparoscopic surgery; as a large number of studies conducted in the field of laser, cryo -, thermal ablation. But really noninvasive methods of practical medicine are radiation and chemotherapy, both metho...

  15. Monitoring high-intensity focused ultrasound (HIFU) therapy using radio frequency ultrasound backscatter to quantify heating

    Science.gov (United States)

    Kaczkowski, Peter J.; Anand, Ajay

    2005-09-01

    The spatial distribution and temporal history of tissue temperature is an essential indicator of thermal therapy progress, and treatment safety and efficacy. Magnetic resonance methods provide the gold standard noninvasive measurement of temperature but are costly and cumbersome compared to the therapy itself. We have been developing the use of ultrasound backscattering for real-time temperature estimation; ultrasonic methods have been limited to relatively low temperature rise, primarily due to lack of sensitivity at protein denaturation temperatures (50-70°C). Through validation experiments on gel phantoms and ex vivo tissue we show that temperature rise can be accurately mapped throughout the therapeutic temperature range using a new BioHeat Transfer Equation (BHTE) model-constrained inverse approach. Speckle-free temperature and thermal dose maps are generated using the ultrasound calibrated model over the imaged region throughout therapy delivery and post-treatment cooling periods. Results of turkey breast tissue experiments are presented for static HIFU exposures, in which the ultrasound calibrated BHTE temperature maps are shown to be very accurate (within a degree) using independent thermocouple measurements. This new temperature monitoring method may speed clinical adoption of ultrasound-guided HIFU therapy. [Work supported by Army MRMC.

  16. Transrectal high-intensity focused ultrasound ablation of prostate cancer: Effective treatment requiring accurate imaging

    International Nuclear Information System (INIS)

    Transrectal HIFU ablation has become a reasonable option for the treatment of localized prostate cancer in non-surgical patients, with 5-year disease-free survival similar to that of radiation therapy. It is also a promising salvage therapy of local recurrence after radiation therapy. These favourable results are partly due to recent improvements in prostate cancer imaging. However, further improvements are needed in patient selection, pre-operative localization of the tumor foci, assessment of the volume treated and early detection of recurrence. A better knowledge of the factors influencing the HIFU-induced tissue destruction and a better pre-operative assessment of them by imaging techniques should improve treatment outcome. Whereas prostate HIFU ablation is currently performed under transrectal ultrasound guidance, MR guidance with real-time operative monitoring of temperature will be available in the near future. If this technique will give better targeting and more uniform tissue destruction, its cost-effectiveness will have to be carefully evaluated. Finally, a recently reported synergistic effect between HIFU ablation and chemotherapy opens possibilities for treatment in high-risk or clinically advanced tumors

  17. High-intensity focused ultrasound-mediated doxorubicin delivery with thermosensitive liposomes

    Science.gov (United States)

    Escoffre, Jean-Michel; Mannaris, Christophoros; Novell, Anthony; Rioc, Laëtitia; Meyre, Marie-Edith; Germain, Matthieu; Averkiou, Michalakis; Bouakaz, Ayache

    2012-10-01

    Local drug delivery of doxorubicin holds promise to improve the therapeutic efficacy and to reduce toxicity profiles. Here, we investigated the release of doxorubicin from thermosensitive liposomes (Dox-TSL) into human glioblastoma (U-87MG) cells. Using Dox-TSL, experiments were carried out in a water bath and showed that 15 min incubation of TSL at 43°C induced the release of 80% doxorubicin loaded TSL compared to the release at 37°C. The cytotoxicity of a range of concentrations of Dox-TSL was also evaluated on U-87MG cells. At 37°C, no cytotoxicity was observed, whereas at 43°C the results showed that the cytotoxicity is dose dependent. At maximal dose of doxorubicin (30 μg/mL), the cell viability was less than 20%. Application of 15 min of HIFU at 1 MHz, 1.5 MPa and 50% duty cycle induced the release of 100% of doxorubicin from Dox-TSL. In the same experimental condition, the cell viability decreased to 40% and 20% at 12h and 48h, respectively, in comparison to that obtained during the incubation of cells with Dox-TSL alone without HIFU. In conclusion, a significant release of doxorubicin from temperature-sensitive liposomes can be achieved leading to an efficient treatment and cell death of tumor cells using HIFU.

  18. Electric and Magnetic Vertical Focusing Study for 100 MeV High Intensity Proton Cyclotron

    Institute of Scientific and Technical Information of China (English)

    2008-01-01

    <正>For the central region design of cyclotrons, the basic problem in the vertical motion is very different from the one in the radial motion. The reason is that vertical tune is almost zero at the center of cyclotrons,

  19. Max Tech and Beyond: High-Intensity Discharge Lamps

    Energy Technology Data Exchange (ETDEWEB)

    Scholand, Michael

    2012-04-01

    High-intensity discharge (HID) lamps are most often found in industrial and commercial applications, and are the light source of choice in street and area lighting, and sports stadium illumination. HID lamps are produced in three types - mercury vapor (MV), high pressure sodium (HPS) and metal halide (MH). Of these, MV and MH are considered white-light sources (although the MV exhibits poor color rendering) and HPS produces a yellow-orange color light. A fourth lamp, low-pressure sodium (LPS), is not a HID lamp by definition, but it is used in similar applications and thus is often grouped with HID lamps. With the notable exception of MV which is comparatively inefficient and in decline in the US from both a sales and installed stock point of view; HPS, LPS and MH all have efficacies over 100 lumens per watt. The figure below presents the efficacy trends over time for commercially available HID lamps and LPS, starting with MV and LPS in 1930's followed by the development of HPS and MH in the 1960's. In HID lamps, light is generated by creating an electric arc between two electrodes in an arc tube. The particles in the arc are partially ionized, making them electrically conductive, and a light-emitting 'plasma' is created. This arc occurs within the arc tube, which for most HID lamps is enclosed within an evacuated outer bulb that thermally isolates and protects the hot arc tube from the surroundings. Unlike a fluorescent lamp that produces visible light through down-converting UV light with phosphors, the arc itself is the light source in an HID lamp, emitting visible radiation that is characteristic of the elements present in the plasma. Thus, the mixture of elements included in the arc tube is one critical factor determining the quality of the light emitted from the lamp, including its correlated color temperature (CCT) and color rendering index (CRI). Similar to fluorescent lamps, HID lamps require a ballast to start and maintain stable

  20. Vortex dynamics and shear layer instability in high intensity cyclotrons

    CERN Document Server

    Cerfon, Antoine J

    2016-01-01

    We show that the space charge dynamics of high intensity beams in the plane perpendicular to the magnetic field in cyclotrons is described by the two-dimensional Euler equations for an incompressible fluid. This analogy with fluid dynamics gives a unified and intuitive framework to explain the beam spiraling and beam break up behavior observed in experiments and in simulations. In particular, we demonstrate that beam break up is the result of a classical instability occurring in fluids subject to a sheared flow. We give scaling laws for the instability and predict the nonlinear evolution of beams subject to it. Our work suggests that cyclotrons may be uniquely suited for the experimental study of shear layers and vortex distributions that are not achievable in Penning-Malmberg traps.